PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Feng, JF; Jiang, JY				Feng, Junfeng; Jiang, Jiyao			Traumatic brain injury in 2019: databases, biomarkers, and stratified treatment	LANCET NEUROLOGY			English	Editorial Material									[Feng, Junfeng; Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China; [Feng, Junfeng; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China	Shanghai Jiao Tong University	Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.; Jiang, JY (corresponding author), Shanghai Inst Head Trauma, Shanghai, Peoples R China.	jiyaojiang@126.com						Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; Li LM, 2019, BRAIN, V142, P3280, DOI 10.1093/brain/awz252; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	5	2	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2020	19	1					5	+		10.1016/S1474-4422(19)30447-8	http://dx.doi.org/10.1016/S1474-4422(19)30447-8			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3SM	31839248				2022-12-18	WOS:000502286000006
J	Bayona-Ortiz, H; Useche, JN; Yanez, N; Velasco, SC				Bayona-Ortiz, Hernan; Nicolas Useche, Juan; Yanez, Nicolas; Velasco, Sofia Catalina			Availability of stroke units in Colombia	LANCET NEUROLOGY			English	Letter									[Bayona-Ortiz, Hernan] Univ Los Andes, Dept Neurol, Bogota, Colombia; [Nicolas Useche, Juan] Univ El Bosque, Dept Neuroradiol & Radiol, Bogota, Colombia; [Yanez, Nicolas] Univ El Bosque, Epidemiol Program, Bogota, Colombia; [Nicolas Useche, Juan; Velasco, Sofia Catalina] Univ Hosp Fdn Santa Fe Bogota, Dept Diagnost Imaging, Bogota 110111, Colombia	Universidad de los Andes (Colombia); Universidad El Bosque; Universidad El Bosque	Bayona-Ortiz, H (corresponding author), Univ Los Andes, Dept Neurol, Bogota, Colombia.	hernan.bayona@fsfb.org.co	BAYONA, HERNAN/I-3060-2019	BAYONA, HERNAN/0000-0003-4450-174X				Martins SCO, 2019, LANCET NEUROL, V18, P674, DOI 10.1016/S1474-4422(19)30068-7	1	2	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2019	18	11					988	988		10.1016/S1474-4422(19)30332-1	http://dx.doi.org/10.1016/S1474-4422(19)30332-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JC8HI	31609207	Bronze			2022-12-18	WOS:000489517000006
J	Desviat, LR; Mallebrera, CJ; Vallejo-Illarramendi, A; Mayan, MD; Nogales-Gadea, G; Arechavala-Gomeza, V				Desviat, Lourdes R.; Mallebrera, Cecilia Jimenez; Vallejo-Illarramendi, Ainara; Mayan, Maria D.; Nogales-Gadea, Gisela; Arechavala-Gomeza, Virginia			COST Actions: fostering collaborative research for rare diseases	LANCET NEUROLOGY			English	Letter							ANTISENSE OLIGONUCLEOTIDES; ALTERNATIVE THERAPY; SPLICING MODULATION; FUNCTIONAL-ANALYSIS; IDS GENE; CHALLENGES; MUTATIONS; EXPLOIT		[Desviat, Lourdes R.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa UAM CSIC, CIBERER, IdiPaz, E-28049 Madrid, Spain; [Mallebrera, Cecilia Jimenez] Spanish Biomed Res Networking Ctr CIBERER, Unidad Patol Neuromuscular, Serv Neurol, Inst Recerca St Joan Deu,Hosp St Joan Deu, Barcelona, Spain; [Vallejo-Illarramendi, Ainara] Univ Basque Country, Dept Pediat, Hosp Donostia IIS Biodonostia, Donostia San Sebastian, Spain; [Mayan, Maria D.] Inst Biomed Res Coruna INIBIC, CellCOM Res Grp, Serv Galego Saude SERGAS, La Coruna, Spain; [Nogales-Gadea, Gisela] Univ Autonoma Barcelona, Neuromuscular & Neuropediat Res Grp, Inst Invest Ciencies Salut Germans Trias & Pujol, Campus Can Ruti, Badalona, Spain; [Arechavala-Gomeza, Virginia] Biocruces Bizkaia Hlth Res Inst, Neuromuscular Disorders Grp, Baracaldo, Bizkaia, Spain; [Arechavala-Gomeza, Virginia] Ikerbasque, Basque Fdn Sci, Bilbao, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Barcelona; University Hospital Donostia; University of Basque Country; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Basque Foundation for Science	Desviat, LR (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa UAM CSIC, CIBERER, IdiPaz, E-28049 Madrid, Spain.	lruiz@cbm.csic.es	Arechavala-Gomeza, Virginia/C-1546-2008; Nogales-Gadea, Gisela/N-4004-2014; Vallejo Illarramendi, Ainara/J-7503-2012; Mayán, María D./AAR-9227-2021; Mayan, Maria D./C-8813-2012; DESVIAT, LOURDES R/L-3055-2013	Arechavala-Gomeza, Virginia/0000-0001-7703-3255; Nogales-Gadea, Gisela/0000-0002-7414-212X; Vallejo Illarramendi, Ainara/0000-0002-2409-8263; Mayán, María D./0000-0002-5809-9440; Mayan, Maria D./0000-0002-5809-9440; DESVIAT, LOURDES R/0000-0003-0492-3323				Aartsma-Rus A, 2018, NAT REV NEUROL, V14, P454, DOI 10.1038/s41582-018-0033-8; Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P67, DOI 10.1089/nat.2017.0665; Aartsma-Rus A, 2016, MOL THER, V24, P193, DOI 10.1038/mt.2016.14; Anthony K, 2014, NEUROLOGY, V83, P2062, DOI 10.1212/WNL.0000000000001025; Arechavala-Gomeza V, 2014, APPL CLIN GENET, V7, P245, DOI 10.2147/TACG.S71506; Godfrey C, 2017, EMBO MOL MED, V9, P545, DOI 10.15252/emmm.201607199; Hiller M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204485; Martinez-Pizarro A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007360; Matos L, 2015, DATA BRIEF, V5, P810, DOI 10.1016/j.dib.2015.10.011; Matos L, 2015, BBA-MOL BASIS DIS, V1852, P2712, DOI 10.1016/j.bbadis.2015.09.011; Perez B, 2014, NUCLEIC ACID THER, V24, P48, DOI 10.1089/nat.2013.0453; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7	12	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2019	18	11					989	991		10.1016/S1474-4422(19)30366-7	http://dx.doi.org/10.1016/S1474-4422(19)30366-7			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JC8HI	31609208				2022-12-18	WOS:000489517000008
J	Miaka, EM; Hasker, E; Verle, P; Torr, SJ; Boelaert, M				Miaka, Erick M.; Hasker, Epco; Verle, Paul; Torr, Steve J.; Boelaert, Marleen			Sleeping sickness in the Democratic Republic of the Congo	LANCET NEUROLOGY			English	Letter									[Miaka, Erick M.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Miaka, Erick M.; Hasker, Epco; Verle, Paul; Torr, Steve J.; Boelaert, Marleen] TRYP ELIM Consortium, Antwerp, Belgium; [Hasker, Epco; Verle, Paul; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Torr, Steve J.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	Institute of Tropical Medicine (ITM); Liverpool School of Tropical Medicine	Boelaert, M (corresponding author), TRYP ELIM Consortium, Antwerp, Belgium.; Boelaert, M (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	mboelaert@itg.be	Torr, Stephen/N-7161-2016	Torr, Stephen/0000-0001-9550-4030	Bill & Melinda Gates Foundation; Belgian government	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Belgian government	We declare no competing interests. We acknowledge the generous financial support of the Bill & Melinda Gates Foundation and the Belgian government for this HAT elimination program, as well as a drug donation by Sanofi-Aventis.	Burton Adrian, 2019, Lancet Neurol, V18, P332, DOI 10.1016/S1474-4422(19)30082-1; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Hasker E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006664; Mahamat MH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005792; Rock KS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005162	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2019	18	11					988	989		10.1016/S1474-4422(19)30284-4	http://dx.doi.org/10.1016/S1474-4422(19)30284-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JC8HI	31609206	Bronze, Green Accepted			2022-12-18	WOS:000489517000007
J	Giovannoni, G				Giovannoni, Gavin			Do we have equipoise when it comes to how we treat active multiple sclerosis?	LANCET NEUROLOGY			English	Editorial Material							DISEASE-MODIFYING THERAPY; INTERFERON BETA-1A; ALEMTUZUMAB; FINGOLIMOD; SWITCH		[Giovannoni, Gavin] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London	Giovannoni, G (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.	g.giovannoni@qmul.ac.uk			Bayer-Schering Healthcare; Biogen-Idec; GW Pharma; Merck; Merck-Serono; Merz; Novartis; Teva; Sanofi-Aventis	Bayer-Schering Healthcare; Biogen-Idec(Biogen); GW Pharma; Merck(Merck & Company); Merck-Serono(Merck & Company); Merz; Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Sanofi-Aventis(Sanofi-Aventis)	I have received research grant support from Bayer-Schering Healthcare, Biogen-Idec, GW Pharma, Merck, Merck-Serono, Merz, Novartis, Teva, and Sanofi-Aventis. I have also received personal compensation for participating on advisory boards in relation to clinical trial design, trial steering committees, and data and safety monitoring committees from Abbvie, Bayer-Schering Healthcare, Biogen-Idec, Canbex, Eisai, Elan, Fiveprime, Genzyme, Genentech, GlaxoSmithKline, Ironwood, Merck, Merck-Serono, Novartis, Pfizer, Roche, Sanofi-Aventis, Synthon BV, Teva, Union Chimique Belge Pharma, and Vertex Pharmaceuticals.	Brown JWL, 2019, JAMA-J AM MED ASSOC, V321, P175, DOI 10.1001/jama.2018.20588; Capra R, 2017, MULT SCLER J, V23, P1757, DOI 10.1177/1352458516687402; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Coles AJ, 2011, LANCET NEUROL, V10, P338, DOI 10.1016/S1474-4422(11)70020-5; Giovannoni G, 2019, BRAIN, V142, P1166, DOI 10.1093/brain/awz101; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; He A, 2015, JAMA NEUROL, V72, P405, DOI 10.1001/jamaneurol.2014.4147; Kalincik T, 2015, ANN NEUROL, V77, P425, DOI 10.1002/ana.24339; Kappos L, 2015, NEW ENGL J MED, V373, P1418, DOI 10.1056/NEJMoa1501481; Ontaneda D, 2019, LANCET NEUROL, V18, P973, DOI 10.1016/S1474-4422(19)30151-6	11	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2019	18	10					909	911		10.1016/S1474-4422(19)30227-3	http://dx.doi.org/10.1016/S1474-4422(19)30227-3			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6HN	31375367				2022-12-18	WOS:000485784000006
J	McDonald, PJ; Lau, C; McCall, IC; Lipsman, N; Illes, J				McDonald, Patrick J.; Lau, Chloe; McCall, Iris Coates; Lipsman, Nir; Illes, Judy			Regulatory oversights for implantable neurodevices	LANCET NEUROLOGY			English	Letter									[McDonald, Patrick J.] Univ British Columbia, Div Neurosurg, Dept Surg, Vancouver, BC V6H 3N1, Canada; [McDonald, Patrick J.; Lau, Chloe; McCall, Iris Coates; Illes, Judy] Univ British Columbia, Div Neurol, Dept Med, Neuroeth Canada, Vancouver, BC V6H 3N1, Canada; [McDonald, Patrick J.] Univ British Columbia, Vancouver, BC V6H 3N1, Canada; [McDonald, Patrick J.] BC Childrens Hosp Res Inst, Vancouver, BC, Canada; [Lipsman, Nir] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Toronto	McDonald, PJ (corresponding author), Univ British Columbia, Div Neurosurg, Dept Surg, Vancouver, BC V6H 3N1, Canada.; McDonald, PJ (corresponding author), Univ British Columbia, Div Neurol, Dept Med, Neuroeth Canada, Vancouver, BC V6H 3N1, Canada.; McDonald, PJ (corresponding author), Univ British Columbia, Vancouver, BC V6H 3N1, Canada.; McDonald, PJ (corresponding author), BC Childrens Hosp Res Inst, Vancouver, BC, Canada.	patrick.mcdonald@cw.bc.ca		Coates McCall, Iris/0000-0002-8984-5928; McDonald, Patrick/0000-0002-7083-3927				[Anonymous], 2018, CBC NEWS; International Consortium of Investigative Journalists, 2018, MED DEV HARM PAT WOR; Marks W, 2017, EUR J PAEDIATR NEURO, V21, P218, DOI 10.1016/j.ejpn.2016.06.002; Perrone M., 2018, BLOOMBERG; U. S. Food and Drug Administration, REC CORR REM DEV; US Food and Drug Administration, 2018, PREM APPR PMA	6	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2019	18	10					913	913		10.1016/S1474-4422(19)30330-8	http://dx.doi.org/10.1016/S1474-4422(19)30330-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6HN	31526749	Bronze			2022-12-18	WOS:000485784000009
J	Paulsen, JS; Coffey, CS				Paulsen, Jane S.; Coffey, Christopher S.			Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease	LANCET NEUROLOGY			English	Editorial Material									[Paulsen, Jane S.] Univ Iowa, Dept Neurol Psychiat Psychol & Brain Sci, Iowa City, IA 52242 USA; [Coffey, Christopher S.] Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Paulsen, JS (corresponding author), Univ Iowa, Dept Neurol Psychiat Psychol & Brain Sci, Iowa City, IA 52242 USA.	jane-paulsen@uiowa.edu	Paulsen, Jane/AAQ-2932-2020	Paulsen, Jane/0000-0002-0983-228X	NCRR NIH HHS [M01 RR000059] Funding Source: Medline; NHGRI NIH HHS [R01 HG003330] Funding Source: Medline; NINDS NIH HHS [R01 NS040068] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Frank S, 2016, JAMA-J AM MED ASSOC, V316, P40, DOI 10.1001/jama.2016.8655; Marshall FJ, 2006, NEUROLOGY, V66, P366, DOI 10.1212/01.wnl.0000198586.85250.13; Paulsen JS, 2006, ARCH NEUROL-CHICAGO, V63, P883, DOI 10.1001/archneur.63.6.883; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Tabrizi SJ, 2019, NEW ENGL J MED, V380, P2307, DOI 10.1056/NEJMoa1900907	5	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2019	18	10					911	912		10.1016/S1474-4422(19)30329-1	http://dx.doi.org/10.1016/S1474-4422(19)30329-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6HN	31526747				2022-12-18	WOS:000485784000007
J	Adler, A; Knight, H				Adler, Ai; Knight, H.			Ocrelizumab for primary progressive multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material									[Adler, Ai] Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England; [Adler, Ai; Knight, H.] Natl Inst Hlth & Care Excellence, London SW1A 2BU, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institute for Health & Care Excellence	Adler, A (corresponding author), Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England.; Adler, A (corresponding author), Natl Inst Hlth & Care Excellence, London SW1A 2BU, England.	Amanda.adler@nice.org.uk							0	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2019	18	9					816	817		10.1016/S1474-4422(19)30245-5	http://dx.doi.org/10.1016/S1474-4422(19)30245-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IO1IZ	31279744				2022-12-18	WOS:000479136100011
J	Ziai, WC; Gusdon, AM; Hanley, DF				Ziai, Wendy C.; Gusdon, Aaron M.; Hanley, Daniel F.			Blood pressure in intracerebral haemorrhage: which variables matter?	LANCET NEUROLOGY			English	Editorial Material							CLINICAL-OUTCOMES		[Ziai, Wendy C.; Gusdon, Aaron M.; Hanley, Daniel F.] Johns Hopkins Univ, Dept Neurol, Div Brain Injury Outcomes, Baltimore, MD 21287 USA	Johns Hopkins University	Ziai, WC (corresponding author), Johns Hopkins Univ, Dept Neurol, Div Brain Injury Outcomes, Baltimore, MD 21287 USA.	weziai@jhmi.edu		Hanley, Daniel/0000-0002-9536-4258				Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Boulouis G, 2017, J NEUROL NEUROSUR PS, V88, P339, DOI 10.1136/jnnp-2016-315346; de Havenon A, 2018, STROKE, V49, P1981, DOI 10.1161/STROKEAHA.118.022133; Gong S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10892-z; Lattanzi S, 2017, CEREBROVASC DIS, V43, P207, DOI 10.1159/000462986; Manning L, 2014, LANCET NEUROL, V13, P364, DOI 10.1016/S1474-4422(14)70018-3; Meeks JR, 2019, INT J STROKE, V14, P987, DOI 10.1177/1747493019827763; Moullaali TJ, 2019, LANCET NEUROL, V18, P857, DOI 10.1016/S1474-4422(19)30196-6; Qureshi AI, 2016, NEW ENGL J MED, V375, P1033, DOI 10.1056/NEJMoa1603460; Shi L, 2017, SCI REP-UK, V7, DOI [10.1038/srep46025, 10.1038/s41598-017-13111-x]; Sykora M, 2009, J NEUROL SCI, V284, P108, DOI 10.1016/j.jns.2009.04.028	11	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2019	18	9					810	812		10.1016/S1474-4422(19)30268-6	http://dx.doi.org/10.1016/S1474-4422(19)30268-6			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IO1IZ	31397281				2022-12-18	WOS:000479136100007
J	Saposnik, G; Hachinski, V				Saposnik, Gustavo; Hachinski, Vladimir			The pathway towards an effective reduction of stroke burden worldwide: teamwork	LANCET NEUROLOGY			English	Editorial Material									[Saposnik, Gustavo] Univ Toronto, Div Neurol, Dept Med, Toronto, ON, Canada; [Saposnik, Gustavo] Univ Toronto, Outcomes & Decis Neurosci Res Unit, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada; [Hachinski, Vladimir] Western Univ, Dept Clin Neurol Sci, London, ON N6A 5A5, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Western University (University of Western Ontario)	Hachinski, V (corresponding author), Western Univ, Dept Clin Neurol Sci, London, ON N6A 5A5, Canada.	vladimir.hachinski@lhsc.on.ca	Saposnik, Gustavo/M-3937-2017	Saposnik, Gustavo/0000-0002-5950-9886	Roche; Heart and Stroke Foundation of Canada Career Scientist Award; Boheringer	Roche(Roche Holding); Heart and Stroke Foundation of Canada Career Scientist Award; Boheringer	GS reports grants from Roche, grants and personal fees from Boheringer, is supported by the Heart and Stroke Foundation of Canada Career Scientist Award, is an Associate Editor for the Emerging Section of Stroke Journal, and is an advisory board member of Journal of Stroke and Cerebrovascular Disease and International Journal of Stroke. VH declares no competing interests.	[Anonymous], 2018, NEW ENGL J MED, V379, P2429, DOI [DOI 10.1056/NEJMOA1804492, 10.1056/NEJMoa1804492]; Darwin CR, 1859, ORIGIN SPECIES MEANS; Hachinski V, 2018, INT J STROKE, V13, P780, DOI 10.1177/1747493018799965; Haw JS, 2015, ANN NY ACAD SCI, V1353, P138, DOI 10.1111/nyas.12950; Hsieh FI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160426; Institute for Health Metrics and Evaluation (IHME), 2016, GBD COMP DAT VIS; Kalkonde YV, 2018, STROKE, V49, P3092, DOI 10.1161/STROKEAHA.118.017384; Martins SCO, 2019, LANCET NEUROL, V18, P674, DOI 10.1016/S1474-4422(19)30068-7; Saposnik G, 2014, STROKE, V45, P1862, DOI 10.1161/STROKEAHA.114.005413	9	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2019	18	7					622	623		10.1016/S1474-4422(19)30198-X	http://dx.doi.org/10.1016/S1474-4422(19)30198-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC7SE	31202465				2022-12-18	WOS:000471176500007
J	Jokubaitis, VG; Probstel, AK; Arrambide, G; Costello, F; Waubant, E				Jokubaitis, Vilija G.; Probstel, Anne-Katrin; Arrambide, Georgina; Costello, Fiona; Waubant, Emmanuelle			Introducing the International Women in Multiple Sclerosis network	LANCET NEUROLOGY			English	Letter									[Jokubaitis, Vilija G.] Monash Univ, Dept Neurosci, Melbourne, Vic 3004, Australia; [Jokubaitis, Vilija G.] Alfred Hlth, Dept Neurol, Melbourne, Vic 3004, Australia; [Probstel, Anne-Katrin; Waubant, Emmanuelle] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Probstel, Anne-Katrin; Waubant, Emmanuelle] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Probstel, Anne-Katrin] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland; [Probstel, Anne-Katrin] Univ Basel, Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland; [Arrambide, Georgina] Ctr Esclerosi Multiple Catalunya Cemcat, Serv Neurol Neuroimmunol, Barcelona, Spain; [Arrambide, Georgina] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Hosp Univ Vall dHebron, Barcelona, Spain; [Costello, Fiona] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Waubant, Emmanuelle] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA	Monash University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Basel; University of Basel; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Calgary; University of California System; University of California San Francisco	Jokubaitis, VG (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic 3004, Australia.; Jokubaitis, VG (corresponding author), Alfred Hlth, Dept Neurol, Melbourne, Vic 3004, Australia.	vilija.jokubaitis@monash.edu	Jokubaitis, Vilija G./AAD-5949-2019; Pröbstel, Anne-Katrin/ABC-2153-2020	Jokubaitis, Vilija G./0000-0002-3942-4340; Pröbstel, Anne-Katrin/0000-0002-7748-1872; Arrambide, Georgina/0000-0002-2657-5510					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2019	18	6					521	521		10.1016/S1474-4422(19)30160-7	http://dx.doi.org/10.1016/S1474-4422(19)30160-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HY7RQ	31122489	Bronze			2022-12-18	WOS:000468334100007
J	[Anonymous]				[Anonymous]			Adding stroke to the political agenda in Europe	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2019	18	6					513	513		10.1016/S1474-4422(19)30157-7	http://dx.doi.org/10.1016/S1474-4422(19)30157-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HY7RQ	31122484	Bronze			2022-12-18	WOS:000468334100002
J	Anderson, CS				Anderson, Craig S.			Reduction of iron neurotoxicity in intracerebral haemorrhage	LANCET NEUROLOGY			English	Editorial Material									[Anderson, Craig S.] Univ New South Wales, Fac Med, George Inst Global Hlth, Sydney, NSW, Australia; [Anderson, Craig S.] Peking Univ, George Inst Global Hlth China, Hlth Sci Ctr, Beijing, Peoples R China	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Peking University	Anderson, CS (corresponding author), Univ New South Wales, Fac Med, George Inst Global Hlth, Sydney, NSW, Australia.; Anderson, CS (corresponding author), Peking Univ, George Inst Global Hlth China, Hlth Sci Ctr, Beijing, Peoples R China.	canderson@georgeinstitute.org.au						Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6; Hanley DF, 2019, LANCET, V393, P1021, DOI 10.1016/S0140-6736(19)30195-3; Selim M, 2019, LANCET NEUROL, V18, P428, DOI 10.1016/S1474-4422(19)30069-9; Selim M, 2018, STROKE, V49, P1299, DOI 10.1161/STROKEAHA.117.019541; Selim M, 2015, TRANSL STROKE RES, V6, P104, DOI 10.1007/s12975-015-0389-7; Sprigg N, 2018, LANCET, V391, P2107, DOI 10.1016/S0140-6736(18)31033-X; Wei JW, 2010, STROKE, V41, P1877, DOI 10.1161/STROKEAHA.110.586909	8	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2019	18	5					416	417		10.1016/S1474-4422(19)30108-5	http://dx.doi.org/10.1016/S1474-4422(19)30108-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HS8SW	30898551				2022-12-18	WOS:000464140400004
J	Kivipelto, M; Ngandu, T				Kivipelto, Miia; Ngandu, Tiia			Good for the heart and good for the brain?	LANCET NEUROLOGY			English	Editorial Material									[Kivipelto, Miia; Ngandu, Tiia] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Clin Geriatr, Stockholm, Sweden; [Kivipelto, Miia] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Kivipelto, Miia] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Kivipelto, Miia] Imperial Coll London, Sch Publ Hlth, AGE Unit, London, England; [Ngandu, Tiia] Natl Inst Hlth & Welf THL, Publ Hlth Promot Unit, Helsinki, Finland	Karolinska Institutet; University of Eastern Finland; University of Eastern Finland; Imperial College London; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Clin Geriatr, Stockholm, Sweden.; Kivipelto, M (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.; Kivipelto, M (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.; Kivipelto, M (corresponding author), Imperial Coll London, Sch Publ Hlth, AGE Unit, London, England.	miia.kivipelto@ki.se	Kivipelto, Miia/AAS-3557-2021	Ngandu, Tiia/0000-0002-3698-2021				Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Prince M., 2015, WORLD ALZHEIMER REPO, DOI DOI 10.1111/j.0963-7214.2004.00293.x; Rouch L, 2015, CNS DRUGS, V29, P113, DOI 10.1007/s40263-015-0230-6; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; World Health Organization, 2015, MIN C GLOB ACT DEM	7	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2019	18	4					327	328		10.1016/S1474-4422(19)30087-0	http://dx.doi.org/10.1016/S1474-4422(19)30087-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO7ZR	30878097				2022-12-18	WOS:000461169400008
J	Cupini, LM; Calabresi, P				Cupini, Letizia Maria; Calabresi, Paolo			The Madwoman: a portrait of a choreic woman?	LANCET NEUROLOGY			English	Letter									[Cupini, Letizia Maria] Osped S Eugenio, Unita Operat Complessa Neurol, Stroke Unit, Dipartimento Emergenza, I-00144 Rome, Italy; [Calabresi, Paolo] Univ Perugia, Azienda Osped, Dipartimento Med, Clin Neurol, Perugia, Italy	Sant'Eugenio Hospital; University of Perugia; Azienda Ospedaliera di Perugia	Cupini, LM (corresponding author), Osped S Eugenio, Unita Operat Complessa Neurol, Stroke Unit, Dipartimento Emergenza, I-00144 Rome, Italy.	lecupini@tin.it	Calabresi, Paolo/G-8496-2011	Calabresi, Paolo/0000-0003-0326-5509				Balla E., 1984, CON BALLA; Huntington G., 1871, MED SURG REPORTER, VXXVI, P789	2	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2019	18	3					233	233		10.1016/S1474-4422(18)30502-7	http://dx.doi.org/10.1016/S1474-4422(18)30502-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL2BV	30784552	Bronze			2022-12-18	WOS:000458509100015
J	Ho, PR; Campbell, N; Chang, I				Ho, Pei-Ran; Campbell, Nolan; Chang, Ih			The risk of PML from natalizumab reply	LANCET NEUROLOGY			English	Letter									[Ho, Pei-Ran; Campbell, Nolan; Chang, Ih] Biogen, Cambridge, MA 02142 USA	Biogen	Ho, PR (corresponding author), Biogen, Cambridge, MA 02142 USA.	peiran.ho@biogen.com						[Anonymous], 2016, PHYS INFORM MANAGEME; [Anonymous], 2018, TYS NAT SUMM PROD CH; Ho PR, 2017, LANCET NEUROL, V16, P925, DOI 10.1016/S1474-4422(17)30282-X	3	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2019	18	3					230	231		10.1016/S1474-4422(19)30022-5	http://dx.doi.org/10.1016/S1474-4422(19)30022-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL2BV	30784549	Bronze			2022-12-18	WOS:000458509100012
J	Melis, M; Ricci, S; Toni, D				Melis, Maurizio; Ricci, Stefano; Toni, Danilo		Editorial Comm Italian Natl	Optimal stroke prevention in patients with PFO	LANCET NEUROLOGY			English	Letter									[Melis, Maurizio] Azienda Osped G Brotzu, Neurosci & Rehabil Dept, Neurol & Stroke Unit, I-09134 Cagliari, Italy; [Ricci, Stefano] USL Umbria 1, Neurol Unit, Citta Di Castello, Italy; [Toni, Danilo] Sapienza Univ, Dept Human Neurosci, Neurovasc Treatment Unit, Rome, Italy	Sapienza University Rome	Melis, M (corresponding author), Azienda Osped G Brotzu, Neurosci & Rehabil Dept, Neurol & Stroke Unit, I-09134 Cagliari, Italy.	mauriziomelis@aob.it	Toni, Danilo/K-3151-2016	Toni, Danilo/0000-0003-2735-8427				[Anonymous], RACC RAP ICT CRIPT F; Kasner SE, 2018, LANCET NEUROL, V17, P1053, DOI 10.1016/S1474-4422(18)30319-3; Meier B, 2018, LANCET NEUROL, V17, P1027, DOI 10.1016/S1474-4422(18)30369-7; Pristipino C, 2019, EUROINTERVENTION, V14, P1389, DOI 10.4244/EIJ-D-18-00622; Turc G, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008356	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2019	18	3					231	231		10.1016/S1474-4422(19)30017-1	http://dx.doi.org/10.1016/S1474-4422(19)30017-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL2BV	30784551				2022-12-18	WOS:000458509100013
J	Thorogood, A; Maki-Petaja-Leinonen, A; Dalpe, G; Gastmans, C; Gauthier, S				Thorogood, Adrian; Maki-Petaja-Leinonen, Anna; Dalpe, Gratien; Gastmans, Chris; Gauthier, Serge			Openness, inclusion, and respect in dementia research	LANCET NEUROLOGY			English	Letter							CONSENT		[Thorogood, Adrian; Dalpe, Gratien] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 0G1, Canada; [Maki-Petaja-Leinonen, Anna] Univ Eastern Finland, Law Sch, Fac Social Sci & Business Studies, Joensuu, Finland; [Gastmans, Chris] Katholieke Univ Leuven, Interfac Ctr Biomed Eth & Law, Leuven, Belgium; [Gauthier, Serge] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; University of Eastern Finland; KU Leuven	Thorogood, A (corresponding author), McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 0G1, Canada.	adrian.thorogood@mcgill.ca	Gastmans, Chris/Y-5504-2019; Gastmans, Chris/GWZ-3728-2022	Gastmans, Chris/0000-0002-5522-0639; Thorogood, Adrian/0000-0001-5078-8164; Dalpe, Gratien/0000-0002-3049-3315	Genome Quebec; Genome Canada; Government of Canada; Ministere de l'Economie, and Innovation et Exportation du Quebec (Can-SHARE grant) [141210]	Genome Quebec; Genome Canada(Genome Canada); Government of Canada(CGIAR); Ministere de l'Economie, and Innovation et Exportation du Quebec (Can-SHARE grant)	We declare no competing interests. We gratefully acknowledge the financial support of Genome Quebec, Genome Canada, the Government of Canada, the Ministere de l'Economie, and Innovation et Exportation du Quebec (Can-SHARE grant 141210).	Global Alliance for Genomics and Health, 2014, FRAM RESP SHAR GEN H; Palmer BW, 2017, CLIN GERONTOLOGIST, V40, P24, DOI 10.1080/07317115.2016.1197352; Thorogood A, 2018, ALZHEIMERS DEMENT, V14, P1334, DOI 10.1016/j.jalz.2018.05.011; UN (United Nations), 2007, CONV RIGHTS PERS DIS	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2019	18	2					135	136		10.1016/S1474-4422(18)30445-9	http://dx.doi.org/10.1016/S1474-4422(18)30445-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI0TY	30663603	Bronze, Green Accepted			2022-12-18	WOS:000456158200007
J	Quadri, M; Mandemakers, W; Kuipers, D; Breedveld, GJ; Bonifati, V				Quadri, Marialuisa; Mandemakers, Wim; Kuipers, Demy; Breedveld, Guido J.; Bonifati, Vincenzo			LRP10 in alpha-synucleinopathies reply	LANCET NEUROLOGY			English	Letter									[Quadri, Marialuisa; Mandemakers, Wim; Kuipers, Demy; Breedveld, Guido J.; Bonifati, Vincenzo] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Bonifati, V (corresponding author), Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands.	v.bonifati@erasmusmc.nl		Mandemakers, Wim/0000-0003-2673-5972	Stichting ParkinsonFonds and Erasmus MC; Stichting ParkinsonFonds (Netherlands); Dorpmans-Wigmans Stichting (Netherlands); Erasmus MC (MRace promotie grant); Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie (ZonMw; Memorabel programme) [733051065]; Centre for Human Drug Research (Netherlands); Elsevier Ltd; Springer Science and Business Media LLC	Stichting ParkinsonFonds and Erasmus MC; Stichting ParkinsonFonds (Netherlands); Dorpmans-Wigmans Stichting (Netherlands); Erasmus MC (MRace promotie grant); Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie (ZonMw; Memorabel programme); Centre for Human Drug Research (Netherlands); Elsevier Ltd; Springer Science and Business Media LLC	MQ has a patent pending for the role for low-density lipoprotein receptor-related protein in progressive brain disease. WM reports grants from Stichting ParkinsonFonds and Erasmus MC, and has a patent pending for the role for low-density lipoprotein receptor-related protein in progressive brain disease. VB receives grants from Stichting ParkinsonFonds (Netherlands), Dorpmans-Wigmans Stichting (Netherlands), Erasmus MC (MRace promotie grant), Nederlandse organisatie voor gezondheidsonderzoek en zorginnovatie (ZonMw; Memorabel programme, grant 733051065, under the aegis of the EU Joint Programme Neurodegenerative Disease Research), and the Centre for Human Drug Research (Netherlands), and has a patent pending for the role for low-density lipoprotein receptor-related protein in progressive brain disease. VB also receives financial compensation from Elsevier Ltd, and from Springer Science and Business Media LLC, and has received honoraria from the International Parkinson and Movement Disorder Society, and Sun Pharmaceutical Laboratories Limited. DK and GJB declare no competing interests.	Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Klein C, 2011, MOVEMENT DISORD, V26, P1793, DOI 10.1002/mds.23853; Quadri M, 2018, LANCET NEUROL, V17, P597, DOI 10.1016/S1474-4422(18)30179-0; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2018	17	12					1035	1036		10.1016/S1474-4422(18)30408-3	http://dx.doi.org/10.1016/S1474-4422(18)30408-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA3AA	30507388	Bronze			2022-12-18	WOS:000450119300013
J	Rafii, MS				Rafii, Michael S.			Diagnostic biomarkers of Alzheimer's disease in Down syndrome	LANCET NEUROLOGY			English	Editorial Material							NEUROFILAMENT LIGHT; NEURODEGENERATION; ADULTS		[Rafii, Michael S.] Univ Southern Calif, Keck Sch Med, Alzheimers Therapeut Res Inst, San Diego, CA 92121 USA	University of Southern California	Rafii, MS (corresponding author), Univ Southern Calif, Keck Sch Med, Alzheimers Therapeut Res Inst, San Diego, CA 92121 USA.	mrafii@usc.edu						Firth NC, 2018, ANN CLIN TRANSL NEUR, V5, P741, DOI 10.1002/acn3.571; Fortea J, 2018, LANCET NEUROL, V17, P860, DOI 10.1016/S1474-4422(18)30285-0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Hartley D, 2015, ALZHEIMERS DEMENT, V11, P700, DOI 10.1016/j.jalz.2014.10.007; Hartley SL, 2017, NEUROBIOL AGING, V58, P68, DOI 10.1016/j.neurobiolaging.2017.05.019; Matthews Dawn C, 2016, Alzheimers Dement (N Y), V2, P69, DOI 10.1016/j.trci.2016.02.004; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Moran JA, 2013, MAYO CLIN PROC, V88, P831, DOI 10.1016/j.mayocp.2013.04.024; Rafii MS, 2017, J ALZHEIMERS DIS, V60, P439, DOI 10.3233/JAD-170390; Rafii Michael S, 2015, Front Behav Neurosci, V9, P239, DOI 10.3389/fnbeh.2015.00239; Strydom A, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0367-x	11	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2018	17	10					831	832		10.1016/S1474-4422(18)30293-X	http://dx.doi.org/10.1016/S1474-4422(18)30293-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT9LD	30172623				2022-12-18	WOS:000444862200003
J	Josephs, KA				Josephs, Keith A.			Fitting TDP-43 into the APOE epsilon 4 and neurodegeneration story	LANCET NEUROLOGY			English	Editorial Material							FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; HIPPOCAMPAL SCLEROSIS; PATHOLOGY; ATROPHY; AGE		[Josephs, Keith A.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Josephs, Keith A.] Mayo Clin, Grad Sch, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Josephs, KA (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.; Josephs, KA (corresponding author), Mayo Clin, Grad Sch, Rochester, MN 55905 USA.	josephs.keith@mayo.edu			US National Institutes of Health; NATIONAL INSTITUTE ON AGING [R01AG037491] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I have received funding from the US National Institutes of Health.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Josephs KA, 2017, LANCET NEUROL, V16, P917, DOI 10.1016/S1474-4422(17)30284-3; Josephs KA, 2017, ACTA NEUROPATHOL, V133, P705, DOI 10.1007/s00401-017-1681-2; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Nelson PT, 2013, ACTA NEUROPATHOL, V126, P161, DOI 10.1007/s00401-013-1154-1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Wilson RS, 2013, JAMA NEUROL, V70, P1418, DOI 10.1001/jamaneurol.2013.3961; Yang SH, 2018, LANCET NEUROL, DOI [10.1016/S1474-4422(18)30251-5, DOI 10.1016/S1474-4422(18)30251-5]	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2018	17	9					735	737		10.1016/S1474-4422(18)30288-6	http://dx.doi.org/10.1016/S1474-4422(18)30288-6			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ3AO	30093251	Green Accepted			2022-12-18	WOS:000441532100004
J	Magy, L				Magy, Laurent			Fingolimod and CIDP: insights from negative results	LANCET NEUROLOGY			English	Editorial Material							INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CONTROLLED-TRIAL; ORAL FINGOLIMOD; FTY720		[Magy, Laurent] CHU Limoges, Ctr Reference Neuropathies Peripher Rares, Serv & Lab Neurol, FILNEMUS,EA MMNP 6309, F-87042 Limoges, France	CHU Limoges	Magy, L (corresponding author), CHU Limoges, Ctr Reference Neuropathies Peripher Rares, Serv & Lab Neurol, FILNEMUS,EA MMNP 6309, F-87042 Limoges, France.	laurent.magy@unilim.fr			CSL Behring; Grifols; LFB; Novartis; Biogen	CSL Behring; Grifols; LFB; Novartis(Novartis); Biogen(Biogen)	I have received personal fees and non-financial support from CSL Behring, Grifols, LFB, and Novartis, and grants, personal fees, and non-financial support from Biogen.	Bright RJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-26; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Grand View Research, 2018, INTR IMM IVIG MARK S; Huehnchen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23949-4; Hughes R, 2018, LANCET NEUROL, V17, P933, DOI 10.1016/S1474-4422(18)30202-3; Hughes RAC, 2009, LANCET NEUROL, V8, P158, DOI 10.1016/S1474-4422(08)70299-0; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Mahdi-Rogers M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003280.pub5; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Nobile-Orazio E, 2015, J NEUROL NEUROSUR PS, V86, P729, DOI 10.1136/jnnp-2013-307515; Zhang Z, 2008, EXP NEUROL, V210, P681, DOI 10.1016/j.expneurol.2007.12.025	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2018	17	8					655	656		10.1016/S1474-4422(18)30246-1	http://dx.doi.org/10.1016/S1474-4422(18)30246-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GN5BH	30001924				2022-12-18	WOS:000439057500004
J	Iranzo, A				Iranzo, Alex			Dissecting premotor Parkinson's disease with multimodality neuroimaging	LANCET NEUROLOGY			English	Editorial Material							SLEEP BEHAVIOR DISORDER		[Iranzo, Alex] Hosp Clin Barcelona, Neurol Serv, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona	Iranzo, A (corresponding author), Hosp Clin Barcelona, Neurol Serv, E-08036 Barcelona, Spain.	airanzo@clinic.ub.es						Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Hogl B, 2018, NAT REV NEUROL, V14, P40, DOI 10.1038/nrneurol.2017.157; Iranzo A., CELL TISSUE RES; Iranzo A, 2016, LANCET NEUROL, V15, P405, DOI 10.1016/S1474-4422(16)00057-0; Knudsen K, 2018, LANCET NEUROL, V17, P618, DOI 10.1016/S1474-4422(18)30162-5; Stokholm MG, 2017, LANCET NEUROL, V16, P789, DOI 10.1016/S1474-4422(17)30173-4; Vilas D, 2016, LANCET NEUROL, V15, P708, DOI 10.1016/S1474-4422(16)00080-6	7	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2018	17	7					574	576		10.1016/S1474-4422(18)30196-0	http://dx.doi.org/10.1016/S1474-4422(18)30196-0			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK8RP	29866442				2022-12-18	WOS:000436495200005
J	Kalviainen, R; Straus, S; Dogne, JM; Bakchine, S; Haas, M				Kalviainen, Reetta; Straus, Sabine; Dogne, Jean-Michel; Bakchine, Serge; Haas, Manuel			Reducing valproate use in women with epilepsy	LANCET NEUROLOGY			English	Letter							SPECTRUM DISORDERS; EXPOSURE; AUTISM		[Kalviainen, Reetta] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Straus, Sabine] Med Evaluat Board, Dept Policy & Regulatory Affairs, Utrecht, Netherlands; [Dogne, Jean-Michel] Univ Namur, Dept Pharm, Namur, Belgium; [Bakchine, Serge] Hop Maison Blanche, Dept Neurol, Reims, France; [Haas, Manuel] European Med Agcy, Dept Evaluat, London E14 5EU, England	University of Eastern Finland; University of Namur; CHU de Reims; Universite de Reims Champagne-Ardenne	Haas, M (corresponding author), European Med Agcy, Dept Evaluat, London E14 5EU, England.	manuel.haas@ema.europa.eu	Dogné, Jean-Michel/AAD-5773-2021		Academy of Finland; Vaajasalo Foundation; Saastamoinen Foundation; Eisai; UCB pharma; Orion Pharma; Sage Therapeutics; Fenno Medical; Takeda; GW Pharmaceuticals	Academy of Finland(Academy of Finland); Vaajasalo Foundation; Saastamoinen Foundation; Eisai(Eisai Co Ltd); UCB pharma(UCB Pharma SA); Orion Pharma; Sage Therapeutics; Fenno Medical; Takeda(Takeda Pharmaceutical Company Ltd); GW Pharmaceuticals	The views presented are those of the authors and should not be understood or quoted as being made on behalf of the European Medicines Agency or its scientific committees. MH is an employee of the European Medicines Agengy. RK reports grants from the Academy of Finland, Vaajasalo Foundation, and Saastamoinen Foundation, costs for her institution and academic research from Eisai and UCB Pharma paid to her insitution, and personal fees from Eisai, UCB pharma, Orion Pharma, Sage Therapeutics, Fenno Medical, Takeda, and GW Pharmaceuticals. All other authors declare no competing interests.	Agence Nationale de Securite du Medicament et des Produits de Sante, 2016, LETTRE LINSHS; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; European Medicines Agency, 2018, PRAC REC NEW MEAS AV; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Virta LJ, 2018, EUR J NEUROL, V25, P869, DOI 10.1111/ene.13610	6	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2018	17	7					580	+		10.1016/S1474-4422(18)30172-8	http://dx.doi.org/10.1016/S1474-4422(18)30172-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK8RP	29914703	Bronze			2022-12-18	WOS:000436495200011
J	Schwamm, LH				Schwamm, Lee H.			Disruptive innovation in acute stroke systems of care	LANCET NEUROLOGY			English	Editorial Material							ISCHEMIC-STROKE; THROMBECTOMY; OUTCOMES		[Schwamm, Lee H.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Schwamm, LH (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	lschwamm@mgh.harvard.edu			US National Institute of Neurological Disorders and Stroke; Massachusetts Department of Public Health; LifeImage; Lundbeck; Medtronic; Penumbra	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Massachusetts Department of Public Health; LifeImage; Lundbeck(Lundbeck Corporation); Medtronic(Medtronic); Penumbra	LHS declares grants from the US National Institute of Neurological Disorders and Stroke, personal fees from the Massachusetts Department of Public Health and LifeImage for consultancy, personal fees from Lundbeck for serving on a steering committee, personal fees from Medtronic for serving on a steering committee and organising a symposium, and personal fees from Penumbra for serving on a data safety monitoring board.	Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Broderick JP, 2016, STROKE, V47, P301, DOI 10.1161/STROKEAHA.115.011743; Campbell BCV, 2018, NEW ENGL J MED, V378, P1573, DOI 10.1056/NEJMoa1716405; Higashida R, 2013, STROKE, V44, P2961, DOI 10.1161/STR.0b013e3182a6d2b2; Kunz A, 2016, LANCET NEUROL, V15, P1035, DOI 10.1016/S1474-4422(16)30129-6; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Schwamm LH, 2018, ANN NEUROL, V83, P980, DOI 10.1002/ana.25235; Schwamm LH, 2005, CIRCULATION, V111, P1078, DOI 10.1161/01.CIR.0000154252.62394.1E; Sheth KN, 2015, STROKE, V46, P732, DOI 10.1161/STROKEAHA.114.007506; Silva GS, 2012, STROKE, V43, P2078, DOI 10.1161/STROKEAHA.111.645861	10	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2018	17	7					576	578		10.1016/S1474-4422(18)30197-2	http://dx.doi.org/10.1016/S1474-4422(18)30197-2			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK8RP	29807813				2022-12-18	WOS:000436495200006
J	Birnkrant, DJ; Bushby, K; Bann, CM				Birnkrant, D. J.; Bushby, K.; Bann, C. M.			Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management (vol 17, pg 251, 2018)	LANCET NEUROLOGY			English	Correction													Birnkrant, David/AAT-2838-2020	Birnkrant, David/0000-0001-6327-5616				Birnkrant DJ, 2018, LANCET NEUROL, V17, P251, DOI 10.1016/S1474-4422(18)30024-3	1	2	2	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2018	17	6					495	495		10.1016/S1474-4422(18)30125-X	http://dx.doi.org/10.1016/S1474-4422(18)30125-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1RD		Bronze			2022-12-18	WOS:000432463400010
J	Etemadifar, M; Sabeti, F				Etemadifar, Masoud; Sabeti, Fateme			Applying the 2017 McDonald diagnostic criteria for multiple sclerosis	LANCET NEUROLOGY			English	Letter							CSF; IGG		[Etemadifar, Masoud] Isfahan Univ Med Sci, Dept Neurol, Esfahan, Iran; [Sabeti, Fateme] Isfahan Multiple Sclerosis Ctr, Esfahan, Iran; [Sabeti, Fateme] Isfahan Univ Med Sci, Alzahra Res Inst, Alzahra Hosp, Isfahan Res Comm Multiple Sclerosis, Esfahan 8174673461, Iran	Isfahan University Medical Science; Isfahan University Medical Science	Sabeti, F (corresponding author), Isfahan Multiple Sclerosis Ctr, Esfahan, Iran.; Sabeti, F (corresponding author), Isfahan Univ Med Sci, Alzahra Res Inst, Alzahra Hosp, Isfahan Res Comm Multiple Sclerosis, Esfahan 8174673461, Iran.	sabetifateme@yahoo.com						Bourahoui A, 2004, EUR J NEUROL, V11, P525, DOI 10.1111/j.1468-1331.2004.00822.x; KOSTULAS VK, 1987, ARCH NEUROL-CHICAGO, V44, P1041, DOI 10.1001/archneur.1987.00520220043014; Malter MP, 2013, SEIZURE-EUR J EPILEP, V22, P136, DOI 10.1016/j.seizure.2012.12.013; MCLEAN BN, 1995, J NEUROL NEUROSUR PS, V58, P548, DOI 10.1136/jnnp.58.5.548; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2	5	2	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2018	17	6					497	497		10.1016/S1474-4422(18)30165-0	http://dx.doi.org/10.1016/S1474-4422(18)30165-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1RD	29778356	Bronze			2022-12-18	WOS:000432463400015
J	Pennell, PB				Pennell, Page B.			Prescribing antiepileptic drugs to women of reproductive age	LANCET NEUROLOGY			English	Editorial Material							COMPARATIVE SAFETY; SEIZURE FREQUENCY; PREGNANCY; LAMOTRIGINE; OUTCOMES; EPILEPSY; MALFORMATIONS; METAANALYSIS; CLEARANCE; VALPROATE		[Pennell, Page B.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Pennell, Page B.] Brigham & Womens Hosp, Div Epilepsy, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Pennell, PB (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Pennell, PB (corresponding author), Brigham & Womens Hosp, Div Epilepsy, 75 Francis St, Boston, MA 02115 USA.	ppennell@bwh.harvard.edu			Epilepsy Foundation; Epilepsy Therapy Project; Milken Family Foundation; Harvard Catalyst; National Institutes of Health; American Epilepsy Society; American Academy of Neurology; Southern Epilepsy and EEG Society; University of Montreal Hospital Center Foundation; Ministry of Peru; Massachusetts Neurological Association; governmental and academic institutions for CME lectures	Epilepsy Foundation; Epilepsy Therapy Project; Milken Family Foundation; Harvard Catalyst; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Epilepsy Society; American Academy of Neurology; Southern Epilepsy and EEG Society; University of Montreal Hospital Center Foundation; Ministry of Peru; Massachusetts Neurological Association; governmental and academic institutions for CME lectures	I have received research grants from the Epilepsy Foundation, the Epilepsy Therapy Project, the Milken Family Foundation, Harvard Catalyst, and the National Institutes of Health. I have also received financial travel support or honoraria, or both, from the American Epilepsy Society, American Academy of Neurology, Southern Epilepsy and EEG Society, University of Montreal Hospital Center Foundation, the Ministry of Peru, Massachusetts Neurological Association, the National Institutes of Health, and the governmental and academic institutions for CME lectures.	Bjork M, 2018, JAMA NEUROL, V75, P160, DOI 10.1001/jamaneurol.2017.3897; Bromley RL, 2016, NEUROLOGY, V87, P1943, DOI 10.1212/WNL.0000000000003157; Harden CL, 2009, NEUROLOGY, V73, P133, DOI 10.1212/WNL.0b013e3181a6b312; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Herzog AG, 2009, NEUROLOGY, V72, P911, DOI 10.1212/01.wnl.0000344167.78102.f0; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Pennell PB, 2008, NEUROLOGY, V70, P2130, DOI 10.1212/01.wnl.0000289511.20864.2a; Pirie DAJ, 2014, EUR J OBSTET GYN R B, V172, P26, DOI 10.1016/j.ejogrb.2013.10.021; Reisinger TL, 2013, EPILEPSY BEHAV, V29, P13, DOI 10.1016/j.yebeh.2013.06.026; Tomson T, 2018, LANCET NEUROL, V17, P530, DOI 10.1016/S1474-4422(18)30107-8; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Veroniki AA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0845-1	12	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2018	17	6					485	486		10.1016/S1474-4422(18)30154-6	http://dx.doi.org/10.1016/S1474-4422(18)30154-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1RD	29680207				2022-12-18	WOS:000432463400004
J	Rothwell, PM				Rothwell, Peter M.			Clinical innovation in stroke: getting the simple things right	LANCET NEUROLOGY			English	Editorial Material							PATENT FORAMEN OVALE; RANDOMIZED CONTROLLED-TRIALS; TRANSIENT ISCHEMIC ATTACK; EARLY RECURRENT STROKE; POOLED ANALYSIS; CLOSURE; THERAPY; THROMBECTOMY		[Rothwell, Peter M.] Univ Oxford, John Radcliffe Hosp, Ctr Prevent Stroke & Dementia, Oxford OX3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, John Radcliffe Hosp, Ctr Prevent Stroke & Dementia, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	Bayer; Bristol-Myers Squibb	Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb)	I have received personal fees from Bayer for serving on the Executive Committee for the ARRIVE trial, and from Bristol-Myers Squibb for attending an advisory board meeting.	Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2016, STROKE, V47, P798, DOI 10.1161/STROKEAHA.115.012360; DELZOPPO GJ, 1988, STROKE, V19, P307, DOI 10.1161/01.STR.19.3.307; Kent DM, 2016, J AM COLL CARDIOL, V67, P907, DOI 10.1016/j.jacc.2015.12.023; Mas JL, 2017, NEW ENGL J MED, V377, P1011, DOI 10.1056/NEJMoa1705915; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2006, LANCET, V368, P262, DOI 10.1016/S0140-6736(06)69010-7; Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2001, LANCET, V357, P1612, DOI 10.1016/S0140-6736(00)04730-9; Saver JL, 2017, NEW ENGL J MED, V377, P1022, DOI 10.1056/NEJMoa1610057; Smith WS, 2016, STROKE, V47, pE23, DOI 10.1161/STROKEAHA.115.010863; Sondergaard L, 2017, NEW ENGL J MED, V377, P1033, DOI 10.1056/NEJMoa1707404; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	17	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2018	17	6					491	493		10.1016/S1474-4422(18)30113-3	http://dx.doi.org/10.1016/S1474-4422(18)30113-3			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1RD	29653768				2022-12-18	WOS:000432463400008
J	Cronberg, T				Cronberg, Tobias			White matter is what matters after cardiac arrest	LANCET NEUROLOGY			English	Editorial Material									[Cronberg, Tobias] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Neurol, Lund, Sweden	Lund University; Skane University Hospital	Cronberg, T (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, Neurol, Lund, Sweden.	tobias.cronberg@skane.se						Dragancea I, 2017, RESUSCITATION, V117, P50, DOI 10.1016/j.resuscitation.2017.05.014; Gold B, 2014, RESUSCITATION, V85, P211, DOI 10.1016/j.resuscitation.2013.10.030; Greer D, 2011, NEUROCRIT CARE, V14, P61, DOI 10.1007/s12028-010-9457-8; Hirsch KG, 2015, J NEUROIMAGING, V25, P430, DOI 10.1111/jon.12143; Kim YJ, 2016, RESUSCITATION, V101, P1, DOI 10.1016/j.resuscitation.2016.01.004; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Velly L, 2018, LANCET NEUROL	7	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2018	17	4					291	292		10.1016/S1474-4422(18)30079-6	http://dx.doi.org/10.1016/S1474-4422(18)30079-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ3AO	29500153				2022-12-18	WOS:000427458000003
J	Frisoni, GB; Jessen, F				Frisoni, Giovanni B.; Jessen, Frank			One step towards dementia prevention	LANCET NEUROLOGY			English	Editorial Material							PRECLINICAL ALZHEIMERS-DISEASE; SUBJECTIVE COGNITIVE DECLINE; CLINICAL PROGRESSION		[Frisoni, Giovanni B.] Univ Geneva, Dept Internal Med Rehabil & Geriatr, CH-1208 Geneva, Switzerland; [Frisoni, Giovanni B.] Univ Hosp, CH-1208 Geneva, Switzerland; [Jessen, Frank] Univ Cologne, Med Fac, Dept Psychiat, Cologne, Germany; [Jessen, Frank] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Geneva; University of Geneva; University of Cologne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Frisoni, GB (corresponding author), Univ Geneva, Dept Internal Med Rehabil & Geriatr, CH-1208 Geneva, Switzerland.; Frisoni, GB (corresponding author), Univ Hosp, CH-1208 Geneva, Switzerland.	giovanni.frisoni@hcuge.ch	Frisoni, Giovanni B./K-1360-2016; Jessen, Frank/AAK-6170-2020	Frisoni, Giovanni B./0000-0002-6419-1753; 	Alzheimer Forum Suisse; ASSM (Academie Suisse des Sciences Medicales); Avid/Lilly; Biogen; GE International; Guerbert; IFRAD Suisse (Association Suisse pour la Recherche sur l'Alzheimer); Ixico; Merz; Nestle; Novartis; Piramal; Roche; Siemens; Teva Pharma; Vifor Pharma; Alzheimer's Association; AstraZeneca; Elan; Lundbeck; Pfizer; Taurx; AC Immune; Janssen; Lilly; Merck	Alzheimer Forum Suisse; ASSM (Academie Suisse des Sciences Medicales); Avid/Lilly; Biogen(Biogen); GE International(General Electric); Guerbert; IFRAD Suisse (Association Suisse pour la Recherche sur l'Alzheimer); Ixico; Merz; Nestle(Nestle SA); Novartis(Novartis); Piramal; Roche(Roche Holding); Siemens(Siemens AG); Teva Pharma(Teva Pharmaceutical Industries); Vifor Pharma; Alzheimer's Association(Alzheimer's Association); AstraZeneca(AstraZeneca); Elan; Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Taurx; AC Immune; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly(Eli Lilly); Merck(Merck & Company)	GBF has received grants from Alzheimer Forum Suisse, ASSM (Academie Suisse des Sciences Medicales), Avid/Lilly, Biogen, GE International, Guerbert, IFRAD Suisse (Association Suisse pour la Recherche sur l'Alzheimer), Ixico, Merz, Nestle, Novartis, Piramal, Roche, Siemens, Teva Pharma, and Vifor Pharma, and the Alzheimer's Association, and has received personal fees from AstraZeneca, Avid/Lilly, Elan, GE International, Lundbeck, Pfizer, and Taurx. FJ has received consultation fees from AC Immune, Biogen, Janssen, Lilly, Merck, and Roche. He is a principle investigator in trials for Axovant, Biogene, Boehringer, and Eli Lilly.	Donohue MC, 2017, JAMA-J AM MED ASSOC, V317, P2305, DOI 10.1001/jama.2017.6669; Dubois B, 2018, LANCET NEUROL; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Jessen F, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-017-0314-2; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; van Harten AC, 2013, ALZHEIMERS DEMENT, V9, P481, DOI 10.1016/j.jalz.2012.08.004; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wolfsgruber S, 2017, J ALZHEIMERS DIS, V58, P939, DOI 10.3233/JAD-161252	10	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2018	17	4					294	295		10.1016/S1474-4422(18)30086-3	http://dx.doi.org/10.1016/S1474-4422(18)30086-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ3AO	29500155				2022-12-18	WOS:000427458000005
J	McMillan, T; Bigler, ED; Teasdale, G; Ponsford, J; Murray, GD				McMillan, Thomas; Bigler, Erin D.; Teasdale, Graham; Ponsford, Jennie; Murray, Gordon D.			Outcome assessment after traumatic brain injury	LANCET NEUROLOGY			English	Letter									[McMillan, Thomas; Teasdale, Graham] Univ Glasgow, Glasgow G12 0XH, Lanark, Scotland; [Bigler, Erin D.] Brigham Young Univ, Provo, UT 84602 USA; [Ponsford, Jennie] Monash Univ, Melbourne, Vic, Australia; [Murray, Gordon D.] Univ Edinburgh, Edinburgh, Midlothian, Scotland	University of Glasgow; Brigham Young University; Monash University; University of Edinburgh	McMillan, T (corresponding author), Univ Glasgow, Glasgow G12 0XH, Lanark, Scotland.	thomas.mcmillan@glasgow.ac.uk			US National Institutes of Health; US Department of Defense; Forensic Consultation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Forensic Consultation	EDB reports grants from the US National Institutes of Health and the US Department of Defense, personal fees from Forensic Consultation, and royalties from Oxford University Press. All other authors declare no competing interests.	Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Kean J, 2014, ARCH PHYS MED REHAB, V95, P1225, DOI 10.1016/j.apmr.2014.03.023; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2018	17	4					299	299		10.1016/S1474-4422(18)30041-3	http://dx.doi.org/10.1016/S1474-4422(18)30041-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ3AO	29553377	Green Accepted, Bronze			2022-12-18	WOS:000427458000010
J	Howard, JF; O'Brien, F; Wang, JJ				Howard, James F., Jr.; O'Brien, Fanny; Wang, Jing-Jing			Distinct representation of muscle weakness in QMG and MG-ADL reply	LANCET NEUROLOGY			English	Letter							GENERALIZED MYASTHENIA-GRAVIS; DOUBLE-BLIND; ECULIZUMAB		[Howard, James F., Jr.; O'Brien, Fanny; Wang, Jing-Jing] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Howard, JF (corresponding author), Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA.	howardj@neurology.unc.edu			Alexion Pharmaceuticals; Centers for Disease Control and Prevention (Atlanta, GA); Muscular Dystrophy Association; National Institutes of Health; National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases; UCB Biosciences	Alexion Pharmaceuticals; Centers for Disease Control and Prevention (Atlanta, GA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases; UCB Biosciences	JFH Jr reports research support from Alexion Pharmaceuticals, the Centers for Disease Control and Prevention (Atlanta, GA) and the Muscular Dystrophy Association; reports grants from Alexion Pharmaceuticals, the National Institutes of Health (including the National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases), and UCB Biosciences; and reports non-financial support from Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Argentx, Ra Pharmaceuticals, and Toleranzia. FOB and JJW are employed by and own stocks in Alexion Pharmaceuticals.	Howard JF, 2017, LANCET NEUROL, V16, P976, DOI 10.1016/S1474-4422(17)30369-1; Howard JF, 2017, MUSCLE NERVE, V56, P328, DOI 10.1002/mus.25529; Howard JF, 2013, MUSCLE NERVE, V48, P76, DOI 10.1002/mus.23839; Howard Jr JF, 2017, AM ASS NEUR EL MED A; Wolfe GI, 2008, MUSCLE NERVE, V38, P1429, DOI 10.1002/mus.21142	5	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2018	17	3					205	206		10.1016/S1474-4422(18)30036-X	http://dx.doi.org/10.1016/S1474-4422(18)30036-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FW1WE	29452680	Bronze			2022-12-18	WOS:000425090000011
J	Werring, DJ				Werring, David J.			CT scanning to diagnose CAA: back to the future?	LANCET NEUROLOGY			English	Editorial Material							CEREBRAL AMYLOID ANGIOPATHY		[Werring, David J.] UCL, Natl Hosp Neurol & Neurosurg, Dept Brain Repair & Rehabil, Stroke Res Ctr,Inst Neurol, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Werring, DJ (corresponding author), UCL, Natl Hosp Neurol & Neurosurg, Dept Brain Repair & Rehabil, Stroke Res Ctr,Inst Neurol, London WC1N 3BG, England.	d.werring@ucl.ac.uk	Werring, David/Q-8435-2019	Werring, David/0000-0003-2074-1861				Banerjee G, 2017, J NEUROL NEUROSUR PS, V88, P982, DOI 10.1136/jnnp-2016-314697; Charidimou A, 2017, NEUROLOGY, V89, P820, DOI 10.1212/WNL.0000000000004259; Greenberg SM, 2014, LANCET NEUROL, V13, P419, DOI 10.1016/S1474-4422(14)70003-1; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Rodrigues MA, 2018, LANCET NEUROL; Wilson D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2484	6	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2018	17	3					197	198		10.1016/S1474-4422(18)30005-X	http://dx.doi.org/10.1016/S1474-4422(18)30005-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FW1WE	29331632	Green Published, hybrid			2022-12-18	WOS:000425090000004
J	Aartsma-Rus, A				Aartsma-Rus, Annemieke			Genetic therapies for spinal muscular atrophy type 1	LANCET NEUROLOGY			English	Editorial Material							NUSINERSEN		[Aartsma-Rus, Annemieke] Leiden Univ, Med Ctr, Dept Human Genet, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aartsma-Rus, A (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	a.m.rus@lumc.nl		Aartsma-Rus, Annemieke/0000-0003-1565-654X	Duchenne Parent Project; Prinses Beatrix Spierfonds; Association Francaise contre les Myopathies; European Union 7th Framework Programme [2012-305121]; ZonMw	Duchenne Parent Project; Prinses Beatrix Spierfonds; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Union 7th Framework Programme; ZonMw(Netherlands Organization for Health Research and Development)	I report grants from the Duchenne Parent Project, Prinses Beatrix Spierfonds, the Association Francaise contre les Myopathies, European Union 7th Framework Programme (grant agreement number: 2012-305121), and ZonMw; and honoraria for consulting paid to Leiden University Medical Center from PTC Therapeutics, BioMarin, Summit Therapeutics, Bristol-Myers Squibb, and Mirrx Therapeutics.	Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P67, DOI 10.1089/nat.2017.0665; [Anonymous], 2017, LANCET NEUROL, V16, P761, DOI 10.1016/S1474-4422(17)30295-8; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Simoens S, 2017, GENE THER, V24, P539, DOI 10.1038/gt.2017.79	6	2	2	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2018	17	2					111	112		10.1016/S1474-4422(17)30436-2	http://dx.doi.org/10.1016/S1474-4422(17)30436-2			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT0PA	29229374	Green Submitted			2022-12-18	WOS:000422828500007
J	van Schaik, IN; Bril, V; van Geloven, N				van Schaik, I. N.; Bril, V; van Geloven, N.			Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial (vol 17, pg 35, 2018)	LANCET NEUROLOGY			English	Correction													BRIL, vera/ABA-6509-2020					van Schaik IN, 2018, LANCET NEUROL, V17, P35, DOI 10.1016/S1474-4422(17)30378-2	1	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2018	17	1					26	26		10.1016/S1474-4422(17)30378-2	http://dx.doi.org/10.1016/S1474-4422(17)30378-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ7VE		Green Submitted, Green Published			2022-12-18	WOS:000418570500017
J	Haroche, J; Cohen-Aubart, F; Emile, JF; Donadieu, J; Amoura, Z				Haroche, Julien; Cohen-Aubart, Fleur; Emile, Jean-Francois; Donadieu, Jean; Amoura, Zahir			Neurodegeneration in histiocytoses might start in utero	LANCET NEUROLOGY			English	Editorial Material							LANGERHANS CELL HISTIOCYTOSIS; MUTATION; NEOPLASMS; DISEASE		[Haroche, Julien; Cohen-Aubart, Fleur; Amoura, Zahir] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Serv Med Interne 2,Ctr Reference Histiocytoses,In, Paris, France; [Emile, Jean-Francois] Ambroise Pare Hosp, AP HP, EA4340, Boulogne, France; [Emile, Jean-Francois] Ambroise Par Hosp, AP HP, Pathol Dept, Boulogne, France; [Emile, Jean-Francois] Versailles Univ, Boulogne, France; [Donadieu, Jean] Univ Paris 06, Hop Trousseau, AP HP, Ctr Reference Histiocytoses,Serv Hematol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Haroche, J (corresponding author), Univ Paris 06, Hop Pitie Salpetriere, AP HP, Serv Med Interne 2,Ctr Reference Histiocytoses,In, Paris, France.	julien.haroche@aphp.fr	Aubart, Fleur Cohen/P-6583-2017					Durham BH, 2017, BLOOD, V130, P176, DOI 10.1182/blood-2016-12-757377; Emile JF, 2016, BLOOD, V127, P2672, DOI [10.1182/blood-2016-01690636, 10.1182/blood-2016-01-690636]; Haroche J, 2017, LANCET ONCOL, V18, pE113, DOI 10.1016/S1470-2045(17)30031-1; Heritier S, 2016, J CLIN ONCOL, V34, P3023, DOI 10.1200/JCO.2015.65.9508; Hervier B, 2014, BLOOD, V124, P1119, DOI 10.1182/blood-2013-12-543793; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; Rigaud C, 2016, BRIT J HAEMATOL, V174, P887, DOI 10.1111/bjh.14140	9	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2017	16	12					953	954		10.1016/S1474-4422(17)30373-3	http://dx.doi.org/10.1016/S1474-4422(17)30373-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8DJ	29111143				2022-12-18	WOS:000415315400006
J	Howard, JF; Utsugisawa, K; Benatar, M				Howard, J. F., Jr.; Utsugisawa, K.; Benatar, M.			Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebocontrolled, multicentre study (vol 16, pg 976, 2017)	LANCET NEUROLOGY			English	Correction													Benatar, Michael/AAF-6605-2019	Benatar, Michael/0000-0003-4241-5135; Roberts, Leslie/0000-0002-6040-8572				Howard JF, 2017, LANCET NEUROL, V16, P976, DOI 10.1016/S1474-4422(17)30369-1	1	2	2	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2017	16	12					954	954		10.1016/S1474-4422(17)30369-1	http://dx.doi.org/10.1016/S1474-4422(17)30369-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8DJ					2022-12-18	WOS:000415315400008
J	[Anonymous]				[Anonymous]			Alzheimer's disease: evolution of research diagnostic criteria	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2017	16	12					945	945		10.1016/S1474-4422(17)30376-9	http://dx.doi.org/10.1016/S1474-4422(17)30376-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8DJ	29165249	Bronze			2022-12-18	WOS:000415315400001
J	Oliver, D; de Visser, M; Voltz, R				Oliver, David; de Visser, Marianne; Voltz, Raymond			Palliative care in neurology	LANCET NEUROLOGY			English	Letter									[Oliver, David] Univ Kent, Tizard Ctr, Canterbury, Kent, England; [de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Voltz, Raymond] Univ Hosp Cologne, Dept Palliat Med, Cologne, Germany	University of Kent; University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne	Voltz, R (corresponding author), Univ Hosp Cologne, Dept Palliat Med, Cologne, Germany.	raymond.voltz@uk-koeln.de			Deutsche Multiple Sklerose Gesellschaft (DMSG)/Hertie Foundation; Federal Ministry of Education and Research (BMBF)	Deutsche Multiple Sklerose Gesellschaft (DMSG)/Hertie Foundation; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	RV reports grants from Deutsche Multiple Sklerose Gesellschaft (DMSG)/Hertie Foundation, and the Federal Ministry of Education and Research (BMBF). DO and MdV declare no competing interests.	[Anonymous], 2017, LANCET NEUROL, V16, P489, DOI 10.1016/S1474-4422(17)30176-X; German Guideline Programme in Oncology (German Cancer Society, EV BAS GUID PALL CAR; Oliver DJ, 2016, EUR J NEUROL, V23, P30, DOI 10.1111/ene.12889; Pace A, 2017, LANCET ONCOL, V18, pE330, DOI 10.1016/S1470-2045(17)30345-5	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2017	16	11					868	868		10.1016/S1474-4422(17)30320-4	http://dx.doi.org/10.1016/S1474-4422(17)30320-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FJ3WM		Bronze			2022-12-18	WOS:000412663200010
J	Bermel, RA				Bermel, Robert A.			Unravelling neurodegeneration in multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material							OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY		[Bermel, Robert A.] Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Bermel, RA (corresponding author), Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44106 USA.	bermelr@ccf.org		Bermel, Robert/0000-0003-2334-6883	Biogen; Novartis; Genentech; Genzyme; Teva	Biogen(Biogen); Novartis(Novartis); Genentech(Roche HoldingGenentech); Genzyme(Sanofi-AventisGenzyme Corporation); Teva(Teva Pharmaceutical Industries)	I have received grants and personal fees from Biogen, Novartis, and Genentech; and personal fees from Genzyme and Teva.	Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; Ontaneda D, 2017, LANCET, V389, P1357, DOI 10.1016/S0140-6736(16)31320-4; Petzold A, 2017, LANCET NEUROL, V16, P797, DOI 10.1016/S1474-4422(17)30278-8; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823	8	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2017	16	10					764	766		10.1016/S1474-4422(17)30302-2	http://dx.doi.org/10.1016/S1474-4422(17)30302-2			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG5PI	28920874				2022-12-18	WOS:000410379900004
J	Morgan, J				Morgan, Jules			David Menon: the incredible, incurable, clinical rationalist	LANCET NEUROLOGY			English	Biographical-Item																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2017	16	10					775	775		10.1016/S1474-4422(17)30298-3	http://dx.doi.org/10.1016/S1474-4422(17)30298-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG5PI	28920883				2022-12-18	WOS:000410379900014
J	Charlier, P; Saudamini, D; Lippi, D; Perciaccante, A; Appenzeller, O; Bianucci, R				Charlier, P.; Saudamini, D.; Lippi, D.; Perciaccante, A.; Appenzeller, O.; Bianucci, R.			The cerebrovascular health of Thomas Aquinas (vol 16, pg 502, 2017)	LANCET NEUROLOGY			English	Correction													Bianucci, Raffaella/AAW-1433-2020; Perciaccante, Antonio/R-3796-2017					Charlier P, 2017, LANCET NEUROL, V16, P502, DOI 10.1016/S1474-4422(17)30177-1	1	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2017	16	8					584	584		10.1016/S1474-4422(17)30177-1	http://dx.doi.org/10.1016/S1474-4422(17)30177-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA1LP	28653645				2022-12-18	WOS:000405201300011
J	Coley, N; Andrieu, S				Coley, Nicola; Andrieu, Sandrine		MAPT Study Grp	Lessons from the Multidomain Alzheimer Preventive Trial Reply	LANCET NEUROLOGY			English	Letter									[Coley, Nicola; Andrieu, Sandrine; MAPT Study Grp] Univ Toulouse III, INSERM, UMR 1027, Dept Epidemiol & Publ Hlth,CHU Toulouse, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Andrieu, S (corresponding author), Univ Toulouse III, INSERM, UMR 1027, Dept Epidemiol & Publ Hlth,CHU Toulouse, Toulouse, France.	sandrine.andrieu@univ-tlse3.fr	ANDRIEU, Sandrine/G-1343-2018; Coley, Nicola L/E-7048-2016	ANDRIEU, Sandrine/0000-0002-1142-770X; Coley, Nicola L/0000-0002-1671-824X	Ipsen; France Alzheimer; Biogen; Nutrition Sante; Pfizer; Icon; AMPA Association	Ipsen(Ipsen); France Alzheimer; Biogen(Biogen); Nutrition Sante; Pfizer(Pfizer); Icon; AMPA Association	SA has received grants from Europe, Ipsen, and France Alzheimer, served as a consultant for Ipsen, Pierre Fabre, Lilly, Nestle, Sanofi, and Servier, and received non-financial support from Biogen, Nutrition Sante, Pfizer, and Icon, and other support from the AMPA Association. NC declares no competing interests.	Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6	1	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2017	16	8					586	586		10.1016/S1474-4422(17)30226-0	http://dx.doi.org/10.1016/S1474-4422(17)30226-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA1LP	28721923	Bronze			2022-12-18	WOS:000405201300015
J	[Anonymous]				[Anonymous]			WHO has a dementia plan, now we need action	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2017	16	8					571	571		10.1016/S1474-4422(17)30207-7	http://dx.doi.org/10.1016/S1474-4422(17)30207-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA1LP	28721914	Bronze			2022-12-18	WOS:000405201300001
J	Charlier, P; Saudamini, D; Lippi, D; Perciaccante, A; Appenzeller, O; Bianucci, R				Charlier, Philippe; Saudamini, Deo; Lippi, Donatella; Perciaccante, Antonio; Appenzeller, Otto; Bianucci, Raffaella			The cerebrovascular health of Thomas Aquinas	LANCET NEUROLOGY			English	Editorial Material													Bianucci, Raffaella/AAW-1433-2020; Perciaccante, Antonio/R-3796-2017						0	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2017	16	7					502	502		10.1016/S1474-4422(17)30177-1	http://dx.doi.org/10.1016/S1474-4422(17)30177-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX4MH	28653645				2022-12-18	WOS:000403208400012
J	Schott, JM				Schott, Jonathan M.			Imaging the ageing brain: identifying early disease or opening Pandora's box?	LANCET NEUROLOGY			English	Editorial Material							ALZHEIMERS-DISEASE		[Schott, Jonathan M.] UCL, Dementia Res Ctr, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Schott, JM (corresponding author), UCL, Dementia Res Ctr, Inst Neurol, London WC1N 3BG, England.	j.schott@ucl.ac.uk	Schott, Jonathan M/A-9065-2011	Schott, Jonathan M/0000-0003-2059-024X	Roche; Eli Lilly; Merck Sharpe Dohme; AVID Radiopharmaceuticals; Axon Neuroscience; National Institute of Health Research Queen Square Dementia Biomedical Research Unit; University College London/Hospitals Biomedical Research Centre; Wolfson Foundation; Engineering and Physical Sciences Research Council; Medical Research Council; Alzheimer's Research UK; Brain Research Trust; European Union's Horizon programme	Roche(Roche Holding); Eli Lilly(Eli Lilly); Merck Sharpe Dohme(Merck & Company); AVID Radiopharmaceuticals; Axon Neuroscience; National Institute of Health Research Queen Square Dementia Biomedical Research Unit; University College London/Hospitals Biomedical Research Centre(General Electric); Wolfson Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Brain Research Trust; European Union's Horizon programme	I report personal fees for consulting from Roche, Eli Lilly, and Merck Sharpe Dohme; grants and non-financial support from AVID Radiopharmaceuticals; and fees for serving on a Drug Safety Monitoring Board from Axon Neuroscience. I have received support from the National Institute of Health Research Queen Square Dementia Biomedical Research Unit and University College London/Hospitals Biomedical Research Centre, Wolfson Foundation, Engineering and Physical Sciences Research Council, Medical Research Council, Alzheimer's Research UK, Brain Research Trust and the European Union's Horizon 2020 programme.	Chobanian AV, 2017, JAMA-J AM MED ASSOC, V317, P579, DOI 10.1001/jama.2017.0105; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack Jr CR, 2011, ANN NEUROL; Jack Jr CR, 2017, LANCET NEUROL; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V19, P1924; Mormino EC, 2016, JAMA NEUROL, V73, P1185, DOI 10.1001/jamaneurol.2016.2237; Schott JM, PRACT NEURO IN PRESS; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tosun D, 2017, BRAIN	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2017	16	6					411	413		10.1016/S1474-4422(17)30116-3	http://dx.doi.org/10.1016/S1474-4422(17)30116-3			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU1WD	28456480				2022-12-18	WOS:000400815800003
J	Campbell, BCV; Mitchell, PJ; Davis, SM; Donnan, GA				Campbell, Bruce C. V.; Mitchell, Peter J.; Davis, Stephen M.; Donnan, Geoffrey A.			The long-term benefits of endovascular therapy	LANCET NEUROLOGY			English	Editorial Material							ACUTE ISCHEMIC-STROKE; INTRAVENOUS ALTEPLASE; CONTROLLED-TRIAL; THROMBECTOMY; METAANALYSIS		[Campbell, Bruce C. V.; Davis, Stephen M.] Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Mitchell, Peter J.] Royal Melbourne Hosp, Dept Radiol, Parkville, Vic, Australia; [Campbell, Bruce C. V.; Donnan, Geoffrey A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	Royal Melbourne Hospital; Royal Melbourne Hospital; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Donnan, GA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	gdonnan@unimelb.edu.au	Campbell, Bruce/AGY-4147-2022; Campbell, Bruce/J-1220-2019; Davis, Stephen/L-5260-2013	Campbell, Bruce/0000-0003-3632-9433; Davis, Stephen/0000-0003-0962-2300	Stryker; Medtronic	Stryker; Medtronic(Medtronic)	We did the EXTEND-IA trial of thrombectomy for which Medtronic provided an unrestricted grant to the Florey Institute of Neuroscience and Mental Health. PJM also declares serving without remuneration on medical advisory boards for Codman Johnson and Johnson and receipt of speaker's fees from Stryker and Medtronic.	Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Davalos A, 2017, LANCET NEUROL; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Lindsay P, 2014, INT J STROKE, V9, P4, DOI 10.1111/ijs.12371; Mocco J, 2016, STROKE, V47, P2331, DOI 10.1161/STROKEAHA.116.013372; Muir KW, 2017, J NEUROL NEUROSUR PS, V88, P38, DOI 10.1136/jnnp-2016-314117; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; van den Berg L, 2016, EUR STROK ORG C BARC	13	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2017	16	5					337	338		10.1016/S1474-4422(17)30079-0	http://dx.doi.org/10.1016/S1474-4422(17)30079-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER4PH	28318983				2022-12-18	WOS:000398782100004
J	Darweesh, SKL; Koudstaal, PJ; Ikram, MK; Ikram, MA				Darweesh, Sirwan K. L.; Koudstaal, Peter J.; Ikram, M. Kamran; Ikram, M. Arfan			Cognitive decline before diagnosis of Parkinson's disease	LANCET NEUROLOGY			English	Letter									[Darweesh, Sirwan K. L.; Ikram, M. Kamran; Ikram, M. Arfan] Erasmus MC Univ, Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Darweesh, Sirwan K. L.; Koudstaal, Peter J.; Ikram, M. Kamran; Ikram, M. Arfan] Erasmus MC Univ, Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [Darweesh, Sirwan K. L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Ikram, M. Arfan] Erasmus MC Univ, Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC	Ikram, MA (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands.; Ikram, MA (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands.; Ikram, MA (corresponding author), Erasmus MC Univ, Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands.	m.a.ikram@erasmusmc.nl	Darweesh, Sirwan/AHB-3068-2022; Ikram, M. Arfan/AAM-5225-2021; Darweesh, Sirwan/ABG-8906-2021	Darweesh, Sirwan/0000-0002-4361-4593; Ikram, Mohammad Kamran/0000-0003-0173-9571				Darweesh SKL, 2017, BRAIN, V140, P429, DOI 10.1093/brain/aww291; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Schrag A, 2017, LANCET NEUROL, V16, P66, DOI 10.1016/S1474-4422(16)30328-3	4	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2017	16	4					262	262		10.1016/S1474-4422(17)30042-X	http://dx.doi.org/10.1016/S1474-4422(17)30042-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN9RF	28327331				2022-12-18	WOS:000396336600011
J	Schrag, A; Weintraub, D; Schott, JM				Schrag, Anette; Weintraub, Daniel; Schott, Jonathan M.			Cognitive decline before diagnosis of Parkinson's disease Reply	LANCET NEUROLOGY			English	Letter									[Schrag, Anette; Schott, Jonathan M.] UCL, UCL Inst Neurol, London, England; [Weintraub, Daniel] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of London; University College London; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center	Schrag, A (corresponding author), UCL, UCL Inst Neurol, London, England.	a.schrag@ucl.ac.uk	Schott, Jonathan M/A-9065-2011; Weintraub, Daniel/AAD-8309-2020; Schrag, Anette/AAA-9344-2020; Weintraub, Daniel/AAC-5232-2020	Schott, Jonathan M/0000-0003-2059-024X; Schrag, Anette/0000-0002-9872-6680; Weintraub, Daniel/0000-0003-0633-7168	Economic and Social Research Council; GE Healthcare; Parkinson's UK; EU FP7; Movement Disorders Society; Medtronic; AstraZeneca; Roche; Eli Lilly; AVID Radiopharmaceuticals	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); GE Healthcare(General ElectricGE Healthcare); Parkinson's UK(Parkinson's UK); EU FP7(European Commission); Movement Disorders Society; Medtronic(Medtronic); AstraZeneca(AstraZeneca); Roche(Roche Holding); Eli Lilly(Eli Lilly); AVID Radiopharmaceuticals	AS reports grants from Economic and Social Research Council, GE Healthcare, Parkinson's UK, EU FP7, and the Movement Disorders Society; and personal fees from Medtronic and AstraZeneca. JMS reports personal fees from Roche and Eli Lilly, grants and non-financial support from AVID Radiopharmaceuticals, and serves on a data safety management board for Axon Neuroscience. DW declares no competing interests.	Chahine LM, 2016, MOVEMENT DISORD, V31, P86, DOI 10.1002/mds.26373; Darweesh SKL, 2017, BRAIN, V140, P429, DOI 10.1093/brain/aww291; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Schrag A, 2015, LANCET NEUROL; Schrag A, 2017, LANCET NEUROL, V16, P66, DOI 10.1016/S1474-4422(16)30328-3	5	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2017	16	4					262	262		10.1016/S1474-4422(17)30043-1	http://dx.doi.org/10.1016/S1474-4422(17)30043-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN9RF	28327332	Bronze			2022-12-18	WOS:000396336600012
J	Albanese, E; Shah, H; Rudan, I; Dua, T				Albanese, Emiliano; Shah, Hirai; Rudan, Igor; Dua, Tarun		WHO's Res Priority Setting Grp Dem	Dementia research priorities-1	LANCET NEUROLOGY			English	Letter							HEALTH RESEARCH		[Albanese, Emiliano] Univ Geneva, Dept Psychiat, CH-1211 Geneva 4, Switzerland; [Shah, Hirai] Columbia Univ, Dept Neurol, New York, NY USA; [Rudan, Igor] Univ Edinburgh, Usher Inst, Ctr Global Hlth Res, Edinburgh EH8 9YL, Midlothian, Scotland; [Dua, Tarun] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva 27, Switzerland	University of Geneva; Columbia University; University of Edinburgh; World Health Organization	Dua, T (corresponding author), WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva 27, Switzerland.	duat@who.int	Rudan, Igor/I-1467-2012	Rudan, Igor/0000-0001-6993-6884	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Rudan I, 2012, PUBLIC HEALTH, V126, P237, DOI 10.1016/j.puhe.2011.12.001; Rudan I, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010501; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Schneider LS, 2016, LANCET NEUROL, V15, P1202, DOI 10.1016/S1474-4422(16)30258-7; Shah H, 2016, LANCET NEUROL, V15, P1283, DOI 10.1016/S1474-4422(16)30235-6; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010507	6	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2017	16	3					180	181		10.1016/S1474-4422(17)30006-6	http://dx.doi.org/10.1016/S1474-4422(17)30006-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK4ZC	28229884	Bronze			2022-12-18	WOS:000393935700009
J	Quaglio, G; Corbetta, M; Karapiperis, T; Amunts, K; Koroshetz, W; Yamamori, T; Draghia-Akli, R				Quaglio, Gianluca; Corbetta, Maurizio; Karapiperis, Theodoros; Amunts, Katrin; Koroshetz, Walter; Yamamori, Tetsuo; Draghia-Akli, Ruxandra			Understanding the brain through large, multidisciplinary research initiatives	LANCET NEUROLOGY			English	Letter							NEUROSCIENCE		[Quaglio, Gianluca; Karapiperis, Theodoros] European Parliament, European Parliamentary Res Serv, Sci Foresight Unit Sci & Technol Opt Assessment, Brussels, Belgium; [Corbetta, Maurizio] Univ Padua, Padua, Italy; [Corbetta, Maurizio] Washington Univ, Sch Med, St Louis, MO USA; [Amunts, Katrin] Inst Neurosci & Med, INM 1, Julich Res Ctr, Julich, Germany; [Amunts, Katrin] Univ Hosp Dusseldorf, Cecile & Oskar Vogt Brain Res, Dusseldorf, Germany; Human Brain Project, Sci & Infrastruct Board, Vienna, Austria; [Koroshetz, Walter] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Koroshetz, Walter] Natl Inst Hlth Brain Initiat, Bethesda, MD USA; [Yamamori, Tetsuo] Riken Brain Sci Inst, Wako, Saitama, Japan; [Yamamori, Tetsuo] Brain MINDS Project, Wako, Saitama, Japan; [Draghia-Akli, Ruxandra] European Commiss, Directorate General Res & Innovat, Brussels, Belgium	University of Padua; Washington University (WUSTL); Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; RIKEN	Quaglio, G (corresponding author), European Parliament, European Parliamentary Res Serv, Sci Foresight Unit Sci & Technol Opt Assessment, Brussels, Belgium.	gianluca.quaglio@europarl.europa.eu	Corbetta, Maurizio/AAZ-5219-2020; Yamamori, Tetsuo/N-6536-2015; Amunts, Katrin/I-3470-2013	Yamamori, Tetsuo/0000-0001-5016-0078; Draghia-Akli, Ruxandra/0000-0001-6372-4039; CORBETTA, MAURIZIO/0000-0001-8295-3304; Amunts, Katrin/0000-0001-5828-0867	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	KA reports grants from the European Commission. All other authors declare no competing interests. The views expressed in this letter are the sole responsibility of the authors and do not necessarily reflect the views of their affiliated organisations.	Amunts K, 2016, NEURON, V92, P574, DOI 10.1016/j.neuron.2016.10.046; Brose K, 2016, NEURON, V92, P557, DOI 10.1016/j.neuron.2016.10.047; Dyson FJ, 2012, SCIENCE, V338, P1426, DOI 10.1126/science.1232773; Huang ZJ, 2015, SCIENCE, V350, P42, DOI 10.1126/science.aad4120; Jorgenson LA, 2015, PHILOS T R SOC LON B; Michie PT, 2016, NEURON, V92, P597, DOI 10.1016/j.neuron.2016.10.038; Poo MM, 2016, NEURON, V92, P591, DOI 10.1016/j.neuron.2016.10.050	7	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2017	16	3					183	184		10.1016/S1474-4422(17)30020-0	http://dx.doi.org/10.1016/S1474-4422(17)30020-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK4ZC	28229889	Bronze, Green Published			2022-12-18	WOS:000393935700014
J	Wills, AM				Wills, Anne-Marie			Blockade of the neurite outgrowth inhibitor Nogo-A in amyotrophic lateral sclerosis	LANCET NEUROLOGY			English	Editorial Material							MODEL		[Wills, Anne-Marie] Massachusetts Gen Hosp, Dept Neurol, WACC 715,55 Fruit St, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Wills, AM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, WACC 715,55 Fruit St, Boston, MA 02114 USA.	Awills@partners.org						Bros-Facer V, 2014, HUM MOL GENET, V23, P4187, DOI 10.1093/hmg/ddu136; Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522; Jokic N, 2006, EMBO REP, V7, P1162, DOI 10.1038/sj.embor.7400826; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Meininger V, 2017, LANCET NEUROL; Meininger V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097803; Miller R. G., 2012, COCHRANE DB SYST REV, V3; Smith R, 2017, NEUROTHERAPEUTICS, V14, P762, DOI 10.1007/s13311-016-0508-5; Tanaka M., 2016, NEUROLOGY S, V86; Wojcik S, 2006, Acta Myol, V25, P116	11	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2017	16	3					175	176		10.1016/S1474-4422(17)30009-1	http://dx.doi.org/10.1016/S1474-4422(17)30009-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK4ZC	28139348				2022-12-18	WOS:000393935700004
J	[Anonymous]				[Anonymous]			The Human Brain Project: adjusting the flagship's course	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2017	16	3					171	171		10.1016/S1474-4422(17)30013-3	http://dx.doi.org/10.1016/S1474-4422(17)30013-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK4ZC	28229880	Bronze			2022-12-18	WOS:000393935700001
J	Brigo, F				Brigo, Francesco			Lacosamide monotherapy for newly diagnosed epilepsy	LANCET NEUROLOGY			English	Editorial Material							PARTIAL-ONSET SEIZURES; CONTROLLED-RELEASE CARBAMAZEPINE; RANDOMIZED CONTROLLED-TRIAL; ANTIEPILEPTIC DRUGS; ADJUNCTIVE THERAPY; EFFICACY; SAFETY		[Brigo, Francesco] Univ Verona, Dept Neurosci Biomed & Movement, I-1037134 Verona, Italy; [Brigo, Francesco] Franz Tappeiner Hosp, Div Neurol, Merano, Italy	Ospedale Franz Tappeiner	Brigo, F (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement, I-1037134 Verona, Italy.; Brigo, F (corresponding author), Franz Tappeiner Hosp, Div Neurol, Merano, Italy.	dr.francescobrigo@gmail.com	Brigo, Francesco/H-6513-2013	Brigo, Francesco/0000-0003-0928-1577				[Anonymous], 2010, GUID CLIN INV MED PR; Baulac M, 2016, LANCET NEUROL; Baulac M, 2012, LANCET NEUROL, V11, P579, DOI 10.1016/S1474-4422(12)70105-9; Ben-Menachem E, 2007, EPILEPSIA, V48, P1308, DOI 10.1111/j.1528-1167.2007.01188.x; Ben-Menachem E, 2016, NEUROLOGY, V87, pE20; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; Chung S, 2010, EPILEPSIA, V51, P958, DOI 10.1111/j.1528-1167.2009.02496.x; Glauser T, 2013, EPILEPSIA; Halasz P, 2009, EPILEPSIA, V50, P443, DOI 10.1111/j.1528-1167.2008.01951.x; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Mintzer S, 2015, LANCET NEUROL, V14, P1229, DOI 10.1016/S1474-4422(15)00229-X; Perucca E, 1998, EPILEPSIA, V39, P5, DOI 10.1111/j.1528-1157.1998.tb01268.x; Porter RJ, 2010, EPILEPSY RES, V89, P163, DOI 10.1016/j.eplepsyres.2010.02.005	13	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2017	16	1					20	22		10.1016/s1474-4422(16)30279-4	http://dx.doi.org/10.1016/s1474-4422(16)30279-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE8IP	27889313				2022-12-18	WOS:000389869200013
J	Roshdy, A; Saleh, AS				Roshdy, Ashraf; Saleh, Ahmad Sabry			Salzburg criteria: can we extend validation to critical care?	LANCET NEUROLOGY			English	Letter							NONCONVULSIVE STATUS EPILEPTICUS; ADULTS; EEG		[Roshdy, Ashraf] Univ Alexandria, Dept Crit Care Med, Fac Med, Alexandria 21563, Egypt; [Saleh, Ahmad Sabry] Okba Ben Nafee Hosp, Intens Care Unit, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	Roshdy, A (corresponding author), Univ Alexandria, Dept Crit Care Med, Fac Med, Alexandria 21563, Egypt.	ashrafroshdy76@hotmail.com	Roshdy, Ashraf/D-9715-2014; Saleh, Ahmad Sabry/AAG-9732-2019	Roshdy, Ashraf/0000-0002-8656-9606; Saleh, Ahmad Sabry/0000-0001-9791-1086				Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Fernandez-Torre JL, 2012, CLIN NEUROPHYSIOL, V123, P244, DOI 10.1016/j.clinph.2011.06.020; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Holtkamp Martin, 2011, Ther Adv Neurol Disord, V4, P169, DOI 10.1177/1756285611403826; Leitinger M, 2016, LANCET NEUROL, V15, P1054, DOI 10.1016/S1474-4422(16)30137-5	5	2	3	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2017	16	1					25	25		10.1016/S1474-4422(16)30347-7	http://dx.doi.org/10.1016/S1474-4422(16)30347-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE8IP	27979347	Bronze			2022-12-18	WOS:000389869200018
J	Lynch, DR; Kichula, E				Lynch, David R.; Kichula, Elizabeth			Challenges ahead for trials in Friedreich's ataxia	LANCET NEUROLOGY			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; CLINICAL-TRIAL; PROGRESSION; IDEBENONE		[Lynch, David R.; Kichula, Elizabeth] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Lynch, David R.; Kichula, Elizabeth] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; [Lynch, David R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Lynch, DR (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.; Lynch, DR (corresponding author), Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA.; Lynch, DR (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	lynchd@mail.med.upenn.edu						Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; Friedman LS, 2010, MOVEMENT DISORD, V25, P426, DOI 10.1002/mds.22912; Lynch DR, 2012, MOVEMENT DISORD, V27, P1026, DOI 10.1002/mds.25058; Lynch DR, 2010, ARCH NEUROL-CHICAGO, V67, P941, DOI 10.1001/archneurol.2010.168; Lynch DR, MEASURING FRIEDREICH; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Patel M, 2016, ANN CLIN TRANSL NEUR, V3, P684, DOI 10.1002/acn3.332; Reetz K, 2017, LANCET NEUROL, V16, P954, DOI 10.1016/S1474-4422(16)30287-3; Reetz K, 2015, LANCET NEUROL, V14, P174, DOI 10.1016/S1474-4422(14)70321-7; Regner SR, 2012, J CHILD NEUROL, V27, P1152, DOI 10.1177/0883073812448462; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Seyer L, 2015, ACTA NEUROL SCAND, V132, P7, DOI 10.1111/ane.12337; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023	13	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2016	15	13					1300	1301		10.1016/S1474-4422(16)30281-2	http://dx.doi.org/10.1016/S1474-4422(16)30281-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB6XV	27839636				2022-12-18	WOS:000387529800004
J	Scorza, FA; Scorza, CA; Cavalheiro, EA				Scorza, Fulvio A.; Scorza, Carla A.; Cavalheiro, Esper A.			Omega-3 fatty acids and SUDEP prevention	LANCET NEUROLOGY			English	Letter							SUDDEN UNEXPECTED DEATH; EPILEPSY		[Scorza, Fulvio A.; Scorza, Carla A.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Neurociencia, BR-04039032 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Scorza, FA (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Disciplina Neurociencia, BR-04039032 Sao Paulo, Brazil.	scorza@unifesp.br	Scorza, Carla Alessandra/C-4199-2013; Cavalheiro, Esper/N-3985-2019; Cavalheiro, Esper A/I-3084-2016; Scorza, Carla A/AAV-2417-2020; Scorza, Fulvio/C-7048-2013; Cavalheiro, Esper A/F-4325-2014	Scorza, Carla Alessandra/0000-0001-7810-4748; Cavalheiro, Esper/0000-0002-0854-3582; Cavalheiro, Esper A/0000-0002-0854-3582; Scorza, Carla A/0000-0001-7810-4748; Scorza, Fulvio/0000-0002-0694-8674; Cavalheiro, Esper A/0000-0002-0854-3582				DeGiorgio CM, EXPERT REV IN PRESS; Devinsky O, 2016, LANCET NEUROL, V15, P1075, DOI 10.1016/S1474-4422(16)30158-2; Pansani AP, 2016, EXPERT REV NEUROTHER, V16, P561, DOI 10.1586/14737175.2016.1169925; Scorza FA, 2008, EPILEPSY BEHAV, V13, P279, DOI 10.1016/j.yebeh.2008.04.011; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2016	15	13					1303	1303		10.1016/S1474-4422(16)30290-3	http://dx.doi.org/10.1016/S1474-4422(16)30290-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB6XV	27839640				2022-12-18	WOS:000387529800011
J	Ross, OA; Rademakers, R				Ross, Owen A.; Rademakers, Rosa			Modifiers of LRRK2 parkinsonism: new therapeutic targets	LANCET NEUROLOGY			English	Editorial Material							DISEASE; DYNAMIN; AGE		[Ross, Owen A.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Ross, OA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu		Ross, Owen/0000-0003-4813-756X				Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Hill-Burns EM, 2016, HUM MOL GENET, V25, P3849, DOI 10.1093/hmg/ddw206; Lill CM, 2015, MOVEMENT DISORD, V30, P847, DOI 10.1002/mds.26237; Marder K, 2015, NEUROLOGY, V85, P89, DOI 10.1212/WNL.0000000000001708; Nalls MA, 2015, MOVEMENT DISORD, V30, P850, DOI 10.1002/mds.26192; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Stafa K, 2014, HUM MOL GENET, V23, P2055, DOI 10.1093/hmg/ddt600; Trinh J, 2016, LANCET NEUROL	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2016	15	12					1200	1201		10.1016/S1474-4422(16)30243-5	http://dx.doi.org/10.1016/S1474-4422(16)30243-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA0YO	27692901				2022-12-18	WOS:000386315700005
J	Werring, DJ				Werring, David J.			Outlook for intracerebral haemorrhage after a MISTIE spell	LANCET NEUROLOGY			English	Editorial Material							SURGERY; METAANALYSIS		[Werring, David J.] UCL, Inst Neurol, Ctr Stroke Res, Dept Brain Repair & Rehabil,Natl Hosp Neurol & Ne, Queen Sq, London WC1N 3BG, England	University of London; University College London	Werring, DJ (corresponding author), UCL, Inst Neurol, Ctr Stroke Res, Dept Brain Repair & Rehabil,Natl Hosp Neurol & Ne, Queen Sq, London WC1N 3BG, England.	d.werring@ucl.ac.uk	Werring, David/Q-8435-2019	Werring, David/0000-0003-2074-1861	Stroke Association [TSABHF2009/01] Funding Source: researchfish	Stroke Association		Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Hanley DF, 2016, LANCET NEUROL, V15, P1226, DOI 10.1016/S1474-4422(16)30234-4; Langhorne P, 2013, STROKE, V44, P3044, DOI 10.1161/STROKEAHA.113.001564; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Zhou XY, 2012, STROKE, V43, P2923, DOI 10.1161/STROKEAHA.112.667535	8	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2016	15	12					1197	1199		10.1016/S1474-4422(16)30245-9	http://dx.doi.org/10.1016/S1474-4422(16)30245-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA0YO	27751536	Green Submitted			2022-12-18	WOS:000386315700003
J	Calabro, RS; Bramanti, P; Naro, A				Calabro, Rocco Salvatore; Bramanti, Placido; Naro, Antonino			Towards new methods of diagnosis in disorders of consciousness	LANCET NEUROLOGY			English	Letter							VEGETATIVE STATE; AWARENESS		[Calabro, Rocco Salvatore; Bramanti, Placido; Naro, Antonino] IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy	IRCCS Bonino Pulejo	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, I-98124 Messina, Italy.	salbro77@tiscali.it	calabro, rocco salvatore/L-9570-2019; Calabrò, Rocco S/K-7520-2016; Bramanti, Placido/K-5117-2016	calabro, rocco salvatore/0000-0002-8566-3166; 				Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Formisano R, 2013, BRAIN INJURY, V27, P1332, DOI 10.3109/02699052.2013.809555; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2016	15	11					1114	1115		10.1016/S1474-4422(16)30202-2	http://dx.doi.org/10.1016/S1474-4422(16)30202-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX3MJ	27647635	Bronze			2022-12-18	WOS:000384276900009
J	Winblad, B; Qiu, CX; Ballard, C; Johansson, G				Winblad, Bengt; Qiu, Chengxuan; Ballard, Clive; Johansson, Gunilla			Evidence-based prevention and treatment of dementia Reply	LANCET NEUROLOGY			English	Letter							RISK; BMI		[Winblad, Bengt; Johansson, Gunilla] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Neurogeriatr, SE-14157 Huddinge, Sweden; [Qiu, Chengxuan] Karolinska Inst, Ageing Res Ctr, SE-14157 Huddinge, Sweden; [Winblad, Bengt] Karolinska Inst, SE-14157 Huddinge, Sweden; [Winblad, Bengt] Karolinska Univ Hosp, Dept Geriatr Med, Huddinge, Sweden; [Ballard, Clive] Kings Coll London, Wolfson Ctr Age Related Dis, London, England	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of London; King's College London	Winblad, B (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Div Neurogeriatr, SE-14157 Huddinge, Sweden.; Winblad, B (corresponding author), Karolinska Inst, SE-14157 Huddinge, Sweden.; Winblad, B (corresponding author), Karolinska Univ Hosp, Dept Geriatr Med, Huddinge, Sweden.	bengt-winblad-swedishbrainpower@ki.se		Ballard, Clive/0000-0003-0022-5632				Gustafson D, 2015, LANCET DIABETES ENDO, V3, P397, DOI 10.1016/S2213-8587(15)00085-6; Irish Department of Health, 2014, IR NAT DEM STRAT; Pareja-Galeano H, 2015, LANCET DIABETES ENDO, V3, P499, DOI 10.1016/S2213-8587(15)00214-4; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Qiu CX, 2015, NAT REV CARDIOL, V12, P267, DOI 10.1038/nrcardio.2014.223; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P501, DOI 10.1016/S2213-8587(15)00220-X; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Smith AD, 2010, PLOS ONE, V5; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4	9	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2016	15	10					1007	1008		10.1016/S1474-4422(16)30128-4	http://dx.doi.org/10.1016/S1474-4422(16)30128-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT1ZJ	27450477	Bronze			2022-12-18	WOS:000381280300014
J	Martinez-Lapiscina, EH; Andorra, M; Sanchez-Dalmau, B; Villoslada, P				Martinez-Lapiscina, Elena H.; Andorra, Magi; Sanchez-Dalmau, Bernardo; Villoslada, Pablo			Phenytoin for neuroprotection	LANCET NEUROLOGY			English	Letter							ACUTE OPTIC NEURITIS; MULTIPLE-SCLEROSIS		[Martinez-Lapiscina, Elena H.; Andorra, Magi; Sanchez-Dalmau, Bernardo; Villoslada, Pablo] Inst Invest Biomed August Pi Sunyer, Barcelona, Spain; [Sanchez-Dalmau, Bernardo] Univ Barcelona, Hosp Clin Barcelona, Barcelona, Spain; [Villoslada, Pablo] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of California System; University of California San Francisco	Martinez-Lapiscina, EH (corresponding author), Inst Invest Biomed August Pi Sunyer, Barcelona, Spain.	hernandez@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019; Martínez-Lapiscina, Elena H/L-1161-2014; Andorra, Magi/D-8726-2015	Martínez-Lapiscina, Elena H/0000-0003-4272-0826; Sanchez-Dalmau, Bernardo F./0000-0001-8950-9759; Andorra, Magi/0000-0002-0491-3144				Balcer LJ, 2000, MULT SCLER J, V6, P163, DOI 10.1191/135245800701566025; Gabilondo I, 2015, ANN NEUROL, V77, P517, DOI 10.1002/ana.24351; Pineles SL, 2011, AM J OPHTHALMOL, V152, P133, DOI 10.1016/j.ajo.2011.01.023; Raftopoulos R, 2016, LANCET NEUROL, V15, P259, DOI 10.1016/S1474-4422(16)00004-1; Saidha S, 2016, LANCET NEUROL, V15, P233, DOI 10.1016/S1474-4422(16)00024-7	5	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2016	15	9					901	902		10.1016/S1474-4422(16)30093-X	http://dx.doi.org/10.1016/S1474-4422(16)30093-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT1YY	27478946	Bronze			2022-12-18	WOS:000381279200009
J	Stewart, W; Smith, DH				Stewart, William; Smith, Douglas H.			Time to be blunt about blast traumatic brain injury	LANCET NEUROLOGY			English	Editorial Material									[Stewart, William; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Stewart, William; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Pennsylvania; University of Pennsylvania; Queen Elizabeth University Hospital (QEUH); University of Glasgow	Stewart, W (corresponding author), Univ Penn, Penn Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Stewart, W (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.; Stewart, W (corresponding author), Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland.; Stewart, W (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	William.Stewart@glasgow.ac.uk		Stewart, William/0000-0003-2199-2582	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS056202, R01NS092398, R01NS094003, R01NS038104] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS038104, R01 NS094003, R01 NS092398, P01 NS056202] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shively SB, 2016, LANCET NEUROL, DOI DOI 10.1016/51474-4422; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; US Army Medical Research and Materiel Command, 2015, ANN REPORT; US Department of Defense, SPEC REP TRAUM BRIAN	10	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2016	15	9					896	898		10.1016/S1474-4422(16)30058-8	http://dx.doi.org/10.1016/S1474-4422(16)30058-8			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT1YY	27291519	Bronze, Green Accepted			2022-12-18	WOS:000381279200005
J	Warf, B				Warf, Benjamin			Surgery for epilepsy: the need for global acceptance and access	LANCET NEUROLOGY			English	Editorial Material							HYDROCEPHALUS		[Warf, Benjamin] Harvard Med Sch, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA; [Warf, Benjamin] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Warf, B (corresponding author), Harvard Med Sch, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.; Warf, B (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	Benjamin.warf@childrens.harvard.edu						Boling W, 2009, EPILEPSIA, V50, P1256, DOI 10.1111/j.1528-1167.2008.01984.x; Jette N, 2016, LANCET NEUROL, V15, P982, DOI 10.1016/S1474-4422(16)30127-2; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; RWIZA HT, 1992, EPILEPSIA, V33, P1051, DOI 10.1111/j.1528-1157.1992.tb01758.x; Warf BC, 2005, J NEUROSURG, V102, P1, DOI 10.3171/ped.2005.102.1.0001; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221	7	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2016	15	9					898	899		10.1016/S1474-4422(16)30141-7	http://dx.doi.org/10.1016/S1474-4422(16)30141-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT1YY	27478944				2022-12-18	WOS:000381279200006
J	Romano, S; Coarelli, G; Vanacore, N; Salvetti, M; Ristori, G				Romano, Silvia; Coarelli, Giulia; Vanacore, Nicola; Salvetti, Marco; Ristori, Giovanni			Riluzole in patients with hereditary cerebellar ataxia Reply	LANCET NEUROLOGY			English	Letter							DOUBLE-BLIND; TRIAL		[Romano, Silvia; Coarelli, Giulia; Salvetti, Marco; Ristori, Giovanni] Univ Roma La Sapienza, Fac Med 2, S Andrea Hosp, Ctr Expt Neurol Therapies CENTERS, I-00189 Rome, Italy; [Vanacore, Nicola] Natl Inst Hlth, Natl Ctr Epidemiol, Rome, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Istituto Superiore di Sanita (ISS)	Ristori, G (corresponding author), Univ Roma La Sapienza, Fac Med 2, S Andrea Hosp, Ctr Expt Neurol Therapies CENTERS, I-00189 Rome, Italy.	giovanni.ristori@uniroma1.it	Salvetti, Marco/K-3836-2016; Vanacore, Nicola/ABC-7196-2021; Romano, Silvia/P-7984-2015	Romano, Silvia/0000-0003-0499-8843; RISTORI, Giovanni/0000-0002-6598-6777				Durr A, 2015, LANCET NEUROL, V14, P968, DOI 10.1016/S1474-4422(15)00217-3; Jacobi H, 2015, LANCET NEUROL, V14, P1101, DOI 10.1016/S1474-4422(15)00202-1; Ristori G, 2010, NEUROLOGY, V74, P839, DOI 10.1212/WNL.0b013e3181d31e23; Romano S, 2015, LANCET NEUROL, V14, P985, DOI 10.1016/S1474-4422(15)00201-X	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2016	15	8					789	789		10.1016/S1474-4422(16)00117-4	http://dx.doi.org/10.1016/S1474-4422(16)00117-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO1NR	27302353				2022-12-18	WOS:000377545800012
J	Tariot, PN; Langbaum, JB; Reiman, EM				Tariot, Pierre N.; Langbaum, Jessica B.; Reiman, Eric M.		Alzheimer's Prevention Initiative	What are we willing to accept for preventing Alzheimer's disease? Reply	LANCET NEUROLOGY			English	Letter							GENE; METAANALYSIS; ASSOCIATION; RISK; APOE		[Tariot, Pierre N.; Langbaum, Jessica B.; Reiman, Eric M.; Alzheimer's Prevention Initiative] Banner Alzheimers Inst, Phoenix, AZ 85006 USA	Banner Research; Banner Health; Banner Alzheimer's Institute	Tariot, PN (corresponding author), Banner Alzheimers Inst, Phoenix, AZ 85006 USA.	Pierre.Tariot@bannerhealth.com			NIA NIH HHS [P30 AG019610, UF1 AG046150] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [UF1AG046150, P30AG019610] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; Langbaum JB, 2014, ALZHEIMERS DEMENT, V10, P666, DOI 10.1016/j.jalz.2014.02.002; Reiman EM, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.177; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Strobel G., 2011, SCI REGULATORS DISCU	10	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2016	15	7					660	661		10.1016/S1474-4422(16)30055-2	http://dx.doi.org/10.1016/S1474-4422(16)30055-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM7OG	27302231	Bronze			2022-12-18	WOS:000376549300014
J	von Kummer, R				von Kummer, Ruediger			Early CT Score to establish stroke treatment	LANCET NEUROLOGY			English	Editorial Material							ACUTE ISCHEMIC-STROKE; CEREBRAL-ARTERY OCCLUSION; THROMBOLYTIC THERAPY; ALTEPLASE; TRIAL; ECASS; RATS		[von Kummer, Ruediger] Univ Hosp Carl Gustav Carus, Inst Diagnost & Intervent Neuroradiol, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	von Kummer, R (corresponding author), Univ Hosp Carl Gustav Carus, Inst Diagnost & Intervent Neuroradiol, D-01307 Dresden, Germany.	ruediger.vonkummer@uniklinikum-dresden.de	von Kummer, Rüdiger/AAA-4478-2019	von Kummer, Rüdiger/0000-0003-0119-4604				Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Dzialowski I, 2004, J NEUROIMAGING, V14, P42, DOI 10.1177/1051228403258135; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; GARCIA JH, 1995, STROKE, V26, P636, DOI 10.1161/01.STR.26.4.636; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HEISS WD, 1983, ANN NEUROL, V14, P294, DOI 10.1002/ana.410140307; Hill MD, 2003, STROKE, V34, P1925, DOI 10.1161/01.STR.0000082483.37127.D0; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; von Kummer R, 2001, RADIOLOGY, V219, P95, DOI 10.1148/radiology.219.1.r01ap0695; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Yoo AJ, 2016, LANCET NEUROL, V15, P685, DOI 10.1016/S1474-4422(16)00124-1	13	2	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2016	15	7					651	653		10.1016/S1474-4422(16)30032-1	http://dx.doi.org/10.1016/S1474-4422(16)30032-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM7OG	27302223				2022-12-18	WOS:000376549300003
J	Aboulenein-Djamshidian, F; Serbecic, N; Kristoferitsch, W				Aboulenein-Djamshidian, Fahmy; Serbecic, Nermin; Kristoferitsch, Wolfgang			Optical coherence tomography in multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material									[Aboulenein-Djamshidian, Fahmy; Kristoferitsch, Wolfgang] Karl Landsteiner Inst Neuroimmunol & Neurodegener, Vienna, Austria; [Aboulenein-Djamshidian, Fahmy] SMZ Ost Donauspital, Dept Neurol, A-1220 Vienna, Austria; [Serbecic, Nermin] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Donauspital; Ruprecht Karls University Heidelberg	Aboulenein-Djamshidian, F (corresponding author), Karl Landsteiner Inst Neuroimmunol & Neurodegener, Vienna, Austria.; Aboulenein-Djamshidian, F (corresponding author), SMZ Ost Donauspital, Dept Neurol, A-1220 Vienna, Austria.	fahmy.aboulenein@meduniwien.ac.at						Aboulenein-Djamshidian F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142272; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Kesselring J, 1997, MULTIPLE SCLEROSIS; Martinez-Lapiscina E. H., 2016, LANCET NEUROL; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Serbecic N, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00020; Serbecic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019843; Serbecic N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013877; ULRICH J, 1983, NEURO-OPHTHALMOLOGY, V3, P149, DOI 10.3109/01658108309009732	9	2	2	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2016	15	6					537	538		10.1016/S1474-4422(16)00113-7	http://dx.doi.org/10.1016/S1474-4422(16)00113-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI9PW	27017471				2022-12-18	WOS:000373835900004
J	Bauer, PR; Sander, JW				Bauer, Prisca R.; Sander, Josemir W.			Cannabidiol in patients with treatment-resistant epilepsy	LANCET NEUROLOGY			English	Letter									[Bauer, Prisca R.; Sander, Josemir W.] NIHR Univ Coll London Hosp Biomed Res Ctr, UCL Inst Neurol, London WC1N 3BG, England; [Bauer, Prisca R.; Sander, Josemir W.] Stichting Epilepsie Instellingen Nederland, Achterweg, Heemstede, Netherlands; [Sander, Josemir W.] Epilepsy Soc, Gerrards Cross, Bucks, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Sander, JW (corresponding author), NIHR Univ Coll London Hosp Biomed Res Ctr, UCL Inst Neurol, London WC1N 3BG, England.; Sander, JW (corresponding author), Stichting Epilepsie Instellingen Nederland, Achterweg, Heemstede, Netherlands.	l.sander@ucl.ac.uk	Bauer, Prisca R/U-4769-2017; Sander, Josemir/C-1576-2008; Bauer, Prisca R./AAK-2138-2021	Bauer, Prisca R/0000-0002-9448-6528; Sander, Josemir/0000-0001-6041-9661; Bauer, Prisca R./0000-0002-9448-6528				Brodie MJ, 2010, NEUROLOGY, V75, P1817, DOI 10.1212/WNL.0b013e3181fd6170; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Maa E, 2014, EPILEPSIA, V55, P783, DOI 10.1111/epi.12610	3	2	2	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2016	15	6					544	544		10.1016/S1474-4422(16)00118-6	http://dx.doi.org/10.1016/S1474-4422(16)00118-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI9PW	27302118	Green Submitted, Bronze			2022-12-18	WOS:000373835900010
J	Eikelboom, JW; Bosch, J; Hart, RG				Eikelboom, John W.; Bosch, Jacqueline; Hart, Robert G.			Rapid reversal of haematoma expansion associated with vitamin K antagonists	LANCET NEUROLOGY			English	Editorial Material							PROTHROMBIN COMPLEX CONCENTRATE; INTRACEREBRAL HEMORRHAGE; RANDOMIZED-TRIAL; WARFARIN; ANTICOAGULATION; IDARUCIZUMAB; DABIGATRAN; EFFICACY; SAFETY; PLASMA		[Eikelboom, John W.; Bosch, Jacqueline; Hart, Robert G.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Eikelboom, John W.; Bosch, Jacqueline; Hart, Robert G.] McMaster Univ, Hamilton, ON L8S 4L8, Canada; [Eikelboom, John W.] 237 Barton St East, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute; McMaster University	Eikelboom, JW (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada.; Eikelboom, JW (corresponding author), McMaster Univ, Hamilton, ON L8S 4L8, Canada.; Eikelboom, JW (corresponding author), 237 Barton St East, Hamilton, ON L8L 2X2, Canada.	eikelbj@mcmaster.ca	Eikelboom, John/AAG-6117-2019; Bosch, Jacqueline/AAP-6910-2021	Eikelboom, John/0000-0003-4126-1285; Bosch, Jacqueline/0000-0001-6292-4207				Aguilar MI, 2007, MAYO CLIN PROC, V82, P82, DOI 10.1016/s0025-6196(11)60970-1; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Eikelboom JW, 2015, CIRCULATION, V132, P2412, DOI 10.1161/CIRCULATIONAHA.115.019628; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Goldstein JN, 2015, LANCET, V385, P2077, DOI 10.1016/S0140-6736(14)61685-8; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Steiner T, 2016, LANCET NEUROL, V15, P566, DOI 10.1016/S1474-4422(16)00110-1	14	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2016	15	6					535	537		10.1016/S1474-4422(16)30008-4	http://dx.doi.org/10.1016/S1474-4422(16)30008-4			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI9PW	27302113				2022-12-18	WOS:000373835900003
J	McDermott, CJ; Bradburn, MJ				McDermott, Christopher J.; Bradburn, Mike J.			Diaphragm pacing in patients with amyotrophic lateral sclerosis Reply	LANCET NEUROLOGY			English	Letter									[McDermott, Christopher J.; Bradburn, Mike J.] Univ Sheffield, Sheffield S10 2HQ, S Yorkshire, England	University of Sheffield	McDermott, CJ (corresponding author), Univ Sheffield, Sheffield S10 2HQ, S Yorkshire, England.	c.j.mcdermott@sheffield.ac.uk	McDermott, Christopher/AAU-4988-2020; McDermott, Chris/GQZ-3919-2022	McDermott, Christopher/0000-0002-1269-9053; Shaw, Pamela/0000-0002-8925-2567				Assistance Publique-Hopitaux de Paris, SCLER LAT AM SLA MAL; McDermott CJ, 2015, LANCET NEUROL, V14, P883, DOI 10.1016/S1474-4422(15)00152-0	2	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2016	15	6					543	544		10.1016/S1474-4422(16)30010-2	http://dx.doi.org/10.1016/S1474-4422(16)30010-2			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI9PW	27302116	Bronze			2022-12-18	WOS:000373835900009
J	Miller, RG; Lewis, RA				Miller, Robert G.; Lewis, Richard A.			Diaphragm pacing in patients with amyotrophic lateral sclerosis	LANCET NEUROLOGY			English	Letter									[Miller, Robert G.] Calif Pacific Med Ctr, Forbes Norris MDA ALS Res Ctr, San Francisco, CA USA; [Lewis, Richard A.] Cedars Sinai Med Ctr, Electromyog Lab, Los Angeles, CA 90048 USA	California Pacific Medical Center; Cedars Sinai Medical Center	Miller, RG (corresponding author), Calif Pacific Med Ctr, Forbes Norris MDA ALS Res Ctr, San Francisco, CA USA.	millerrx@cpmcri.org						Elmo M, 2015, AMYOTROPH LATERAL S1, V16, P29; Lepore AC, 2010, NEUROBIOL DIS, V39, P252, DOI 10.1016/j.nbd.2010.03.021; McDermott CJ, 2015, LANCET NEUROL, V14, P883, DOI 10.1016/S1474-4422(15)00152-0; US Food and Drug Administration, 2011, SUMM SAF PROB BEN SS	4	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2016	15	6					542	542		10.1016/S1474-4422(16)30012-6	http://dx.doi.org/10.1016/S1474-4422(16)30012-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI9PW	27302114	Bronze			2022-12-18	WOS:000373835900007
J	Easton, A				Easton, Ava			Encephalitis: raising awareness and collaborating in research	LANCET NEUROLOGY			English	Letter									[Easton, Ava] Encephalitis Soc, Malton YO17 7DT, N Yorkshire, England		Easton, A (corresponding author), Encephalitis Soc, Malton YO17 7DT, N Yorkshire, England.	ava@encephalitis.info		Easton, Ava/0000-0002-1739-2915				Britton PN, 2015, INTERN MED J, V45, P563, DOI 10.1111/imj.12749; Granerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064; Graus F, 2016, LANCET NEUROL; Jmor F, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-134; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Leypoldt F, 2015, ANN NY ACAD SCI, V1338, P94, DOI 10.1111/nyas.12553; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014	7	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2016	15	4					353	353		10.1016/S1474-4422(16)00059-4	http://dx.doi.org/10.1016/S1474-4422(16)00059-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DG3MP	26906966	Bronze			2022-12-18	WOS:000371974000010
J	Gilhus, NE; Verschuuren, JJ				Gilhus, Nils Erik; Verschuuren, Jan J.			Myasthenia gravis: subgroup classifications Reply	LANCET NEUROLOGY			English	Letter									[Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Gilhus, Nils Erik] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Verschuuren, Jan J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	University of Bergen; University of Bergen; Haukeland University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gilhus, NE (corresponding author), Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway.; Gilhus, NE (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.	Nils.Gilhus@uib.no		Verschuuren, Jan/0000-0002-4572-1501				Camicia R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0474-2; Dalakas MC, 2015, THER ADV NEUROL DISO, V8, P316, DOI 10.1177/1756285615605700; Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; VanderPluym J, 2013, PEDIATRICS, V132, pE939, DOI 10.1542/peds.2013-0814	5	2	3	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2016	15	4					357	358		10.1016/S1474-4422(16)00035-1	http://dx.doi.org/10.1016/S1474-4422(16)00035-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DG3MP	26971656	Bronze			2022-12-18	WOS:000371974000015
J	Kohler, S; Losen, M; Alexander, T; Hiepe, F; Meisel, A				Kohler, Siegfried; Losen, Mario; Alexander, Tobias; Hiepe, Falk; Meisel, Andreas			Myasthenia gravis: subgroup classifications	LANCET NEUROLOGY			English	Letter							DEPLETES PLASMA-CELLS		[Kohler, Siegfried; Meisel, Andreas] Charite, NeuroCure Clin Res Ctr, Dept Expt Neurol, D-10117 Berlin, Germany; [Kohler, Siegfried; Meisel, Andreas] Charite, Dept Neurol, D-10117 Berlin, Germany; [Alexander, Tobias; Hiepe, Falk] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Losen, Mario] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Maastricht University	Kohler, S (corresponding author), Charite, NeuroCure Clin Res Ctr, Dept Expt Neurol, D-10117 Berlin, Germany.; Kohler, S (corresponding author), Charite, Dept Neurol, D-10117 Berlin, Germany.	siegfried.kohler@charite.de		Hiepe, Falk/0000-0003-3584-5292; Losen, Mario/0000-0002-9761-0002; Meisel, Andreas/0000-0001-7233-5342				Alexander T, 2015, ANN RHEUM DIS, V74, P1474, DOI 10.1136/annrheumdis-2014-206016; Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Gomez AM, 2014, J IMMUNOL, V193, P1055, DOI 10.4049/jimmunol.1301555; Gomez AM, 2011, J IMMUNOL, V186, P2503, DOI 10.4049/jimmunol.1002539; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763	6	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2016	15	4					356	357		10.1016/S1474-4422(16)00033-8	http://dx.doi.org/10.1016/S1474-4422(16)00033-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DG3MP	26971655	Bronze			2022-12-18	WOS:000371974000014
J	Algra, A; Rinkel, GJE				Algra, Ale; Rinkel, Gabriel J. E.			Prognosis of cerebral cavernomas: on to treatment decisions	LANCET NEUROLOGY			English	Editorial Material							INTRACRANIAL ANEURYSMS; MALFORMATIONS; MULTICENTER; MANAGEMENT; COHORT		[Algra, Ale; Rinkel, Gabriel J. E.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, NL-3508 GA Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Algra, A (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, NL-3508 GA Utrecht, Netherlands.	a.algra@umcutrecht.nl						Al-Shahi R, 2003, STROKE, V34, P1163, DOI 10.1161/01.STR.0000069018.90456.C9; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Greving JP, 2009, NEUROLOGY, V73, P258, DOI 10.1212/01.wnl.0b013e3181a2a4ea; Horne MA, 2015, LANCET NEUROL; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Poorthuis MHF, 2014, J NEUROL NEUROSUR PS, V85, P1319, DOI 10.1136/jnnp-2013-307349; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Stapf C, 2014, LANCET, V383, P1635, DOI 10.1016/S0140-6736(14)60786-8; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; van Asch CJJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5762	10	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2016	15	2					129	130		10.1016/S1474-4422(15)00340-3	http://dx.doi.org/10.1016/S1474-4422(15)00340-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DA9GC	26654286	hybrid, Green Submitted			2022-12-18	WOS:000368116000004
J	Velazquez-Perez, L				Velazquez-Perez, Luis			An insight into the natural history of spinocerebellar ataxias	LANCET NEUROLOGY			English	Editorial Material							PROGRESSION; COHORT		Ctr Res & Rehabil Hereditary Ataxias, Holguin, Cuba		Velazquez-Perez, L (corresponding author), Ctr Res & Rehabil Hereditary Ataxias, Holguin, Cuba.	lvp@cristal.hlg.sld.cu	Velázquez-Pérez, Luis/AAM-4460-2020					Ashizawa T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-177; du Montcel ST, 2012, ARCH NEUROL-CHICAGO, V69, P500, DOI 10.1001/archneurol.2011.2713; Franca MC, 2009, MOVEMENT DISORD, V24, P1387, DOI 10.1002/mds.22627; Jacobi H, 2015, LANCET NEUROLOGY; Jardim LB, 2010, CEREBELLUM, V9, P419, DOI 10.1007/s12311-010-0179-4; Klockgether T, 2011, CURR OPIN NEUROL, V24, P339, DOI 10.1097/WCO.0b013e32834875ba; Lee YC, 2011, MOVEMENT DISORD, V26, P2081, DOI 10.1002/mds.23809; Saute JAM, 2012, CEREBELLUM, V11, P488, DOI 10.1007/s12311-011-0316-8; Velazquez-Perez L, 2004, ANN NEUROL, V56, P444, DOI 10.1002/ana.20220; Velazquez-Perez L, 2014, LANCET NEUROL, V13, P482, DOI 10.1016/S1474-4422(14)70027-4; Yasui K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0118-4	11	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2015	14	11					1067	1069		10.1016/S1474-4422(15)00218-5	http://dx.doi.org/10.1016/S1474-4422(15)00218-5			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT7DY	26377378				2022-12-18	WOS:000362975200003
J	Goldman, SM				Goldman, Samuel M.			A diagnostic algorithm for Parkinson's disease: what next?	LANCET NEUROLOGY			English	Editorial Material							PATHOLOGY; RISK		[Goldman, Samuel M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Goldman, Samuel M.] San Francisco VA Hlth Care Syst, San Francisco, CA USA	University of California System; University of California San Francisco	Goldman, SM (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA.	samuel.goldman@ucsf.edu	Goldman, Samuel/A-2225-2014	Goldman, Samuel/0000-0002-3039-9927				Abbott RD, 2005, NEUROLOGY, V65, P1442, DOI 10.1212/01.wnl.0000183056.89590.0d; Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Erro R, 2016, J NEUROL NEUROSUR PS, V87, P319, DOI 10.1136/jnnp-2014-310256; Nalls MA, 2015, LANCET NEUROL; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Ross GW, 2012, PARKINSONISM RELA S1, V18, pS199, DOI DOI 10.1016/S1353-8020(11)70062-1; Schrag A, 2015, LANCET NEUROL, V14, P57, DOI 10.1016/S1474-4422(14)70287-X	11	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2015	14	10					971	973		10.1016/S1474-4422(15)00192-1	http://dx.doi.org/10.1016/S1474-4422(15)00192-1			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR2VI	26271531				2022-12-18	WOS:000361188400004
J	Mitsumoto, H				Mitsumoto, Hiroshi			Non-invasive ventilation and diaphragmatic pacing in ALS	LANCET NEUROLOGY			English	Editorial Material							PATIENT; DESIGN; TRIAL		Columbia Univ, Dept Neurol, Med Ctr, Eleanor & Lou Gehrig MDA ALS Ctr, New York, NY 10032 USA	Columbia University	Mitsumoto, H (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, Eleanor & Lou Gehrig MDA ALS Ctr, New York, NY 10032 USA.	hm264@columbia.edu						Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Atkeson AD, 2011, NEUROLOGY, V77, P549, DOI 10.1212/WNL.0b013e318228c0fb; Center for Devices and Radiologic Health, 2011, SUMM SAF PROB BEN SS; DiPALS Writing Committee on behalf of the DiPALS Study Group Collaborators, 2015, LANCET NEUROL; Fitzgerald S., 2011, NEUROLOGY TODAY, V11, P44; Kuffner R, 2015, NAT BIOTECHNOL, V33, P51, DOI 10.1038/nbt.3051; Lechtzin N, 2007, AMYOTROPH LATERAL SC, V8, P185, DOI 10.1080/17482960701262392; Miller RG, 2011, NEUROLOGY, V77, P973, DOI 10.1212/WNL.0b013e31822dc7a5; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Miller RG, 1999, J NEUROL SCI, V169, P2, DOI 10.1016/S0022-510X(99)00209-9; Onders RP, 2005, SURG ENDOSC, V19, P633, DOI 10.1007/s00464-004-8934-6	11	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2015	14	9					868	869		10.1016/S1474-4422(15)00185-4	http://dx.doi.org/10.1016/S1474-4422(15)00185-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP4YZ	26234553	hybrid			2022-12-18	WOS:000359889800002
J	Stocchi, F				Stocchi, Fabrizio			Neuroprotection in Parkinson's disease: a difficult challenge	LANCET NEUROLOGY			English	Editorial Material							DELAYED-START TRIAL; GAMMA AGONISTS; DOUBLE-BLIND; RASAGILINE; THERAPY		IRCCS San Raffaele, Inst Res & Med Care, I-00163 Rome, Italy	IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Stocchi, F (corresponding author), IRCCS San Raffaele, Inst Res & Med Care, Via Pisana 235, I-00163 Rome, Italy.	fabrizio.stocchi@fastwebnet.it	stocchi, fabrizio/K-5089-2016	stocchi, fabrizio/0000-0002-5763-0033				Barbiero JK, 2014, BEHAV BRAIN RES, V274, P390, DOI 10.1016/j.bbr.2014.08.014; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Carta AR, 2013, CURR DRUG TARGETS, V14, P743, DOI 10.2174/1389450111314070004; Carta AR, 2013, NEUROTOX RES, V23, P112, DOI 10.1007/s12640-012-9342-7; He P, 2015, CONTEMP CLIN TRIALS, V45, P103, DOI 10.1016/j.cct.2015.05.018; Hirsch EC, 2013, MOVEMENT DISORD, V28, P24, DOI 10.1002/mds.25032; Lang AE, 2013, MOVEMENT DISORD, V28, P86, DOI 10.1002/mds.24997; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators, 2015, LANCET NEUROL; Olanow CW, 2009, ANN NEUROL, V66, P432, DOI 10.1002/ana.21832; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Rascol O, 2011, LANCET NEUROL, V10, P415, DOI 10.1016/S1474-4422(11)70073-4	12	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2015	14	8					780	781		10.1016/S1474-4422(15)00143-X	http://dx.doi.org/10.1016/S1474-4422(15)00143-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM7MZ	26116314				2022-12-18	WOS:000357879200002
J	[Anonymous]				[Anonymous]			Alzheimer's disease: a time for cautious optimism	LANCET NEUROLOGY			English	Editorial Material																		Degenhardt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076635	1	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2015	14	8					779	779		10.1016/S1474-4422(15)00154-4	http://dx.doi.org/10.1016/S1474-4422(15)00154-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM7MZ	26194922				2022-12-18	WOS:000357879200001
J	Jehi, L; Chagin, K; Yardi, R; Tassi, L; Lo Russo, G; Worrell, G; Cendes, F; Morita, M; Bartolomei, F; Chauvel, P; Najm, I; Gonzalez-Martinez, J; Bingaman, W; Kattan, MW				Jehi, Lara; Chagin, Kevin; Yardi, Ruta; Tassi, Laura; Lo Russo, Giorgio; Worrell, Gregory; Cendes, Fernando; Morita, Marcia; Bartolomei, Fabrice; Chauvel, Patrick; Najm, Imad; Gonzalez-Martinez, Jorge; Bingaman, William; Kattan, Michael W.			Promise and pitfalls of prognostic models for epilepsy surgery Reply	LANCET NEUROLOGY			English	Letter									[Jehi, Lara; Yardi, Ruta; Najm, Imad; Gonzalez-Martinez, Jorge; Bingaman, William; Kattan, Michael W.] Cleveland Clin, Epilepsy Ctr, Cleveland, OH 44106 USA; [Chagin, Kevin] Quantitat Hlth Sci, Cleveland, OH USA; [Tassi, Laura; Lo Russo, Giorgio] Osped Maggiore Niguarda, Epilepsy Surg Ctr, Milan, Italy; [Worrell, Gregory] Mayo Clin, Dept Neurol, Div Epilepsy, Rochester, MN USA; [Cendes, Fernando; Morita, Marcia] Univ Estadual Campinas, Campinas, SP, Brazil; [Bartolomei, Fabrice; Chauvel, Patrick] Assistance Publ Hop Marseille, Epileptol Dept, Marseille, France; [Bartolomei, Fabrice; Chauvel, Patrick] Assistance Publ Hop Marseille, Dept Clin Neurophysiol, Marseille, France; [Bartolomei, Fabrice; Chauvel, Patrick] Inst Neurosci Syst, Marseille, France	Cleveland Clinic Foundation; Mayo Clinic; Universidade Estadual de Campinas; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Jehi, L (corresponding author), Cleveland Clin, Epilepsy Ctr, Cleveland, OH 44106 USA.	jehil@ccf.org	Kattan, Michael/AAF-9735-2021; Cendes, Fernando/C-1301-2012; Najm, Imad/R-2143-2019; Russo, Giorgio Lo/AAC-5261-2022; Tassi, Laura/K-2302-2016	Kattan, Michael/0000-0002-3840-4161; Cendes, Fernando/0000-0001-9336-9568; Chauvel, Patrick/0000-0003-2161-6077; Najm, Imad/0000-0001-5192-2089; Tassi, Laura/0000-0002-0632-7296; Lo Russo, Giorgio/0000-0003-0209-412X				COX DR, 1972, J R STAT SOC B, V34, P187; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Jehi L, 2015, LANCET NEUROL, V14, P283, DOI 10.1016/S1474-4422(14)70325-4; PENFIELD W, 1952, ANN SURG, V136, P625; Roberts JI, 2015, NEUROLOGY, V84, P159, DOI 10.1212/WNL.0000000000001127	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2015	14	7					684	684		10.1016/S1474-4422(15)00102-7	http://dx.doi.org/10.1016/S1474-4422(15)00102-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK4LS	26067118				2022-12-18	WOS:000356195900015
J	Turan, TN; Chimowitz, MI				Turan, Tanya N.; Chimowitz, Marc I.			Yet again no benefit of stenting over medical therapy	LANCET NEUROLOGY			English	Editorial Material							POSTERIOR CIRCULATION REGISTRY; ARTERY-STENOSIS; DISEASE; STROKE; TRIAL; RISK		[Turan, Tanya N.; Chimowitz, Marc I.] Med Univ S Carolina, Dept Neurol, Stroke Program, Charleston, SC 29425 USA	Medical University of South Carolina	Turan, TN (corresponding author), Med Univ S Carolina, Dept Neurol, Stroke Program, 19 Hagood Ave,Suite 501, Charleston, SC 29425 USA.	mchimow@musc.edu		Turan, Tanya/0000-0001-5399-8845				Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Caplan LR, 2004, ANN NEUROL, V56, P389, DOI 10.1002/ana.20204; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Gulli G, 2013, STROKE, V44, P598, DOI 10.1161/STROKEAHA.112.669929; Hong KS, 2011, CIRCULATION, V123, P2111, DOI 10.1161/CIRCULATIONAHA.109.934786; van der Worp HB, 2015, LANCET NEUROL; Wityk RJ, 1998, ARCH NEUROL-CHICAGO, V55, P470, DOI 10.1001/archneur.55.4.470; Zaidat OO, 2015, JAMA-J AM MED ASSOC, V313, P1240, DOI DOI 10.1001/JAMA.2015.1693	9	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2015	14	6					565	566		10.1016/S1474-4422(15)00049-6	http://dx.doi.org/10.1016/S1474-4422(15)00049-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI5WG	25908091				2022-12-18	WOS:000354829900005
J	Larrue, V				Larrue, Vincent			Brain CT signs and the effect of alteplase after stroke	LANCET NEUROLOGY			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; RISK-FACTORS		Univ Toulouse, Dept Neurol, Hosp Pierre Paul Riquet, F-31059 Toulouse 9, France		Larrue, V (corresponding author), Univ Toulouse, Dept Neurol, Hosp Pierre Paul Riquet, F-31059 Toulouse 9, France.	larrue.v@chu-toulouse.fr						Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Ford GA, 2010, STROKE, V41, P2568, DOI 10.1161/STROKEAHA.110.581884; IST-3 collaborative group, 2015, LANCET NEUROL; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Patel SC, 2001, JAMA-J AM MED ASSOC, V286, P2830, DOI 10.1001/jama.286.22.2830; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331	7	2	2	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2015	14	5					458	460		10.1016/S1474-4422(15)00013-7	http://dx.doi.org/10.1016/S1474-4422(15)00013-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG6SY	25819483	hybrid			2022-12-18	WOS:000353433900004
J	Schwamm, LH				Schwamm, Lee H.			Breaking up is hard to do: tenecteplase in acute stroke	LANCET NEUROLOGY			English	Editorial Material							ACUTE ISCHEMIC-STROKE; ENDOVASCULAR THERAPY; IMAGING SELECTION; RANDOMIZED-TRIAL; ALTEPLASE		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Stroke Serv, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Schwamm, LH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Stroke Serv, Boston, MA 02114 USA.	lschwamm@mgh.harvard.edu						Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Copen WA, 2015, AM J NEURORADIOL, V36, P638, DOI 10.3174/ajnr.A4186; Delpolyi AR, 2012, J MAGN RESON IMAGING, V36, P1083, DOI 10.1002/jmri.23740; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Huang X, 2015, LANCET NEUROL, P70017; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842	11	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2015	14	4					343	345		10.1016/S1474-4422(15)70036-0	http://dx.doi.org/10.1016/S1474-4422(15)70036-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE5RD	25726503				2022-12-18	WOS:000351892400003
J	Lynch, DR; Perlman, SL				Lynch, David R.; Perlman, Susan L.			Friedreich's ataxia: the European consortium	LANCET NEUROLOGY			English	Editorial Material									[Lynch, David R.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Lynch, David R.] Childrens Hosp Philadelphia, Dept Neurol, Philadelphia, PA 19104 USA; [Lynch, David R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Perlman, Susan L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lynch, DR (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.	lynchd@maiLmed.upenn.edu						Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Friedman LS, 2010, MOVEMENT DISORD, V25, P426, DOI 10.1002/mds.22912; Lynch DR, 2006, NEUROLOGY, V66, P1711, DOI 10.1212/01.wnl.0000218155.46739.90; Lynch DR, 2011, 4 INT FRIEDR AT SCI; Reetz K, 2015, LANCET NEUROL; Regner SR, 2012, J CHILD NEUROL, V27, P1152, DOI 10.1177/0883073812448462; Tai G, 2015, J NEUROL NEUROSUR PS, V86, P660, DOI 10.1136/jnnp-2014-308022	7	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2015	14	2					130	131		10.1016/S1474-4422(14)70327-8	http://dx.doi.org/10.1016/S1474-4422(14)70327-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AY9KS	25566997				2022-12-18	WOS:000347869400005
J	[Anonymous]				[Anonymous]			SUDEP research without walls	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2015	14	2					125	125		10.1016/S1474-4422(15)70001-3	http://dx.doi.org/10.1016/S1474-4422(15)70001-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AY9KS	25772883	Bronze			2022-12-18	WOS:000347869400001
J	Arnulf, I				Arnulf, Isabelle			Sleep: what the day owes the night	LANCET NEUROLOGY			English	Editorial Material							KLEINE-LEVIN SYNDROME; DISEASE		Univ Paris 06, Hop La Pitie Salpetriere, Sleep Disorder Unit, F-75651 Paris 13, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Arnulf, I (corresponding author), Univ Paris 06, Hop La Pitie Salpetriere, Sleep Disorder Unit, F-75651 Paris 13, France.	isabelle.arnulf@psl.aphp.fr		Arnulf, Isabelle/0000-0002-2240-2516				Arnulf I, 2012, LANCET NEUROL, V11, P918, DOI 10.1016/S1474-4422(12)70187-4; Belaid H, 2014, J NEUROSCI, V34, P9124, DOI 10.1523/JNEUROSCI.0181-14.2014; Kas A, 2014, BRAIN, V137, P2077, DOI 10.1093/brain/awu112; Ooms S, 2014, JAMA NEUROL, V71, P971, DOI 10.1001/jamaneurol.2014.1173; Strollo PJ, 2014, NEW ENGL J MED, V370, P139, DOI 10.1056/NEJMoa1308659; Tiriac A, 2014, CURR BIOL, V24, P2136, DOI 10.1016/j.cub.2014.07.053; Videnovic A, 2014, JAMA NEUROL, V71, P463, DOI 10.1001/jamaneurol.2013.6239; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	8	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					19	+		10.1016/S1474-4422(14)70234-0	http://dx.doi.org/10.1016/S1474-4422(14)70234-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25496888				2022-12-18	WOS:000346885300011
J	Berg, D; Deuschl, G				Berg, Daniela; Deuschl, Guenther			Movement disorders: discoveries in pathophysiology and therapy	LANCET NEUROLOGY			English	Editorial Material							PARKINSONS-DISEASE; CONTROLLED-TRIAL; ALPHA-SYNUCLEIN; OPEN-LABEL; ATAXIA		[Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Berg, Daniela] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Deuschl, Guenther] Univ Kiel, Dept Neurol, UKSH, Kiel, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Kiel; Schleswig Holstein University Hospital	Berg, D (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany.	g.deuschl@neurologie.uni-kiel.de	Berg, Daniela/A-8728-2019; Deuschl, Gunther/A-7986-2010	Berg, Daniela/0000-0001-5796-5442; Deuschl, Gunther/0000-0002-4176-9196				Brachmann S, 2014, SUCCESSFUL PHASE 1 T; Cicchetti F, 2014, ANN NEUROL, V76, P31, DOI 10.1002/ana.24174; Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8; Libri V, 2014, LANCET, V384, P504, DOI 10.1016/S0140-6736(14)60382-2; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Sturkenboom IHWM, 2014, LANCET NEUROL, V13, P557, DOI 10.1016/S1474-4422(14)70055-9; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Volkmann J, 2014, LANCET NEUROL, V13, P875, DOI 10.1016/S1474-4422(14)70143-7; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143	12	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					9	11		10.1016/S1474-4422(14)70307-2	http://dx.doi.org/10.1016/S1474-4422(14)70307-2			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25496883				2022-12-18	WOS:000346885300006
J	Fratta, P; Hanna, MG				Fratta, Pietro; Hanna, Michael G.			Neuromuscular diseases: progress in gene discovery drives diagnostics and therapeutics	LANCET NEUROLOGY			English	Editorial Material							MUSCULAR-DYSTROPHY; TRANSPLANTATION		[Fratta, Pietro; Hanna, Michael G.] UCL Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England	University of London; University College London	Fratta, P (corresponding author), UCL Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England.	m.hanna@ucl.ac.uk	Fratta, Pietro/G-1296-2019	Fratta, Pietro/0000-0002-8762-8188; fratta, pietro/0000-0002-7554-1632; Hanna, Michael/0000-0003-0825-4075	Motor Neurone Disease Association [Fratta/Jan15/946-795] Funding Source: researchfish; MRC [MR/M008606/1, MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/M008606/1, MR/K000608/1] Funding Source: Medline; Motor Neurone Disease Association [FRATTA/JAN15/946-795] Funding Source: Medline	Motor Neurone Disease Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association		Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Perie S, 2014, MOL THER, V22, P219, DOI 10.1038/mt.2013.155; Rohrer J, LANCET NEUR IN PRESS; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4	6	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					13	14		10.1016/S1474-4422(14)70239-X	http://dx.doi.org/10.1016/S1474-4422(14)70239-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25496885				2022-12-18	WOS:000346885300008
J	Trojan, M; Tortorella, C				Trojan, Maria; Tortorella, Carla			MS and related disorders: looking for markers of phenotypes	LANCET NEUROLOGY			English	Editorial Material							PROGRESSIVE MULTIPLE-SCLEROSIS; MOG ANTIBODY; DOUBLE-BLIND; MULTICENTER; TRIAL		[Trojan, Maria; Tortorella, Carla] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro	Trojan, M (corresponding author), Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, I-70124 Bari, Italy.	maria.trojano@uniba.it	tortorella, carla/J-2557-2012	tortorella, carla/0000-0001-9037-7300; Trojano, Maria/0000-0002-6329-8946				Du S, 2014, P NATL ACAD SCI USA, V111, P2806, DOI 10.1073/pnas.1307091111; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Kezuka T, 2012, J NEURO-OPHTHALMOL, V32, P107, DOI 10.1097/WNO.0b013e31823c9b6c; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Tur C, 2014, NEUROLOGY, V83, P1712, DOI 10.1212/WNL.0000000000000959; Villar LM, 2014, ANN NEUROL, V76, P231, DOI 10.1002/ana.24190; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079	9	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					11	13		10.1016/S1474-4422(14)70291-1	http://dx.doi.org/10.1016/S1474-4422(14)70291-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25496884				2022-12-18	WOS:000346885300007
J	[Anonymous]				[Anonymous]			Raising standards in dementia care	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2014	13	12					1161	1161		10.1016/S1474-4422(14)70272-8	http://dx.doi.org/10.1016/S1474-4422(14)70272-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU5XG	25453447				2022-12-18	WOS:000345676300001
J	Lombard, F; Britz, GW; Warner, DS				Lombard, Frederick; Britz, Gavin W.; Warner, David S.			Simvastatin in subarachnoid haemorrhage: beyond the short-term	LANCET NEUROLOGY			English	Letter							MULTICENTER; TRIAL		[Lombard, Frederick; Britz, Gavin W.; Warner, David S.] Duke Univ, Durham, NC 27705 USA	Duke University	Lombard, F (corresponding author), Duke Univ, Durham, NC 27705 USA.	frederick.lombard@dm.duke.edu		Britz, Gavin/0000-0002-2358-3005; Lombard, Frederick/0000-0002-4272-9671				Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Anderson SW, 2006, ANN NEUROL, V60, P518, DOI 10.1002/ana.21018; HUGHES JT, 1978, J NEUROSURG, V48, P515, DOI 10.3171/jns.1978.48.4.0515; Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5; Takata K, 2006, J NEUROSURG ANESTHES, V18, P295; Thiel A, 2011, STROKE, V42, P507, DOI 10.1161/STROKEAHA.110.598821; Wong GKC, 2013, NEUROSURGERY, V72, P840, DOI 10.1227/NEU.0b013e31828ab413	7	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2014	13	11					1073	1073		10.1016/S1474-4422(14)70229-7	http://dx.doi.org/10.1016/S1474-4422(14)70229-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR7TZ	25316014				2022-12-18	WOS:000343783900013
J	Norton, S; Matthews, FE; Barnes, DE; Yaffe, K; Brayne, C				Norton, S.; Matthews, F. E.; Barnes, D. E.; Yaffe, K.; Brayne, C.			Potential for primary prevention of Alzheimer's disease: an analysis of population-based data (vol 13, pg 788, 2014)	LANCET NEUROLOGY			English	Correction													Brayne, Carol/AAA-4285-2020; Norton, Sam J/A-1898-2009; Matthews, Fiona/O-6932-2015	Brayne, Carol/0000-0001-5307-663X; Norton, Sam J/0000-0003-1714-9963; Matthews, Fiona/0000-0002-1728-2388				Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X	1	2	2	3	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2014	13	11					1070	1070		10.1016/S1474-4422(14)70136-X	http://dx.doi.org/10.1016/S1474-4422(14)70136-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR7TZ		Green Submitted			2022-12-18	WOS:000343783900009
J	Montalban, X; Sastre-Garriga, J				Montalban, Xavier; Sastre-Garriga, Jaume			Diagnosis and trials of clinically isolated syndrome	LANCET NEUROLOGY			English	Editorial Material							DEFINITE MULTIPLE-SCLEROSIS; 1ST DEMYELINATING EVENT; INTERFERON BETA-1A; CONVERSION; MS; CRITERIA		[Montalban, Xavier; Sastre-Garriga, Jaume] Hosp Univ Vail Hebron, Ctr Esclerosi Multiple Catalunya Cemcat, Dept Neurol Neuroimmunol, Barcelona 08035, Spain	Hospital Universitari Vall d'Hebron	Montalban, X (corresponding author), Hosp Univ Vail Hebron, Ctr Esclerosi Multiple Catalunya Cemcat, Dept Neurol Neuroimmunol, Passeig Vail Hebron 119-129, Barcelona 08035, Spain.	xavier.montalban@cem-cat.org	Sastre-Garriga, Jaume/E-8605-2018; Montalban, Xavier/J-5938-2016	Sastre-Garriga, Jaume/0000-0002-1589-2254; Montalban, Xavier/0000-0002-0098-9918				Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2012, LANCET NEUROL, V11, P33, DOI 10.1016/S1474-4422(11)70262-9; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Leist TP, 2014, LANCET NEUROL, V13, P257, DOI 10.1016/S1474-4422(14)70005-5; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Miller AE, 2014, LANCET NEUROL; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302	12	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2014	13	10					962	963		10.1016/S1474-4422(14)70202-9	http://dx.doi.org/10.1016/S1474-4422(14)70202-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP3EZ	25192850				2022-12-18	WOS:000341959700002
J	Okonkwo, OC				Okonkwo, Ozioma C.			At the crossroads of preclinical AD and normal brain ageing	LANCET NEUROLOGY			English	Editorial Material							ALZHEIMERS-DISEASE; NEURODEGENERATION		[Okonkwo, Ozioma C.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Dept Med, Madison, WI 53792 USA; [Okonkwo, Ozioma C.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Inst, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Okonkwo, OC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Dept Med, Madison, WI 53792 USA.	ozioma@medicine.wisc.edu			NIA NIH HHS [P50 AG033514, K23 AG045957] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG045957, P50AG033514] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Jack CR, 2014, NEUROLOGY, V82, P1605, DOI 10.1212/WNL.0000000000000386; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jack Jr CR, 2014, LANCET NEUROL; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Okonkwo OC, NEUROLOGY IN PRESS; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9	10	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2014	13	10					965	966		10.1016/S1474-4422(14)70207-8	http://dx.doi.org/10.1016/S1474-4422(14)70207-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP3EZ	25201513	Green Accepted			2022-12-18	WOS:000341959700004
J	Della Marca, G; Iorio, R; Losurdo, A; Mirabella, M; Frisullo, G				Della Marca, Giacomo; Iorio, Raffaele; Losurdo, Anna; Mirabella, Massimiliano; Frisullo, Giovanni			Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia?	LANCET NEUROLOGY			English	Letter									[Della Marca, Giacomo; Losurdo, Anna; Mirabella, Massimiliano; Frisullo, Giovanni] Univ Cattolica Sacro Cuore, Inst Neurol, Policlin Univ A Gemelli, Lgo A Gemelli 8, I-00168 Rome, Italy; [Iorio, Raffaele] Don Carlo Gnocchi Profit Org Social Util Fdn, Milan, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Della Marca, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Neurol, Policlin Univ A Gemelli, Lgo A Gemelli 8, I-00168 Rome, Italy.	dellamarca@rm.unicatt.it	Frisullo, Giovanni/ABC-7406-2021; Iorio, Raffaele/HDN-3072-2022; Della Marca, Giacomo/A-8159-2010; Iorio, Raffaele/E-1236-2014; MIRABELLA, Massimiliano/AAC-4016-2020	Iorio, Raffaele/0000-0002-6270-0956; Della Marca, Giacomo/0000-0001-6914-799X; Iorio, Raffaele/0000-0002-6270-0956; MIRABELLA, Massimiliano/0000-0002-7783-114X; Frisullo, Giovanni/0000-0002-1604-6594				Batocchi AP, 2001, ANN NEUROL, V50, P668, DOI 10.1002/ana.1261; Frisullo G, 2007, EXP NEUROL; Lugaresi E, 2001, SLEEP MED REV, V5, P313, DOI 10.1053/smrv.2001.0166; Provini F, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0341-8; Sabater L, 2014, LANCET NEUROL, V13, P575, DOI 10.1016/S1474-4422(14)70051-1	5	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2014	13	9					864	864		10.1016/S1474-4422(14)70127-9	http://dx.doi.org/10.1016/S1474-4422(14)70127-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO5SK	25142452	Bronze			2022-12-18	WOS:000341405400008
J	Teasdale, G; Maas, A; Lecky, F; Manley, G; Stocchetti, N; Murray, G				Teasdale, G.; Maas, A.; Lecky, F.; Manley, G.; Stocchetti, N.; Murray, G.			The Glasgow Coma Scale at 40 years: standing the test of time (vol 13, pg 844, 2014)	LANCET NEUROLOGY			English	Correction													Stocchetti, Nino/O-7444-2017	Stocchetti, Nino/0000-0003-3250-6834				Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	1	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2014	13	9					863	863		10.1016/S1474-4422(14)70120-6	http://dx.doi.org/10.1016/S1474-4422(14)70120-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO5SK					2022-12-18	WOS:000341405400007
J	Mole, SE				Mole, Sara E.			Development of new treatments for Batten disease	LANCET NEUROLOGY			English	Editorial Material							NEURONAL CEROID-LIPOFUSCINOSIS		UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; UCL, UCL Inst Child Hlth, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	Mole, SE (corresponding author), UCL, MRC Lab Mol Cell Biol, Mortimer St, London WC1E 6BT, England.	s.mole@ucl.ac.uk		Mole, Sara/0000-0003-4385-4957				Gavin M, 2013, JIMD REP, V11, P87, DOI 10.1007/8904_2013_226; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Levin WS, 2014, LANCET NEUROL; Palmer D.N., 2011, NEURONAL CEROID LIPO, V2nd ed., DOI [10.1093/med/9780199590018.003.0018, DOI 10.1093/MED/9780199590018.003.0018]; SANTAVUORI P, 1993, J INHERIT METAB DIS, V16, P227, DOI 10.1007/BF00710250; Selden NR, 2013, J NEUROSURG-PEDIATR, V11, P643, DOI 10.3171/2013.3.PEDS12397; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022	8	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2014	13	8					749	751		10.1016/S1474-4422(14)70151-6	http://dx.doi.org/10.1016/S1474-4422(14)70151-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AL9JB	24997881				2022-12-18	WOS:000339456300003
J	Albers, GW				Albers, Gregory W.			Endovascular treatment for stroke: when does the window for good outcome close?	LANCET NEUROLOGY			English	Editorial Material							ISCHEMIC-STROKE; REPERFUSION; TRIAL		Stanford Univ, Sch Med, Stanford Stroke Ctr, Stanford, CA 94305 USA	Stanford University	Albers, GW (corresponding author), Stanford Univ, Sch Med, Stanford Stroke Ctr, Stanford, CA 94305 USA.	albers@stanford.edu		Albers, Gregory/0000-0003-0263-4632				Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Fisher M, 2013, ANN NEUROL, V73, P4, DOI 10.1002/ana.23744; Hill MD, 2014, STROKE, V45, P444, DOI 10.1161/STROKEAHA.113.003580; Inoue M, 2013, STROKE, V44, P1885, DOI 10.1161/STROKEAHA.111.000371; Khatri P, 2014, LANCET NEUROL; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Leiva-Salinas C, 2013, NEURORADIOLOGY, V55, P807, DOI 10.1007/s00234-013-1164-7; Marks MP, 2014, INT J STROKE, V9, P860, DOI 10.1111/ijs.12271	9	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2014	13	6					529	531		10.1016/S1474-4422(14)70086-9	http://dx.doi.org/10.1016/S1474-4422(14)70086-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI8YK	24784551				2022-12-18	WOS:000337212700004
J	Calabresi, PA; Radue, EW; Goodin, D				Calabresi, P. A.; Radue, E-W; Goodin, D.			Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial (vol 13, pg 545, 2014)	LANCET NEUROLOGY			English	Correction													Calabresi, Peter A./AAF-2288-2019					Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3	1	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2014	13	6					536	536		10.1016/S1474-4422(14)70089-4	http://dx.doi.org/10.1016/S1474-4422(14)70089-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI8YK					2022-12-18	WOS:000337212700009
J	Goodrick, S				Goodrick, Steven			Lifeline	LANCET NEUROLOGY			English	Editorial Material																		Adie W, 1926, BRAIN, V49, P275; Dewhurst K, 1982, HIST ASPECTS NEUROSC; Gelineau J, 1880, GAZ HOPITAUX, V53, P735; Lennox WG, 1939, ARCH NEURO PSYCHIATR, V41, P348, DOI 10.1001/archneurpsyc.1939.02270140134010; Partinen M, 2014, LANCET NEUROL, V13, P610	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2014	13	6					542	542		10.1016/S1474-4422(14)70108-5	http://dx.doi.org/10.1016/S1474-4422(14)70108-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI8YK	24331793				2022-12-18	WOS:000337212700015
J	Rye, D				Rye, David			Paralysis lost: a new cause for a common parasomnia ? Comment	LANCET NEUROLOGY			English	Editorial Material							SLEEP BEHAVIOR DISORDER; ENCEPHALITIS		Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Emory University	Rye, D (corresponding author), Emory Univ, Dept Neurol, Atlanta, GA 30322 USA.	drye@emory.edu						Adams C, 2011, ARCH NEUROL-CHICAGO, V68, P521, DOI 10.1001/archneurol.2011.56; Black MA, 2009, EUR J NEUROSCI, V30, P2190, DOI 10.1111/j.1460-9568.2009.07000.x; Compta Y, 2007, SLEEP, V30, P767, DOI 10.1093/sleep/30.6.767; Cornelius JR, 2011, ARCH NEUROL-CHICAGO, V68, P733, DOI 10.1001/archneurol.2011.106; De la Herran-Arita AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007762; Iranzo A, 2006, ANN NEUROL, V59, P178, DOI 10.1002/ana.20693; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Peever J, 2014, TRENDS NEUROSCI, V37, P279, DOI 10.1016/j.tins.2014.02.009; Sabater L, 2014, LANCET NEUROL; Stamelou M, 2012, MOVEMENT DISORD, V27, P1360, DOI 10.1002/mds.25072	10	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2014	13	6					531	532		10.1016/S1474-4422(14)70099-7	http://dx.doi.org/10.1016/S1474-4422(14)70099-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI8YK	24813537				2022-12-18	WOS:000337212700005
J	Cameron, MH; Bourdette, D				Cameron, Michelle H.; Bourdette, Dennis			New treatments for multiple sclerosis: at what long-term risk?	LANCET NEUROLOGY			English	Editorial Material							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; THERAPEUTICS		[Cameron, Michelle H.; Bourdette, Dennis] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Oregon Health & Science University	Cameron, MH (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	bourdett@ohsu.edu		Cameron, Michelle/0000-0001-7971-4679				Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Giovannoni G, 2010, N ENGL J MED; Goodin DS, 2003, NEUROLOGY, V61, P1332, DOI 10.1212/01.WNL.0000095425.84407.39; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Leist TP, 2014, LANCET NEUROL, V13, P257, DOI 10.1016/S1474-4422(14)70005-5; Leist TP, 2011, CLIN NEUROPHARMACOL, V34, P28, DOI 10.1097/WNF.0b013e318204cd90; Rice GPA, 2000, NEUROLOGY	10	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2014	13	3					235	237		10.1016/S1474-4422(13)70303-X	http://dx.doi.org/10.1016/S1474-4422(13)70303-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC1NW	24502831				2022-12-18	WOS:000332264300003
J	Rascol, O				Rascol, Olivier			Jejunal levodopa infusion in Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material							FLUCTUATIONS		[Rascol, Olivier] Clin Investigat Ctr CIC 9302, NS Park Network, Toulouse, France; [Rascol, Olivier] Toulouse Univ Hosp, INSERM, Dept Clin Pharmacol, Toulouse, France; [Rascol, Olivier] Toulouse Univ Hosp, INSERM, Dept Neurosci, Toulouse, France; [Rascol, Olivier] Univ Toulouse 3, F-31062 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Rascol, O (corresponding author), Clin Investigat Ctr CIC 9302, NS Park Network, Toulouse, France.	olivier.rascol@univ-tlse3.fr						Diederich NJ, 2008, NEUROLOGY, V71, P677, DOI 10.1212/01.wnl.0000324635.49971.3d; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; KURLAN R, 1986, ANN NEUROL, V20, P262, DOI 10.1002/ana.410200213; Nilsson D, 2001, ACTA NEUROL SCAND, V104, P343, DOI 10.1034/j.1600-0404.2001.00153.x; Nutt JG, 2008, MOVEMENT DISORD, V23, pS580, DOI 10.1002/mds.22037; Olanow CW, 2006, LANCET NEUROL, V5, P677, DOI 10.1016/S1474-4422(06)70521-X; Olanow CW, 2013, LANCET NEUROL, DOI DOI 10.1016/51474-4422(13)70293-X; QUINN N, 1982, LANCET, V2, P412; Rascol O, 2011, MOVEMENT DISORD, V26, P1072, DOI 10.1002/mds.23714; SHOULSON I, 1975, NEUROLOGY, V25, P1144, DOI 10.1212/WNL.25.12.1144; Wirth R, 2012, J AM MED DIR ASSOC, V13, P228, DOI 10.1016/j.jamda.2011.07.010	11	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2014	13	2					128	129		10.1016/S1474-4422(13)70291-6	http://dx.doi.org/10.1016/S1474-4422(13)70291-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301QE	24361113	Green Submitted			2022-12-18	WOS:000330546200002
J	Poewe, W; Mahlknecht, P				Poewe, Werner; Mahlknecht, Philipp			Movement disorders: new insights into disease mechanisms and treatment	LANCET NEUROLOGY			English	Editorial Material							PARKINSONS-DISEASE		[Poewe, Werner; Mahlknecht, Philipp] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Poewe, W (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	werner.poewe@i-med.ac.at	Mahlknecht, Philipp/AAI-6137-2020	Mahlknecht, Philipp/0000-0003-0671-0516				Berg D, 2013, LANCET NEUROL, V12, P514, DOI 10.1016/S1474-4422(13)70047-4; Cummings J, 2013, LANCET, DOI DOI 10.1016/10.1016/S0140-6736(13)62106-6; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; Jacobi H, 2013, LANCET NEUROL, V12, P650, DOI 10.1016/S1474-4422(13)70104-2; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115; Schapira AHV, 2013, LANCET NEUROL, V12, P747, DOI 10.1016/S1474-4422(13)70117-0; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Sprenger FS, 2014, MOVEMENT DISORD, V29, P1220, DOI 10.1002/mds.25631; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7	10	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2014	13	1					9	11		10.1016/S1474-4422(13)70288-6	http://dx.doi.org/10.1016/S1474-4422(13)70288-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	280AL	24331784				2022-12-18	WOS:000329000900006
J	[Anonymous]				[Anonymous]			G8 dementia summit: a chance for united action	LANCET NEUROLOGY			English	Editorial Material																			0	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2014	13	1					1	1		10.1016/S1474-4422(13)70275-8	http://dx.doi.org/10.1016/S1474-4422(13)70275-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	280AL	24291218	Bronze			2022-12-18	WOS:000329000900001
J	Puig, JG; Torres, RJ				Puig, Juan G.; Torres, Rosa J.			Enzyme activity and brain anatomy: lessons from HPRT deficiency	LANCET NEUROLOGY			English	Editorial Material							LESCH-NYHAN-SYNDROME; DISORDER; DISEASE		[Puig, Juan G.] La Paz Univ Hosp, Dept Internal Med, Metab Vasc Unit JGP, IdiPaz, Madrid 28046, Spain; La Paz Univ Hosp, IdiPaz, Dept Biochem RGT, Madrid 28046, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz	Puig, JG (corresponding author), La Paz Univ Hosp, Dept Internal Med, Metab Vasc Unit JGP, IdiPaz, Madrid 28046, Spain.	juangarciapuig@gmail.com	Torres, Rosa J/C-2670-2014; Torres, Rosa J/AAE-7539-2020	Torres, Rosa J/0000-0003-4438-8900				Draganski B, 2010, CURR OPIN NEUROL, V23, P413, DOI 10.1097/WCO.0b013e32833bc59c; Ernst M, 1996, NEW ENGL J MED, V334, P1568, DOI 10.1056/NEJM199606133342403; Garcia MG, 2008, MOL GENET METAB, V94, P167, DOI 10.1016/j.ymgme.2008.01.006; Garcia MG, 2012, J INHERIT METAB DIS, V35, P1129, DOI 10.1007/s10545-012-9470-5; Harris JC, 1998, ARCH NEUROL-CHICAGO, V55, P547, DOI 10.1001/archneur.55.4.547; Jinnah HA, 2010, BRAIN, V133, P671, DOI 10.1093/brain/awq013; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Puig JG, 2001, MEDICINE, V80, P102, DOI 10.1097/00005792-200103000-00003; Schretlen DJ, 2013, LANCET NEUROL, DOI DOI 10.1016/51474-4422(13)70238-2; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; Torres RJ, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-48	11	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2013	12	12					1129	1131		10.1016/S1474-4422(13)70247-3	http://dx.doi.org/10.1016/S1474-4422(13)70247-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	265BG	24383090				2022-12-18	WOS:000327924100003
J	Walters, AS				Walters, Arthur S.			Opioids and restless legs syndrome	LANCET NEUROLOGY			English	Editorial Material							DOUBLE-BLIND; OXYCODONE; TRIAL		Vanderbilt Univ, Sch Med, Med Ctr N, Nashville, TN 37232 USA	Vanderbilt University	Walters, AS (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr N, A-0118,1161 21st Ave South, Nashville, TN 37232 USA.	arthur.walters@vanderbilt.edu						Aurora RN, 2012, SLEEP, V35; Deandrade M, 2013, WORLD ASS SLEEP MED; HENING WA, 1986, NEUROLOGY, V36, P1363, DOI 10.1212/WNL.36.10.1363; Hening WA, 2010, MOVEMENT DISORD, V25, P1675, DOI 10.1002/mds.23157; Hornyak M, 2012, NEUROLOGY, V79, P2361, DOI 10.1212/WNL.0b013e318278b5e7; Ondo WG, 2005, MOVEMENT DISORD, V20, P345, DOI 10.1002/mds.20359; Sandner-Kiesling A, 2010, INT J CLIN PRACT, V64, P763, DOI 10.1111/j.1742-1241.2010.02360.x; Silver N, 2011, SLEEP MED, V12, P440, DOI 10.1016/j.sleep.2010.11.002; Trenkwalder C, 2013, LANCET NEUROL, V12, P1141, DOI 10.1016/S1474-4422(13)70239-4; Walters AS, 2009, J NEUROL SCI, V279, P62, DOI 10.1016/j.jns.2008.12.022; Walters AS, 2001, MOVEMENT DISORD, V16, P1105, DOI 10.1002/mds.1214; WALTERS AS, 1993, SLEEP, V16, P327, DOI 10.1093/sleep/16.4.327; Willis T., 1672, ANIMA BRUTORUM	13	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2013	12	12					1128	1129		10.1016/S1474-4422(13)70248-5	http://dx.doi.org/10.1016/S1474-4422(13)70248-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	265BG	24140443				2022-12-18	WOS:000327924100002
J	Bath, PMW				Bath, Philip M. W.			Albumin for hyperacute stroke: another failed neuroprotectant	LANCET NEUROLOGY			English	Editorial Material							ACUTE ISCHEMIC-STROKE; PART 1; TRIAL; SAFETY		Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, Nottingham NG5 1PB, England	University of Nottingham	Bath, PMW (corresponding author), Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, City Hosp Campus, Nottingham NG5 1PB, England.	philip.bath@nottingham.ac.uk	Bath, Philip/F-9020-2011	Bath, Philip/0000-0003-2734-5132	National Institute for Health Research [NF-SI-0611-10003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Bath PMW, 2000, STROKE, V31, P2257; Bath PMW, 2001, LANCET, V358, P702, DOI 10.1016/S0140-6736(01)05837-8; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Ginsberg MD, 2006, STROKE, V37, P2100, DOI 10.1161/01.STR.0000231388.72646.05; Ginsberg MD, 2013, LANCET NEUROL, V12, P1049, DOI 10.1016/S1474-4422(13)70223-0; Ginsberg MD, 2011, STROKE, V42, P119, DOI 10.1161/STROKEAHA.110.596072; Hill MD, 2011, STROKE, V42, P1621, DOI 10.1161/STROKEAHA.110.610980; Sandercock P, 1997, LANCET, V349, P1569; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saver JL, FIELD ADM STROKE THE; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240	14	2	5	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2013	12	11					1036	1037		10.1016/S1474-4422(13)70212-6	http://dx.doi.org/10.1016/S1474-4422(13)70212-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	239ZC	24076338				2022-12-18	WOS:000326063500002
J	Strambi, LF				Strambi, Luigi Ferini			A need for new treatments in narcolepsy	LANCET NEUROLOGY			English	Editorial Material							HISTAMINE; RECEPTOR		Univ Vita Salute, Sleep Disorders Ctr, Dept Neurosci, Osped San Raffaele, I-20127 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Strambi, LF (corresponding author), Univ Vita Salute, Sleep Disorders Ctr, Dept Neurosci, Osped San Raffaele, Via Stamira Ancona 20, I-20127 Milan, Italy.	ferinistrambi.luigi@hsr.it	STRAMBI, Luigi FERINI/K-3620-2018	STRAMBI, Luigi FERINI/0000-0003-2867-5424				Bartus RT, 2013, NEUROLOGY, V80, P1698, DOI 10.1212/WNL.0b013e3182904faa; Cao M, 2011, CURR NEUROL NEUROSCI, V11, P227, DOI 10.1007/s11910-010-0172-9; Dauvilliers Y, 2013, LANCET NEUROL, DOI DOI 10.1016/51474-4422(13)70225-4; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Mochizuki T, 2011, P NATL ACAD SCI USA, V108, P4471, DOI 10.1073/pnas.1012456108; Oishi Y, 2013, J NEUROSCI, V33, P9743, DOI 10.1523/JNEUROSCI.0499-13.2013; Sansa G, 2010, SLEEP MED, V11, P93, DOI 10.1016/j.sleep.2009.02.009; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x	8	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2013	12	11					1039	1040		10.1016/S1474-4422(13)70178-9	http://dx.doi.org/10.1016/S1474-4422(13)70178-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	239ZC	24107291				2022-12-18	WOS:000326063500004
J	Meschia, JF				Meschia, James F.			Raising the red flag over white-matter changes	LANCET NEUROLOGY			English	Editorial Material									Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Mayo Clinic	Meschia, JF (corresponding author), Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA.	meschia.james@mayo.edu	Meschia, James/GPP-1636-2022	Meschia, James/0000-0002-4475-8142				Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Bijuklic K, 2012, J AM COLL CARDIOL, V59, P1383, DOI 10.1016/j.jacc.2011.11.035; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Dumont TM, 2013, J NEUROINTERV SURG, DOI [10.1136/neurointsurg-2013-010721, DOI 10.1136/NEUR0INTSURG-2013-010721]; Ederle J, 2013, LANCET NEUROL, DOI DOI 10.1016/S1474-4422(13)70135-2; Gensicke H, 2013, STROKE, V44, P80, DOI 10.1161/STROKEAHA.112.673152; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Naggara O, 2011, STROKE, V42, P380, DOI 10.1161/STROKEAHA.110.588772; Verdelho A, 2007, J NEUROL NEUROSUR PS, V78, P1325, DOI 10.1136/jnnp.2006.110361; Voeks JH, 2011, STROKE, V42, P3484, DOI 10.1161/STROKEAHA.111.624155	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2013	12	9					841	842		10.1016/S1474-4422(13)70131-5	http://dx.doi.org/10.1016/S1474-4422(13)70131-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	210WU	23849947				2022-12-18	WOS:000323866600003
J	[Anonymous]				[Anonymous]			The road map to integrated dementia prevention and care	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2013	12	9					839	839		10.1016/S1474-4422(13)70203-5	http://dx.doi.org/10.1016/S1474-4422(13)70203-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	210WU	23948168				2022-12-18	WOS:000323866600001
J	Sechi, G; Sechi, E				Sechi, GianPietro; Sechi, Elia			Restless legs syndrome and cerebrovascular disease	LANCET NEUROLOGY			English	Letter							PERIODIC LIMB MOVEMENTS; STROKE		[Sechi, GianPietro; Sechi, Elia] Univ Sassari, Dept Clin & Expt Med, Neurol Clin, I-07100 Sassari, Italy	University of Sassari	Sechi, G (corresponding author), Univ Sassari, Dept Clin & Expt Med, Neurol Clin, I-07100 Sassari, Italy.	gpsechi@uniss.it	Sechi, Elia/AAN-7592-2021	Sechi, Elia/0000-0003-4698-663X				Berger K, 2004, ARCH INTERN MED, V164, P196, DOI 10.1001/archinte.164.2.196; Lee SJ, 2009, MOVEMENT DISORD, V24, P77, DOI 10.1002/mds.22303; Mehanna R, 2013, LANCET NEUROL, V12, P597, DOI 10.1016/S1474-4422(13)70057-7; Coelho FMS, 2010, J CLIN SLEEP MED, V6, P428; Sechi G, 2008, PARKINSONISM RELAT D, V14, P157, DOI 10.1016/j.parkreldis.2007.02.004	5	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2013	12	8					734	734		10.1016/S1474-4422(13)70106-6	http://dx.doi.org/10.1016/S1474-4422(13)70106-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	195GP	23867193	Bronze			2022-12-18	WOS:000322690600007
J	Jentsch, TJ				Jentsch, Thomas J.			From mice to man: chloride transport in leukoencephalopathy	LANCET NEUROLOGY			English	Editorial Material							MEGALENCEPHALIC LEUKOENCEPHALOPATHY; SUBCORTICAL CYSTS; DISRUPTION; GLIALCAM; PROTEIN; CELLS; CLCN2		[Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de		Jentsch, Thomas/0000-0002-3509-2553				Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Depienne C, 2013, LANCET NEUROL; Jeworutzki E, 2012, NEURON, V73, P951, DOI 10.1016/j.neuron.2011.12.039; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Lopez-Hernandez T, 2011, AM J HUM GENET, V88, P422, DOI 10.1016/j.ajhg.2011.02.009; Menichella DM, 2006, J NEUROSCI, V26, P10984, DOI 10.1523/JNEUROSCI.0304-06.2006; Niemeyer MI, 2010, NAT GENET, V42, P3, DOI 10.1038/ng0110-3; Scheper GC, 2010, GENET TEST MOL BIOMA, V14, P255, DOI 10.1089/gtmb.2009.0148; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0	10	2	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2013	12	7					626	628		10.1016/S1474-4422(13)70068-1	http://dx.doi.org/10.1016/S1474-4422(13)70068-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172CH	23707148				2022-12-18	WOS:000320977100004
J	Eikelboom, JW; Hart, RG				Eikelboom, John W.; Hart, Robert G.			Anticoagulant therapy in acute brain ischaemia	LANCET NEUROLOGY			English	Editorial Material							TRIAL; STROKE		[Eikelboom, John W.; Hart, Robert G.] McMaster Univ, Dept Med Thrombosis, Hamilton, ON L8L 2X2, Canada	McMaster University	Eikelboom, JW (corresponding author), McMaster Univ, Dept Med Thrombosis, Hamilton, ON L8L 2X2, Canada.	eikelbj@mcmaster.ca	Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285				Adams HP, 1999, NEUROLOGY, V53, P122, DOI 10.1212/WNL.53.1.122; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Sandercock PA, 2009, COCHRANE DATABASE SY, V2; Wang YJ, 2010, AM HEART J, V160, P380, DOI 10.1016/j.ahj.2010.05.017; Whiteley WN, 2013, LANCET NEUROL, DOI DOI 10.1016/51474-4422(13)70079-6	6	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUN	2013	12	6					526	527		10.1016/S1474-4422(13)70083-8	http://dx.doi.org/10.1016/S1474-4422(13)70083-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	161SL	23642344				2022-12-18	WOS:000320213500002
J	Montgomery, EB				Montgomery, Erwin B., Jr.			Subthalamic versus globus pallidus deep brain stimulation	LANCET NEUROLOGY			English	Letter									Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Montgomery, EB (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	emontgom@uab.edu						Copi IM, 1953, INTRO LOGIC; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Wellek S., 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184	3	2	2	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2013	12	4					329	329		10.1016/S1474-4422(13)70045-0	http://dx.doi.org/10.1016/S1474-4422(13)70045-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SZ	23518323				2022-12-18	WOS:000318531600005
J	Schneider, LS				Schneider, Lon S.			Quantifying an amyloid beta model for Alzheimer's disease	LANCET NEUROLOGY			English	Editorial Material									[Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Schneider, LS (corresponding author), Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA.	lschneid@usc.edu						Australian Bureau of Statistics, 2009, 3302 0 55 001 LIF TA; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kokjohn TA, 2012, ALZHEIMERS DEMENT, V8, P574, DOI 10.1016/j.jalz.2011.05.2429; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9	7	2	2	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2013	12	4					327	328		10.1016/S1474-4422(13)70050-4	http://dx.doi.org/10.1016/S1474-4422(13)70050-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SZ	23477990				2022-12-18	WOS:000318531600004
J	Simonsen, CZ; Andersen, G; Gonzalez, RG; Yoo, AJ				Simonsen, Claus Z.; Andersen, Grethe; Gonzalez, R. Gilberto; Yoo, Albert J.			Selection of patients for intra-arterial therapy	LANCET NEUROLOGY			English	Letter							ISCHEMIC-STROKE; ARTERY		[Simonsen, Claus Z.; Andersen, Grethe] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Gonzalez, R. Gilberto; Yoo, Albert J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol,Div Diagnost & Intervent Neuroradiol, Boston, MA 02114 USA	Aarhus University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Simonsen, CZ (corresponding author), Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark.	ajyoo@partners.org		Andersen, Grethe/0000-0001-6807-2500; Claus, Simonsen/0000-0003-1363-0266				Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Hakimelahi R, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-132; Hill MD, 2003, STROKE, V34, P1925, DOI 10.1161/01.STR.0000082483.37127.D0; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656	7	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2013	12	3					225	225		10.1016/S1474-4422(13)70018-8	http://dx.doi.org/10.1016/S1474-4422(13)70018-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SW	23415562	Bronze			2022-12-18	WOS:000318531300007
J	Lal, BK; Brott, TG				Lal, Brajesh K.; Brott, Thomas G.			Restenosis after carotid endarterectomy and stenting Reply	LANCET NEUROLOGY			English	Letter									[Lal, Brajesh K.] Univ Maryland, Dept Surg, Div Vasc Surg, Baltimore, MD 21201 USA; [Brott, Thomas G.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	University System of Maryland; University of Maryland Baltimore; Mayo Clinic	Lal, BK (corresponding author), Univ Maryland, Dept Surg, Div Vasc Surg, Baltimore, MD 21201 USA.	brott.thomas@mayo.edu	Lal, Brajesh/AAA-2620-2022					Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X	1	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	FEB	2013	12	2					130	131		10.1016/S1474-4422(12)70260-0	http://dx.doi.org/10.1016/S1474-4422(12)70260-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	081NZ	23151439	Bronze			2022-12-18	WOS:000314330200011
J	Phan, TG				Phan, Thanh G.			Disorders of consciousness: are we ready for a paradigm shift?	LANCET NEUROLOGY			English	Letter									Monash Univ, Dept Neurol, Monash Med Ctr, Clayton Stroke & Aging Res Grp,Dept Med, Melbourne, Vic 3168, Australia	Monash University	Phan, TG (corresponding author), Monash Univ, Dept Neurol, Monash Med Ctr, Clayton Stroke & Aging Res Grp,Dept Med, 246 Clayton Rd, Melbourne, Vic 3168, Australia.	thanh.phan@monash.edu						Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0; Kuehlmeyer K, 2012, J NEUROL, V259, P2076, DOI 10.1007/s00415-012-6459-9; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370	5	2	2	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2013	12	2					131	132		10.1016/S1474-4422(12)70289-2	http://dx.doi.org/10.1016/S1474-4422(12)70289-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	081NZ	23260187				2022-12-18	WOS:000314330200012
J	Arnold, M				Arnold, Marcel			Transient isolated brainstem symptoms: time for reappraisal?	LANCET NEUROLOGY			English	Editorial Material							ISCHEMIC ATTACK; STROKE; GUIDELINES; RISK		[Arnold, Marcel] Univ Hosp Bern, Dept Neurol, Inselspital, CH-3010 Bern, Switzerland; [Arnold, Marcel] Univ Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Arnold, M (corresponding author), Univ Hosp Bern, Dept Neurol, Inselspital, Freiburgstr 4, CH-3010 Bern, Switzerland.	marcel.arnold@insel.ch		Fischer, Urs/0000-0003-0521-4051				Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Paul NLM, 2012, LANCET NEUROL; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2	6	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2013	12	1					29	30		10.1016/S1474-4422(12)70303-4	http://dx.doi.org/10.1016/S1474-4422(12)70303-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	055PR	23206552				2022-12-18	WOS:000312429400017
J	[Anonymous]				[Anonymous]			Challenging age-old ideas about stroke	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2012	11	12					1013	1013		10.1016/S1474-4422(12)70274-0	http://dx.doi.org/10.1016/S1474-4422(12)70274-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	044CX	23153400				2022-12-18	WOS:000311598100001
J	van de Beek, D				van de Beek, Diederik			The burden of serogroup B meningococcal disease	LANCET NEUROLOGY			English	Editorial Material							IMMUNOGENICITY; TOLERABILITY; VACCINE; ADULTS		Univ Amsterdam, Dept Neurol, Ctr Infect & Immun CINIMA, Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van de Beek, D (corresponding author), Univ Amsterdam, Dept Neurol, Ctr Infect & Immun CINIMA, Acad Med Ctr, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X				Bronner MB, 2009, PEDIATR CRIT CARE ME, V10, P636, DOI 10.1097/PCC.0b013e3181ae5c1a; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; McIntyre PB, 2012, LANCET IN PRESS; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; van de Beek D, 2002, J INFECT DIS, V186, P1047, DOI 10.1086/344229; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Viner R, 2012, OPTN SRTR ANN REP	11	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2012	11	9					743	745		10.1016/S1474-4422(12)70184-9	http://dx.doi.org/10.1016/S1474-4422(12)70184-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994DS	22863607				2022-12-18	WOS:000307911700004
J	Clark, CM; Pontecorvo, MJ; Beach, TG				Clark, C. M.; Pontecorvo, M. J.; Beach, T. G.			Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study (vol 11, pg 669, 2012)	LANCET NEUROLOGY			English	Correction																		Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4	1	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2012	11	8					658	658		10.1016/S1474-4422(12)70142-4	http://dx.doi.org/10.1016/S1474-4422(12)70142-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983AX					2022-12-18	WOS:000307089700006
J	Hart, RG; Eikelboorn, JW				Hart, Robert G.; Eikelboorn, John W.			Reducing the risk of recurrent stroke in patients with AF	LANCET NEUROLOGY			English	Editorial Material							ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; WARFARIN; ASPIRIN		[Hart, Robert G.; Eikelboorn, John W.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University	Hart, RG (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	robert.hart@phri.ca	Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285				Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 2004, STROKE, V35, P948, DOI 10.1161/01.STR.0000120741.34866.1D; Hart RG, 2002, STROKE, V33, P2722, DOI 10.1161/01.STR.0000035735.49388.4A; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2012	11	6					479	481		10.1016/S1474-4422(12)70096-0	http://dx.doi.org/10.1016/S1474-4422(12)70096-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	952JW	22572203				2022-12-18	WOS:000304789800003
J	Walter, S; Kostopoulos, P; Haass, A				Walter, S.; Kostopoulos, P.; Haass, A.			Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial (vol 11, pg 397, 2012)	LANCET NEUROLOGY			English	Correction																		Walter S, 2012, LANCET NEUROL, V11, P397, DOI 10.1016/S1474-4422(12)70057-1	1	2	2	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2012	11	6					483	483		10.1016/S1474-4422(12)70057-1	http://dx.doi.org/10.1016/S1474-4422(12)70057-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	952JW					2022-12-18	WOS:000304789800006
J	Young, GB; Sharpe, MD				Young, G. Bryan; Sharpe, Michael D.			Donation after cardiac death: enter the neurologist	LANCET NEUROLOGY			English	Editorial Material							WITHDRAWAL; TIME		[Young, G. Bryan; Sharpe, Michael D.] Univ Western Ontario, Div Crit Care, Univ Hosp, London, ON N6A 5A5, Canada	Western University (University of Western Ontario)	Young, GB (corresponding author), Univ Western Ontario, Div Crit Care, Univ Hosp, Room B10-106,339 Windermere Rd, London, ON N6A 5A5, Canada.	bryan.young@lhsc.on.ca						Bernat JL, 2009, PROG BRAIN RES, V177, P21, DOI 10.1016/S0079-6123(09)17703-8; Dharamsi S, 2011, ACAD MED, V86, P1108, DOI 10.1097/ACM.0b013e318226b43b; Hernadez-Alejandro R, 2011, CAN J ANESTH, V58, P599, DOI 10.1007/s12630-011-9511-9; Lewis Jonathan, 2003, Prog Transplant, V13, P265; Rabinstein AA, 2012, LANCET NEUROL, V11, P414, DOI 10.1016/S1474-4422(12)70060-1; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wind J, 2012, CRIT CARE MED, V40, P766, DOI 10.1097/CCM.0b013e318232e2e7; Yee AH, 2010, NEUROLOGY, V74, P1380, DOI 10.1212/WNL.0b013e3181dad5f0	8	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2012	11	5					385	386		10.1016/S1474-4422(12)70068-6	http://dx.doi.org/10.1016/S1474-4422(12)70068-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	930KM	22494957				2022-12-18	WOS:000303138300004
J	Flemming, KD				Flemming, Kelly D.			Predicting the clinical behaviour of cavernous malformations	LANCET NEUROLOGY			English	Editorial Material									Mayo Clin, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic	Flemming, KD (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	flemming.kelly@mayo.edu						Barker FG, 2001, NEUROSURGERY, V49, P15, DOI 10.1097/00006123-200107000-00002; Duffau H, 1997, ACTA NEUROCHIR, V139, P914, DOI 10.1007/BF01411299; Flemming KD, 2011, YOUMANS NEUROLOGICAL, V6th, P4016, DOI DOI 10.1016/B978-1-4160-5316-3.00387-7; Flemming KD, 2011, J NEUROSURG, V115, P1175, DOI 10.3171/2011.8.JNS11751; Salman RAS, 2012, LANCET NEUROL, V11, P217, DOI 10.1016/S1474-4422(12)70004-2; Salman RAS, 2008, STROKE, V39, P3222, DOI 10.1161/STROKEAHA.108.515544; Stapf C, 2008, STROKE, V39, P3129, DOI 10.1161/STROKEAHA.108.520783	7	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2012	11	3					202	203		10.1016/S1474-4422(12)70016-9	http://dx.doi.org/10.1016/S1474-4422(12)70016-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902BZ	22297118				2022-12-18	WOS:000301014900002
J	Moreno-De-Luca, A; Ledbetter, DH; Martin, CL				Moreno-De-Luca, A.; Ledbetter, D. H.; Martin, C. L.			Genomic insights into the causes and classification of cerebral palsies (vol 11, pg 283, 2012)	LANCET NEUROLOGY			English	Correction													De Luca, Andres Moreno/AAB-3570-2021	De Luca, Andres Moreno/0000-0002-2732-4043				Moreno-De-Luca A, 2012, LANCET NEUROL, V11, P283, DOI 10.1016/S1474-4422(11)70287-3	1	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2012	11	3					208	208		10.1016/S1474-4422(12)70028-5	http://dx.doi.org/10.1016/S1474-4422(12)70028-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902BZ		Bronze			2022-12-18	WOS:000301014900007
J	Volkmann, J				Volkmann, Jens			Deep brain stimulation in Parkinson's disease: opening up the race towards better technology	LANCET NEUROLOGY			English	Editorial Material							THERAPY; TRIAL		Univ Hosp Wurzburg, D-97080 Wurzburg, Germany	University of Wurzburg	Volkmann, J (corresponding author), Univ Hosp Wurzburg, D-97080 Wurzburg, Germany.	volkmann_j@klinik.uni-wuerzburg.de	Volkmann, Jens/AAK-7570-2020	Volkmann, Jens/0000-0002-9570-593X				Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Rascol O, 2005, LANCET, V365, P947, DOI 10.1016/S0140-6736(05)71083-7; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4	6	2	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2012	11	2					121	123		10.1016/S1474-4422(12)70002-9	http://dx.doi.org/10.1016/S1474-4422(12)70002-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885EF	22239916				2022-12-18	WOS:000299760600003
J	Giovannoni, G				Giovannoni, Gavin			The REFLEX study: a missed opportunity?	LANCET NEUROLOGY			English	Editorial Material							DEFINITE MULTIPLE-SCLEROSIS; 1ST DEMYELINATING EVENT; FOLLOW-UP; IMMUNOGENICITY; FORMULATION; DISABILITY; THERAPY; SAFETY		Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England	University of London; Queen Mary University London	Giovannoni, G (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England.	g.giovannoni@qmul.ac.uk						*ABN, 2009, ASS BRIT NEUR GUID P; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2012, LANCET NEUROL, V11, P33, DOI 10.1016/S1474-4422(11)70262-9; *EUR MED AG, 2011, SUMM OP POST REB INT; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Giovannoni G, 2009, MULT SCLER J, V15, P219, DOI 10.1177/1352458508097299; GIOVANNONI G, MULT SCLER IN PRESS; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Kinkel RP, 2006, NEUROLOGY, V66, P678; Manfredonia Francesco, 2008, Neuropsychiatr Dis Treat, V4, P321; McCabe C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1786; Petersen B, 2006, MULT SCLER J, V12, P247, DOI 10.1191/135248505ms1324oa; Phillips JT, 2004, CLIN THER, V26, P511, DOI 10.1016/S0149-2918(04)90053-7	16	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2012	11	1					22	24		10.1016/S1474-4422(11)70282-4	http://dx.doi.org/10.1016/S1474-4422(11)70282-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	868HG	22146410				2022-12-18	WOS:000298513700013
J	O'Connor, P				O'Connor, P.			250 mu g or 500 mu g interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)	LANCET NEUROLOGY			English	Correction													Filippi, Massimo/K-1755-2018	Filippi, Massimo/0000-0002-5485-0479				O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1	1	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2012	11	1					27	27		10.1016/S1474-4422(09)70226-1	http://dx.doi.org/10.1016/S1474-4422(09)70226-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	868HG		Green Accepted			2022-12-18	WOS:000298513700016
J	French, J				French, Jacqueline			What is a fair comparison in head-to-head trials of antiepileptic drugs?	LANCET NEUROLOGY			English	Editorial Material							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; QUALITY STANDARDS SUBCOMMITTEE; AMERICAN ACADEMY; EFFICACY; EPILEPSY; TOLERABILITY; THERAPEUTICS; NEUROLOGY		NYU, Comprehens Epilepsy Ctr, New York, NY 10003 USA	New York University	French, J (corresponding author), NYU, Comprehens Epilepsy Ctr, New York, NY 10003 USA.	jacqueline.french@nyumc.org	French, Jacqueline A/G-6795-2013	French, Jacqueline A/0000-0003-2242-8027				French JA, 2004, NEUROLOGY, V62, P1252, DOI 10.1212/01.WNL.0000123693.82339.FC; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; French JA, 2007, LANCET, V369, P970, DOI 10.1016/S0140-6736(07)60470-X; Gamble CL, 2006, COCHRANE DB SYST REV, V1; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; Kwan P, 2011, LANCET NEUROL, V10, P881, DOI 10.1016/S1474-4422(11)70154-5; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Marson AG, 1996, BMJ-BRIT MED J, V313, P1169, DOI 10.1136/bmj.313.7066.1169; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Ryvlin P, 2005, EUR J NEUROL, V12, P12, DOI 10.1111/j.1468-1331.2005.01327.x	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2011	10	10					866	867		10.1016/S1474-4422(11)70191-0	http://dx.doi.org/10.1016/S1474-4422(11)70191-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832OP	21889409				2022-12-18	WOS:000295814600002
J	[Anonymous]				[Anonymous]			Making EUReMS count for people with multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2011	10	10					865	865		10.1016/S1474-4422(11)70215-0	http://dx.doi.org/10.1016/S1474-4422(11)70215-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832OP	21939893	Bronze			2022-12-18	WOS:000295814600001
J	Earley, CJ				Earley, Christopher J.			Another dopamine agonist for treatment of restless legs syndrome	LANCET NEUROLOGY			English	Editorial Material							AUGMENTATION		Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA	Johns Hopkins University	Earley, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA.	cearley@jhmi.edu						AKPINAR S, 1987, CLIN NEUROPHARMACOL, V10, P69; Allen RP, 2011, SLEEP MED, V12, P431, DOI 10.1016/j.sleep.2011.03.003; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Allen RP, 1996, SLEEP, V19, P205, DOI 10.1093/sleep/19.3.205; Earley Christopher J, 2011, Handb Clin Neurol, V99, P913, DOI 10.1016/B978-0-444-52007-4.00015-1; Earley CJ, 2010, SLEEP MED, V11, P807, DOI 10.1016/j.sleep.2010.07.007; Hening WA, 2004, SLEEP, V27, P560, DOI 10.1093/sleep/27.3.560; OERTEL W, LANCET, DOI DOI 10.1016/S1474-4422(11)70127-2; Oertel WH, 2010, SLEEP MED, V11, P848, DOI 10.1016/j.sleep.2010.02.014; Silver N, 2011, SLEEP MED, V12, P440, DOI 10.1016/j.sleep.2010.11.002	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2011	10	8					675	677		10.1016/S1474-4422(11)70146-6	http://dx.doi.org/10.1016/S1474-4422(11)70146-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	803WJ	21705274				2022-12-18	WOS:000293612600004
J	Mollenhauer, B; Schulz-Schaeffer, WJ; Schlossmacher, MG				Mollenhauer, Brit; Schulz-Schaeffer, Walter J.; Schlossmacher, Michael G.			CSF alpha-synuclein, tau, and amyloid beta in Parkinson's disease reply	LANCET NEUROLOGY			English	Letter							LEWY BODIES; DEMENTIA; PATHOLOGY		[Mollenhauer, Brit] Paracelsus Elena Klin, Kassel, Germany; [Schulz-Schaeffer, Walter J.] Univ Gottingen, Univ Med Ctr, Dept Neuropathol, D-3400 Gottingen, Germany; [Schlossmacher, Michael G.] Univ Ottawa, Div Neurosci, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON K1N 6N5, Canada; [Schlossmacher, Michael G.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada	University of Gottingen; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Mollenhauer, B (corresponding author), Paracelsus Elena Klin, Kassel, Germany.	brit.mollenhauer@pk-mx.de						Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Frasier M, 2010, BIOMARK MED, V4, P723, DOI [10.2217/bmm.10.89, 10.2217/BMM.10.89]; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Mollenhauer B, 2005, DEMENT GERIATR COGN, V19, P164, DOI 10.1159/000083178; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Mollenhauer B, 2011, J NEURAL TRANSM, V118, P691, DOI 10.1007/s00702-010-0543-z; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b	10	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2011	10	8					681	683		10.1016/S1474-4422(11)70161-2	http://dx.doi.org/10.1016/S1474-4422(11)70161-2			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	803WJ					2022-12-18	WOS:000293612600009
J	Hauser, WA				Hauser, W. Allen			Antiepileptic drugs in pregnancy: refinement of risk estimates	LANCET NEUROLOGY			English	Editorial Material							UK-EPILEPSY		Columbia Univ Coll Phys & Surg, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Hauser, WA (corresponding author), Columbia Univ Coll Phys & Surg, Mailman Sch Publ Hlth, 630 W 168th St, New York, NY 10032 USA.	wahauser@optonline.net	Hauser, W Allen/AAB-5277-2020					Bromfield EB, 2008, EPILEPSIA, V49, P2122, DOI 10.1111/j.1528-1167.2008.01696.x; Janz D.J.G.M.M., 1964, GER MED MON, V9, P20; Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581; MEADOW SR, 1968, LANCET, V2, P1296; Molgaard-Nielsen D, 2011, JAMA-J AM MED ASSOC, V305, P1996, DOI 10.1001/jama.2011.624; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Tomson T, 2010, EPILEPSIA, V51, P909, DOI 10.1111/j.1528-1167.2010.02525.x; Vajda FJE, 2005, ACTA NEUROL SCAND, V112, P137, DOI 10.1111/j.1600-0404.2005.00458.x	10	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2011	10	7					592	593		10.1016/S1474-4422(11)70129-6	http://dx.doi.org/10.1016/S1474-4422(11)70129-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	789BD	21652012				2022-12-18	WOS:000292487400002
J	Gorelick, PB				Gorelick, Philip B.			Is reduction of blood pressure in acute stroke justified?	LANCET NEUROLOGY			English	Editorial Material							MANAGEMENT; GUIDELINES		Univ Illinois, Ctr Stroke Res, Coll Med Chicago, Dept Neurol & Rehabil, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gorelick, PB (corresponding author), Univ Illinois, Ctr Stroke Res, Coll Med Chicago, Dept Neurol & Rehabil, Chicago, IL 60612 USA.	pgorelic@uic.edu						Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Aiyagari V, 2009, STROKE, V40, P2251, DOI 10.1161/STROKEAHA.108.531574; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hankey GJ, 2011, LANCET, V377, P696, DOI 10.1016/S0140-6736(11)60163-3; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	7	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2011	10	4					295	296		10.1016/S1474-4422(11)70040-0	http://dx.doi.org/10.1016/S1474-4422(11)70040-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	745SB	21435591				2022-12-18	WOS:000289185000005
J	Mollenhauer, B; Locascio, JJ; Schulz-Schaeffer, W; Sixel-Doring, F; Trenkwalder, C; Schlossmacher, MG				Mollenhauer, B.; Locascio, J. J.; Schulz-Schaeffer, W.; Sixel-Doering, F.; Trenkwalder, C.; Schlossmacher, M. G.			alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)	LANCET NEUROLOGY			English	Correction													Trenkwalder, Claudia/ABD-6559-2021; Trenkwalder, Claudia/AHD-1232-2022	Trenkwalder, Claudia/0000-0001-6407-1199				Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X	1	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2011	10	4					297	297		10.1016/S1474-4422(11)70014-X	http://dx.doi.org/10.1016/S1474-4422(11)70014-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	745SB					2022-12-18	WOS:000289185000007
J	[Anonymous]				[Anonymous]			Why patients with aSAH need multidisciplinary follow-up	LANCET NEUROLOGY			English	Editorial Material																			0	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2011	10	4					289	289		10.1016/S1474-4422(11)70050-3	http://dx.doi.org/10.1016/S1474-4422(11)70050-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	745SB	21435590				2022-12-18	WOS:000289185000001
J	Ringman, JM				Ringman, John M.			Setting the stage for prevention of familial Alzheimer's disease	LANCET NEUROLOGY			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Mary S Easton Ctr Alzheimers Dis Res, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ringman, JM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Mary S Easton Ctr Alzheimers Dis Res, Dept Neurol, Los Angeles, CA 90095 USA.	jringman@mednet.ucla.edu						ACOSTABAENA N, 2011, LANCET NEUROL, DOI DOI 10.1016/51474-4422(10)70323-9; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; GUNK WE, 2007, J NEUROSCI, V27, P6174; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; Parra MA, 2010, BRAIN, V133, P2702, DOI 10.1093/brain/awq148; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Ringman JM, 2009, ALZHEIMERS DEMENT, V5, P166, DOI 10.1016/j.jalz.2008.12.002	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2011	10	3					200	201		10.1016/S1474-4422(10)70328-8	http://dx.doi.org/10.1016/S1474-4422(10)70328-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	736HR	21296021				2022-12-18	WOS:000288482200002
J	Shatunov, A; Mok, K; Newhouse, S				Shatunov, A.; Mok, K.; Newhouse, S.			Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study (vol 9, pg 986, 2010)	LANCET NEUROLOGY			English	Correction													Newhouse, Stephen J/C-9330-2011; Shatunov, Alexey/HHN-5183-2022; Mok, Kin/U-6893-2019; Shatunov, Aleksey/E-6946-2011	Newhouse, Stephen J/0000-0002-1843-9842; Shatunov, Alexey/0000-0002-2671-8040; Mok, Kin/0000-0003-3145-880X; 				Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6	1	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2011	10	3					205	205		10.1016/S1474-4422(10)70197-6	http://dx.doi.org/10.1016/S1474-4422(10)70197-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	736HR		hybrid, Green Published, Green Submitted			2022-12-18	WOS:000288482200006
J	O'Connor, P; Filippi, M; Amason, B				O'Connor, P.; Filippi, M.; Amason, B.		BEYOND Study Grp	250 mu g or 500 mu g interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)	LANCET NEUROLOGY			English	Correction													Filippi, Massimo/K-1755-2018	Filippi, Massimo/0000-0002-5485-0479				O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1	1	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2011	10	2					115	115		10.1016/S1474-4422(09)70226-1	http://dx.doi.org/10.1016/S1474-4422(09)70226-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721IT		Green Accepted			2022-12-18	WOS:000287347500005
J	Blackstone, C				Blackstone, Craig			Infantile parkinsonism-dystonia due to dopamine transporter gene mutations: another genetic twist	LANCET NEUROLOGY			English	Editorial Material									NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Blackstone, C (corresponding author), NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA.	blackstc@ninds.nih.gov						Assmann BE, 2004, NEUROLOGY, V62, P1872, DOI 10.1212/01.WNL.0000126440.16612.51; Bannon MJ, 2005, TOXICOL APPL PHARM, V204, P355, DOI 10.1016/j.taap.2004.08.013; Blackstone C, 2009, J CLIN INVEST, V119, P1455, DOI 10.1172/JCI39632; Kagi G, 2010, J NEUROL NEUROSUR PS, V81, P5, DOI 10.1136/jnnp.2008.157370; Kurian MA, 2011, LANCET NEUROL, V10, P54, DOI 10.1016/S1474-4422(10)70269-6; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Pons R, 2009, J INHERIT METAB DIS, V32, P321, DOI 10.1007/s10545-008-1007-6; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Schneider SA, 2010, CURR NEUROL NEUROSCI, V10, P431, DOI 10.1007/s11910-010-0136-0; Varrone A, 2010, J NUCL MED, V51, P1331, DOI 10.2967/jnumed.109.065656	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2011	10	1					24	25		10.1016/S1474-4422(10)70280-5	http://dx.doi.org/10.1016/S1474-4422(10)70280-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	701HX	21112252				2022-12-18	WOS:000285810100014
J	Stoessl, AJ				Stoessl, A. Jon			Movement disorders: new insights into Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material							ALPHA-SYNUCLEIN		Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia	Stoessl, AJ (corresponding author), Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada.	jstoessl@interchange.ubc.ca	Stoessl, A Jon/J-9661-2015	Stoessl, A Jon/0000-0002-9778-7246				Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	11	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2011	10	1					5	7		10.1016/S1474-4422(10)70303-3	http://dx.doi.org/10.1016/S1474-4422(10)70303-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	701HX	21163435				2022-12-18	WOS:000285810100004
J	Shafrir, Y				Shafrir, Yuval			Vaccination and Dravet syndrome	LANCET NEUROLOGY			English	Letter									Sinai Hosp Baltimore Pediat, Baltimore, MD 21215 USA	Sinai Hospital of Baltimore	Shafrir, Y (corresponding author), Sinai Hosp Baltimore Pediat, Baltimore, MD 21215 USA.			SHAFRIR, YUVAL/0000-0002-5258-0719				McIntosh AM, 2010, LANCET NEUROL, V9, P592, DOI 10.1016/S1474-4422(10)70107-1; Miyama S, 2008, PEDIATR NEUROL, V39, P120, DOI 10.1016/j.pediatrneurol.2008.04.003; Nieto-Barrera M, 2003, REV NEUROLOGIA, V37, P64, DOI 10.33588/rn.3701.2003184; Swann JW, 2008, EPILEPSY COMPREHENSI, P469	4	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2010	9	12					1147	1148		10.1016/S1474-4422(10)70288-X	http://dx.doi.org/10.1016/S1474-4422(10)70288-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	691KG	21087737				2022-12-18	WOS:000285078100009
J	Freeman, WD; Vatz, KA; Demaerschalk, BM				Freeman, William D.; Vatz, Kenneth A.; Demaerschalk, Bart M.			Telemedicine in 2010: robotic caveats	LANCET NEUROLOGY			English	Letter							NEUROLOGY		[Freeman, William D.] Mayo Clin, Jacksonville, FL 32224 USA; [Vatz, Kenneth A.] CommunityHealth, Chicago, IL USA; [Demaerschalk, Bart M.] Mayo Clin, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Freeman, WD (corresponding author), Mayo Clin, Jacksonville, FL 32224 USA.	freeman.william1@mayo.edu		Freeman, M.D., William D./0000-0003-2326-0633				Demaerschalk BM, 2010, AM J MANAG CARE, V16, P537; Duncan C, 2010, SCOT MED J, V55, P3, DOI 10.1258/rsmsmj.55.1.3; Freeman WD, 2010, NEUROL CLIN, V28, P537, DOI 10.1016/j.ncl.2009.11.006; Patterson V, 2005, J TELEMED TELECARE, V11, P55, DOI 10.1258/1357633053499840; Williams Ruth, 2010, Lancet Neurol, V9, P346, DOI 10.1016/S1474-4422(10)70075-2	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2010	9	11					1046	1046		10.1016/S1474-4422(10)70261-1	http://dx.doi.org/10.1016/S1474-4422(10)70261-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680PL	20965432				2022-12-18	WOS:000284246800010
J	Griggs, RC				Griggs, Robert C.			Duchenne muscular dystrophy: an important negative trial	LANCET NEUROLOGY			English	Editorial Material							MONONUCLEAR-CELL ANALYSIS; MUSCLE BIOPSIES; PREDNISONE		Univ Rochester, Dept Neurol, Rochester, NY 14627 USA	University of Rochester	Griggs, RC (corresponding author), Univ Rochester, Dept Neurol, Rochester, NY 14627 USA.	robert_griggs@urmc.rochester.edu		Griggs, Robert/0000-0001-7988-4854				Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Frosk P, 2004, NEUROMUSCULAR DISORD, V14, P579; GRIGGS RC, 1993, NEUROLOGY, V43, P520, DOI 10.1212/WNL.43.3_Part_1.520; Kirschner J, 2010, LANCET NEUROL, V9, P1053, DOI 10.1016/S1474-4422(10)70196-4; KISSEL JT, 1991, NEUROLOGY, V41, P667, DOI 10.1212/WNL.41.5.667; KISSEL JT, 1993, NEUROLOGY, V43, P532, DOI 10.1212/WNL.43.3_Part_1.532; Manzur AY, 2004, COCHRANE DB SYST REV, V2; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Moxley RT, 2005, NEUROLOGY, V64, P13, DOI 10.1212/01.WNL.0000148485.00049.B7; RIFAI Z, 1995, AM J PHYSIOL-ENDOC M, V268, pE67, DOI 10.1152/ajpendo.1995.268.1.E67; SHARMA KR, 1993, NEUROLOGY, V43, P527, DOI 10.1212/WNL.43.3_Part_1.527	12	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2010	9	11					1038	1039		10.1016/S1474-4422(10)70210-6	http://dx.doi.org/10.1016/S1474-4422(10)70210-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680PL	20801086				2022-12-18	WOS:000284246800002
J	Hutchinson, C; Elbers, J; Halliday, W; Benseler, SM				Hutchinson, C.; Elbers, J.; Halliday, W.; Benseler, Susanne M.			Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study (vol 9, pg 1078, 2010)	LANCET NEUROLOGY			English	Correction									[Benseler, Susanne M.] Univ Toronto, Toronto, ON M5S 1A1, Canada	University of Toronto								Hutchinson C, 2010, LANCET NEUROL, V9, P1078, DOI 10.1016/S1474-4422(10)70243-X	1	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2010	9	11					1045	1045		10.1016/S1474-4422(10)70243-X	http://dx.doi.org/10.1016/S1474-4422(10)70243-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680PL					2022-12-18	WOS:000284246800008
J	Verstraete, E; Veldink, JH; van den Berg, LH				Verstraete, Esther; Veldink, Jan H.; van den Berg, Leonard H.			Would riluzole be efficacious in the new ALS trial design?	LANCET NEUROLOGY			English	Letter							AMYOTROPHIC-LATERAL-SCLEROSIS		[Verstraete, Esther; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Verstraete, E (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, POB 85500, NL-3508 GA Utrecht, Netherlands.	l.h.vandenBerg@umcutrecht.nl		Veldink, Jan/0000-0001-5572-9657				Aggarwal SP, 2010, LANCET NEUROL, V9, P481, DOI 10.1016/S1474-4422(10)70068-5; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Kriz J, 2003, ANN NEUROL, V53, P429, DOI 10.1002/ana.10500; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Piepers S, 2009, ANN NEUROL, V66, P227, DOI 10.1002/ana.21620	7	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2010	9	10					949	950		10.1016/S1474-4422(10)70230-1	http://dx.doi.org/10.1016/S1474-4422(10)70230-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672WC	20864047	Bronze			2022-12-18	WOS:000283616700008
J	Honnorat, J				Honnorat, Jerome			Is autoimmune limbic encephalitis a channelopathy?	LANCET NEUROLOGY			English	Editorial Material							ANTIBODIES		Hop Neurol & Neurochirurg P Wertheimer, Serv Neurol B, F-69677 Bron, France	CHU Lyon	Honnorat, J (corresponding author), Hop Neurol & Neurochirurg P Wertheimer, Serv Neurol B, F-69677 Bron, France.	jerome.honnorat@chu-lyon.fr	Honnorat, jerome/G-6394-2017	Honnorat, jerome/0000-0002-4721-5952				Barber PA, 2000, NEUROLOGY, V54, P771, DOI 10.1212/WNL.54.3.771; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Graus F, 2008, NEUROLOGY, V71, P930, DOI 10.1212/01.wnl.0000325917.48466.55; Honnorat J, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-22; Lai MZ, 2010, LANCET NEUROL, V9, P776, DOI 10.1016/S1474-4422(10)70137-X; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; SHILLITO P, 1995, ANN NEUROL, V38, P714, DOI 10.1002/ana.410380505; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Vincent A, 2009, ANN NEUROL, V66, pS3	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2010	9	8					753	755		10.1016/S1474-4422(10)70162-9	http://dx.doi.org/10.1016/S1474-4422(10)70162-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	635LS	20580614				2022-12-18	WOS:000280657800003
J	Amarenco, P; Meseguer, E; Touboul, PJ				Amarenco, Pierre; Meseguer, Elena; Touboul, Pierre-Jean			Cerebral microemboli: smoking gun or innocent bystanders?	LANCET NEUROLOGY			English	Editorial Material							ASYMPTOMATIC CAROTID STENOSIS; STROKE PREVENTION; AGGRESSIVE REDUCTION; TRIAL; ATHEROSCLEROSIS; METAANALYSIS; STATINS; RISK		[Amarenco, Pierre; Meseguer, Elena; Touboul, Pierre-Jean] INSERM, U698, Paris, France; [Amarenco, Pierre; Meseguer, Elena; Touboul, Pierre-Jean] Hop Xavier Bichat, Dept Neurol, Paris, France; [Amarenco, Pierre; Meseguer, Elena; Touboul, Pierre-Jean] Hop Xavier Bichat, Stroke Ctr, Paris, France; [Amarenco, Pierre; Meseguer, Elena; Touboul, Pierre-Jean] Paris Diderot Univ, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Amarenco, P (corresponding author), INSERM, U698, Paris, France.	pierre.amarenco@bch.aphp.fr	meseguer, elena/ABI-4071-2020	meseguer, elena/0000-0002-7184-2614; Touboul, Pierre-Jean/0000-0002-8872-9917				Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Amarenco P, 2009, STROKE, V40, P2486, DOI 10.1161/STROKEAHA.108.546135; Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Rothwell PM, 2004, STROKE, V35, P2425, DOI 10.1161/01.STR.0000141706.50170.a7; Sillesen H, 2008, STROKE, V39, P3297, DOI 10.1161/STROKEAHA.108.516450; Spence JD, 2010, ARCH NEUROL-CHICAGO, V67, P180, DOI 10.1001/archneurol.2009.289	9	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2010	9	7					644	645		10.1016/S1474-4422(10)70138-1	http://dx.doi.org/10.1016/S1474-4422(10)70138-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	617NF	20542738				2022-12-18	WOS:000279286900001
J	Fazekas, F				Fazekas, Franz			Where to go next with neuroprotection in multiple sclerosis?	LANCET NEUROLOGY			English	Editorial Material							LAMOTRIGINE; DISEASE; MRI		Med Univ Graz, Dept Neurol, A-8036 Graz, Austria	Medical University of Graz	Fazekas, F (corresponding author), Med Univ Graz, Dept Neurol, Auenbruggerpl 22, A-8036 Graz, Austria.	franz.fazekas@medunigraz.at						Barkhof F, 2009, NAT REV NEUROL, V5, P182, DOI 10.1038/nrneurol.2009.31; Bechtold DA, 2006, J NEUROL, V253, P1542, DOI 10.1007/s00415-006-0204-1; Fazekas F, 2007, J NEUROIMAGING, V17, p50S, DOI 10.1111/j.1552-6569.2007.00138.x; KAPOOR R, 2010, LANCET NEUROL, DOI DOI 10.1016/S1474-4422(10)7O131-9; Leandri M, 2000, J NEUROL, V247, P556, DOI 10.1007/s004150070157; Thompson A, 2009, LANCET, V373, P697, DOI 10.1016/S0140-6736(09)60414-1; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Zivadinov R, 2008, NEUROLOGY, V71, P136, DOI 10.1212/01.wnl.0000316810.01120.05	8	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2010	9	7					647	648		10.1016/S1474-4422(10)70133-2	http://dx.doi.org/10.1016/S1474-4422(10)70133-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	617NF	20621710				2022-12-18	WOS:000279286900003
J	Hill, MD; Menon, BK				Hill, Michael D.; Menon, Bijoy K.			Effect modification and ischaemic stroke treatment	LANCET NEUROLOGY			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; SEX-BASED DIFFERENCES; POOLED ANALYSIS; INTRAVENOUS ALTEPLASE; ECASS; TRIALS; THROMBOLYSIS; ATLANTIS; THERAPY; EPITHET		[Hill, Michael D.; Menon, Bijoy K.] Univ Calgary, Calgary Stroke Program, Dept Clin Neurosci, Calgary, AB, Canada; [Hill, Michael D.; Menon, Bijoy K.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Hill, Michael D.] Foothills Prov Gen Hosp, Calgary, AB T2N 2T9, Canada	University of Calgary; University of Calgary	Hill, MD (corresponding author), Univ Calgary, Calgary Stroke Program, Dept Clin Neurosci, Calgary, AB, Canada.	michael.hill@ucalgary.ca	MENON, BIJOY K/B-7718-2014; Hill, Michael D/C-9073-2012	Hill, Michael D/0000-0002-6269-1543				Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Hill MD, 2006, AM J NEURORADIOL, V27, P1612; Hill MD, 2003, STROKE, V34, P1925, DOI 10.1161/01.STR.0000082483.37127.D0; Hill MD, 2006, STROKE, V37, P2322, DOI 10.1161/01.STR.0000237060.21472.47; Kent DM, 2005, STROKE, V36, P62, DOI 10.1161/01.STR.0000150515.15576.29; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lyden PD, 2009, LANCET NEUROL, V8, P1074, DOI 10.1016/S1474-4422(09)70274-1; Saver JL, 2010, LANCET, V375, P1667, DOI 10.1016/S0140-6736(10)60634-4; Shobha N, 2010, NEUROLOGY, V74, P767, DOI 10.1212/WNL.0b013e3181d5275c	14	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2010	9	7					649	651		10.1016/S1474-4422(10)70136-8	http://dx.doi.org/10.1016/S1474-4422(10)70136-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	617NF	20610335				2022-12-18	WOS:000279286900004
J	Wiznitzer, M				Wiznitzer, Max			Dravet syndrome and vaccination: when science prevails over speculation	LANCET NEUROLOGY			English	Editorial Material							PERTUSSIS		[Wiznitzer, Max] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Wiznitzer, Max] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Wiznitzer, Max] Case Western Reserve Univ, Dept Int Hlth, Cleveland, OH 44106 USA; [Wiznitzer, Max] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Wiznitzer, M (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	max.wiznitzer@cwru.edu						Baker JP, 2003, VACCINE, V21, P4003, DOI 10.1016/S0264-410X(03)00302-5; Berkovic SF, 2006, LANCET NEUROL, V5, P488, DOI 10.1016/S1474-4422(06)70446-X; Davis Robert L, 2003, Paediatr Drugs, V5, P717, DOI 10.2165/00148581-200305110-00001; Deprez L, 2009, NEUROLOGY, V72, P273, DOI 10.1212/01.wnl.0000339494.76377.d6; Dravet C., 2005, EPILEPTIC SYNDROMES, V4, P89; Evans G, 1999, VACCINE, V17, pS25, DOI 10.1016/S0264-410X(99)00291-1; Gross L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000114; MCINTOSH AM, 2010, LANCET NEUROL, DOI DOI 10.1016/S1474-4422(10)170102-1; MENKES JH, 1990, NEUROPEDIATRICS, V21, P171, DOI 10.1055/s-2008-1071488	9	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUN	2010	9	6					559	561		10.1016/S1474-4422(10)70109-5	http://dx.doi.org/10.1016/S1474-4422(10)70109-5			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	607NY	20447869				2022-12-18	WOS:000278512000004
J	[Anonymous]				[Anonymous]			Vitamin D: hope on the horizon for MS prevention?	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2010	9	6					555	555		10.1016/S1474-4422(10)70121-6	http://dx.doi.org/10.1016/S1474-4422(10)70121-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	607NY	20494316				2022-12-18	WOS:000278512000001
J	Meschia, JF; Ross, OA				Meschia, James F.; Ross, Owen A.			Does mitochondrial DNA have a protective role in stroke?	LANCET NEUROLOGY			English	Editorial Material							MTDNA; POLYMORPHISMS; POPULATION; DISEASE		[Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Ross, Owen A.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Meschia, JF (corresponding author), Mayo Clin, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	meschia.james@mayo.edu	Meschia, James/GPP-1636-2022; Ross, Owen/D-7573-2013	Meschia, James/0000-0002-4475-8142; Ross, Owen/0000-0003-4813-756X				Benn M, 2008, CIRCULATION, V117, P2492, DOI 10.1161/CIRCULATIONAHA.107.756809; Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1; Dubut V, 2004, EUR J HUM GENET, V12, P293, DOI 10.1038/sj.ejhg.5201145; Feder J, 2007, EUR J HUM GENET, V15, P498, DOI 10.1038/sj.ejhg.5201764; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; Rosa A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-57; Testai FD, 2010, ARCH NEUROL-CHICAGO, V67, P19, DOI 10.1001/archneurol.2009.309; Tousoulis D, 2008, TRENDS MOL MED, V14, P441, DOI 10.1016/j.molmed.2008.08.004	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2010	9	5					453	454		10.1016/S1474-4422(10)70092-2	http://dx.doi.org/10.1016/S1474-4422(10)70092-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	592MY	20362513				2022-12-18	WOS:000277384600005
J	[Anonymous]				[Anonymous]			Neurological burden of acute rheumatic fever and rheumatic heart disease: the case for action	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2010	9	5					447	447		10.1016/S1474-4422(10)70096-X	http://dx.doi.org/10.1016/S1474-4422(10)70096-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	592MY	20398851				2022-12-18	WOS:000277384600001
J	Diener, HC				Diener, Hans-Christoph			Single-pulse transcranial magnetic stimulation: a new way to treat migraine attacks with aura	LANCET NEUROLOGY			English	Editorial Material							CEREBRAL HYPOPERFUSION; HEADACHE; TRIALS		[Diener, Hans-Christoph] Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, D-45147 Essen, Germany; [Diener, Hans-Christoph] Univ Duisburg Essen, Headache Ctr, Univ Hosp Essen, D-45147 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Diener, HC (corresponding author), Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, Hufelandstr 55, D-45147 Essen, Germany.	h.diener@uni-essen.de	Diener, Hans-Christoph/AAF-7275-2019					Cunnington M, 2009, HEADACHE, V49, P1414, DOI 10.1111/j.1526-4610.2009.01529.x; Cutrer FM, 1998, ANN NEUROL, V43, P25, DOI 10.1002/ana.410430108; del Rio MS, 1999, CEPHALALGIA, V19, P701, DOI 10.1046/j.1468-2982.1999.019008701.x; Denuelle M, 2008, CEPHALALGIA, V28, P856, DOI 10.1111/j.1468-2982.2008.01623.x; Dodick DW, 2004, HEADACHE, V44, pS20, DOI 10.1111/j.1526-4610.2004.04105.x; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Fregni F, 2007, EXP NEUROL, V204, P462, DOI 10.1016/j.expneurol.2006.09.019; Lipton RB, 2010, LANCET NEUROL, V9, P373, DOI 10.1016/S1474-4422(10)70054-5; Macedo A, 2006, EUR J CLIN PHARMACOL, V62, P161, DOI 10.1007/s00228-005-0088-5; Olesen J, 2004, EUR J NEUROL, V11, P671, DOI 10.1111/j.1468-1331.2004.00914.x; Tfelt-Hansen P, 2000, CEPHALALGIA, V20, P765; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505	12	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2010	9	4					335	337		10.1016/S1474-4422(10)70063-6	http://dx.doi.org/10.1016/S1474-4422(10)70063-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576KA	20206580				2022-12-18	WOS:000276142000004
J	Klit, H; Finnerup, NB; Jensen, TS				Klit, Henriette; Finnerup, Nanna B.; Jensen, Troels S.			Defining post-stroke pain: diagnostic challenges Reply	LANCET NEUROLOGY			English	Letter									[Klit, Henriette; Finnerup, Nanna B.; Jensen, Troels S.] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark; [Jensen, Troels S.] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Klit, H (corresponding author), Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark.	henriette.klit@ki.au.dk	Jensen, Troels Staehelin/A-3418-2009; Finnerup, Nanna Brix/ABA-8219-2020	Jensen, Troels Staehelin/0000-0002-3487-6380; Finnerup, Nanna Brix/0000-0001-5541-0240					0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2010	9	4					344	345		10.1016/S1474-4422(10)70073-9	http://dx.doi.org/10.1016/S1474-4422(10)70073-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576KA					2022-12-18	WOS:000276142000011
J	Gorson, KC				Gorson, Kenneth C.			A new trick for an old dog: pulsed dexamethasone treatment for chronic inflammatory demyelinating polyneuropathy	LANCET NEUROLOGY			English	Editorial Material							HIGH-DOSE DEXAMETHASONE; CONTROLLED TRIAL; POLYRADICULONEUROPATHY		Tufts Univ, St Elizabeths Med Ctr, Sch Med, Boston, MA 02135 USA	St. Elizabeth's Medical Center; Tufts University	Gorson, KC (corresponding author), Tufts Univ, St Elizabeths Med Ctr, Sch Med, Boston, MA 02135 USA.	kengorson@comcast.net	Gorson, Kenneth/K-7778-2019					Cheng YF, 2003, NEW ENGL J MED, V349, P831, DOI 10.1056/NEJMoa030254; DYCK PJ, 1982, ANN NEUROL, V11, P136, DOI 10.1002/ana.410110205; Hughes R, 2001, ANN NEUROL, V50, P195, DOI 10.1002/ana.1088; Hughes RAC, 2006, EUR J NEUROL, V13, P326, DOI 10.1111/j.1468-1331.2006.01278.x; Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0; Koller H, 2005, NEW ENGL J MED, V352, P1343, DOI 10.1056/nejmra041347; Lopate G, 2005, ARCH NEUROL-CHICAGO, V62, P249, DOI 10.1001/archneur.62.2.249; Molenaar DSM, 1997, J NEUROL NEUROSUR PS, V62, P388, DOI 10.1136/jnnp.62.4.388; Muley SA, 2008, ARCH NEUROL-CHICAGO, V65, P1460, DOI 10.1001/archneur.65.11.1460; VANSCHAIK IN, 2010, LANCET NEUROL	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2010	9	3					228	229		10.1016/S1474-4422(10)70031-4	http://dx.doi.org/10.1016/S1474-4422(10)70031-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	565BL	20133203				2022-12-18	WOS:000275263400002
J	Fei, Z; Luo, P; Zhang, L				Fei, Zhou; Luo, Peng; Zhang, Lei			Prognostic predictors for outcome after childhood stroke	LANCET NEUROLOGY			English	Letter									[Fei, Zhou; Luo, Peng; Zhang, Lei] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University	Fei, Z (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn		Fullerton, Heather/0000-0002-4828-1687; Luo, Peng/0000-0003-0746-939X				Goldenberg NA, 2009, LANCET NEUROL, V8, P1120, DOI 10.1016/S1474-4422(09)70241-8; Potter JF, 2009, LANCET NEUROL, V8, P48, DOI 10.1016/S1474-4422(08)70263-1; Rafay MF, 2009, STROKE, V40, P58, DOI 10.1161/STROKEAHA.108.519066; Srinivasan J, 2009, PEDIATRICS, V124, pE227, DOI 10.1542/peds.2008-3544; Tikhonoff V, 2009, LANCET NEUROL, V8, P938, DOI 10.1016/S1474-4422(09)70184-X	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2010	9	2					141	141		10.1016/S1474-4422(10)70013-2	http://dx.doi.org/10.1016/S1474-4422(10)70013-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	547XB	20129163				2022-12-18	WOS:000273922000009
J	Dickson, DW; Braak, H; Duda, JE				Dickson, D. W.; Braak, H.; Duda, J. E.			Neuropothological assessment of Parkinson's disease: refining the diagnostic criteria. (vol 8, pg 1150, 2009)	LANCET NEUROLOGY			English	Correction																		Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8	1	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2010	9	1					29	29		10.1016/S1474-4422(09)70238-8	http://dx.doi.org/10.1016/S1474-4422(09)70238-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	538QS					2022-12-18	WOS:000273199700017
J	Schott, AM				Schott, Anne-Marie			Randomised trials of endovascular treatment of stroke are needed	LANCET NEUROLOGY			English	Letter									Univ Lyon 1, RECIF, EA Sante Individus Soc, F-69008 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Schott, AM (corresponding author), Univ Lyon 1, RECIF, EA Sante Individus Soc, F-69008 Lyon, France.	anne-marie.schott-pethelaz@chu-lyon.fr	Schott, Anne-Marie/V-7580-2018	Schott, Anne-Marie/0000-0003-3337-4474				CHATARD S, 2009, JEUR S, V22, pA22; Debiais S, 2007, REV NEUROL-FRANCE, V163, P817, DOI 10.1016/S0035-3787(07)91464-2; *FRALYSE TRIAL, COMP CLASS RT PA PRO; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2010	9	1					30	31		10.1016/S1474-4422(09)70350-3	http://dx.doi.org/10.1016/S1474-4422(09)70350-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	538QS	20083032				2022-12-18	WOS:000273199700019
J	[Anonymous]				[Anonymous]			A new voice for global neurology?	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2010	9	1					1	1		10.1016/S1474-4422(09)70347-3	http://dx.doi.org/10.1016/S1474-4422(09)70347-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	538QS	20083020				2022-12-18	WOS:000273199700001
J	Rudick, RA; Fisher, E				Rudick, Richard A.; Fisher, Elizabeth			Do interferon beta-1b and glatiramer acetate grow brain?	LANCET NEUROLOGY			English	Letter							REMITTING MULTIPLE-SCLEROSIS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND		[Fisher, Elizabeth] Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH USA	Cleveland Clinic Foundation		rudickr@ccf.org						Barkhof F, 2007, ARCH NEUROL-CHICAGO, V64, P1292, DOI 10.1001/archneur.64.9.1292; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; Miller DH, 2007, NEUROLOGY, V68, P1390, DOI 10.1212/01.wnl.0000260064.77700.fd; O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662	6	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	DEC	2009	8	12					1085	1086		10.1016/S1474-4422(09)70312-6	http://dx.doi.org/10.1016/S1474-4422(09)70312-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523WS	19909906	Bronze			2022-12-18	WOS:000272106100011
J	O'Connor, P; Filippi, M; Arnason, B				O'Connor, P.; Filippi, M.; Arnason, B.			250 mu g or 500 mu g interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study (vol 8, pg 889, 2009)	LANCET NEUROLOGY			English	Correction													Filippi, Massimo/K-1755-2018	Filippi, Massimo/0000-0002-5485-0479				O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1	1	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2009	8	11					981	981		10.1016/S1474-4422(09)70226-1	http://dx.doi.org/10.1016/S1474-4422(09)70226-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513GC		Green Accepted			2022-12-18	WOS:000271309600009
J	Coles, A				Coles, Alasdair			Trials of diminishing relapses for diminishing returns	LANCET NEUROLOGY			English	Editorial Material							MULTIPLE-SCLEROSIS; MULTICENTER		Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Coles, A (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Box 165, Cambridge CB2 0QQ, England.	ajc1020@medschl.cam.ac.uk		Coles, Alasdair/0000-0003-4738-0760				DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; OCONNOR P, 2009, LANCET NEUROL	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2009	8	10					870	871		10.1016/S1474-4422(09)70234-0	http://dx.doi.org/10.1016/S1474-4422(09)70234-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498BS	19729345				2022-12-18	WOS:000270111200002
J	Bovet, P; Shamlaye, C; Paccaud, F				Bovet, Pascal; Shamlaye, Conrad; Paccaud, Fred			Stroke mortality in the Seychelles: methodological issues	LANCET NEUROLOGY			English	Letter							RISK-FACTORS; COUNTRY		[Bovet, Pascal] Minist Hlth & Social Dev, Victoria, Seychelles; Univ Inst Social & Prevent Med, CH-1005 Lausanne, Switzerland		Bovet, P (corresponding author), Minist Hlth & Social Dev, POB 52, Victoria, Seychelles.	pascal.bovet@chuv.ch	paccaud, fred/M-7516-2019; Bovet, Pascal/F-4477-2011	Bovet, Pascal/0000-0002-0242-4259				Bovet P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-9; Bovet P, 2008, STROKE, V39, P628; Bovet P, 2007, STROKE, V38, P535; Danon-Hersch N, 2007, EPIDEMIOLOGY, V18, P493, DOI 10.1097/EDE.0b013e318063eebf; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2009	8	8					700	700		10.1016/S1474-4422(09)70189-9	http://dx.doi.org/10.1016/S1474-4422(09)70189-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477YV	19608094				2022-12-18	WOS:000268555800008
J	Burt, RK; Loh, Y; Cohen, B; Stefoski; Balabanov; Katsamakis				Burt, R. K.; Loh, Y.; Cohen, B.; Dr Stefoski; Dr Balabanov; Dr Katsamakis			Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis a phase I/II study. (vol 8, pg 244, 2009)	LANCET NEUROLOGY			English	Correction									[Dr Stefoski; Dr Balabanov; Dr Katsamakis] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University								Burt RK, 2009, LANCET NEUROL, V8, P244, DOI 10.1016/S1474-4422(09)70017-1	1	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2009	8	4					309	309		10.1016/S1474-4422(09)70017-1	http://dx.doi.org/10.1016/S1474-4422(09)70017-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	425CH		Green Submitted			2022-12-18	WOS:000264614100007
J	Das, A; Kesavadas, C				Das, Abhijit; Kesavadas, Chandrasekharan			Perilesional brain oedema and seizure activity: cause or effect?	LANCET NEUROLOGY			English	Letter							ABNORMALITIES; EPILEPSY; MRI		[Das, Abhijit] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum 695011, Kerala, India; Sree Chitra Tirunal Inst Med Sci & Technol, Dept Imaging Sci & Intervent Radiol, Trivandrum 695011, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Das, A (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum 695011, Kerala, India.	abhijit.neuro@gmail.com	KESAVADAS, CHANDRASEKHARAN/ABG-8488-2020; Das, Abhijit/AAQ-1729-2020	KESAVADAS, CHANDRASEKHARAN/0000-0003-4914-8666; 				Briellmann RS, 2005, EPILEPSIA, V46, P760, DOI 10.1111/j.1528-1167.2005.47604.x; Cole AJ, 2004, EPILEPSIA, V45, P72, DOI 10.1111/j.0013-9580.2004.04014.x; Nash TE, 2008, LANCET NEUROL, V7, P1099, DOI 10.1016/S1474-4422(08)70243-6; Oh JB, 2004, SEIZURE-EUR J EPILEP, V13, P509, DOI 10.1016/j.seizure.2003.12.005; Raghavendra S, 2007, EPILEPSY RES, V73, P129, DOI 10.1016/j.eplepsyres.2006.10.007	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2009	8	3					225	225		10.1016/S1474-4422(09)70028-6	http://dx.doi.org/10.1016/S1474-4422(09)70028-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	412FZ	19233028				2022-12-18	WOS:000263711200006
J	Mancardi, G				Mancardi, Gianluigi			Further data on autologous haemopoietic stem cell transplantation in multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material							THERAPY		[Mancardi, Gianluigi] Univ Genoa, San Martino Hosp, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; [Mancardi, Gianluigi] Univ Genoa, San Martino Hosp, Ctr Excellence Biomed Res, Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Mancardi, G (corresponding author), Univ Genoa, San Martino Hosp, Dept Neurosci Ophthalmol & Genet, Genoa, Italy.	glmancardi@neurologia.unige.it	Mancardi, Giovanni Luigi/K-8656-2016	Mancardi, Giovanni Luigi/0000-0001-8427-118X				BURT RK, 2006, LANCET NEUROL, DOI DOI 10.1016/S1474-4422(09)70017-1; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Fagius J, 2009, MULT SCLER, V15, P229, DOI 10.1177/1352458508096875; Kimiskidis V, 2008, MULT SCLER J, V14, P278, DOI 10.1177/1352458507082604; Mancardi G, 2008, LANCET NEUROL, V7, P626, DOI 10.1016/S1474-4422(08)70138-8; Mancardi GL, 2005, MULT SCLER, V11, P367, DOI 10.1191/1352458505ms1181cr; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Portaccio E, 2007, MULT SCLER J, V13, P676, DOI 10.1177/1352458506073502; Shevchenko YL, 2008, EXP HEMATOL, V36, P922, DOI 10.1016/j.exphem.2008.03.001	9	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2009	8	3					219	221		10.1016/S1474-4422(09)70018-3	http://dx.doi.org/10.1016/S1474-4422(09)70018-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	412FZ	19186106				2022-12-18	WOS:000263711200003
J	Stone, LA				Stone, Lael A.			Getting the measure of multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material							PROGRESSION; DISABILITY		Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA		Stone, LA (corresponding author), Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA.	stonel@ccf.org						Bakshi R, 2008, ARCH NEUROL-CHICAGO, V65, P1449, DOI 10.1001/archneur.65.11.1449; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Hartung HP, 2009, LANCET NEUROL, V8, P28, DOI 10.1016/S1474-4422(08)70281-3; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Petkau J, 2008, MULT SCLER J, V14, P770, DOI 10.1177/1352458507088104; Rudick RA, 2002, MULT SCLER, V8, P359, DOI 10.1191/1352458502ms845oa	7	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2009	8	3					221	222		10.1016/S1474-4422(09)70022-5	http://dx.doi.org/10.1016/S1474-4422(09)70022-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	412FZ	19201655				2022-12-18	WOS:000263711200004
J	[Anonymous]				[Anonymous]			Leprosy as a neurological disease	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2009	8	3					217	217		10.1016/S1474-4422(09)70026-2	http://dx.doi.org/10.1016/S1474-4422(09)70026-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	412FZ	19233026				2022-12-18	WOS:000263711200001
J	Dodick, DW; Schwedt, T				Dodick, David W.; Schwedt, Todd			Headache: challenging conventional wisdom	LANCET NEUROLOGY			English	Editorial Material							MIGRAINE		[Dodick, David W.] Mayo Clin Arizona, Dept Neurol, Phoenix, AZ 85054 USA; [Schwedt, Todd] Washington Univ, Sch Med, Headache Ctr, St Louis, MO 63110 USA	Mayo Clinic; Mayo Clinic Phoenix; Washington University (WUSTL)	Dodick, DW (corresponding author), Mayo Clin Arizona, Dept Neurol, Phoenix, AZ 85054 USA.	dodick.david@mayo.edu		Schwedt, Todd/0000-0002-7780-7086				Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Denuelle M, 2008, CEPHALALGIA, V28, P856, DOI 10.1111/j.1468-2982.2008.01623.x; Ho TW, 2008, HEADACHE, V48, pS7; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Schoonman GG, 2008, BRAIN, V131, P2192, DOI 10.1093/brain/awn094	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2009	8	1					12	14		10.1016/S1474-4422(08)70275-8	http://dx.doi.org/10.1016/S1474-4422(08)70275-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386CU	19081504				2022-12-18	WOS:000261860700007
J	Farlow, MR				Farlow, Martin R.			The SERAD study of the safety and efficacy of galantamine in severe Alzheimer's disease	LANCET NEUROLOGY			English	Editorial Material							DOUBLE-BLIND; DONEPEZIL; MEMANTINE; MODERATE; TRIAL		Indiana Univ, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Farlow, MR (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN 46202 USA.	mfarlow@iupui.edu						Bentham P, 2004, LANCET, V363, P2105; Burns A, 2009, LANCET NEUROL, V8, P39, DOI 10.1016/S1474-4422(08)70261-8; Farlow MR, 2007, AM J MED, V120, P388, DOI 10.1016/j.amjmed.2006.08.036; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tariot PN, 2001, J AM GERIATR SOC, V49, P1590, DOI 10.1046/j.1532-5415.2001.t01-1-49266.x; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; Winblad B, 2006, LANCET, V367, P1057, DOI 10.1016/S0140-6736(06)68350-5	9	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2009	8	1					22	23		10.1016/S1474-4422(08)70262-X	http://dx.doi.org/10.1016/S1474-4422(08)70262-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386CU	19042160				2022-12-18	WOS:000261860700012
J	Goodman, A				Goodman, Alice			Vladimir Hachinski: a pioneer in the field of stroke	LANCET NEUROLOGY			English	Editorial Material												agoodman1@hvc.rr.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2009	8	1					34	34		10.1016/S1474-4422(08)70285-0	http://dx.doi.org/10.1016/S1474-4422(08)70285-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386CU	19081514	Bronze			2022-12-18	WOS:000261860700019
J	Kretzschmar, H; Illig, T				Kretzschmar, Hans; Illig, Thomas			Are further genetic factors associated with the risk of developing variant Creutzfeldt-Jakob disease?	LANCET NEUROLOGY			English	Editorial Material							TISSUE SAMPLES; PREVALENCE; UK		[Kretzschmar, Hans] Univ Munich, Munich, Germany; Helmholtz Zentrum Munich, Inst Epidemiol, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kretzschmar, H (corresponding author), Univ Munich, Munich, Germany.	hans.kretzschmar@med.uni-muenchen.de						Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Mead S, 2001, AM J HUM GENET, V69, P1225, DOI 10.1086/324710; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Vollmert C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040931; Ward HJT, 2006, ANN NEUROL, V59, P111, DOI 10.1002/ana.20708; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	9	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2009	8	1					25	26		10.1016/S1474-4422(08)70266-7	http://dx.doi.org/10.1016/S1474-4422(08)70266-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386CU	19081509				2022-12-18	WOS:000261860700014
J	Wider, C; Wszolek, ZK				Wider, Christian; Wszolek, Zbigniew K.			Movement disorders: insights into mechanisms and hopes for treatment	LANCET NEUROLOGY			English	Editorial Material							PARKINSONS-DISEASE; DOPAMINE NEURONS; TRANSPLANTATION; PATHOLOGY; TRIAL		[Wider, Christian; Wszolek, Zbigniew K.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	Mayo Clinic	Wider, C (corresponding author), Mayo Clin, Dept Neurol, Cannaday Bldg 2E,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	wszolek.zbigniew@mayo.edu	Wszolek, Zbigniew K./AAB-1431-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015866, P01AG017216] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG017216, R01AG015866] Funding Source: Medline; NINDS NIH HHS [P50NS40256] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albin RL, 2003, NEUROLOGY, V60, P390, DOI 10.1212/01.WNL.0000052681.28286.52; Camargos S, 2008, LANCET NEUROL, V7, P207, DOI 10.1016/S1474-4422(08)70022-X; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Katzenschlager R, 2008, NEUROLOGY, V71, P474, DOI 10.1212/01.wnl.0000310812.43352.66; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Ross OA, 2008, ANN NEUROL, V64, P88, DOI 10.1002/ana.21405; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438	10	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2009	8	1					8	10		10.1016/S1474-4422(08)70273-4	http://dx.doi.org/10.1016/S1474-4422(08)70273-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386CU	19081502				2022-12-18	WOS:000261860700005
J	[Anonymous]				[Anonymous]			National registry offers new hope for ALS	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2009	8	1					1	1		10.1016/S1474-4422(08)70269-2	http://dx.doi.org/10.1016/S1474-4422(08)70269-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	386CU	19081498	Bronze			2022-12-18	WOS:000261860700001
J	MacReady, N				MacReady, Norra			Reforming the US health-care system	LANCET NEUROLOGY			English	Editorial Material												medrite@aol.com							0	2	2	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2008	7	11					986	987		10.1016/S1474-4422(08)70233-3	http://dx.doi.org/10.1016/S1474-4422(08)70233-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	370EP	18940692				2022-12-18	WOS:000260745800008
J	Farrer, MJ; Gibson, R; Hentati, F				Farrer, Matthew J.; Gibson, Rachel; Hentati, Faycal			The ancestry of LRRK2 Gly2019Ser parkinsonism - Reply	LANCET NEUROLOGY			English	Editorial Material							DISEASE		[Farrer, Matthew J.; Gibson, Rachel; Hentati, Faycal] Mayo Clin Florida, Jacksonville, FL 32224 USA	Mayo Clinic	Farrer, MJ (corresponding author), Mayo Clin Florida, Jacksonville, FL 32224 USA.	farrer.matthew@mayo.edu		Gibson, Rachel/0000-0002-1338-1290; Farrer, Matthew/0000-0003-1159-5321				Brett Michael, 1997, BERBERS; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Maddy-Weitzman B, 2006, J NORTH AFR STUD, V11, P71, DOI 10.1080/13629380500409917; Warren L, 2008, PARKINSONISM RELAT D, V14, P77, DOI 10.1016/j.parkreldis.2007.02.001	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	SEP	2008	7	9					770	771		10.1016/S1474-4422(08)70179-0	http://dx.doi.org/10.1016/S1474-4422(08)70179-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	345HZ					2022-12-18	WOS:000258988400008
J	Hughes, RAC; Donofrio, P; Bril, V; Bourgin, P; Zeitzer, JM; Mignot, E; Chin, RFM; Neville, BGR; Peckham, C; Wade, A; Bedford, H; Scott, RC				Hughes, R. A. C.; Donofrio, P.; Bril, V; Bourgin, P.; Zeitzer, J. M.; Mignot, E.; Chin, R. F. M.; Neville, B. G. R.; Peckham, C.; Wade, A.; Bedford, H.; Scott, R. C.		ICE Study Grp	Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial (vol 7, pg 136, 20008)	LANCET NEUROLOGY			English	Correction													BRIL, vera/ABA-6509-2020; Zeitzer, Jamie M/A-1168-2007; Zeitzer, Jamie/AAO-2103-2020	Zeitzer, Jamie M/0000-0001-6174-5282; Zeitzer, Jamie/0000-0001-6174-5282				Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0	1	2	2	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2008	7	9					771	771		10.1016/S1474-4422(08)70180-7	http://dx.doi.org/10.1016/S1474-4422(08)70180-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	345HZ					2022-12-18	WOS:000258988400010
J	Huang, Y; Cheng, Y; Wu, J				Huang, Y.; Cheng, Y.; Wu, J.			On behalf of the cilostazol versus aspirin for secondary ischaemic stroke prevention (CASISP) cooperation investigators. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study (vol 7, pg 494, 2008)	LANCET NEUROLOGY			English	Correction																		Huang YI, 2008, LANCET NEUROL, V7, P494, DOI 10.1016/S1474-4422(08)70094-2	1	2	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2008	7	8					675	675		10.1016/S1474-4422(08)70151-0	http://dx.doi.org/10.1016/S1474-4422(08)70151-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330VA		Bronze			2022-12-18	WOS:000257969700010
J	[Anonymous]				[Anonymous]			A network of memory clinics: when and how?	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2008	7	8					663	663		10.1016/S1474-4422(08)70145-5	http://dx.doi.org/10.1016/S1474-4422(08)70145-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330VA	18635011				2022-12-18	WOS:000257969700001
J	Davis, SM; Donnan, GA; Parsons, MW; Levi, C; Butcher, KS; Barber, PA; Bladin, C; De Silva, DA; Peeters, A				Davis, Stephen M.; Donnan, Geoffrey A.; Parsons, Mark W.; Levi, Christopher; Butcher, Kenneth S.; Barber, P. Alan; Bladin, Christopher; De Silva, Deidre A.; Peeters, Andre		EPITHET Investigators	EPITHET - where next? Reply	LANCET NEUROLOGY			English	Editorial Material							STROKE		[Davis, Stephen M.; De Silva, Deidre A.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia; [Donnan, Geoffrey A.] Univ Melbourne, Natl Stroke Res Inst, Melbourne, Vic 3050, Australia; [Parsons, Mark W.; Levi, Christopher] John Hunter Hosp, Ctr Brain & Mental Hlth Res, Hunter Med Res Inst, Newcastle, NSW, Australia; [Butcher, Kenneth S.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Barber, P. Alan] Auckland City Hosp, Dept Neurol, Auckland, New Zealand; [Peeters, Andre] St Luc Univ Hosp, Brussels, Belgium	Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Alberta; Auckland City Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Davis, SM (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia.	stephen.davis@mh.org.au	bladin, chris/B-9136-2013; Davis, Stephen M/L-5260-2013; Butcher, Ken/AEP-3693-2022; Butcher, Ken/ABC-6632-2020; Parsons, Mark W./G-3750-2014	Davis, Stephen M/0000-0003-0962-2300; Butcher, Ken/0000-0002-0590-7918; Butcher, Ken/0000-0002-0590-7918; Levi, Christopher/0000-0002-9474-796X; Barber, P Alan/0000-0003-2469-9023; De Silva, Deidre Anne/0000-0002-7123-2381; Donnan, Geoffrey/0000-0001-6324-3403				Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Schellinger PD, 2008, LANCET NEUROL, V7, P286, DOI 10.1016/S1474-4422(08)70045-0	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2008	7	7					571	572		10.1016/S1474-4422(08)70124-8	http://dx.doi.org/10.1016/S1474-4422(08)70124-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	320DJ					2022-12-18	WOS:000257213600007
J	Qiu, J				Qiu, Jane			In search of a migraine cure: a matter of heart and mind	LANCET NEUROLOGY			English	Editorial Material												jane@janeqiu.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2008	7	7					576	577		10.1016/S1474-4422(08)70130-3	http://dx.doi.org/10.1016/S1474-4422(08)70130-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	320DJ	18565452				2022-12-18	WOS:000257213600012
J	Diener, HC; Kronfeld, K; Boewing, G				Diener, H-C; Kronfeld, K.; Boewing, G.			Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial (vol 5, pg 310, 2006)	LANCET NEUROLOGY			English	Correction													Diener, Hans-Christoph/AAF-7275-2019					Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9	1	2	2	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2008	7	6					475	475		10.1016/S1474-4422(08)70100-5	http://dx.doi.org/10.1016/S1474-4422(08)70100-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	305WF					2022-12-18	WOS:000256207800007
J	Fregni, F				Fregni, Felipe			Towards novel treatments for paediatric stroke: is transcranial magnetic stimulation beneficial?	LANCET NEUROLOGY			English	Editorial Material							UNAFFECTED HEMISPHERE		Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Fregni, F (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02115 USA.	ffregni@bidmc.harvard.edu		Fregni, Felipe/0000-0001-9359-8643				Fregni F, 2006, STROKE, V37, P2115, DOI 10.1161/01.STR.0000231390.58967.6b; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Kinsbourne M, 1977, Adv Neurol, V18, P41; Kirton A, 2008, LANCET NEUROL, V7, P507, DOI 10.1016/S1474-4422(08)70096-6; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Pascual-Leone A, 1999, NEUROPSYCHOLOGIA, V37, P207; Quintana H, 2005, J ECT, V21, P88, DOI 10.1097/01.yct.0000162556.02720.58; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145	10	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUN	2008	7	6					472	473		10.1016/S1474-4422(08)70097-8	http://dx.doi.org/10.1016/S1474-4422(08)70097-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	305WF	18455962				2022-12-18	WOS:000256207800005
J	Ezzeddine, M				Ezzeddine, Mustapha			Acute hypertensive response in intracerebral haemorrhage: is treatment safe and helpful?	LANCET NEUROLOGY			English	Editorial Material									Univ Minnesota, Dept Neurol, Minneapolis, MN 55403 USA	University of Minnesota System; University of Minnesota Twin Cities	Ezzeddine, M (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55403 USA.	ezzeddin@umn.edu						Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; MAYER SA, FAST TRIAL MAIN RESU; Mendelow AD, 2005, LANCET, V365, P387; Qureshi AI, 2007, NEUROCRIT CARE, V6, P56, DOI 10.1385/NCC:6:1:56; QURESHI AI, 2008, LATE BREAKING SCI AB; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005	8	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2008	7	5					374	375		10.1016/S1474-4422(08)70070-X	http://dx.doi.org/10.1016/S1474-4422(08)70070-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	296AB	18396106				2022-12-18	WOS:000255514800002
J	Stern, MB				Stern, Matthew B.			Transcranial ultrasound in Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material							SONOGRAPHIC DISCRIMINATION; SUBSTANTIA-NIGRA		Univ Penn Hlth Syst, Penn Hosp, Dept Neurol, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine	Stern, MB (corresponding author), Univ Penn Hlth Syst, Penn Hosp, Dept Neurol, 330 South 9th St, Philadelphia, PA 19107 USA.	mbstern@mail.med.upenn.edu						Berg D, 2005, MOVEMENT DISORD, V20, P383, DOI 10.1002/mds.20311; Berg D, 2001, J NEUROL, V248, P684, DOI 10.1007/s004150170114; Gaenslen A, 2008, LANCET NEUROL, V7, P417, DOI 10.1016/S1474-4422(08)70067-X; Siderowf A, 2006, CURR NEUROL NEUROSCI, V6, P295, DOI 10.1007/s11910-006-0021-z; Walter U, 2006, J NEUROL, V253, P448, DOI 10.1007/s00415-005-0023-9; Walter U, 2004, NEUROLOGY, V63, P504, DOI 10.1212/01.WNL.0000133006.17909.32	6	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2008	7	5					376	378		10.1016/S1474-4422(08)70068-1	http://dx.doi.org/10.1016/S1474-4422(08)70068-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	296AB	18394966				2022-12-18	WOS:000255514800004
J	Butcher, J				Butcher, James			On reflection - Neuropolitics gone mad	LANCET NEUROLOGY			English	Editorial Material												james@two-cultures.com		Butcher, James/0000-0001-8546-6093					0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2008	7	4					295	295		10.1016/S1474-4422(08)70056-5	http://dx.doi.org/10.1016/S1474-4422(08)70056-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	285PF					2022-12-18	WOS:000254788000009
J	Siddique, T				Siddique, Teepu			What is missing in ALS	LANCET NEUROLOGY			English	Editorial Material							LATERAL-SCLEROSIS; GENE; POLYMORPHISMS		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Siddique, T (corresponding author), Northwestern Univ, Feinberg Sch Med, Tarry Bldg,303 E Chicago Ave, Chicago, IL 60611 USA.	t-siddique@northwestern.edu	Siddique, Teepu/AAT-8166-2021	Siddique, Teepu/0000-0001-7293-9146				Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Cronin S, 2007, J NEUROL NEUROSUR PS, V78, P984, DOI 10.1136/jnnp.2006.112581; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Morahan JM, 2007, NEUROTOXICOLOGY, V28, P532, DOI 10.1016/j.neuro.2006.11.007; Parboosingh JS, 1999, ARCH NEUROL-CHICAGO, V56, P710, DOI 10.1001/archneur.56.6.710; Saeed M, 2006, NEUROLOGY, V67, P771, DOI 10.1212/01.wnl.0000227187.52002.88; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Slowik A, 2006, NEUROLOGY, V67, P766, DOI 10.1212/01.wnl.0000219565.32247.11; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3	11	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2008	7	4					289	290		10.1016/S1474-4422(08)70049-8	http://dx.doi.org/10.1016/S1474-4422(08)70049-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	285PF	18313987				2022-12-18	WOS:000254788000004
J	Stollberger, C; Finsterer, J				Stoellberger, Claudia; Finsterer, Josef			Idraparinux for stroke prevention in atrial fibrillation	LANCET NEUROLOGY			English	Editorial Material							RECOMBINANT FACTOR VIIA; THROMBOEMBOLISM; THERAPY		[Stoellberger, Claudia; Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, A-1030 Vienna, Austria	Rudolfstiftung Hospital	Stollberger, C (corresponding author), Krankenanstalt Rudolfstiftung Wien, Juchgasse 25, A-1030 Vienna, Austria.	claudia.stoellberger@chello.at						Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Buller HR, 2007, NEW ENGL J MED, V357, P1105; Dao A, 2005, AM J MED, V118, P1172, DOI 10.1016/j.amjmed.2005.04.025; Goodnougha LT, 2007, CURR OPIN HEMATOL, V14, P504, DOI 10.1097/MOH.0b013e32826388c3; Oldenburg J, 2007, THROMB HAEMOSTASIS, V98, P570, DOI 10.1160/TH07-07-0454; Wehinger C, 2001, STROKE, V32, P2246, DOI 10.1161/hs1001.097090	6	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2008	7	4					290	291		10.1016/S1474-4422(08)70051-6	http://dx.doi.org/10.1016/S1474-4422(08)70051-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	285PF	18339343				2022-12-18	WOS:000254788000005
J	Frisoni, GB				Frisoni, Giovanni B.			CD - Interactive neuroimaging	LANCET NEUROLOGY			English	Software Review												gfrisoni@fatebenefratelli.it	Frisoni, Giovanni B./K-1360-2016; Frisoni, Giovanni/K-1360-2016	Frisoni, Giovanni B./0000-0002-6419-1753; Frisoni, Giovanni/0000-0001-7075-7082					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2008	7	3					204	204		10.1016/S1474-4422(08)70036-X	http://dx.doi.org/10.1016/S1474-4422(08)70036-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	268KZ	18360935				2022-12-18	WOS:000253580000011
J	Qiu, J				Qiu, Jane			Injection of hope through China's stem-cell therapies	LANCET NEUROLOGY			English	Editorial Material												jane@janeqiu.com							0	2	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	FEB	2008	7	2					122	123		10.1016/S1474-4422(08)70009-7	http://dx.doi.org/10.1016/S1474-4422(08)70009-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261PY	18207109	Bronze			2022-12-18	WOS:000253093700009
J	Aisen, PS				Aisen, Paul S.			An aspirin a day for Alzheimer's disease?	LANCET NEUROLOGY			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; PROGRESSION; ROFECOXIB; NAPROXEN; PLACEBO		Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aisen, PS (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	psa@georgetown.edu			NATIONAL INSTITUTE ON AGING [U19AG010483] Funding Source: NIH RePORTER; NIA NIH HHS [U19 AG010483] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AD2000 COLL GROUP, 2000, LANCET NEUROL, DOI DOI 10.1016/S1474-4422(07)70293-4; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Bentham P, 2004, LANCET, V363, P2105; Lyketsos CG, 2007, NEUROLOGY, V68, P1800; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Van Gool WA, 2001, LANCET, V358, P455, DOI 10.1016/S0140-6736(01)05623-9	9	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2008	7	1					20	21		10.1016/S1474-4422(07)70296-X	http://dx.doi.org/10.1016/S1474-4422(07)70296-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247FO	18068519				2022-12-18	WOS:000252063300012
J	Kirton, A; Tan, M; Mikulis, D; Fisher, J; Han, J; deVeber, G; Rubin, B				Kirton, Adam; Tan, Marilyn; Mikulis, David; Fisher, Joe; Han, Jay; deVeber, Gabrielle; Rubin, Barry			Recurrent reversible coma in an adolescent	LANCET NEUROLOGY			English	Article							SUDDEN UNEXPLAINED DEATH; THAILAND; SLEEP		[Kirton, Adam] Univ Calgary, Div Neurol, Alberta Childrens Hosp, Calgary, AB T3B 6A8, Canada; [Tan, Marilyn; deVeber, Gabrielle] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Mikulis, David] Toronto Western Res Inst, Dept Radiol, Toronto, ON, Canada; [Fisher, Joe; Han, Jay] Univ Hlth Network, Dept Anesthesia, Toronto, ON, Canada; [Rubin, Barry] Univ Toronto, Fac Med, Div Vasc Surg, Univ Hlth Network, Toronto, ON, Canada	Alberta Childrens Hospital; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kirton, A (corresponding author), Univ Calgary, Div Neurol, Alberta Childrens Hosp, 2888 Shaganappi Trail, Calgary, AB T3B 6A8, Canada.	adam.kirton@calgaryhealthregion.ca	Mikulis, David J/H-5167-2019; Kirton, Adam/L-8875-2016	Mikulis, David/0000-0003-3956-0892; /0000-0002-9584-0576				Maslowski H A, 1996, J Clin Forensic Med, V3, P93, DOI 10.1016/S1353-1131(96)90013-9; Mikulis DJ, 2005, J NEUROSURG, V103, P347, DOI 10.3171/jns.2005.103.2.0347; Munger RG, 1998, INT J EPIDEMIOL, V27, P677, DOI 10.1093/ije/27.4.677; Pamphlett R, 1996, J CHILD NEUROL, V11, P181, DOI 10.1177/088307389601100302; Pamphlett R, 1999, PEDIATRICS, V103, P460, DOI 10.1542/peds.103.2.460; Pollanen MS, 1996, CAN MED ASSOC J, V155, P537; TANCHAISWAD W, 1995, PSYCHIAT CLIN NEUROS, V49, P111, DOI 10.1111/j.1440-1819.1995.tb01872.x; TATSANAVIVAT P, 1992, INT J EPIDEMIOL, V21, P904, DOI 10.1093/ije/21.5.904; TUNGSANGA K, 1993, INT J EPIDEMIOL, V22, P81, DOI 10.1093/ije/22.1.81; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2008	7	1					110	112		10.1016/S1474-4422(07)70328-9	http://dx.doi.org/10.1016/S1474-4422(07)70328-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247FO	18093567				2022-12-18	WOS:000252063300031
J	Soffietti, R; Ruda, R				Soffietti, Riccardo; Ruda, Roberta			Neuro-oncology: new insights and advances in treatment	LANCET NEUROLOGY			English	Editorial Material							LOW-GRADE GLIOMAS; GLIOBLASTOMA; TEMOZOLOMIDE; BEVACIZUMAB; IRINOTECAN		[Soffietti, Riccardo] Univ Turin, Dept Neurosci, Div Neurooncol, Turin, Italy; Univ Turin, Dept Oncol, Turin, Italy; San Giovanni Battista Hosp, Turin, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Soffietti, R (corresponding author), Univ Turin, Dept Neurosci, Div Neurooncol, Turin, Italy.	riccardo.soffietti@unito.it	Soffietti, Riccardo/AAA-7965-2022	Soffietti, Riccardo/0000-0002-9204-7038; RUDA', Roberta/0000-0001-9134-1537				Kaloshi G, 2007, NEUROLOGY, V68, P1831, DOI 10.1212/01.wnl.0000262034.26310.a2; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Pelloski CE, 2007, J CLIN ONCOL, V25, P2288, DOI 10.1200/JCO.2006.08.0705; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wen PY, 2007, NEUROLOGY, V68, P1762, DOI 10.1212/01.wnl.0000266866.13748.a9; Wick A, 2007, J CLIN ONCOL, V25, P3357, DOI 10.1200/JCO.2007.10.7722	7	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2008	7	1					14	16		10.1016/S1474-4422(07)70305-8	http://dx.doi.org/10.1016/S1474-4422(07)70305-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247FO	18093552				2022-12-18	WOS:000252063300009
J	Stovner, LJ				Stovner, Lars Jacob			Headache: new concepts, models, and treatments	LANCET NEUROLOGY			English	Editorial Material							MIGRAINE		Norwegian Univ Sci & Technol, Dept Neurosci, Norwegian Natl Headache Ctr, N-7006 Trondheim, Norway; [Stovner, Lars Jacob] Univ Trondheim Hosp, N-7006 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Stovner, LJ (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Norwegian Natl Headache Ctr, N-7006 Trondheim, Norway.	lars.stovner@ntnu.no						Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; *INT HEAD SOC HEAD, 2004, CEPHALALGIA S1, V24, P8; Schwedt TJ, 2007, CEPHALALGIA, V27, P153, DOI 10.1111/j.1468-2982.2007.01272.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; WHO, 2013, SCHIST PROGR REP 200	7	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2008	7	1					11	12		10.1016/S1474-4422(07)70303-4	http://dx.doi.org/10.1016/S1474-4422(07)70303-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247FO	18093550				2022-12-18	WOS:000252063300007
J	Johnston, SC				Johnston, S. Claiborne			Towards FASTER treatment of TIA and minor stroke	LANCET NEUROLOGY			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK; ANTIPLATELET THERAPY; CONTROLLED TRIAL; CLOPIDOGREL; ASPIRIN; RISK		Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Johnston, SC (corresponding author), Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave, San Francisco, CA 94143 USA.	clay.johnston@ucsfmedctr.org						Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Harker LA, 1998, CIRCULATION, V98, P2461, DOI 10.1161/01.CIR.98.22.2461; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Reimer WJMSO, 2006, STROKE, V37, P1844, DOI 10.1161/01.STR.0000226463.17988.a3; Rothwell PM, 2006, LANCET NEUROL, V5, P323, DOI 10.1016/S1474-4422(06)70408-2; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Yusuf S, 2001, NEW ENGL J MED, V345, P494	13	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2007	6	11					941	943		10.1016/S1474-4422(07)70252-1	http://dx.doi.org/10.1016/S1474-4422(07)70252-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	226VX	17945145				2022-12-18	WOS:000250617700003
J	Kernan, WN; Schindler, JL				Kernan, Walter N.; Schindler, Joseph L.			Rapid intervention for TIA: a new standard emerges	LANCET NEUROLOGY			English	Editorial Material							STROKE		Yale Univ, Sch Med, Dept Med, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06519 USA	Yale University; Yale University	Kernan, WN (corresponding author), Yale Univ, Sch Med, Dept Med, 333 Cedar St, New Haven, CT 06519 USA.	walter.kernan@yale.edu						Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2006, ANN NEUROL, V60, P301, DOI 10.1002/ana.20942; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; ROTHWELL PM, 2007, LANCET          1009	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2007	6	11					940	941		10.1016/S1474-4422(07)70249-1	http://dx.doi.org/10.1016/S1474-4422(07)70249-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	226VX	17928271				2022-12-18	WOS:000250617700002
J	Bird, SM; Matthews, F; Muniz, G				Bird, Sheila M.; Matthews, Fiona; Muniz, Graciela			NICE judgment: good law risks bad science	LANCET NEUROLOGY			English	Editorial Material									MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England	MRC Biostatistics Unit; University of Cambridge	Bird, SM (corresponding author), MRC, Biostat Unit, Inst Publ Hlth, Cambridge CB2 2BW, England.	graciela.muniz@mrc-bsu.cam.ac.uk	Matthews, Fiona/O-6932-2015	Matthews, Fiona/0000-0002-1728-2388	Medical Research Council [MC_U105260794, MC_U105292687] Funding Source: Medline; MRC [MC_U105260794] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	OCT	2007	6	10					843	844		10.1016/S1474-4422(07)70226-0	http://dx.doi.org/10.1016/S1474-4422(07)70226-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	218SQ	17884668				2022-12-18	WOS:000250035600004
J	Marrosu, MG				Marrosu, Maria Giovanna			Susceptibility to multiple sclerosis: the role of interleukin genes	LANCET NEUROLOGY			English	Editorial Material							RECEPTOR		Univ Cagliari, Ctr Sclerosi Multipla, Dipartimento Sci Cardiovasc & Neurol, I-09124 Cagliari, Italy	University of Cagliari	Marrosu, MG (corresponding author), Univ Cagliari, Ctr Sclerosi Multipla, Dipartimento Sci Cardiovasc & Neurol, I-09124 Cagliari, Italy.	gmarrosu@unica.it		Marrosu, Maria Giovanna/0000-0003-2334-2081				Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Peltonen L, 2007, NEW ENGL J MED, V357, P927, DOI 10.1056/NEJMe078147	3	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	OCT	2007	6	10					846	847		10.1016/S1474-4422(07)70228-4	http://dx.doi.org/10.1016/S1474-4422(07)70228-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	218SQ	17884670				2022-12-18	WOS:000250035600006
J	Lim, HS; Lip, GYH				Lim, Hoong Sern; Lip, Gregory Y. H.			Thromboprophylaxis in acute ischaemic stroke: how can we PREVAIL?	LANCET NEUROLOGY			English	Editorial Material							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PREVENTION; HEPARIN		Univ Dept Med, City Hosp, Birmingham B18 7QH, W Midlands, England	University of Birmingham	Lim, HS (corresponding author), Univ Dept Med, City Hosp, Birmingham B18 7QH, W Midlands, England.	g.y.h.lip@bham.ac.uk	Lim, Sern/AAX-4218-2021	Lim, Sern/0000-0002-6569-1805				GUBITZ G, 2004, COCHRANE DB SYST REV, V3; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Kelly J, 2001, STROKE, V32, P262, DOI 10.1161/01.STR.32.1.262; LEYVRAZ PF, 1983, NEW ENGL J MED, V309, P954, DOI 10.1056/NEJM198310203091605; MAZZONE C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001922.PUB2; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; SANDERCOCK PAG, 1993, J NEUROL NEUROSUR PS, V56, P17, DOI 10.1136/jnnp.56.1.17; Sherman DG, 2007, LANCET, V369, P1347, DOI 10.1016/S0140-6736(07)60633-3; TURPIE AGG, 1987, LANCET, V1, P523; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007	10	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2007	6	7					578	579		10.1016/S1474-4422(07)70159-X	http://dx.doi.org/10.1016/S1474-4422(07)70159-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	184WJ	17582355				2022-12-18	WOS:000247673000006
J	de Bakker, PIW; Rosand, J				de Bakker, Paul I. W.; Rosand, Jonathan			In search of genes for stroke	LANCET NEUROLOGY			English	Editorial Material							ISCHEMIC-STROKE; ASSOCIATION; GENETICS; SUBTYPES		Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	de Bakker, PIW (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	jrosand@partners.org	de Bakker, Paul IW/B-8730-2009	de Bakker, Paul IW/0000-0001-7735-7858				Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; Meschia James F, 2003, BMC Neurol, V3, P4, DOI 10.1186/1471-2377-3-4; Meschia James F, 2002, BMC Med Genet, V3, P1, DOI 10.1186/1471-2350-3-1; Sawcer S, 2005, AM J HUM GENET, V77, P454; Schulz UGR, 2004, STROKE, V35, P819, DOI 10.1161/01.STR.0000121646.23955.0f; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Wiklund PG, 2007, NEUROLOGY, V68, P427, DOI 10.1212/01.wnl.0000252955.17126.6a	10	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2007	6	5					383	384		10.1016/S1474-4422(07)70088-1	http://dx.doi.org/10.1016/S1474-4422(07)70088-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	161XO	17434084				2022-12-18	WOS:000246050600004
J	Razvi, SSM; Srikanth, S				Razvi, Saif S. M.; Srikanth, Srinivasan			One WHOSTEPS Stroke tool for all settings?	LANCET NEUROLOGY			English	Editorial Material							RISK-FACTORS		So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; Apollo Hosp, Dept Neurol, Colombo 5, Sri Lanka	University of Glasgow	Razvi, SSM (corresponding author), So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland.	S.Razvi@clinmed.gla.ac.uk		Razvi, Saif/0000-0003-2307-550X				BHARUCHA NE, 1988, STROKE, V19, P60, DOI 10.1161/01.STR.19.1.60; Chakrabarti SD, 2002, ACTA NEUROL SCAND, V105, P124, DOI 10.1034/j.1600-0404.2002.1o196.x; Kaul S, 2000, NEUROL INDIA, V48, P116; Lipska K, 2007, J NEUROL NEUROSUR PS, V78, P959, DOI 10.1136/jnnp.2006.106831; Pandian JD, 2005, STROKE, V36, P644, DOI 10.1161/01.STR.0000154876.08468.a0; RAZDAN S, 1989, STROKE, V20, P1691, DOI 10.1161/01.STR.20.12.1691; Truelsen T, 2007, LANCET NEUROL, V6, P134, DOI 10.1016/S1474-4422(06)70686-X; 2007, WELC VIJ MED ED TRUS	8	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2007	6	5					386	387		10.1016/S1474-4422(07)70090-X	http://dx.doi.org/10.1016/S1474-4422(07)70090-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	161XO	17434086				2022-12-18	WOS:000246050600006
J	Albin, RL				Albin, Roger L.			An advance in molecular imaging of dementias	LANCET NEUROLOGY			English	Editorial Material							LEWY BODIES; CONSENSUS CRITERIA; ALZHEIMERS-DISEASE; DIFFERENTIATION		Ann Arbor VA Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI USA	Geriatric Research Education & Clinical Center; University of Michigan System; University of Michigan	Albin, RL (corresponding author), Ann Arbor VA Med Ctr, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48105 USA.	ralbin@umich.edu						Gilman S, 2004, ANN NEUROL, V55, P774, DOI 10.1002/ana.20088; Koeppe RA, 2005, J NUCL MED, V46, P936; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2000, NEUROLOGY, V54, P1050, DOI 10.1212/WNL.54.5.1050; Piggott MA, 1999, BRAIN, V122, P1449, DOI 10.1093/brain/122.8.1449; Rahkonen T, 2003, J NEUROL NEUROSUR PS, V74, P720, DOI 10.1136/jnnp.74.6.720; Stevens T, 2002, BRIT J PSYCHIAT, V180, P270, DOI 10.1192/bjp.180.3.270; Suzuki M, 2002, ANN NEUROL, V51, P767, DOI 10.1002/ana.10186; Varma AR, 1999, J NEUROL NEUROSUR PS, V66, P184, DOI 10.1136/jnnp.66.2.184; Walker Z, 2002, J NEUROL NEUROSUR PS, V73, P134, DOI 10.1136/jnnp.73.2.134; Williams MM, 2006, NEUROLOGY, V67, P1935, DOI 10.1212/01.wnl.0000247041.63081.98	11	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2007	6	4					288	289		10.1016/S1474-4422(07)70060-1	http://dx.doi.org/10.1016/S1474-4422(07)70060-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149KE	17362826				2022-12-18	WOS:000245145000002
J	Hallevi, H; Grotta, JC				Hallevi, Hen; Grotta, James C.			SITS-MOST: old myths laid to rest	LANCET NEUROLOGY			English	Editorial Material							ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; ALTEPLASE; THROMBOLYSIS; OUTCOMES		Univ Texas, Sch Med, Dept Neurol, Stroke Program, Houston, TX 77025 USA	University of Texas System	Hallevi, H (corresponding author), Univ Texas, Sch Med, Dept Neurol, Stroke Program, Houston, TX 77025 USA.		Grotta, James/AAH-7423-2021					Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Asplund K, 1997, STROKE, V28, P2139, DOI 10.1161/01.STR.28.11.2139; GROTTA JC, 2002, NINDS STROKE STUDY G; Hill MD, 2005, CAN MED ASSOC J, V172, P1307, DOI 10.1503/cmaj.1041561; Lenzer J, 2002, BRIT MED J, V324, P723, DOI 10.1136/bmj.324.7339.723; Mann J, 2002, WESTERN J MED, V176, P192, DOI 10.1136/ewjm.176.3.192; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39	9	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2007	6	4					292	293		10.1016/S1474-4422(07)70063-7	http://dx.doi.org/10.1016/S1474-4422(07)70063-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149KE	17362829				2022-12-18	WOS:000245145000005
J	Qiu, J				Qiu, Jane			Debates on translational research: a balancing act	LANCET NEUROLOGY			English	Editorial Material												jane@janeqiu.com							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2007	6	3					208	209		10.1016/S1474-4422(07)70045-5	http://dx.doi.org/10.1016/S1474-4422(07)70045-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138BU	17328150				2022-12-18	WOS:000244338400008
J	van Berckel, BNM; Scheltens, P				van Berckel, Bart N. M.; Scheltens, Philip			Getting a grip on Alzheimer's disease: imaging amyloid in the brain	LANCET NEUROLOGY			English	Editorial Material							PET					p.scheltens@vumc.nl	Scheltens, Philip/AAL-9631-2020; Scheltens, Philip/E-1205-2012	Scheltens, Philip/0000-0002-1046-6408; 				Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Patwardhan MB, 2004, RADIOLOGY, V231, P73, DOI 10.1148/radiol.2311021620; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Winblad B, 2003, NEURON, V38, P517, DOI 10.1016/S0896-6273(03)00297-6	9	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2007	6	3					204	206		10.1016/S1474-4422(07)70042-X	http://dx.doi.org/10.1016/S1474-4422(07)70042-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138BU	17303523				2022-12-18	WOS:000244338400005
J	Ginsberg, L; Schapiro, AHV; Taanman, JM				Ginsberg, Lionel; Schapiro, Anthony H. V.; Taanman, Jan-Milem			Relapsing neuropathy in an 18-year-old woman	LANCET NEUROLOGY			English	Article							MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; THYMIDINE PHOSPHORYLASE; POLG MUTATIONS; DNA DEPLETION; FABRY-DISEASE; HEREDITARY; POLYNEUROPATHY; PARKINSONISM; NEUROLOGY; PAINFUL		UCL, Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London, England	University of London; University College London	Ginsberg, L (corresponding author), Royal Free Hosp, Dept Neurol, Pond St, London NW3 2QG, England.	lionel.ginsberg@royalfree.nhs.uk	Ginsberg, Lionel/C-8704-2009; Taanman, Jan W/A-5379-2011; Schapira, Anthony/A-1245-2010	Taanman, Jan W/0000-0002-5476-9785; Schapira, Anthony/0000-0002-3018-3966				Anderson M, 2000, J NEUROL NEUROSUR PS, V68, P2, DOI 10.1136/jnnp.68.1.2; ARROYO JG, 1995, NEUROLOGY, V45, P846, DOI 10.1212/WNL.45.4.846-a; Bedlack RS, 2004, MUSCLE NERVE, V29, P364, DOI 10.1002/mus.10546; Brown NS, 1998, BIOCHEM J, V334, P1; Chin RL, 2003, NEUROLOGY, V60, P1581, DOI 10.1212/01.WNL.0000063307.84039.C7; Chinnery P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub2; CHURG J, 1951, AM J PATHOL, V27, P277; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; Crutchfield KE, 1998, NEUROLOGY, V50, P1746, DOI 10.1212/WNL.50.6.1746; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Deegan PB, 2006, J MED GENET, V43, P347, DOI 10.1136/jmg.2005.036327; DESNICK RJ, 2001, METABOLIC MOL BASES, V2, P3733; DONAGHY M, 1985, ANN NEUROL, V17, P49, DOI 10.1002/ana.410170112; DYCK PJ, 1982, MAYO CLIN PROC, V57, P239; Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239; FEASBY TE, 1990, NEUROLOGY, V40, P476, DOI 10.1212/WNL.40.3_Part_1.476; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ginsberg L, 2004, BRAIN, V127, P193, DOI 10.1093/brain/awh017; GINSBERG L, 2006, LANCET HDB TREATMENT, P339; Ginsberg L, 2006, HAND CLINIC, V81, P635, DOI 10.1016/S0072-9752(06)80046-1; Giordano C, 2006, GASTROENTEROLOGY, V130, P893, DOI 10.1053/j.gastro.2006.01.004; HAGIWARA K, 1991, MOL CELL BIOL, V11, P2125, DOI 10.1128/MCB.11.4.2125; HANNA MG, 2005, PERIPHERAL NEUROPATH, V2, P1937; HARA H, 1994, J NEUROL NEUROSUR PS, V57, P1545, DOI 10.1136/jnnp.57.12.1545-a; HARDING AE, 1987, CRIT REV NEUROBIOL, V3, P89; Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24; KISSEL JT, 1985, ANN NEUROL, V18, P251, DOI 10.1002/ana.410180213; KISSEL JT, 2001, DIAGNOSIS MANAGEMENT, P173; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Marti R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179; Martini R, 2004, LANCET NEUROL, V3, P457, DOI 10.1016/S1474-4422(04)00822-1; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; MENDELL JR, 1987, NEUROLOGY, V37, P1291, DOI 10.1212/WNL.37.8.1291; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Nishino I, 2000, ANN NEUROL, V47, P792; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Norman RA, 2004, STRUCTURE, V12, P75, DOI 10.1016/j.str.2003.11.018; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; SCHRODER JM, 1988, ACTA NEUROPATHOL, V76, P471, DOI 10.1007/BF00686386; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002; Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X; Wills AJ, 2002, CURR OPIN NEUROL, V15, P519, DOI 10.1097/00019052-200210000-00001; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2	49	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2007	6	2					192	198		10.1016/S1474-4422(07)70033-9	http://dx.doi.org/10.1016/S1474-4422(07)70033-9			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	130JG	17239807				2022-12-18	WOS:000243795300023
J	Frisoni, GB				Frisoni, Giovanni B.			Dementia: important advances in research in 2006	LANCET NEUROLOGY			English	News Item							ALZHEIMERS-DISEASE; LOAD		IRCCS, Ctr San Giovanni di Dio Fatebenefratelli, Brescia, Italy	IRCCS Fatebenefratelli	Frisoni, GB (corresponding author), IRCCS, Ctr San Giovanni di Dio Fatebenefratelli, Brescia, Italy.	gfrisoni@fatebenefratelli.it	Frisoni, Giovanni B./K-1360-2016; Frisoni, Giovanni/K-1360-2016	Frisoni, Giovanni B./0000-0002-6419-1753; Frisoni, Giovanni/0000-0001-7075-7082				Archer HA, 2006, ANN NEUROL, V60, P145, DOI 10.1002/ana.20889; Bouwman FH, 2007, NEUROBIOL AGING, V28, P1070, DOI 10.1016/j.neurobiolaging.2006.05.006; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Jagust W, 2006, ANN NEUROL, V59, P673, DOI 10.1002/ana.20799; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2007	6	1					4	5		10.1016/S1474-4422(06)70659-7	http://dx.doi.org/10.1016/S1474-4422(06)70659-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	119UI	17166788				2022-12-18	WOS:000243039000003
J	Siva, N				Siva, Nayanah			Patient in a coma plays tennis	LANCET NEUROLOGY			English	News Item																			0	2	2	2	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2006	5	11					906	906		10.1016/S1474-4422(06)70592-0	http://dx.doi.org/10.1016/S1474-4422(06)70592-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	099JY	17086646				2022-12-18	WOS:000241591600010
J	Thomas, L				Thomas, Laura			Musical training improves brain development in children	LANCET NEUROLOGY			English	News Item																			0	2	2	2	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2006	5	11					905	905		10.1016/S1474-4422(06)70591-9	http://dx.doi.org/10.1016/S1474-4422(06)70591-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	099JY	17086645				2022-12-18	WOS:000241591600009
J	Thomas, L				Thomas, L			Nano neuro knitting repairs injured brain	LANCET NEUROLOGY			English	News Item																			0	2	9	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2006	5	5					386	386		10.1016/S1474-4422(06)70430-6	http://dx.doi.org/10.1016/S1474-4422(06)70430-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037LF	16639831				2022-12-18	WOS:000237147600013
J	[Anonymous]				[Anonymous]			The trials and tribulations of Tysabri	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2006	5	5					373	373		10.1016/S1474-4422(06)70418-5	http://dx.doi.org/10.1016/S1474-4422(06)70418-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037LF	16632299	Bronze			2022-12-18	WOS:000237147600001
J	Pilcher, H				Pilcher, H			Gender gene implicated in Parkinson's disease	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2006	5	4					296	296		10.1016/S1474-4422(06)70395-7	http://dx.doi.org/10.1016/S1474-4422(06)70395-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	029CI	16578914				2022-12-18	WOS:000236535200011
J	Thomas, L				Thomas, L			An appetite for learning	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2006	5	4					299	299		10.1016/S1474-4422(06)70400-8	http://dx.doi.org/10.1016/S1474-4422(06)70400-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	029CI	16578920				2022-12-18	WOS:000236535200016
J	Biessels, GJ; Staekenborg, S; Brunner, E; Brayne, C; Scheltens, P				Biessels, GJ; Staekenborg, S; Brunner, E; Brayne, C; Scheltens, P			Risk of dementia in diabetes mellitus: a systematic review (vol 5, pg 65, 2005)	LANCET NEUROLOGY			English	Correction													Scheltens, Philip/AAL-9631-2020; Brunner, Eric/H-2114-2011; Brayne, Carol/AAA-4285-2020	Scheltens, Philip/0000-0002-1046-6408; Brunner, Eric/0000-0002-0595-4474; Brayne, Carol/0000-0001-5307-663X				Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2	1	2	3	4	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2006	5	2					113	113		10.1016/S1474-4422(06)70336-2	http://dx.doi.org/10.1016/S1474-4422(06)70336-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	006RO					2022-12-18	WOS:000234914800009
J	Bradbury, J				Bradbury, J			Low brain oestrogen linked to Alzheimer's disease risk	LANCET NEUROLOGY			English	News Item																		Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102	1	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	FEB	2006	5	2					116	117		10.1016/S1474-4422(06)70339-8	http://dx.doi.org/10.1016/S1474-4422(06)70339-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	006RO	16456935				2022-12-18	WOS:000234914800011
J	McCaffrey, P				McCaffrey, P			SOD1 mutant protein gets loose in ALS	LANCET NEUROLOGY			English	News Item																		Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603	1	2	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	FEB	2006	5	2					119	119		10.1016/S1474-4422(06)70343-X	http://dx.doi.org/10.1016/S1474-4422(06)70343-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	006RO	16456939				2022-12-18	WOS:000234914800015
J	de Visser, M				de Visser, M			Neuromuscular disorders: orphan diseases deserve attention	LANCET NEUROLOGY			English	Editorial Material									Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	de Visser, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.devisser@amc.uva.nl						Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; CHIO A, 2005, BRAIN, V28, P451; Hagemans MLC, 2005, BRAIN, V128, P671, DOI 10.1093/brain/awh384; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC	4	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2006	5	1					13	14		10.1016/S1474-4422(05)70263-5	http://dx.doi.org/10.1016/S1474-4422(05)70263-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998OI	16361013				2022-12-18	WOS:000234328100009
J	Dente, K				Dente, K			Experts divided over carotid stenting for stroke prevention	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2006	5	1					24	24		10.1016/S1474-4422(05)70272-6	http://dx.doi.org/10.1016/S1474-4422(05)70272-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998OI	16400732				2022-12-18	WOS:000234328100017
J	Graus, F; Tortosa, A				Graus, F; Tortosa, A			Neuro-oncology: setting new standards of management	LANCET NEUROLOGY			English	Editorial Material							TEMOZOLOMIDE; GLIOBLASTOMA		Inst Invest Biomed August Pi i Sunyer, Hosp Clin, Neurol Serv, Barcelona, Spain; Univ Barcelona, Dept Infermeria Fonamental, IDIBELL, Hosp Llobregat, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Graus, F (corresponding author), Inst Invest Biomed August Pi i Sunyer, Hosp Clin, Neurol Serv, Barcelona, Spain.	fgraus@clinic.ub.es	Tortosa, Avelina/O-7788-2016	Tortosa, Avelina/0000-0002-9080-2976; Graus, Francesc/0000-0002-8924-8322				Chang SM, 2005, JAMA-J AM MED ASSOC, V293, P557, DOI 10.1001/jama.293.5.557; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2006	5	1					8	9		10.1016/S1474-4422(05)70260-X	http://dx.doi.org/10.1016/S1474-4422(05)70260-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998OI	16361010				2022-12-18	WOS:000234328100006
J	Burton, A				Burton, A			SLITRK1 trouble in Tourette's syndrome	LANCET NEUROLOGY			English	News Item																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	DEC	2005	4	12					801	801		10.1016/S1474-4422(05)70242-8	http://dx.doi.org/10.1016/S1474-4422(05)70242-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989SG	16323357				2022-12-18	WOS:000233693500014
J	[Anonymous]				[Anonymous]			The hard way to a Bill of Rights	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2005	4	12					787	787		10.1016/S1474-4422(05)70228-3	http://dx.doi.org/10.1016/S1474-4422(05)70228-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989SG	16297831				2022-12-18	WOS:000233693500001
J	Burton, A				Burton, A			RNA inhibition of beta-secretase reverts AD in mice	LANCET NEUROLOGY			English	News Item																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2005	4	11					698	698		10.1016/S1474-4422(05)70208-8	http://dx.doi.org/10.1016/S1474-4422(05)70208-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	980GK	16265788				2022-12-18	WOS:000233002400006
J	Chen, V				Chen, V			Novel method of treating Alzheimer's disease	LANCET NEUROLOGY			English	News Item																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	OCT	2005	4	10					599	599		10.1016/S1474-4422(05)70183-6	http://dx.doi.org/10.1016/S1474-4422(05)70183-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	969PG	16208857				2022-12-18	WOS:000232245900010
J	[Anonymous]				[Anonymous]			Over-the-counter triptans - making the switch	LANCET NEUROLOGY			English	Editorial Material																			0	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2005	4	10					587	587		10.1016/S1474-4422(05)70174-5	http://dx.doi.org/10.1016/S1474-4422(05)70174-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	969PG	16168921				2022-12-18	WOS:000232245900002
J	Thomas, L				Thomas, L			Remote memory: a neuroanatomical puzzle?	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2005	4	8					460	461		10.1016/S1474-4422(05)70132-0	http://dx.doi.org/10.1016/S1474-4422(05)70132-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	951EX	16086495				2022-12-18	WOS:000230913000009
J	Wingerchuk, DM; Sirven, JI				Wingerchuk, DM; Sirven, JI			Remission, intractability, and antiepileptic-drug withdrawal	LANCET NEUROLOGY			English	Editorial Material							EPILEPSY; SEIZURES		Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic Phoenix	Wingerchuk, DM (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ USA.	sirven.joseph@mayo.edu						ANNEGERS JF, 1979, EPILEPSIA, V20, P729, DOI 10.1111/j.1528-1157.1979.tb04857.x; Berg AT, 2003, NEUROLOGY, V60, P186, DOI 10.1212/01.WNL.0000031792.89992.EC; Camfield P, 2005, NEUROLOGY, V64, P973, DOI 10.1212/01.WNL.0000154517.82748.A7; CHADWICK D, 1991, LANCET, V337, P1175; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; SIRVEN JI, 2001, COCHRANE DATABASE SY, V3, P1092	6	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2005	4	7					390	391		10.1016/S1474-4422(05)70102-2	http://dx.doi.org/10.1016/S1474-4422(05)70102-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	938TA	15963439				2022-12-18	WOS:000230024700002
J	Franciotta, D; Lolli, F				Franciotta, D; Lolli, F			Infectious causes of multiple sclerosis	LANCET NEUROLOGY			English	Letter									Univ Pavia, Neurol Inst C Mondino, Lab Neuroimmunol, I-27100 Pavia, Italy; Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy	IRCCS Fondazione Casimiro Mondino; University of Pavia; University of Florence	Franciotta, D (corresponding author), Univ Pavia, Neurol Inst C Mondino, Lab Neuroimmunol, Via Palestro 3, I-27100 Pavia, Italy.	diego.franciotta@mondino.it	Lolli, Francesco/C-6439-2008	Lolli, Francesco/0000-0001-7181-6806				Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; MILLER JR, 1983, ANN NEUROL, V13, P53, DOI 10.1002/ana.410130112; PICCOLO G, 1990, J NEUROL, V237, P262, DOI 10.1007/BF00314631; SANDBERGWOLLHEIM M, 1987, J NEUROL SCI, V81, P45, DOI 10.1016/0022-510X(87)90182-1; SINDIC CJM, 1994, J NEUROIMMUNOL, V54, P75, DOI 10.1016/0165-5728(94)90233-X	5	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2005	4	5					268	269		10.1016/S1474-4422(05)70055-7	http://dx.doi.org/10.1016/S1474-4422(05)70055-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	919AE	15847837				2022-12-18	WOS:000228589900007
J	Hayward, P				Hayward, P			Genetic model predicts stroke in sickle-cell disease	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2005	4	5					277	277		10.1016/S1474-4422(05)70067-3	http://dx.doi.org/10.1016/S1474-4422(05)70067-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	919AE	15861559				2022-12-18	WOS:000228589900018
J	Nelson, R				Nelson, R			Exercise could prevent cerebral changes associated with AD	LANCET NEUROLOGY			English	News Item																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2005	4	5					275	275		10.1016/S1474-4422(05)70064-8	http://dx.doi.org/10.1016/S1474-4422(05)70064-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	919AE	15861556				2022-12-18	WOS:000228589900015
J	Senior, K				Senior, K			Gene variants affect response to antiepileptic drugs	LANCET NEUROLOGY			English	News Item																			0	2	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2005	4	5					276	277		10.1016/S1474-4422(05)70066-1	http://dx.doi.org/10.1016/S1474-4422(05)70066-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	919AE	15861558				2022-12-18	WOS:000228589900017
J	Simpson, EP				Simpson, EP			Antioxidant treatment for amyotrophic lateral sclerosis	LANCET NEUROLOGY			English	Editorial Material									Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Baylor College of Medicine	Simpson, EP (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.	esimpson@bcm.tmc.edu						Ascherio A, 2005, ANN NEUROL, V57, P104, DOI 10.1002/ana.20316; MIGLIORE L, 2002, NEUROBIOL AGING, V26, P567; ORRELL RW, 2004, COCHRANE DATABASE SY, V4, DOI UNSP CD002829; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008	5	2	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2005	4	5					266	266		10.1016/S1474-4422(05)70052-1	http://dx.doi.org/10.1016/S1474-4422(05)70052-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	919AE	15847835				2022-12-18	WOS:000228589900004
J	Cruysberg, JRM				Cruysberg, JRM			The neuro-ophthalmology of multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material							NEURITIS TREATMENT TRIAL; OPTIC NEURITIS		Radboud Univ Nijmegen, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Cruysberg, JRM (corresponding author), Radboud Univ Nijmegen, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.cruysberg@ru.nl	Cruysberg, Johannes R. M./D-4313-2009	Cruysberg, Johannes R. M./0000-0002-5330-0774				BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Keltner JL, 1999, AM J OPHTHALMOL, V128, P543, DOI 10.1016/S0002-9394(99)00304-9	4	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2005	4	4					209	209		10.1016/S1474-4422(05)70029-6	http://dx.doi.org/10.1016/S1474-4422(05)70029-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	910ID	15778100				2022-12-18	WOS:000227923600006
J	Bandini, F				Bandini, F			Minocycline in neurological diseases	LANCET NEUROLOGY			English	Letter							ACNE		Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy	University of Genoa	Bandini, F (corresponding author), Univ Genoa, Dept Neurosci Ophthalmol & Genet, Via Toni 5, Genoa, Italy.	fbandini@neurologia.unige.it	Bandini, Fabio/AAE-3431-2020; Bandini, Fabio/A-7710-2008	Yong, V. Wee/0000-0002-2600-3563; Bandini, Fabio/0000-0002-1104-459X				Chiu AM, 1998, AM J OPHTHALMOL, V126, P116, DOI 10.1016/S0002-9394(98)00063-4; DONNET A, 1992, BIOMED PHARMACOTHER, V46, P171, DOI 10.1016/0753-3322(92)90026-4; Goulden V, 1996, BRIT J DERMATOL, V134, P693, DOI 10.1111/j.1365-2133.1996.tb06972.x; Grasset L, 2003, REV MED INTERNE, V24, P305, DOI 10.1016/S0248-8663(02)00017-6; Kesler A, 2004, ACTA NEUROL SCAND, V110, P408, DOI 10.1111/j.1600-0404.2004.00327.x; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2005	4	3					138	139		10.1016/S1474-4422(05)00998-1	http://dx.doi.org/10.1016/S1474-4422(05)00998-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	901QT	15721822				2022-12-18	WOS:000227297700004
J	Caramanos, Z; Arnold, DL				Caramanos, Z; Arnold, DL			Evidence for use of glatiramer acetate in multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material							RELAPSE RATE; DOUBLE-BLIND; DISABILITY; MULTICENTER; TRIAL		McGill Univ, Montreal Neurol Inst, Magnet Resonance Spect Unit, Montreal, PQ, Canada	McGill University	Caramanos, Z (corresponding author), McGill Univ, Montreal Neurol Inst, Magnet Resonance Spect Unit, Montreal, PQ, Canada.	aki@mrs.mni.mcgill.ca; doug@mrs.mni.mcgill.ca	Caramanos, Zografos/A-9553-2011	martinelli boneschi, filippo/0000-0002-9955-1368; Arnold, Douglas/0000-0003-4266-0106				Boneschi FM, 2003, MULT SCLER, V9, P349, DOI 10.1191/1352458503ms932oa; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; MUNARI L, 2004, COCHRANE LIB; Munari LM, 2004, LANCET NEUROL, V3, P641, DOI 10.1016/S1474-4422(04)00899-3; Wolinsky JS, 2004, EXPERT OPIN PHARMACO, V5, P875, DOI 10.1517/eoph.5.4.875.30176; WOLINSKY JS, 2003, MULT SCLER S1, V9, pS120	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2005	4	2					74	75		10.1016/S1474-4422(05)00974-9	http://dx.doi.org/10.1016/S1474-4422(05)00974-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	893IK	15664538				2022-12-18	WOS:000226712300006
J	Munari, L; Filippini, G				Munari, L; Filippini, G			Evidence for use of glatiramer acetate in multiple sclerosis - Reply	LANCET NEUROLOGY			English	Editorial Material							RELAPSE RATE; DOUBLE-BLIND; DISABILITY; MULTICENTER		Azienda Osped Niguarda Ca Granda, Unit Neuroepidemiol, Milan, Italy; Natl Neurol Inst Carlo Besta, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Istituto Neurologico Besta	Munari, L (corresponding author), Azienda Osped Niguarda Ca Granda, Unit Neuroepidemiol, Milan, Italy.							[Anonymous], DRUG APPR REP; Boneschi FM, 2003, MULT SCLER, V9, P349, DOI 10.1191/1352458503ms932oa; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Munari LM, 2004, LANCET NEUROL, V3, P641, DOI 10.1016/S1474-4422(04)00899-3	7	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	FEB	2005	4	2					76	77		10.1016/S1474-4422(05)00976-2	http://dx.doi.org/10.1016/S1474-4422(05)00976-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	893IK					2022-12-18	WOS:000226712300008
J	Bagchi, S				Bagchi, S			Preventable rabies deaths because of wrong vaccine	LANCET NEUROLOGY			English	News Item																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2004	3	11					639	639		10.1016/S1474-4422(04)00896-8	http://dx.doi.org/10.1016/S1474-4422(04)00896-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	865CL	15515240				2022-12-18	WOS:000224680000009
J	Burton, A				Burton, A			9th International Conference on AD and Related Disorders (ICAD)	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	SEP	2004	3	9					510	510		10.1016/S1474-4422(04)00858-0	http://dx.doi.org/10.1016/S1474-4422(04)00858-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849VD	15344278				2022-12-18	WOS:000223568300002
J	Pachner, A				Pachner, A			Anti-interferon antibodies: surprises and lessons	LANCET NEUROLOGY			English	Editorial Material							MULTIPLE-SCLEROSIS; NEUTRALIZING ANTIBODIES; INTERFERON-BETA; IMMUNOGENICITY; IFN		Univ Med & Dent New Jersey, Dept Neurol & Neurosci, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Pachner, A (corresponding author), Univ Med & Dent New Jersey, Dept Neurol & Neurosci, Newark, NJ USA.	pachner@umdnj.edu						Malucchi S, 2004, NEUROLOGY, V62, P2031, DOI 10.1212/01.WNL.0000129265.73259.9E; Pachner AR, 2003, NEUROLOGY, V61, pS24, DOI 10.1212/01.WNL.0000092361.04511.D0; Ross C, 2000, ANN NEUROL, V48, P706, DOI 10.1002/1531-8249(200011)48:5<706::AID-ANA3>3.3.CO;2-M; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	SEP	2004	3	9					515	515		10.1016/S1474-4422(04)00847-6	http://dx.doi.org/10.1016/S1474-4422(04)00847-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849VD	15324716				2022-12-18	WOS:000223568300011
J	Ahmad, K				Ahmad, K			Polio spreads to Western Darfur	LANCET NEUROLOGY			English	News Item													Ahmad, Khabir/G-3903-2012	Ahmad, Khabir/0000-0002-1569-0628					0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2004	3	8					450	450		10.1016/S1474-4422(04)00836-1	http://dx.doi.org/10.1016/S1474-4422(04)00836-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	842OD	15303270				2022-12-18	WOS:000223012800009
J	Ahmad, K				Ahmad, K			Kano to recommence vaccination against poliomyelitis	LANCET NEUROLOGY			English	News Item													Ahmad, Khabir/I-6882-2019; Ahmad, Khabir/G-3903-2012	Ahmad, Khabir/0000-0002-1569-0628; Ahmad, Khabir/0000-0002-1569-0628					0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2004	3	7					388	388		10.1016/S1474-4422(04)00794-X	http://dx.doi.org/10.1016/S1474-4422(04)00794-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832ZQ	15228035				2022-12-18	WOS:000222306600004
J	Brown, P				Brown, P			Fall-out from a possible transfusion-related transmission of vCJD	LANCET NEUROLOGY			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; BLOOD		NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Brown, P (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	brownp@ninds.nih.gov						Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; Brown P, 2003, TRANSFUSION, V43, P425, DOI 10.1046/j.1537-2995.2003.t01-1-00351.x; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X	6	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2004	3	4					203	203		10.1016/S1474-4422(04)00702-1	http://dx.doi.org/10.1016/S1474-4422(04)00702-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	814QU	15039029				2022-12-18	WOS:000220990000011
J	Hayward, P				Hayward, P			Genes, environment, and the onset of Huntington's disease	LANCET NEUROLOGY			English	News Item																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2004	3	4					199	199		10.1016/S1474-4422(04)00721-5	http://dx.doi.org/10.1016/S1474-4422(04)00721-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	814QU					2022-12-18	WOS:000220990000004
J	Simpson, BA				Simpson, BA			Spinal-cord stimulation for reflex sympathetic dystrophy	LANCET NEUROLOGY			English	Editorial Material									Univ Wales Hosp, Dept Neurosurg, Cardiff CF4 4XW, S Glam, Wales	Cardiff University	Simpson, BA (corresponding author), Univ Wales Hosp, Dept Neurosurg, Cardiff CF4 4XW, S Glam, Wales.	brian.simpson@cardiffandvale.wales.nhs.uk						BENNETT DS, 2003, ELECT STIMULATION RE, P111; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kemler MA, 2004, ANN NEUROL, V55, P13, DOI 10.1002/ana.10996; Mitchell SW., 1864, GUNSHOT WOUNDS OTHER; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2004	3	3					142	142		10.1016/S1474-4422(04)00675-1	http://dx.doi.org/10.1016/S1474-4422(04)00675-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	802MK	14980526				2022-12-18	WOS:000220167400013
J	Morris, K				Morris, K			Rat studies of ritalin emphasise need for proper ADHD diagnosis	LANCET NEUROLOGY			English	News Item																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	FEB	2004	3	2					75	75		10.1016/S1474-4422(03)00647-1	http://dx.doi.org/10.1016/S1474-4422(03)00647-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	772AQ					2022-12-18	WOS:000188818500004
J	Waters, KA				Waters, KA			Cytokines in sudden infant death syndrome	LANCET NEUROLOGY			English	Editorial Material							BRAIN		Childrens Hosp, Resp Support Serv, Westmead, NSW, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Univ Sydney, Dept Pediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Waters, KA (corresponding author), Childrens Hosp, Resp Support Serv, Westmead, NSW, Australia.	kaw@med.usyd.edu.au	Waters, Karen A/B-2840-2013	Waters, Karen A/0000-0001-8699-2175				Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Froen TF, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e52; Kadhim H, 2003, NEUROLOGY, V61, P1256, DOI 10.1212/01.WNL.0000092014.14997.47; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Machaalani R, 2003, BRAIN RES, V985, P127, DOI 10.1016/S0006-8993(03)03003-8	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2004	3	2					81	81		10.1016/S1474-4422(03)00657-4	http://dx.doi.org/10.1016/S1474-4422(03)00657-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	772AQ	14746996				2022-12-18	WOS:000188818500014
J	Archibald, S				Archibald, S			Prion protein found outside the CNS	LANCET NEUROLOGY			English	News Item																			0	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2004	3	1					8	8		10.1016/S1474-4422(03)00641-0	http://dx.doi.org/10.1016/S1474-4422(03)00641-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756BZ	14700059				2022-12-18	WOS:000187447100011
J	Polston, DW; Dyck, PJB; Dyck, PJ; Litchy, WJ; Keegan, BM				Polston, DW; Dyck, PJB; Dyck, PJ; Litchy, WJ; Keegan, BM			A 46-year-old man with numbness and shock-like sensations in hands, feet, and jaw	LANCET NEUROLOGY			English	Editorial Material							NERVE-CONDUCTION; LEPROSY; DYSFUNCTION; COHORT; SKIN		Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic	Keegan, BM (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	Keegan.bmark@mayo.edu			NINDS NIH HHS [NS36797] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036797] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbot NC, 1996, NEUROSCI LETT, V206, P57, DOI 10.1016/0304-3940(96)12425-3; Bennett CL, 2001, CURR OPIN NEUROL, V14, P621, DOI 10.1097/00019052-200110000-00011; Brand PW, 1964, LEPROSY THEORY PRACT, P447; Brown TR, 1996, MUSCLE NERVE, V19, P1357; Croft RP, 2000, LEPROSY REV, V71, P154; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; EVANS EB, 2000, NEUROLOGY CLIN PRACT, P1595; Garcia-Carrasco M, 2002, MEDICINE, V81, P270, DOI 10.1097/00005792-200207000-00003; Hansen GHA., 1874, NORSK MAG LAEGEVIDEN, V4, P1; Kaplan G, 2000, LEPROSY REV, V71, pS117; LOCKWOOD DNJ, 1993, INT J LEPROSY, V61, P8; MAGORA A, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P639; MCLEOD JG, 1975, INT J LEPROSY, V43, P21; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; RIDLEY D. S., 1962, LEPROSY REV, V33, P119; ROSE P, 1991, LEPROSY REV, V62, P113; SABIN TD, 1993, PERIPHERAL NEUROPATH, P1354; SEBILLE A, 1978, J NEUROL SCI, V38, P89, DOI 10.1016/0022-510X(78)90249-6; SWIFT T R, 1973, International Journal of Leprosy and Other Mycobacterial Diseases, V41, P25; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WHO, EL LEPR PUBL HLTH PR; Wilder-Smith EPV, 2000, MUSCLE NERVE, V23, P1105, DOI 10.1002/1097-4598(200007)23:7<1105::AID-MUS14>3.0.CO;2-A	23	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2004	3	1					63	67		10.1016/S1474-4422(03)00624-0	http://dx.doi.org/10.1016/S1474-4422(03)00624-0			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756BZ	14693113				2022-12-18	WOS:000187447100027
J	Donnan, GA; Davis, SM				Donnan, GA; Davis, SM			Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy (vol 1, pg 417, 2002)	LANCET NEUROLOGY			English	Correction													DONNAN, GEOFFREY A/A-9947-2008					Donnan GA, 2002, LANCET NEUROL, V1, P417, DOI 10.1016/S1474-4422(02)00189-8	1	2	2	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2003	2	10					594	594		10.1016/S1474-4422(03)00528-3	http://dx.doi.org/10.1016/S1474-4422(03)00528-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723KR		Bronze			2022-12-18	WOS:000185432000014
J	Rinne, JO				Rinne, JO			Endogenous dopamine release in Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material							IN-VIVO; PET		Univ Turku, Turku PET Ctr, FIN-20520 Turku, Finland	University of Turku	Rinne, JO (corresponding author), Univ Turku, Turku PET Ctr, FIN-20520 Turku, Finland.	juha.rinne@pet.tyks.fi						de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Goerendt IK, 2003, BRAIN, V126, P312, DOI 10.1093/brain/awg035; Kaasinen V, 2002, NEUROSCI BIOBEHAV R, V26, P785, DOI 10.1016/S0149-7634(02)00065-9; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Piccini P, 2003, ANN NEUROL, V53, P647, DOI 10.1002/ana.10526; Tedroff J, 1996, NEUROLOGY, V46, P1430, DOI 10.1212/WNL.46.5.1430	7	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2003	2	8					460	461		10.1016/S1474-4422(03)00480-0	http://dx.doi.org/10.1016/S1474-4422(03)00480-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	704AC	12878432				2022-12-18	WOS:000184314700013
J	Brodie, MJ				Brodie, MJ			EUCARE - past, present, and future	LANCET NEUROLOGY			English	Editorial Material									Western Infirm & Associated Hosp, EUCARE Management Grp, Epilepsy Unit, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland		Brodie, MJ (corresponding author), Western Infirm & Associated Hosp, EUCARE Management Grp, Epilepsy Unit, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland.							Brodie MJ, 1997, EPILEPSIA, V38, P1245, DOI 10.1111/j.1528-1157.1997.tb01224.x; BRODIE MJ, 2003, IN PRESS EPILEPSI S2, V44	2	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2003	2	5					269	269		10.1016/S1474-4422(03)00373-9	http://dx.doi.org/10.1016/S1474-4422(03)00373-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	669RC	12849174				2022-12-18	WOS:000182363400011
J	Hayward, P				Hayward, P			Dyfunctional cellular transport causes neurodegeneration	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2003	2	5					266	266		10.1016/S1474-4422(03)00395-8	http://dx.doi.org/10.1016/S1474-4422(03)00395-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	669RC	12849170				2022-12-18	WOS:000182363400006
J	Pandian, JD; Khosla, P				Pandian, JD; Khosla, P			A misdiagnosis of multifocal motor neuropathy	LANCET NEUROLOGY			English	Article									Christian Med Coll & Hosp, Dept Neurol, Ludhiana 141008, Punjab, India; Christian Med Coll & Hosp, Dept Med, Ludhiana 141008, Punjab, India		Pandian, JD (corresponding author), Christian Med Coll & Hosp, Dept Neurol, Ludhiana 141008, Punjab, India.		Pandian, Jeyaraj Durai/AAV-5591-2020	Pandian, Jeyaraj/0000-0003-0028-1968				CHAUDHRY V, 1994, MUSCLE NERVE, V17, P198, DOI 10.1002/mus.880170211; Meucci N, 1997, J NEUROL NEUROSUR PS, V63, P765, DOI 10.1136/jnnp.63.6.765; NOBILEORAZIO E, 1993, NEUROLOGY, V43, P537, DOI 10.1212/WNL.43.3_Part_1.537; Taylor BV, 2000, MUSCLE NERVE, V23, P900, DOI 10.1002/(SICI)1097-4598(200006)23:6<900::AID-MUS9>3.0.CO;2-Y; Van den Berg-Vos RM, 2000, ANN NEUROL, V48, P919, DOI 10.1002/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J; Visser J, 2002, NEUROLOGY, V58, P1593, DOI 10.1212/WNL.58.11.1593	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2003	2	5					317	318		10.1016/S1474-4422(03)00384-3	http://dx.doi.org/10.1016/S1474-4422(03)00384-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	669RC	12849186				2022-12-18	WOS:000182363400020
J	Morris, K				Morris, K			Pain gains first genetic marker	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2003	2	4					205	205		10.1016/S1474-4422(03)00370-3	http://dx.doi.org/10.1016/S1474-4422(03)00370-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	658NH					2022-12-18	WOS:000181726700008
J	Gillick, MR				Gillick, MR			Artificial nutrition and hydration therapy in advanced dementia	LANCET NEUROLOGY			English	Letter							DECISIONS		Hebrew Rehabil Ctr Aged, Dept Med, Boston, MA 02131 USA		Gillick, MR (corresponding author), Hebrew Rehabil Ctr Aged, Dept Med, 1200 Ctr St, Boston, MA 02131 USA.							Levin JR, 1999, J AM GERIATR SOC, V47, P82, DOI 10.1111/j.1532-5415.1999.tb01905.x; MITCHELL S, 2003, IN PRESS J AM GERIAT; Mitchell SL, 2000, J AM GERIATR SOC, V48, P391, DOI 10.1111/j.1532-5415.2000.tb04696.x; Plows CW, 1999, JAMA-J AM MED ASSOC, V281, P937; Schneiderman LJ, 2000, CAMB Q HEALTHC ETHIC, V9, P524, DOI 10.1017/S0963180100904110; The AM, 2002, BRIT MED J, V325, P1326, DOI 10.1136/bmj.325.7376.1326	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	FEB	2003	2	2					76	76		10.1016/S1474-4422(03)00302-8	http://dx.doi.org/10.1016/S1474-4422(03)00302-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	638BY	12849261				2022-12-18	WOS:000180550600013
J	Bevilacqua, JA; Larrain, E; Corredoira, YA				Bevilacqua, JA; Larrain, E; Corredoira, YA			Fibroelastoma of the mitral valve - a curable cause of stroke	LANCET NEUROLOGY			English	Editorial Material							PAPILLARY FIBROELASTOMAS		Univ Chile, Fac Med, ICBM, Program Morfol, Santiago, Chile; Univ Chile, Hosp Clin, Dept Neurol & Neurocirugia, Santiago, Chile; Univ Chile, Hosp Clin, Unidad Cirugia Cardiovasc, Santiago, Chile; Univ Chile, Hosp San Borja Arriaran, Dept Anat Patol, Sede Ctr, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Bevilacqua, JA (corresponding author), Univ Chile, Fac Med, ICBM, Program Morfol, Independencia 1027,CC70079, Santiago, Chile.		Bevilacqua, Jorge A./I-3113-2013	Bevilacqua, Jorge A./0000-0002-0525-9308				Grandmougin D, 2000, J HEART VALVE DIS, V9, P832; Howard RA, 1999, ANN THORAC SURG, V68, P1881, DOI 10.1016/S0003-4975(99)00860-7; Sun JP, 2001, CIRCULATION, V103, P2687; Yee HC, 1997, AM J CARDIOL, V80, P811, DOI 10.1016/S0002-9149(97)00527-4	4	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	OCT	2002	1	6					388	389		10.1016/S1474-4422(02)00166-7	http://dx.doi.org/10.1016/S1474-4422(02)00166-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	599PB	12849402				2022-12-18	WOS:000178343200025
J	Larkin, M				Larkin, M			Celebrity appeals for research dollars "intensifying" in USA	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	OCT	2002	1	6					339	339		10.1016/S1474-4422(02)00186-2	http://dx.doi.org/10.1016/S1474-4422(02)00186-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	599PB	12849391				2022-12-18	WOS:000178343200014
J	Morris, K				Morris, K			Bone-to-brain repair-a matter of remodelling, not replacement	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	OCT	2002	1	6					335	335		10.1016/S1474-4422(02)00178-3	http://dx.doi.org/10.1016/S1474-4422(02)00178-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	599PB					2022-12-18	WOS:000178343200006
J	Bushnell, CD				Bushnell, CD			The Women's Health Initiative trial and stroke risk	LANCET NEUROLOGY			English	Editorial Material							HORMONE-THERAPY; REPLACEMENT		Duke Univ, Med Ctr, Duke Ctr Cerebrovasc Dis, Durham, NC 27710 USA	Duke University	Bushnell, CD (corresponding author), Duke Univ, Med Ctr, Duke Ctr Cerebrovasc Dis, Box 2900, Durham, NC 27710 USA.							Frankel MR, 2000, NEUROLOGY, V55, P952, DOI 10.1212/WNL.55.7.952; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	SEP	2002	1	5					277	277		10.1016/S1474-4422(02)00131-X	http://dx.doi.org/10.1016/S1474-4422(02)00131-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588LB	12849423				2022-12-18	WOS:000177702000014
J	Bonn, D				Bonn, D			Bacterial enzyme promotes recovery after spinal-cord injury	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	JUN	2002	1	2					78	78		10.1016/S1474-4422(02)00064-9	http://dx.doi.org/10.1016/S1474-4422(02)00064-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588HA					2022-12-18	WOS:000177695000008
J	Butcher, J				Butcher, J			Acutely ill neurological patients get raw deal in UK	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2002	1	1					4	4		10.1016/S1474-4422(02)00024-8	http://dx.doi.org/10.1016/S1474-4422(02)00024-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588GQ					2022-12-18	WOS:000177694100003
J	Love, R				Love, R			Mini-genes to treat muscular dystrophy	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2002	1	1					4	4		10.1016/S1474-4422(02)00026-1	http://dx.doi.org/10.1016/S1474-4422(02)00026-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588GQ					2022-12-18	WOS:000177694100005
J	Morris, K				Morris, K			Can a cursor be moved by thought alone?	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2002	1	1					5	5		10.1016/S1474-4422(02)00028-5	http://dx.doi.org/10.1016/S1474-4422(02)00028-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588GQ					2022-12-18	WOS:000177694100007
J	Morris, K				Morris, K			"Neural integrator" may go awry in torticollis	LANCET NEUROLOGY			English	News Item																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2002	1	1					5	5		10.1016/S1474-4422(02)00027-3	http://dx.doi.org/10.1016/S1474-4422(02)00027-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588GQ					2022-12-18	WOS:000177694100006
J	Becker, LL; Ebstein, F; Horn, D; Zouboulis, CC; Kruger, E; Kaindl, AM				Becker, Lena-Luise; Ebstein, Frederic; Horn, Denise; Zouboulis, Christos C.; Krueger, Elke; Kaindl, Angela M.		IFNAR1 Res Grp	Interferon receptor dysfunction in a child with malignant atrophic papulosis and CNS involvement	LANCET NEUROLOGY			English	Letter									[Becker, Lena-Luise; Kaindl, Angela M.] Charite, Dept Pediat Neurol, D-13353 Berlin, Germany; [Becker, Lena-Luise; Kaindl, Angela M.] Charite, Ctr Chronically Sick Children, D-13353 Berlin, Germany; [Becker, Lena-Luise; Kaindl, Angela M.] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Horn, Denise] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Ebstein, Frederic; Krueger, Elke] Greifswald Univ Med, Inst Med Biochem & Mol Biol, Greifswald, Germany; [Zouboulis, Christos C.] Brandenburg Med Sch Theodor Fontane, Fac Hlth Sci, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Dermatol Venerol Allergol, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Immunol, Dessau, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Greifswald Medical School; Dessau Medical Center; Dessau Medical Center	Kaindl, AM (corresponding author), Charite, Dept Pediat Neurol, D-13353 Berlin, Germany.; Kaindl, AM (corresponding author), Charite, Ctr Chronically Sick Children, D-13353 Berlin, Germany.; Kaindl, AM (corresponding author), Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany.	angela.kaindl@charite.de	Krueger, Elke/B-1462-2012	Krueger, Elke/0000-0002-2551-242X				Han CS, 2001, P NATL ACAD SCI USA, V98, P6138, DOI 10.1073/pnas.111139598; Meesilpavikkai K, 2019, ARTHRITIS RHEUMATOL, V71, P829, DOI 10.1002/art.40805; Orak B, 2021, PEDIAT ALLERG IMM-UK, V32, P621, DOI 10.1111/pai.13400; Peng L, 2015, MABS-AUSTIN, V7, P428, DOI 10.1080/19420862.2015.1007810; Sanchez GAM, 2018, J CLIN INVEST, V128, P3041, DOI 10.1172/JCI98814; Theodoridis A, 2014, BRIT J DERMATOL, V170, P110, DOI 10.1111/bjd.12642	6	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2022	21	8					682	+		10.1016/S1474-4422(22)00167-3	http://dx.doi.org/10.1016/S1474-4422(22)00167-3			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	4P3VT	35841902	Bronze			2022-12-18	WOS:000855325100010
J	Uzoigwe, CE; Campbell-Jones, F				Uzoigwe, Chika Edward; Campbell-Jones, Frederick			Antibiotic neuromuscular junction myasthenic mimetics	LANCET NEUROLOGY			English	Letter									[Uzoigwe, Chika Edward] Med & Surg, Harcourt House, Sheffield S10 1DG, S Yorkshire, England; [Campbell-Jones, Frederick] Univ Hosp Leicester NHS Trust, Glenfield Hosp, Dept Anaesthesia, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Uzoigwe, CE (corresponding author), Med & Surg, Harcourt House, Sheffield S10 1DG, S Yorkshire, England.	chika@doctors.org.uk						Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Heraeus Medical, 2020, HIGH VISC RAD READ M; Huijbers MG, 2022, LANCET NEUROL, V21, P163, DOI 10.1016/S1474-4422(21)00357-4; NICE, ANT US PROPH; Sherman WF, 2021, ACTA ORTHOP, V92, P176, DOI 10.1080/17453674.2020.1865031	5	1	1	3	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2022	21	8					681	681		10.1016/S1474-4422(22)00257-5	http://dx.doi.org/10.1016/S1474-4422(22)00257-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	4P3VT	35841900	Bronze			2022-12-18	WOS:000855325100007
J	Gershon, RC; Sliwinski, MJ; Mangravite, L; King, JW; Kaat, AJ; Weiner, MW; Rentz, DM				Gershon, Richard C.; Sliwinski, Marti J.; Mangravite, Lara; King, Jonathan W.; Kaat, Aaron J.; Weiner, Michael W.; Rentz, Dorene M.			The Mobile Toolbox for monitoring cognitive function	LANCET NEUROLOGY			English	Editorial Material									[Gershon, Richard C.; Kaat, Aaron J.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60622 USA; [Sliwinski, Marti J.] Penn State Univ, Penn State Coll Hlth & Human Dev, Ctr Hlth Aging, University Pk, PA 16802 USA; [Mangravite, Lara] Sage Bionetworks, Seattle, WA USA; [King, Jonathan W.] NIA, Div Behav & Social Res, Bethesda, MD 20892 USA; [Weiner, Michael W.] Univ Calif San Francisco, Sch Med, Dept Med, Dept Radiol & Biomed Imaging,Dept Psychiat, San Francisco, CA USA; [Weiner, Michael W.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA; [Rentz, Dorene M.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Rentz, Dorene M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Rentz, Dorene M.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gershon, RC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60622 USA.	gershon@northwestern.edu						Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Condon DM, 2014, INTELLIGENCE, V43, P52, DOI 10.1016/j.intell.2014.01.004; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Sliwinski MJ, 2018, ASSESSMENT, V25, P14, DOI 10.1177/1073191116643164; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded	6	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2022	21	7					589	590		10.1016/S1474-4422(22)00225-3	http://dx.doi.org/10.1016/S1474-4422(22)00225-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	3J4YF	35716687	hybrid			2022-12-18	WOS:000833401200008
J	Saft, C				Saft, Carsten			Huntington's disease: disappointments and new beginnings	LANCET NEUROLOGY			English	Editorial Material									[Saft, Carsten] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Huntington Ctr North Rhine Westphalia, D-44791 Bochum, Germany	Ruhr University Bochum	Saft, C (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Huntington Ctr North Rhine Westphalia, D-44791 Bochum, Germany.	carsten.saft@ruhr-uni-bochum.de			Teva GmbH; Huntington-Stiftung; CHDI Foundation; Biogen	Teva GmbH(Teva Pharmaceutical Industries); Huntington-Stiftung; CHDI Foundation; Biogen(Biogen)	Teva Pharmaceuticals for scientific talks. CS also received travel or accommodation payments in the context of the Registry study of the European Huntington's Disease Network, the MitoNet study, the ENROLL HD study (CHDI Foundation), the ACR16 study (Neurosearch), the AFQ study (Novartis), the Selisistat studies (Siena Biotech), the PRIDE-HD study (Teva Pharmaceuticals), the Amaryllis-study (Pfizer), the PROOF-HD study (Prilenia). CS has also received payments in the context of the CS1 ISIS-443139 ASO study (Ionis Pharmaceuticals), the PRECISION-HD1 study (Wave Life Sciences), the PRECISION-HD2 study (Wave Life Sciences), the SELECT-HD study (Wave Life Sciences), the RG6042 ASO GenExtend study (Roche), the GenerationHD1 study (Roche), the CS2 study (Roche), and the NHS study (Roche). CS has also received research support for a research project with Teva GmbH, Biogen, Huntington-Stiftung, and the CHDI Foundation.	Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Boak L, 2022, CHDI FDN ANN THER C; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Neueder A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01510-z; Pinto RM, 2020, HUM MOL GENET, V29, P2551, DOI 10.1093/hmg/ddaa139; Tabrizi SJ, 2022, LANCET NEUROL, V21, P645, DOI 10.1016/S1474-4422(22)00121-1; Tabrizi SJ, 2022, LANCET NEUROL, V21, P632, DOI 10.1016/S1474-4422(22)00120-X; Tabrizi SJ, 2020, NAT REV NEUROL, V16, P529, DOI 10.1038/s41582-020-0389-4; Tabrizi SJ, 2019, NEW ENGL J MED, V380, P2307, DOI 10.1056/NEJMoa1900907; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Wild EJ, 2016, EBIOMEDICINE, V8, P3, DOI 10.1016/j.ebiom.2016.05.023; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	12	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2022	21	7					582	584		10.1016/S1474-4422(22)00189-2	http://dx.doi.org/10.1016/S1474-4422(22)00189-2			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	3J4YF	35716683				2022-12-18	WOS:000833401200022
J	Wadman, RI; van Rheenen, W; van der Pol, WL; van den Berg, H				Wadman, Renske I.; van Rheenen, Wouter; van der Pol, W. Ludo; van den Berg, H.			Major advances in neuromuscular disorders in the past two decades	LANCET NEUROLOGY			English	Editorial Material							HEXANUCLEOTIDE REPEAT; C9ORF72		[Wadman, Renske I.; van Rheenen, Wouter; van der Pol, W. Ludo; van den Berg, H.] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Neurol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van den Berg, H (corresponding author), Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Neurol, NL-3584 CX Utrecht, Netherlands.	l.h.vandenberg@umcutrecht.nl			Stichting Spieren voor Spieren [W.OS18-1]; Prinses Beatrix Spierfonds [W.F19-03]; Dutch Research Council [09150161810018]; Vriendenloterij; Prinses Beatrix Spierfonds; Stichting Spieren voor Spieren	Stichting Spieren voor Spieren; Prinses Beatrix Spierfonds; Dutch Research Council; Vriendenloterij; Prinses Beatrix Spierfonds; Stichting Spieren voor Spieren	RIW declares a grant (grant number W.OS18-1) from non-profit organisation Stichting Spieren voor Spieren for funding of research in spinal muscular atrophy. WvR declares grants from Prinses Beatrix Spierfonds (Neuromuscular Fellowship W.F19-03) and the Dutch Research Council (VENI scheme grant 09150161810018). WLvdP declares non-profit grants from Prinses Beatrix Spierfonds, Stichting Spieren voor Spieren, and Vriendenloterij; and consultancy fees and for being on a scientific advisory board from Novartis gene therapies, Biogen, Roche, and Takeda. LHvdB declares fees to his institution from Biogen, Wave, Amylyx, Ferrer, and Cytokinetics for being on a scientific advisory board; fees to his institution from Amylyx for a lecture; an unrestricted educational grant from Takeda; and is the Chair of ENCALS and TRICALS.	Chia R, 2022, P NATL ACAD SCI USA, V119, DOI [10.1073/pnas.2108672119, 10.1073/pnas.2209096119]; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Gillmore JD, 2021, NEW ENGL J MED, V385, P493, DOI 10.1056/NEJMoa2107454; Harschnitz O, 2014, J CLIN IMMUNOL, V34, pS112, DOI 10.1007/s10875-014-0026-3; Howard JF, 2017, LANCET NEUROL, V16, P976, DOI 10.1016/S1474-4422(17)30369-1; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Senecal JL, 2017, ARTHRITIS RHEUMATOL, V69, P878, DOI 10.1002/art.40063; Snoeck M, 2015, EUR J NEUROL, V22, P1094, DOI 10.1111/ene.12713; Strauss KA, 2020, NEUROLOGY, V94; Stunnenberg BC, 2018, JAMA-J AM MED ASSOC, V320, P2344, DOI 10.1001/jama.2018.18020; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; van Rheenen W, 2021, NAT GENET, V53, P1636, DOI 10.1038/s41588-021-00973-1; Westeneng HJ, 2018, LANCET NEUROL, V17, P423, DOI 10.1016/S1474-4422(18)30089-9; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Wolfe GI, 2016, NEW ENGL J MED, V375, P511, DOI 10.1056/NEJMoa1602489	20	1	1	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2022	21	7					585	587		10.1016/S1474-4422(22)00190-9	http://dx.doi.org/10.1016/S1474-4422(22)00190-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	3J4YF	35716684				2022-12-18	WOS:000833401200006
J	Duncan, JS				Duncan, John S.			Epilepsy in the 21st century	LANCET NEUROLOGY			English	Editorial Material							GENE-THERAPY; MRI		[Duncan, John S.] UCL, UCL Queen Sq Inst Neurol, London WC1N 3BG, England	University of London; University College London	Duncan, JS (corresponding author), UCL, UCL Queen Sq Inst Neurol, London WC1N 3BG, England.	j.duncan@ucl.ac.uk		Duncan, John S/0000-0002-1373-0681				Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cloppenborg T, 2016, J NEUROL NEUROSUR PS, V87, P1322, DOI 10.1136/jnnp-2016-313831; Duncan JS, 2016, LANCET NEUROL, V15, P420, DOI 10.1016/S1474-4422(15)00383-X; Ellis CA, 2020, LANCET NEUROL, V19, P93, DOI 10.1016/S1474-4422(19)30269-8; Galovic M, 2018, LANCET NEUROL, V17, P143, DOI 10.1016/S1474-4422(17)30404-0; Gill RS, 2021, NEUROLOGY, V97, pE1571, DOI 10.1212/WNL.0000000000012698; Han Z, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz6100; Kullmann DM, 2014, NAT REV NEUROL, V10, P300, DOI 10.1038/nrneurol.2014.43; Lee WS, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031344; Morris G, 2022, NEUROSCIENCE, V490, P309, DOI 10.1016/j.neuroscience.2022.03.010; North RY, 2017, NEUROSURG CLIN N AM, V28, P545, DOI 10.1016/j.nec.2017.06.001; Opheim G, 2021, NEUROLOGY, V96, P327, DOI 10.1212/WNL.0000000000011413; Perucca P, 2020, ANNU REV GENOM HUM G, V21, P205, DOI 10.1146/annurev-genom-120219-074937; Regalia G, 2019, EPILEPSY RES, V153, P79, DOI 10.1016/j.eplepsyres.2019.02.007; Sander JW, 2022, EPILEPSIA, V63, P139, DOI 10.1111/epi.17134; Shlobin NA, 2021, J NEUROL SCI, V427, DOI 10.1016/j.jns.2021.117515; Sisodiya SM, 2022, HUM BRAIN MAPP, V43, P113, DOI 10.1002/hbm.25037; Snowball A, 2019, J NEUROSCI, V39, P3159, DOI 10.1523/JNEUROSCI.1143-18.2019; Taylor PN, 2014, J NEUROSCI METH, V236, P51, DOI 10.1016/j.jneumeth.2014.08.010; Vakharia VN, 2018, ANN NEUROL, V83, P676, DOI 10.1002/ana.25205	20	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2022	21	6					501	503						3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	3Z0EK	35568039				2022-12-18	WOS:000844093900017
J	Huynh, J; Donovan, J; Phu, NH; Nghia, HDT; Thuong, NTT; Thwaites, GE				Huynh, Julie; Donovan, Joseph; Nguyen Hoan Phu; Ho Dang Trung Nghia; Nguyen Thuy Thuong Thuong; Guy E Thwaites			Tuberculous meningitis: progress and remaining questions	LANCET NEUROLOGY			English	Review						factors; eg; prevalence of pulmonary tuberculosis; age	DIAGNOSTIC-ACCURACY; CEREBROSPINAL-FLUID; MORTALITY; THERAPY; ADULTS; INFLAMMATION; BEDAQUILINE; RIFAMPICIN; SEVERITY; GENOTYPE	Tuberculous meningitis is a devastating brain infection that is caused by Mycobacterium tuberculosis and is notoriously difficult to diagnose and treat. New technologies characterising the transcriptome, proteome, and metabolome have identified new molecules and pathways associated with tuberculous meningitis severity and poor outcomes that could offer novel diagnostic and therapeutic targets. The next-generation GeneXpert MTB/RIF Ultra assay, when used on CSF, offers diagnostic sensitivity for tuberculous meningitis of approximately 70%, although it is not widely available and a negative result cannot rule out tuberculous meningitis. Small trials indicate that clinical outcomes might be improved with increased doses of rifampicin, the addition of linezolid or fluoroquinolones to standard antituberculosis therapy, or treatment with adjunctive aspirin combined with corticosteroids. Large phase 3 clinical trials are underway worldwide to address these and other questions concerning the optimal management of tuberculous meningitis; these studies also form a platform for studying pathogenesis and identifying novel diagnostic and treatment strategies, by allowing the implementation of new genomic, transcriptomic, proteomic, and metabolomic technologies in nested substudies.	[Huynh, Julie; Donovan, Joseph; Nguyen Thuy Thuong Thuong; Guy E Thwaites] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Huynh, Julie; Donovan, Joseph; Nguyen Thuy Thuong Thuong; Guy E Thwaites] Univ Oxford, Ctr Trop Med, Clin Res Unit, Ho Chi Minh City, Vietnam; [Nguyen Hoan Phu] Vietnam Natl Univ, Sch Med, Ho Chi Minh City, Vietnam; [Ho Dang Trung Nghia] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Ho Dang Trung Nghia] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford; Vietnam National University Hochiminh City	Thwaites, GE (corresponding author), Univ Oxford, Ctr Trop Med, Clin Res Unit, Ho Chi Minh City, Vietnam.	gthwaites@oucru.org			Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	JH, JD, NTTT, NHP, and GET are supported by the Wellcome Trust, UK. Wellcome had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Abdulaziz ATA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00626; Abo YN, 2020, PEDIATR INFECT DIS J, V39, pE42, DOI 10.1097/INF.0000000000002578; Akkerman OW, 2016, CLIN INFECT DIS, V62, P523, DOI 10.1093/cid/civ921; Bahr NC, 2018, LANCET INFECT DIS, V18, P68, DOI [10.1016/s1473-3099(17)30474-7, 10.1016/S1473-3099(17)30474-7]; Bratkowska D, 2015, J CHROMATOGR B, V988, P187, DOI 10.1016/j.jchromb.2015.02.041; British HIV Association Writing Group, 2021, BRIT HIV ASS GUIDELI; Butov D, 2020, TUBERC RESPIR DIS, V83, P96, DOI 10.4046/trd.2019.0021; Caws M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001173; Chin JH, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00249-19; Colas RA, 2019, FASEB J, V33, P13028, DOI 10.1096/fj.201901590R; Correia-Neves M, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00115-2018; Cresswell FV, 2021, CLIN INFECT DIS, V73, P876, DOI 10.1093/cid/ciab162; Cresswell Fiona V, 2019, Wellcome Open Res, V4, P164, DOI 10.12688/wellcomeopenres.15506.1; Cresswell FV, 2020, LANCET INFECT DIS, V20, P308, DOI 10.1016/S1473-3099(19)30550-X; Dalli J, 2018, CURR OPIN IMMUNOL, V50, P48, DOI 10.1016/j.coi.2017.10.007; Dian S, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01014-18; Ding JJ, 2020, CLIN PHARMACOL THER, V107, P1023, DOI 10.1002/cpt.1783; Donovan J, 2021, CLIN INFECT DIS, V73, pE3536, DOI 10.1093/cid/ciaa1823; Donovan J, 2020, CLIN INFECT DIS, V71, P2002, DOI 10.1093/cid/ciaa473; Donovan Joseph, 2019, Wellcome Open Res, V4, P163, DOI 10.12688/wellcomeopenres.15512.2; Donovan J, 2020, LANCET INFECT DIS, V20, P299, DOI 10.1016/S1473-3099(19)30649-8; Donovan J, 2019, LANCET NEUROL, V18, P771, DOI 10.1016/S1474-4422(19)30154-1; Donovan Joseph, 2018, Wellcome Open Res, V3, P32, DOI 10.12688/wellcomeopenres.14007.1; du Preez K, 2019, LANCET GLOB HEALTH, V7, pE28, DOI 10.1016/S2214-109X(18)30474-1; Garcia-Prats A J, 2018, Int J Tuberc Lung Dis, V22, P15, DOI 10.5588/ijtld.17.0355; Gupta R, 2015, J GLOB INFECT DIS, V7, P5, DOI 10.4103/0974-777X.150882; Hashimoto S, 2018, J PHARM HEALTH CARE, V4, DOI 10.1186/s40780-018-0123-1; Heemskerk AD, 2018, J INFECTION, V77, P509, DOI 10.1016/j.jinf.2018.09.003; Heemskerk AD, 2017, CLIN INFECT DIS, V65, P20, DOI 10.1093/cid/cix230; Heemskerk AD, 2016, NEW ENGL J MED, V374, P124, DOI 10.1056/NEJMoa1507062; HIV Clinic, 2019, ANT MED TUB; Hoel IM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70613-x; Ion-Margineanu A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00398; Jain SK, 2018, NAT IMMUNOL, V19, P521, DOI 10.1038/s41590-018-0119-x; Kalita J, 2020, AM J TROP MED HYG, V103, P689, DOI 10.4269/ajtmh.20-0077; Kamal H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00945; Keddie S, 2018, EUR J NEUROL, V25, P1345, DOI 10.1111/ene.13732; Keeley AJ, 2020, INT J STD AIDS, V31, P808, DOI 10.1177/0956462420915394; Kumar R, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00450; Kwizera Richard, 2019, Wellcome Open Res, V4, P123, DOI 10.12688/wellcomeopenres.15389.2; Thao LTP, 2020, CLIN INFECT DIS, V70, P827, DOI 10.1093/cid/ciz262; Thao LTP, 2018, CLIN INFECT DIS, V66, P523, DOI 10.1093/cid/cix849; Legaspi GD, 2021, NEUROSURG REV, V44, P2201, DOI 10.1007/s10143-020-01396-y; Li HM, 2016, PEDIATR INFECT DIS J, V35, P607, DOI 10.1097/INF.0000000000001114; Loan JJM, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01713-4; Luo Y, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00866; Mai NTH, 2018, ELIFE, V7, DOI [10.7554/elife.33478, 10.7554/eLife.33478]; Manyelo CM, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00376; Marais S, 2017, J INFECT DIS, V215, P677, DOI 10.1093/infdis/jiw561; Marais S, 2013, CLIN INFECT DIS, V56, P450, DOI 10.1093/cid/cis899; Martyn EM, 2021, CLIN INFECT DIS, V73, pE3505, DOI 10.1093/cid/ciaa1444; Meintjes G, 2018, NEW ENGL J MED, V379, P1915, DOI [10.1056/NEJMoa1800762, 10.1056/nejmoa1800762]; Misra UK, 2018, JAMA NEUROL, V75, P1383, DOI 10.1001/jamaneurol.2018.2178; Mota F, 2020, ACS INFECT DIS, V6, P916, DOI 10.1021/acsinfecdis.9b00473; Nahid P, 2019, AM J RESP CRIT CARE, V200, pE93, DOI 10.1164/rccm.201909-1874ST; Nahid P, 2016, CLIN INFECT DIS, V63, P853, DOI 10.1093/cid/ciw566; Nhu NTQ, 2014, J CLIN MICROBIOL, V52, P226, DOI 10.1128/JCM.01834-13; Ordonez AA, 2019, ACS INFECT DIS, V5, P1996, DOI 10.1021/acsinfecdis.9b00207; Pan LP, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00323; Pormohammad A, 2017, J INFECTION, V74, P545, DOI 10.1016/j.jinf.2017.02.012; Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4; Quinn Carson M, 2021, Wellcome Open Res, V6, P208, DOI 10.12688/wellcomeopenres.16967.1; Quinn CM, CLIN INFECT DIS, V73, P3428; Ramachandran P, 2019, NEUROLOGY, V92; Riste M, 2018, LANCET INFECT DIS, V18, P25, DOI 10.1016/S1473-3099(17)30713-2; Rohlwink UK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11783-9; Rohlwink UK, 2017, CLIN INFECT DIS, V65, P1298, DOI 10.1093/cid/cix540; Schoeman JF, 2004, J CHILD NEUROL, V19, P250, DOI 10.1177/088307380401900402; Seddon James A, 2019, Wellcome Open Res, V4, P167, DOI 10.12688/wellcomeopenres.15535.1; Seddon James A, 2019, Wellcome Open Res, V4, P188, DOI 10.12688/wellcomeopenres.15573.1; Sharma K, 2021, INT J TUBERC LUNG D, V25, P626, DOI 10.5588/ijtld.21.0156; Shobo A, 2016, XENOBIOTICA, V46, P247, DOI 10.3109/00498254.2015.1067935; Siddiqi OK, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00652-19; Sigal GB, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01338-18; Svensson EM, 2020, CLIN INFECT DIS, V71, P1817, DOI 10.1093/cid/ciz1071; Theuretzbacher U, 2019, LANCET INFECT DIS, V19, pE40, DOI 10.1016/S1473-3099(18)30513-9; Thuong NTT, 2019, J INFECT DIS, V219, P986, DOI 10.1093/infdis/jiy588; Thuong NTT, 2017, J INFECT DIS, V215, P1020, DOI 10.1093/infdis/jix050; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; Torok ME, 2018, CLIN PHARMACOL THER, V103, P449, DOI 10.1002/cpt.646; Tucker EW, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa445; Tucker EW, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00913-19; Tucker EW, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau0965; van Laarhoven A, 2018, LANCET INFECT DIS, V18, P526, DOI 10.1016/S1473-3099(18)30053-7; van Laarhoven A, 2017, J INFECT DIS, V215, P1029, DOI 10.1093/infdis/jix051; van Toorn R, 2021, CLIN INFECT DIS, V72, pE136, DOI 10.1093/cid/ciaa1826; van Toorn R, 2015, PEDIATR INFECT DIS J, V34, P214, DOI 10.1097/INF.0000000000000539; Verhaeghe T, 2016, CLIN INFECT DIS, V63, P145, DOI 10.1093/cid/ciw164; Visser DH, 2015, CLIN INFECT DIS, V60, P177, DOI 10.1093/cid/ciu781; Wang GR, 2019, J INFECTION, V78, P311, DOI 10.1016/j.jinf.2019.02.010; Wang SN, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01993; Wasserman S, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.00140-21; Whitworth L, 2020, ELIFE, V10; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wilkinson RJ, 2017, NAT REV NEUROL, V13, P581, DOI 10.1038/nrneurol.2017.120; World Health Organization, 2019, WHOCDSTB20193; World Health Organization, 2017, WHO M REP TECHN EXP; World Health Organization, 2021, RAPID COMMUNICATION; World Health Organization (WHO), 2016, US LOOP MED IS AMPL, V1, P38; Wu XC, 2019, INT J INFECT DIS, V81, P91, DOI 10.1016/j.ijid.2019.01.050; Xie YL, 2017, NEW ENGL J MED, V377, P1043, DOI 10.1056/NEJMoa1614915; Yan LP, 2020, INT J INFECT DIS, V96, P270, DOI 10.1016/j.ijid.2020.04.048; Yu GC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199290; Yu J, 2016, INT J TUBERC LUNG D, V20, P494, DOI 10.5588/ijtld.15.0600	109	1	1	3	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2022	21	5					450	464		10.1016/S1474-4422(21)00435-X	http://dx.doi.org/10.1016/S1474-4422(21)00435-X			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	2R9KM	35429482				2022-12-18	WOS:000821423000018
J	Dziewas, R				Dziewas, Rainer			Nutrition in acute stroke management: food for thought Comment	LANCET NEUROLOGY			English	Editorial Material							ACUTE ISCHEMIC-STROKE; GUIDELINE		[Dziewas, Rainer] WWU Munster, Dept Neurol & Neurorehabil, Klinikum Osnabruck, Acad Teaching Hosp, D-49076 Osnabruck, Germany		Dziewas, R (corresponding author), WWU Munster, Dept Neurol & Neurorehabil, Klinikum Osnabruck, Acad Teaching Hosp, D-49076 Osnabruck, Germany.	dziewas@uni-muenster.de						Boulanger JM, 2018, INT J STROKE, V13, P949, DOI 10.1177/1747493018786616; Burgos R, 2018, CLIN NUTR, V37, P354, DOI 10.1016/j.clnu.2017.09.003; Dennis M, 2006, HEALTH TECHNOL ASSES, V10, P1; Dennis M, 2003, STROKE, V34, P1450, DOI 10.1161/01.STR.0000074037.49197.8C; Dziewas R, 2021, EUR STROKE J, V6, DOI 10.1177/23969873211039721; Langdon PC, 2009, NEUROEPIDEMIOLOGY, V32, P107, DOI 10.1159/000177036; Muhle P, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113879; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Warusevitane A, 2015, STROKE, V46, P454, DOI 10.1161/STROKEAHA.114.006639; Zhao JJ, 2022, LANCET NEUROL, V21, P319, DOI 10.1016/S1474-4422(22)00010-2	10	1	1	3	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2022	21	4					296	297		10.1016/S1474-4422(22)00078-3	http://dx.doi.org/10.1016/S1474-4422(22)00078-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	1Y0JM	35219378				2022-12-18	WOS:000807832700002
J	Kosugi, Y; Hara, N; Isobe, A; Matsumoto, F; Sasa, K				Kosugi, Yasuo; Hara, Naoya; Isobe, Akira; Matsumoto, Fumihiko; Sasa, Kesuke			Detection of ionising radiation by the CNS: a case report	LANCET NEUROLOGY			English	Letter									[Kosugi, Yasuo; Sasa, Kesuke] Juntendo Univ, Dept Radiat Oncol, Tokyo 1138421, Japan; [Matsumoto, Fumihiko] Juntendo Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Tokyo 1138421, Japan; [Hara, Naoya; Isobe, Akira] Juntendo Univ Hosp, Dept Radiol, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University	Sasa, K (corresponding author), Juntendo Univ, Dept Radiat Oncol, Tokyo 1138421, Japan.	ksasai@juntendo.ac.jp						Berkowitz AL, 2017, CLIN NEUROL NEUROSUR, P125; Hara N, 2021, J RADIAT RES, V62, P718, DOI 10.1093/jrr/rrab033; Obinata M, 2019, J RADIAT RES, V60, P812, DOI 10.1093/jrr/rrz060; Xydakis MS, 2021, LANCET NEUROL, V20, P753, DOI 10.1016/S1474-4422(21)00182-4; Yang JC, 2013, J CHILD NEUROL, V28, P788, DOI 10.1177/0883073812450616	5	1	1	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2022	21	4					311	312		10.1016/S1474-4422(22)00076-X	http://dx.doi.org/10.1016/S1474-4422(22)00076-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	1Y0JM	35305333	Bronze			2022-12-18	WOS:000807832700007
J	Sandroff, BM; Motl, RW; Yong, VW; Cutter, GR; Giovannoni, G				Sandroff, Brian M.; Motl, Robert W.; Yong, V. Wee; Cutter, Gary R.; Giovannoni, Gavin			Exercise training in multiple sclerosis	LANCET NEUROLOGY			English	Letter									[Sandroff, Brian M.] Kessler Fdn, Ctr Neuropsychol & Neurosci Res, West Orange, NJ 07052 USA; [Motl, Robert W.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Yong, V. Wee] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Cutter, Gary R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL USA; [Giovannoni, Gavin] Queen Mary Univ London, Barts & London Sch Med, Blizard Inst, London, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Calgary; University of Alabama System; University of Alabama Birmingham; University of London; Queen Mary University London	Sandroff, BM (corresponding author), Kessler Fdn, Ctr Neuropsychol & Neurosci Res, West Orange, NJ 07052 USA.	bsandroff@kesslerfoundation.org						Diechmann MD, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11111499; Hvid LG, 2021, SPORTS MED, V51, P1651, DOI 10.1007/s40279-021-01453-6; Langeskov-Christensen M, 2021, NEUROLOGY, V96, pE203, DOI 10.1212/WNL.0000000000011241; Motl RW, 2017, LANCET NEUROL, V16, P848, DOI 10.1016/S1474-4422(17)30281-8; Zivadinov R, 2016, EXPERT REV NEUROTHER, V16, P777, DOI 10.1080/14737175.2016.1181543	5	1	1	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2022	21	4					313	313		10.1016/S1474-4422(22)00045-X	http://dx.doi.org/10.1016/S1474-4422(22)00045-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	1Y0JM	35305335	Bronze			2022-12-18	WOS:000807832700016
J	Smirnov, D; Galasko, D				Smirnov, Denis; Galasko, Douglas			Dynamics of neuroinflammation in Alzheimer's disease Comment	LANCET NEUROLOGY			English	Editorial Material									[Smirnov, Denis; Galasko, Douglas] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Galasko, D (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	dgalasko@ucsd.edu			National Institute on Aging [AGO62429]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We declare no competing interests. DS and DG were supported by a National Institute on Aging grant AGO62429.	Ewers M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav6221; Franzmeier N, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00407-2; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Morenas-Rodrguez E, LANCET NEUROL, V21, P329; Palmqvist S, 2016, BRAIN, V139, P1226, DOI 10.1093/brain/aww015; Suarez-Calvet M, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-018-0301-5; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767	7	1	1	3	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2022	21	4					297	298		10.1016/S1474-4422(22)00087-4	http://dx.doi.org/10.1016/S1474-4422(22)00087-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	1Y0JM	35305329				2022-12-18	WOS:000807832700003
J	Coarelli, G; Heinzmann, A; Ewenczyk, C; Fischer, C; Chupin, M; Monin, ML; Hurmic, H; Calvas, F; Calvas, P; Goizet, C; Thobois, S; Anheim, M; Nguyen, K; Devos, D; Verny, C; Ricigliano, VAG; Mangin, JF; Brice, A; du Montcel, ST; Durr, A				Coarelli, Giulia; Heinzmann, Anna; Ewenczyk, Claire; Fischer, Clara; Chupin, Marie; Monin, Marie-Lorraine; Hurmic, Hortense; Calvas, Fabienne; Calvas, Patrick; Goizet, Cyril; Thobois, Stephane; Anheim, Mathieu; Nguyen, Karine; Devos, David; Verny, Christophe; Ricigliano, Vito A. G.; Mangin, Jean-Francois; Brice, Alexis; du Montcel, Sophie Tezenas; Durr, Alexandra			Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial	LANCET NEUROLOGY			English	Article							CEREBELLAR-ATAXIA; VALIDATION; RISK	Background Riluzole has been reported to be beneficial in patients with cerebellar ataxia; however, effectiveness in individual subtypes of disease is unclear due to heterogeneity in participants' causes and stages of disease. Our aim was to test riluzole in a single genetic disease, spinocerebellar ataxia type 2. Methods We did a randomised, double-blind, placebo-controlled, multicentre trial (the ATRIL study) at eight national reference centres for rare diseases in France that were part of the Neurogene National Reference Centre for Rare Diseases. Participants were patients with spinocerebellar ataxia type 2 with an age at disease onset of up to 50 years and a scale for the assessment and rating of ataxia (SARA) score of at least 5 and up to 26. Patients were randomly assigned centrally (1:1) to receive either riluzole 50 mg orally or placebo twice per day for 12 months. Two visits, at baseline and at 12 months, included clinical measures and 3T brain MRI. The primary endpoint was the proportion of patients whose SARA score improved by at least 1 point. Analyses were done in the intention-to-treat population (all participants who were randomly assigned) and were done with only the observed data (complete case analysis). This trial is registered at ClinicalTrials.gov (NCT03347344) and has been completed. Findings Between Jan 18, 2018, and June 14, 2019, we enrolled 45 patients. 22 patients were randomly assigned to receive riluzole and 23 to receive placebo. Median age was 42 years (IQR 36-57) in the riluzole group and 49 years (40-56) in the placebo group and 23 (51%) participants were women. All participants presented with moderate-stage disease, characterised by a median SARA score of 13.5 (IQR 9.5-16.5). The primary endpoint, SARA score improvement of at least 1 point after 12 months, was observed in seven patients (32%) in the treated group versus nine patients (39%) in the placebo group, with a mean difference of -10.3% (95% CI -37.4% to 19.2%; p=0.75). SARA score showed a median increase (ie, worsening) of 0 . 5 points (IQR -1. 5 to 1. 5) in the riluzole group versus 0.3 points (-1.0 to 2.5) in the placebo group (p=0.70). No serious adverse event was reported in the riluzole-treated group whereas four patients in placebo group had a serious adverse event (hepatic enzyme increase, fracture of external malleolus, rectorrhagia, and depression). The number of patients with adverse events was similar in both groups (riluzole 16 [73%] patients vs placebo 19 [83%] patients; p=0.49). Interpretation We were able to recruit 45 patients moderately affected by spinocerebellar ataxia type 2 for this trial. Riluzole did not improve clinical or radiological outcomes in these patients. However, our findings provide data on progression of spinocerebellar ataxia type 2 that might prove to be valuable for the design of other clinical trials. Copyright (C) 2022 Elsevier Ltd. All rights reserved.	[Coarelli, Giulia; Heinzmann, Anna; Ewenczyk, Claire; Monin, Marie-Lorraine; Hurmic, Hortense; Ricigliano, Vito A. G.; Brice, Alexis; Durr, Alexandra] Sorbonne Univ, Paris Brain Inst, Pitie Salpetriere Univ Hosp,CNRS, Assistance Publ Hop Paris,ICM Inst Cerveau,INSERM, Paris, France; [Coarelli, Giulia; Heinzmann, Anna; Ewenczyk, Claire; Monin, Marie-Lorraine; Hurmic, Hortense; Durr, Alexandra] Pitii Salpetriere Univ Hosp, Assistance Publ Hop Paris, Dept Genet, Neurogene Natl Reference Ctr Rare Dis, Paris, France; [Fischer, Clara; Chupin, Marie; Mangin, Jean-Francois] Sorbonne Univ, CNRS, ICM, CATI, Paris, France; [Fischer, Clara; Chupin, Marie; Mangin, Jean-Francois] Univ Paris Saday, Neurospin, Baobab, CNRS,CEA, Gif Sur Yvette, France; [Calvas, Fabienne] Clin Res Ctr Univ Hosp, Toulouse, France; [Calvas, Patrick] Purpan Univ Hosp, Dept Clin Genet, Toulouse, France; [Goizet, Cyril] Bordeaux Univ, Pelleg Rill Hosp, Natl Reference Ctr Neurogenet Rare Dis, Dept Med Genet,Bordeaux Univ Hosp, Bordeaux, France; [Goizet, Cyril] Bordeaux Univ, Lab MRGM, INSERM U1211, Bordeaux, France; [Thobois, Stephane] Hosp Civils Lyon, Pierre Wertheimer Neurol & Neurosurg Hosp, Dept Neurol C, Bron, France; [Thobois, Stephane] Claude Bernard Lyon 1 Univ, Fac Med Lyon Sud Charles Merieux, Lyon, France; [Thobois, Stephane] Inst Cognit Sci Marc Jeannerod UMR, CNRS, Bron, France; [Anheim, Mathieu] Univres Hosp Strasbourg, Dept Neurol, Wipital Hautepierre, Strasbourg, France; [Anheim, Mathieu] Univ Strasbourg, Federeat Med Translat Strasbourg, Strasbourg, France; [Anheim, Mathieu] Inst Genet & Mol & Cellular Biol, Illkirch Graffenstaden, France; [Nguyen, Karine] Marseille Univ Hosp, APHM AMU, Dept Med Genet, Neurogene Natl Reference Ctr Rare Dis, Marseille, France; [Devos, David] Univ Lille, LiINCog Lille Neurosci & Cognit, CHU Lille, INSERM, Lille, France; [Verny, Christophe] Angers Univ Hosp, Neurol Dept, Angers, France; [du Montcel, Sophie Tezenas] Sorbonne Univ, Pitie Salpitriere Univ Hosp, Assistance Publ Hop Paris, INSERM,Inst Epidemiol & Publ Hlth Pierre Louis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CHU de Toulouse; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite	Durr, A (corresponding author), Paris Brain Inst, Pitie Salpetriere Paris, F-75646 Paris, France.	alexandra.durr@icm-institute.org	GOIZET, Cyril/M-4576-2014; Tezenas du Montcel, Sophie/A-6207-2012	GOIZET, Cyril/0000-0002-1913-889X; Tezenas du Montcel, Sophie/0000-0002-2866-4330; Ricigliano, Vito A. G./0000-0002-8860-3548	French Ministry of Health	French Ministry of Health	French Ministry of Health.	Adanyeguh IM, 2018, NEUROIMAGE-CLIN, V19, P858, DOI 10.1016/j.nicl.2018.06.011; Bellingham MC, 2011, CNS NEUROSCI THER, V17, P4, DOI 10.1111/j.1755-5949.2009.00116.x; Chio A, 2015, NEUROLOGY, V84, P251, DOI 10.1212/WNL.0000000000001159; Coarelli G, 2021, NEUROBIOL DIS, V153, DOI 10.1016/j.nbd.2021.105311; Diallo A, 2018, LANCET NEUROL, V17, P327, DOI 10.1016/S1474-4422(18)30042-5; Du Montcel ST, 2008, BRAIN, V131, P1352, DOI 10.1093/brain/awn059; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fang T, 2018, LANCET NEUROL, V17, P416, DOI 10.1016/S1474-4422(18)30054-1; Federighi P, 2011, BRAIN, V134, P879, DOI 10.1093/brain/awr009; Grobe-Einsler M, 2021, MOVEMENT DISORD, V36, P1242, DOI 10.1002/mds.28478; Hoche F, 2018, BRAIN, V141, P248, DOI 10.1093/brain/awx317; Jacobi H, 2013, CEREBELLUM, V12, P418, DOI 10.1007/s12311-012-0421-3; Jacobi H, 2015, LANCET NEUROL, V14, P1101, DOI 10.1016/S1474-4422(15)00202-1; Jacobi H, 2013, LANCET NEUROL, V12, P650, DOI 10.1016/S1474-4422(13)70104-2; Koscik TR, 2020, BRAIN COMMUN, V2; Moore LR, 2017, MOL THER-NUCL ACIDS, V7, P200, DOI 10.1016/j.omtn.2017.04.005; Nigri A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.616419; Pulst SM, 2016, NEUROLOGY, V86, P2284, DOI 10.1212/WNL.0000000000002777; Ristori G, 2010, NEUROLOGY, V74, P839, DOI 10.1212/WNL.0b013e3181d31e23; Romano S, 2015, LANCET NEUROL, V14, P985, DOI 10.1016/S1474-4422(15)00201-X; Schmahmann JD, 2019, NEUROSCI LETT, V688, P62, DOI 10.1016/j.neulet.2018.07.005; Schmidt J, 2016, J NEUROCHEM, V138, P150, DOI 10.1111/jnc.13606; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Scoles DR, 2017, NATURE, V544, P362, DOI 10.1038/nature22044; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	26	1	1	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2022	21	3					225	233		10.1016/S1474-4422(21)00457-9	http://dx.doi.org/10.1016/S1474-4422(21)00457-9			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZF7BZ	35063116	Green Published			2022-12-18	WOS:000759721800019
J	Lockhart, P				Lockhart, Paul			Advancing the diagnosis of repeat expansion disorders Comment	LANCET NEUROLOGY			English	Editorial Material									[Lockhart, Paul] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth, Parkville, Vic 3052, Australia; [Lockhart, Paul] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne	Lockhart, P (corresponding author), Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth, Parkville, Vic 3052, Australia.; Lockhart, P (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic, Australia.	paul.lockhart@mcri.edu.au	Lockhart, Paul J/E-7753-2011	Lockhart, Paul J/0000-0003-2531-8413				Ashley EA, 2016, NAT REV GENET, V17, P507, DOI 10.1038/nrg.2016.86; Bahlo Melanie, 2018, F1000Res, V7, DOI 10.12688/f1000research.13980.1; Depienne C, 2021, AM J HUM GENET, V108, P764, DOI 10.1016/j.ajhg.2021.03.011; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Ellerby LM, 2019, NEUROTHERAPEUTICS, V16, P924, DOI 10.1007/s13311-019-00823-3; Ibanez K, 2022, LANCET NEUROL, V21, P234, DOI 10.1016/S1474-4422(21)00462-2; Ngo KJ, 2020, HUM MUTAT, V41, P487, DOI 10.1002/humu.23946; Paulson Henry, 2018, Handb Clin Neurol, V147, P105, DOI 10.1016/B978-0-444-63233-3.00009-9; Rehm HL, 2017, NAT REV GENET, V18, P259, DOI 10.1038/nrg.2016.162; Tankard RM, 2018, AM J HUM GENET, V103, P858, DOI 10.1016/j.ajhg.2018.10.015	10	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2022	21	3					205	207		10.1016/S1474-4422(22)00033-3	http://dx.doi.org/10.1016/S1474-4422(22)00033-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZF7BZ	35182498				2022-12-18	WOS:000759721800005
J	Velazquez-Perez, L; Rodriguez-Labrada, R				Velazquez-Perez, Luis; Rodriguez-Labrada, Roberto			Riluzole and spinocerebellar ataxia type 2: the ATRIL trial Comment	LANCET NEUROLOGY			English	Editorial Material							CEREBELLAR-ATAXIA; DOUBLE-BLIND		[Velazquez-Perez, Luis] Cuban Acad Sci, Havana, Cuba; [Rodriguez-Labrada, Roberto] Cuban Neurosci Ctr, Havana, Cuba	Academia de Ciencias de Cuba	Velazquez-Perez, L (corresponding author), Cuban Acad Sci, Havana, Cuba.	luisvelazquez@ceniai.inf.cu						Buijsen RAM, 2019, NEUROTHERAPEUTICS, V16, P263, DOI 10.1007/s13311-018-00696-y; Rodriguez-Diaz JC, 2018, MOVEMENT DISORD, V33, P1481, DOI 10.1002/mds.27437; Coarelli G, 2022, LANCET NEUROL, DOI [10.1016/S1474-4422(22)00028-X, DOI 10.1016/S1474-4422(22)00028-X]; Dell'Orco JM, 2017, HUM MOL GENET, V26, P3935, DOI 10.1093/hmg/ddx281; Diallo A, 2021, J NEUROL, V268, P2749, DOI 10.1007/s00415-020-09815-2; Kasumu AW, 2012, CHEM BIOL, V19, P1340, DOI 10.1016/j.chembiol.2012.07.013; Nag N, 2013, CEREBELLUM, V12, P74, DOI 10.1007/s12311-012-0399-x; Ristori G, 2010, NEUROLOGY, V74, P839, DOI 10.1212/WNL.0b013e3181d31e23; Romano S, 2015, LANCET NEUROL, V14, P985, DOI 10.1016/S1474-4422(15)00201-X; Schmidt J, 2016, J NEUROCHEM, V138, P150, DOI 10.1111/jnc.13606	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2022	21	3					204	205		10.1016/S1474-4422(22)00028-X	http://dx.doi.org/10.1016/S1474-4422(22)00028-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZF7BZ	35063118				2022-12-18	WOS:000759721800004
J	Drouin, E; Kwiatkowski, A; Hautecoeur, P				Drouin, Emmanuel; Kwiatkowski, Arnaud; Hautecoeur, Patrick			Focal Point The Bell-Magendie debate	LANCET NEUROLOGY			English	Editorial Material																		Bell C, 1821, PHIL T, V111, P398, DOI DOI 10.1098/RSTL.1821.0029; Bell C., 1822, PHIL T R SOC LOND, V112, P284; Magendie F., 1822, J PHYSL EXP, V2, P276	3	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2022	21	2					121	121		10.1016/S1474-4422(22)00003-5	http://dx.doi.org/10.1016/S1474-4422(22)00003-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	1N3AC	35065034				2022-12-18	WOS:000800530800001
J	Seeher, K; Cataldi, R; Chowdhary, N; Kolappa, K; Dua, T				Seeher, Katrin; Cataldi, Rodrigo; Chowdhary, Neerja; Kolappa, Kavitha; Dua, Tarun			The need for a better global dementia response	LANCET NEUROLOGY			English	Letter									[Seeher, Katrin; Cataldi, Rodrigo; Chowdhary, Neerja; Kolappa, Kavitha; Dua, Tarun] World Hlth Org, Dept Mental Hlth & Subst Use, CH-1211 Geneva, Switzerland	World Health Organization	Seeher, K (corresponding author), World Hlth Org, Dept Mental Hlth & Subst Use, CH-1211 Geneva, Switzerland.	seeherk@who.int		Brayne, Carol/0000-0001-5307-663X; Lessa Cataldi, Rodrigo/0000-0002-3862-7824				[Anonymous], 2021, LANCET NEUROL, V20, P699; Das PJ, 2022, EDUC PRIM CARE, DOI 10.1080/14739879.2022.2137856; Dua T., 2017, GLOB ACT PLAN PUBL H, DOI 10.1016/j.jalz.2017.07.758; Lee K, 2009, GLOB INST, P1	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2022	21	2					115	115		10.1016/S1474-4422(21)00460-9	http://dx.doi.org/10.1016/S1474-4422(21)00460-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	1N3AB	34922642	Green Published			2022-12-18	WOS:000800530700001
J	Kanter, BR; Lykken, CM; Moser, EI; Moser, MB				Kanter, Benjamin R.; Lykken, Christine M.; Moser, Edvard, I; Moser, May-Britt			Neuroscience in the 21st century: circuits, computation, and behaviour	LANCET NEUROLOGY			English	Editorial Material									[Moser, May-Britt] Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, NO-7491 Trondheim, Norway; Norwegian Univ Sci & Technol NTNU, Ctr Neural Computat, NO-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, MB (corresponding author), Norwegian Univ Sci & Technol NTNU, Kavli Inst Syst Neurosci, NO-7491 Trondheim, Norway.	may-britt.moser@ntnu.no						Churchland PS, 2017, COMPUT NEUROSCI-MIT; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Eliav T, 2021, SCIENCE, V372, P933, DOI 10.1126/science.abg4020; EVANS DA, 2018, NATURE; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Laurent G, 2020, NAT REV NEUROSCI, V21, P395, DOI 10.1038/s41583-020-0323-1; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Moser EI, 2017, NAT NEUROSCI, V20, P1448, DOI 10.1038/nn.4653; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Piasini E, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21010062; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Zong WJ, 2021, NAT METHODS, V18, P46, DOI 10.1038/s41592-020-01024-z	21	1	1	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2022	21	1					19	21		10.1016/S1474-4422(21)00427-0	http://dx.doi.org/10.1016/S1474-4422(21)00427-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XV0SP	34942127				2022-12-18	WOS:000734663200012
J	Petri, S				Petri, Susanne			Major research advances in amyotrophic lateral sclerosis in 2021	LANCET NEUROLOGY			English	Editorial Material									[Petri, Susanne] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany	Hannover Medical School	Petri, S (corresponding author), Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany.	Petri.Susanne@mh-hannover.de	Petri, Susanne/AID-7665-2022					Ashton Nicholas J, 2021, Nat Commun, V12, P3400, DOI 10.1038/s41467-021-23620-z; Bjornevik K, 2021, NEUROLOGY, V97, pE1466, DOI 10.1212/WNL.0000000000012632; Cudkowicz M, 2021, LANCET NEUROL, V20, P821, DOI 10.1016/S1474-4422(21)00242-8; Halbgebauer S, 2022, J NEUROL NEUROSUR PS, V93, P68, DOI 10.1136/jnnp-2021-327129; Hannaford A, 2021, ANN NEUROL, V89, P979, DOI 10.1002/ana.26045; Maor-Nof M, 2021, CELL, V184, P689, DOI 10.1016/j.cell.2020.12.025; Paganoni S, 2021, MUSCLE NERVE, V63, P31, DOI 10.1002/mus.27091; van Eijk RPA, 2021, NEUROLOGY, V97, P528, DOI 10.1212/WNL.0000000000012545; Wainger BJ, 2021, JAMA NEUROL, V78, P186, DOI 10.1001/jamaneurol.2020.4300; Westeneng HJ, 2021, LANCET NEUROL, V20, P373, DOI 10.1016/S1474-4422(21)00042-9	10	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2022	21	1					14	15		10.1016/S1474-4422(21)00420-8	http://dx.doi.org/10.1016/S1474-4422(21)00420-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XV0SP	34942124				2022-12-18	WOS:000734663200010
J	Puy, L; Cordonnier, C				Puy, Laurent; Cordonnier, Charlotte			Stroke research in 2021: insights into the reorganisation of stroke care	LANCET NEUROLOGY			English	Editorial Material									[Puy, Laurent; Cordonnier, Charlotte] Univ Lille, U1172 Lille Neurosci & Cognit LilNCog, CHU Lille, INSERM, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Cordonnier, C (corresponding author), Univ Lille, U1172 Lille Neurosci & Cognit LilNCog, CHU Lille, INSERM, F-59000 Lille, France.	charlotte.cordonnier@univ-lille.fr						Ebinger M, 2021, JAMA-J AM MED ASSOC, V325, P454, DOI 10.1001/jama.2020.26345; Grotta JC, 2021, NEW ENGL J MED, V385, P971, DOI 10.1056/NEJMoa2103879; Peyre M, 2021, NEW ENGL J MED, V385, P996, DOI 10.1056/NEJMoa2100440; Requena M, 2021, JAMA NEUROL, V78, P1099, DOI 10.1001/jamaneurol.2021.2385; Schreuder FHBM, 2021, LANCET NEUROL, V20, P907, DOI 10.1016/S1474-4422(21)00298-2; SoSTART Collaboration, 2021, Lancet Neurol, V20, P842, DOI 10.1016/S1474-4422(21)00264-7	6	1	1	2	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2022	21	1					2	3		10.1016/S1474-4422(21)00410-5	http://dx.doi.org/10.1016/S1474-4422(21)00410-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XV0SP	34942128				2022-12-18	WOS:000734663200003
J	Abbasi, N; Hamidi, S				Abbasi, Nooshin; Hamidi, Samer			GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 17, pg 939, 2018)	LANCET NEUROLOGY			English	Correction																		ABBASI N, 2018, LANCET NEUROL, V17, P939	1	1	1	25	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2021	20	12					E7	E7		10.1016/S1474-4422(18)30295-3	http://dx.doi.org/10.1016/S1474-4422(18)30295-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YZ6RX		hybrid, Green Published			2022-12-18	WOS:000755602800001
J	Citerio, G; Robba, C; Graziano, F; Rebora, P				Citerio, Giuseppe; Robba, Chiara; Graziano, Francesca; Rebora, Paola			Intracranial pressure monitoring and unfavourable outcomes reply	LANCET NEUROLOGY			English	Letter							BRAIN-INJURY; TRIAL		[Citerio, Giuseppe; Robba, Chiara; Graziano, Francesca; Rebora, Paola] Univ Milano Bicocca, Sch Med & Surg, I-20900 Monza, Italy	University of Milano-Bicocca	Citerio, G (corresponding author), Univ Milano Bicocca, Sch Med & Surg, I-20900 Monza, Italy.	giuseppe.citerio@unimib.it	Rebora, Paola/M-9098-2016	Rebora, Paola/0000-0003-0606-5852				Chesnut RM, 2013, INTENS CARE MED, V39, P771, DOI 10.1007/s00134-013-2852-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Robba C, 2021, LANCET NEUROL, V20, P548, DOI 10.1016/S1474-4422(21)00138-1; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2021	20	12					979	979		10.1016/S1474-4422(21)00370-7	http://dx.doi.org/10.1016/S1474-4422(21)00370-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YZ6RX	34800408	Bronze			2022-12-18	WOS:000755602800013
J	Mok, KY				Mok, Kin Y.		East Asian Parkinson Dis Genomic	The East Asian Parkinson Disease Genomics Consortium	LANCET NEUROLOGY			English	Letter									[Mok, Kin Y.] UCL, UK Dementia Res Inst, London WC1E 6AU, England; [Mok, Kin Y.] UCL, Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6AU, England; [Mok, Kin Y.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China	University of London; University College London; University of London; University College London; Hong Kong University of Science & Technology	Mok, KY (corresponding author), UCL, UK Dementia Res Inst, London WC1E 6AU, England.; Mok, KY (corresponding author), UCL, Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6AU, England.; Mok, KY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China.	k.mok@ucl.ac.uk	Funayama, Manabu/E-6485-2013; Mok, Kin Ying/F-5860-2012; Mok, Kin/U-6893-2019; Hardy, John/C-2451-2009	Funayama, Manabu/0000-0002-7412-3631; Mok, Kin Ying/0000-0003-3145-880X; Mok, Kin/0000-0003-3145-880X; Pfaff, Abigail/0000-0002-2231-9800; Hardy, John/0000-0002-3122-0423	Michael J Fox Program Genetic Diversity in Parkinson's Disease 2019 [17474]; Global Parkinson's Genetic Program; Aligning Science Across Parkinson's	Michael J Fox Program Genetic Diversity in Parkinson's Disease 2019; Global Parkinson's Genetic Program; Aligning Science Across Parkinson's(Aligning Science Across Parkinson's (ASAP))	We declare no competing interests. The EAPDGC is funded by the Michael J Fox Program Genetic Diversity in Parkinson's Disease 2019 (grant number 17474), the Global Parkinson's Genetic Program, and Aligning Science Across Parkinson's. Members of the EAPDGC are listed in the appendix.	Gilbert RM, 2020, MOVEMENT DISORD, V35, P231, DOI 10.1002/mds.27906; Rizig M, 2021, LANCET NEUROL, V20, P335, DOI 10.1016/S1474-4422(21)00100-9; Sirugo G, 2019, CELL, V177, P26, DOI 10.1016/j.cell.2019.02.048; Tan AH, 2021, MOVEMENT DISORD, V36, P842, DOI 10.1002/mds.28494; Wojcik GL, 2019, NATURE, V570, P514, DOI 10.1038/s41586-019-1310-4	5	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2021	20	12					982	982		10.1016/S1474-4422(21)00373-2	http://dx.doi.org/10.1016/S1474-4422(21)00373-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YZ6RX	34800411	Green Submitted			2022-12-18	WOS:000755602800016
J	Niedhammer, I; Chastang, JF				Niedhammer, Isabelle; Chastang, Jean-Francois			Overall fraction of disease attributable to multiple dependent risk factors: a new formula	LANCET NEUROLOGY			English	Letter									[Niedhammer, Isabelle; Chastang, Jean-Francois] Univ Angers, INSERM, F-49045 Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Niedhammer, I (corresponding author), Univ Angers, INSERM, F-49045 Angers, France.	isabelle.niedhammer@inserm.fr						Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Niedhammer I, 2022, INT ARCH OCC ENV HEA, V95, P233, DOI 10.1007/s00420-021-01737-4; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2021	20	12					979	+		10.1016/S1474-4422(21)00366-5	http://dx.doi.org/10.1016/S1474-4422(21)00366-5			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YZ6RX	34800409	Bronze			2022-12-18	WOS:000755602800014
J	Quaglio, G; Toia, P; Moser, EI; Karapiperis, T; Amunts, K; Okabe, S; Poo, MM; Rah, JC; De Koninck, Y; Ngai, J; Richards, L; Bjaalie, JG				Quaglio, Gianluca; Toia, Patrizia; Moser, Edvard I.; Karapiperis, Theodoros; Amunts, Katrin; Okabe, Shigeo; Poo, Mu-ming; Rah, Jong-Cheol; De Koninck, Yves; Ngai, John; Richards, Linda; Bjaalie, Jan G.			The International Brain Initiative: enabling collaborative science	LANCET NEUROLOGY			English	Editorial Material													De Koninck, Yves/C-2659-2008; Richards AO, Linda/P-6372-2014	De Koninck, Yves/0000-0002-5779-9330; Richards AO, Linda/0000-0002-7590-7390					0	1	1	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2021	20	12					985	986		10.1016/S1474-4422(21)00389-6	http://dx.doi.org/10.1016/S1474-4422(21)00389-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YZ6RX	34800415				2022-12-18	WOS:000755602800020
J	Pahwa, R				Pahwa, Rajesh			Amantadine: an old drug reborn Comment	LANCET NEUROLOGY			English	Editorial Material							LEVODOPA-INDUCED DYSKINESIA; EXTENDED-RELEASE CAPSULES		[Pahwa, Rajesh] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Pahwa, R (corresponding author), Univ Kansas, Med Ctr, Kansas City, KS 66160 USA.	rpahwa@kumc.edu						Hauser RA, 2019, CLIN PHARMACOKINET, V58, P77, DOI 10.1007/s40262-018-0663-4; Hauser RA, 2017, J PARKINSON DIS, V7, P511, DOI 10.3233/JPD-171134; Isaacson SH, 2018, MOV DISORD CLIN PRAC, V5, P183, DOI 10.1002/mdc3.12595; Oertel W, 2021, MDS VIRT C SEPT 17 2; Oertel W, 2017, MOVEMENT DISORD, V32, P1701, DOI 10.1002/mds.27131; Pahwa R, 2017, JAMA NEUROL, V74, P941, DOI 10.1001/jamaneurol.2017.0943; Rascol O, 2021, LANCET NEUROL, V20, P1048, DOI 10.1016/S1474-4422(21)00249-0; Sharma VD, 2018, THER CLIN RISK MANAG, V14, P665, DOI 10.2147/TCRM.S144481	8	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2021	20	12					975	977		10.1016/S1474-4422(21)00356-2	http://dx.doi.org/10.1016/S1474-4422(21)00356-2		NOV 2021	4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YZ6RX	34678172				2022-12-18	WOS:000755602800010
J	DeCarli, C				DeCarli, Charles			The link between blood pressure and Alzheimer's disease	LANCET NEUROLOGY			English	Editorial Material									[DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	DeCarli, C (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.; DeCarli, C (corresponding author), Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA.	cdecarli@ucdavis.edu						DeCarli C, 2013, J ALZHEIMERS DIS, V33, pS417, DOI 10.3233/JAD-2012-129004; Kehoe PG, 2021, LANCET NEUROL, V20, P895, DOI 10.1016/S1474-4422(21)00263-5; Lewis CE, 2021, NEW ENGL J MED, V384, P1921, DOI 10.1056/NEJMoa1901281; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Marchant NL, 2013, JAMA NEUROL, V70, P488, DOI 10.1001/2013.jamaneurol.405; Saavedra JM, 2021, PHYSIOLOGY, V36, P160, DOI 10.1152/physiol.00036.2020; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Seymour RS, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170846; Thacker EL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000635; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442	10	1	1	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2021	20	11					878	879		10.1016/S1474-4422(21)00340-9	http://dx.doi.org/10.1016/S1474-4422(21)00340-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WL5PY	34687619				2022-12-18	WOS:000710458300001
J	Hoglinger, GU				Hoeglinger, Guenter U.			Neuropathology of progressive supranuclear palsy after treatment with tilavonemab reply	LANCET NEUROLOGY			English	Letter									[Hoeglinger, Guenter U.] German Ctr Neurodegenerat Dis, Munich, Germany; [Hoeglinger, Guenter U.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Hoeglinger, Guenter U.] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Hannover Medical School	Hoglinger, GU (corresponding author), German Ctr Neurodegenerat Dis, Munich, Germany.; Hoglinger, GU (corresponding author), Tech Univ Munich, Dept Neurol, Munich, Germany.; Hoglinger, GU (corresponding author), Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany.	hoeglinger.guenter@mh-hannover.de	Hoglinger, Gunter/F-2388-2015	Hoglinger, Gunter/0000-0001-7587-6187				Brendel M, 2020, JAMA NEUROL, V77, P1408, DOI 10.1001/jamaneurol.2020.2526; Hoglinger GU, 2021, LANCET NEUROL, V20, P182, DOI 10.1016/S1474-4422(20)30489-0; Kim B, 2021, ACTA NEUROPATHOL, V142, P243, DOI 10.1007/s00401-021-02318-y; Koga S, 2021, LANCET NEUROL, V20, P786, DOI 10.1016/S1474-4422(21)00283-0; Novak P.K.B., 2021, NATURE AGING, V1, P521, DOI DOI 10.1038/S43587-021-00070-2; Saijo E, 2020, ACTA NEUROPATHOL, V139, P63, DOI 10.1007/s00401-019-02080-2; West T, 2017, JPAD-J PREV ALZHEIM, V4, P236, DOI 10.14283/jpad.2017.36	7	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2021	20	10					787	788		10.1016/S1474-4422(21)00284-2	http://dx.doi.org/10.1016/S1474-4422(21)00284-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY8AW	34536400	Bronze			2022-12-18	WOS:000701741000025
J	Caso, V; Mosconi, MG				Caso, Valeria; Mosconi, Maria Giulia			Lessons to be learned in intracerebral haemorrhage research	LANCET NEUROLOGY			English	Editorial Material									[Caso, Valeria; Mosconi, Maria Giulia] Univ Perugia, Santa Maria Misericordia Hosp, Stroke Unit, I-06156 Perugia, Italy	Hospital Santa Maria della Misericordia; University of Perugia	Caso, V (corresponding author), Univ Perugia, Santa Maria Misericordia Hosp, Stroke Unit, I-06156 Perugia, Italy.	valeria.caso@ospedale.perugia.it	CASO, VALERIA/AAC-5156-2022; Mosconi, Maria Giulia/AGF-0237-2022	CASO, VALERIA/0000-0002-2020-8891; Mosconi, Maria Giulia/0000-0002-0456-9160	ARS UMBRIA (Associazione Ricerca Stroke); PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF)	ARS UMBRIA (Associazione Ricerca Stroke); PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF)	We declare no competing interests. We acknowledge funding from ARS UMBRIA (Associazione Ricerca Stroke) and PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation (PRESTIGE-AF).	Ahmed N, 2019, EUR STROKE J, V4, P307, DOI 10.1177/2396987319863606; Hawkes MA, 2018, NEUROL-CLIN PRACT, V8, P48, DOI 10.1212/CPJ.0000000000000425; Hindricks G, 2021, EUR HEART J, V42, P373, DOI [10.1093/eurheartj/ehaa612, 10.15829/1560-4071-2021-4701]; Tsivgoulis G, 2017, THER ADV NEUROL DISO, V10, P241, DOI 10.1177/1756285617699588	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2021	20	10					779	780		10.1016/S1474-4422(21)00296-9	http://dx.doi.org/10.1016/S1474-4422(21)00296-9		SEP 2021	2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY8AW	34487723				2022-12-18	WOS:000701741000006
J	Liu, KY; Howard, R				Liu, Kathy Y.; Howard, Robert			Pimavanserin and dementia-related psychosis: can HARMONY prevail?	LANCET NEUROLOGY			English	Editorial Material							EFFICACY		[Liu, Kathy Y.; Howard, Robert] UCL, Div Psychiat, London W1T 7NF, England	University of London; University College London	Howard, R (corresponding author), UCL, Div Psychiat, London W1T 7NF, England.	robert.howard@ucl.ac.uk		Howard, Robert/0000-0002-3071-2338	Medical Research Council [MR/S021418/1]; UCLH NIHR Biomedical Research Centre	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCLH NIHR Biomedical Research Centre	KL is supported by the Medical Research Council (MR/S021418/1) . RH is supported by the UCLH NIHR Biomedical Research Centre. The authors' funding sources were not involved in the writing of the Comment or the decision to submit it for publication.	[Anonymous], 2016, PIMAVANSERIN NEW CHE; Ballard C, 2018, LANCET NEUROL, V17, P213, DOI 10.1016/S1474-4422(18)30039-5; Center for Drug Evaluation and Research, 2019, ENR STRAT CLIN TRIAL; Ghaemi SN, 2017, J CLIN TRANSL SCI, V1, P198, DOI 10.1017/cts.2017.2; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Naasan Georges, 2021, Brain, V144, P999, DOI 10.1093/brain/awaa413; Schneider LS, 2018, LANCET NEUROL, V17, P194, DOI 10.1016/S1474-4422(18)30052-8; Tampi RR, 2016, THER ADV CHRONIC DIS, V7, P229, DOI 10.1177/2040622316658463; Tariot PN, 2021, NEW ENGL J MED, V385, P309, DOI 10.1056/NEJMoa2034634	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2021	20	10					783	784		10.1016/S1474-4422(21)00257-X	http://dx.doi.org/10.1016/S1474-4422(21)00257-X		SEP 2021	2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY8AW	34390645	Green Submitted			2022-12-18	WOS:000701741000008
J	Marignier, R; Hacohen, Y; Cobo-Calvo, A				Marignier, R.; Hacohen, Y.; Cobo-Calvo, A.			Myelin-oligodendrocyte glycoprotein antibody - associated disease (vol 20, pg 762, 2021)	LANCET NEUROLOGY			English	Correction																		Marignier R, 2021, LANCET NEUROL, V20, P762, DOI 10.1016/S1474-4422(21)00218-0	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2021	20	10					E6	E6		10.1016/S1474-4422(21)00290-8	http://dx.doi.org/10.1016/S1474-4422(21)00290-8		SEP 2021	1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY8AW		Bronze			2022-12-18	WOS:000701741000022
J	Pandian, JD; Sebastian, IA				Pandian, Jeyaraj Durai; Sebastian, Ivy Anne			Integrated approach to stroke burden: are we doing enough?	LANCET NEUROLOGY			English	Editorial Material							PREVENTION		[Pandian, Jeyaraj Durai] Christian Med Coll & Hosp, Dept Neurol, Ludhiana 141008, Punjab, India; [Pandian, Jeyaraj Durai] World Stroke Org, Geneva, Switzerland; [Pandian, Jeyaraj Durai] Indian Stroke Assoc, Chennai, Tamil Nadu, India; [Sebastian, Ivy Anne] St Stephens Hosp, Dept Neurol, Delhi, India	St. Stephen's Hospital	Pandian, JD (corresponding author), Christian Med Coll & Hosp, Dept Neurol, Ludhiana 141008, Punjab, India.; Pandian, JD (corresponding author), World Stroke Org, Geneva, Switzerland.; Pandian, JD (corresponding author), Indian Stroke Assoc, Chennai, Tamil Nadu, India.	jeyaraj.pandian@cmcludhiana.in	Sebastian, Ivy/HDO-4802-2022	Pandian, Jeyaraj/0000-0003-0028-1968				Brainin M, 2018, INT J STROKE, V13, P633, DOI 10.1177/1747493018761190; Caso V, 2018, CNS, V4, P32; Feigin VL, 2021, LANCET NEUROL, V20, P795, DOI 10.1016/S1474-4422(21)00252-0; Feigin VL, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000306; Feigin VL, 2016, NAT REV NEUROL, V12, P501, DOI 10.1038/nrneurol.2016.107; Lindsay P, 2014, INT J STROKE, V9, P4, DOI 10.1111/ijs.12371; Pandian JD, 2020, LANCET, V396, P1443, DOI 10.1016/S0140-6736(20)31374-X; Scott K, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0304-x; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Stroke Organization, 2021, DUGONG SEAGRASS HUB	10	1	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2021	20	10					774	775		10.1016/S1474-4422(21)00287-8	http://dx.doi.org/10.1016/S1474-4422(21)00287-8		SEP 2021	2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UY8AW	34487724				2022-12-18	WOS:000701741000003
J	O'Connor, A				O'Connor, Aine			Nursing homes with a difference: the outdoors inside	LANCET NEUROLOGY			English	Editorial Material								The prospect of entering a nursing home can fill some people with dread, but for many individuals with neurological conditions, that transition is inevitable. A new model for nursing homes, which might dispel these fears, has been developed in the Netherlands. Aine O'Connor investigates.											0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2021	20	9					703	704		10.1016/S1474-4422(21)00260-X	http://dx.doi.org/10.1016/S1474-4422(21)00260-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UK3MC	34418393				2022-12-18	WOS:000691876000010
J	Dauvilliers, Y				Dauvilliers, Yves			Identifying the best biomarkers for alpha-synucleinopathies	LANCET NEUROLOGY			English	Editorial Material							SLEEP BEHAVIOR DISORDER		[Dauvilliers, Yves] CHU Montpellier, Gui de Chauliac Hosp, Natl Reference Ctr Narcolepsy, Sleep Unit,Dept Neurol, Montpellier, France; [Dauvilliers, Yves] Univ Montpellier, INSERM, Inst Neurosci Montpellier INM, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Dauvilliers, Y (corresponding author), CHU Montpellier, Gui de Chauliac Hosp, Natl Reference Ctr Narcolepsy, Sleep Unit,Dept Neurol, Montpellier, France.; Dauvilliers, Y (corresponding author), Univ Montpellier, INSERM, Inst Neurosci Montpellier INM, Montpellier, France.	ydauvilliers@yahoo.fr						[Anonymous], 2018, Nat Rev Dis Primers, V4, P20, DOI 10.1038/s41572-018-0020-9; Arnaldi D, 2021, BRAIN, V144, P278, DOI 10.1093/brain/awaa365; Boeve BF, 2013, SLEEP MED, V14, P754, DOI 10.1016/j.sleep.2012.10.015; Iranzo A, 2021, LANCET NEUROL, V20, P203, DOI 10.1016/S1474-4422(20)30449-X; Krohn L, 2020, NEUROLOGY, V95, pE1008, DOI 10.1212/WNL.0000000000010042; Miglis MG, 2021, LANCET NEUROL, V20, P671, DOI 10.1016/S1474-4422(21)00176-9; Postuma RB, 2012, NEUROLOGY, V79, P428, DOI 10.1212/WNL.0b013e31825dd383; Postuma RB, 2019, BRAIN, V142, P744, DOI 10.1093/brain/awz030; Schenck CH, 2013, SLEEP MED, V14, P795, DOI 10.1016/j.sleep.2013.02.016; Videnovic A, 2020, J NEUROL NEUROSUR PS, V91, P740, DOI 10.1136/jnnp-2020-322875	10	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2021	20	8					593	594		10.1016/S1474-4422(21)00201-5	http://dx.doi.org/10.1016/S1474-4422(21)00201-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TP6CG	34302778				2022-12-18	WOS:000677684700007
J	Kochanek, PM; Jha, RM				Kochanek, Patrick M.; Jha, Ruchira M.			Fluid therapy after brain injury: the pendulum swings again	LANCET NEUROLOGY			English	Editorial Material							MANAGEMENT		[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Dept Crit Care Med,Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Jha, Ruchira M.] Barrow Neurol Inst, Phoenix, AZ 85013 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Barrow Neurological Institute	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Dept Crit Care Med,Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA.	kochanekpm@pitt.edu			US National Institute of Neurological Disorders and Stroke [K23NS101036, R01NS115815]; Barrow Neurological Foundation; Chuck Noll Foundation; Ake Grenvik Chair	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Barrow Neurological Foundation; Chuck Noll Foundation; Ake Grenvik Chair	RMJ is a paid consultant and on the scientific advisory board for Biogen. PMK declares no competing interests. RMJ is supported by grant K23NS101036 and grant R01NS115815 from the US National Institute of Neurological Disorders and Stroke, the Chuck Noll Foundation, and the Barrow Neurological Foundation. PMK is supported by the Ake Grenvik Chair and the Chuck Noll Foundation.	Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Silversides JA, 2017, INTENS CARE MED, V43, P155, DOI 10.1007/s00134-016-4573-3; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wiegers EJA, 2021, LANCET NEUROL, V20, P627, DOI 10.1016/S1474-4422(21)00162-9	10	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2021	20	8					587	589		10.1016/S1474-4422(21)00204-0	http://dx.doi.org/10.1016/S1474-4422(21)00204-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TP6CG	34302775	Green Accepted			2022-12-18	WOS:000677684700004
J	Maier, B; Desilles, JP; Mazighi, M				Maier, Benjamin; Desilles, Jean-Philippe; Mazighi, Mikael		Bp-Target Investigators	Intraparenchymal haemorrhages as a primary outcome measure Reply	LANCET NEUROLOGY			English	Letter									[Maier, Benjamin; Desilles, Jean-Philippe; Mazighi, Mikael] Hop Fdn Ophtalmolog Adolphe Rothschild, Intervent Neuroradiol Dept, Paris, France; [Maier, Benjamin; Desilles, Jean-Philippe; Mazighi, Mikael] Univ Paris, Dept Neurol, Paris, France; [Maier, Benjamin; Desilles, Jean-Philippe; Mazighi, Mikael] FHU Neurovasc, Paris, France; [Maier, Benjamin; Desilles, Jean-Philippe; Mazighi, Mikael] Lab Vasc Translat Sci, INSERM U1148, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mazighi, M (corresponding author), Hop Fdn Ophtalmolog Adolphe Rothschild, Intervent Neuroradiol Dept, Paris, France.; Mazighi, M (corresponding author), Univ Paris, Dept Neurol, Paris, France.; Mazighi, M (corresponding author), FHU Neurovasc, Paris, France.	mmazighi@for.paris						Hao YG, 2019, J NEUROINTERV SURG, V11, P123, DOI 10.1136/neurintsurg-2018-013848; Maier B, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.599908; Mazighi M, 2021, LANCET NEUROL, V20, P265, DOI 10.1016/S1474-4422(20)30483-X	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2021	20	8					595	596						2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TP6CG	34302779	Bronze			2022-12-18	WOS:000677684700021
J	Fontaine, D; Lanteri-Minet, M				Fontaine, Denys; Lanteri-Minet, Michel			Occipital nerve stimulation for chronic cluster headache	LANCET NEUROLOGY			English	Editorial Material									[Fontaine, Denys] Univ Cote dAzur, Dept Neurosurg, Nice, France; [Fontaine, Denys; Lanteri-Minet, Michel] Univ Cote dAzur, FHU INOVPAIN, Nice, France; [Lanteri-Minet, Michel] Univ Cote dAzur, CHU Nice, Pain Dept, Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Fontaine, D (corresponding author), Univ Cote dAzur, Dept Neurosurg, Nice, France.; Fontaine, D (corresponding author), Univ Cote dAzur, FHU INOVPAIN, Nice, France.	fontaine.d@chu-nice.fr						D'Amico D, 2020, HEADACHE, V60, P809, DOI 10.1111/head.13784; Donnet A, 2007, J NEUROL NEUROSUR PS, V78, P1354, DOI 10.1136/jnnp.2006.112037; Lee MJ, 2019, CEPHALALGIA, V39, P1249, DOI 10.1177/0333102419845660; Leplus A, 2021, NEUROSURGERY, V88, P375, DOI 10.1093/neuros/nyaa373; Martelletti P, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-86; Mitsikostas DD, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-79; Wilbrink LA, 2021, LANCET NEUROL, V20, P515, DOI 10.1016/S1474-4422(21)00101-0	7	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2021	20	7					498	499		10.1016/S1474-4422(21)00163-0	http://dx.doi.org/10.1016/S1474-4422(21)00163-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UD5TG	34146497				2022-12-18	WOS:000687268300002
J	Sanchez-Valle, R				Sanchez-Valle, Raquel			Pioglitazone for prevention of cognitive impairment: results and lessons	LANCET NEUROLOGY			English	Editorial Material									[Sanchez-Valle, Raquel] Univ Barcelona, Hosp Clin Barcelona, Serv Neurol, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona 08036, Spain	University of Barcelona; Hospital Clinic de Barcelona	Sanchez-Valle, R (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Serv Neurol, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona 08036, Spain.	rsanchez@clinic.cat	Sanchez-Valle, Raquel/I-4217-2015	Sanchez-Valle, Raquel/0000-0001-7750-896X				Burns DK, 2021, LANCET NEUROL, V20, P537, DOI 10.1016/S1474-4422(21)00043-0; Heneka MT, 2015, ANN NEUROL, V78, P284, DOI 10.1002/ana.24439; Ito K, 2020, INT REV NEUROBIOL, V153, P213, DOI 10.1016/bs.irn.2020.03.032; Jacobs Diane M, 2017, Alzheimers Dement (N Y), V3, P531, DOI 10.1016/j.trci.2017.08.010; Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001; Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6	7	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2021	20	7					500	502		10.1016/S1474-4422(21)00140-X	http://dx.doi.org/10.1016/S1474-4422(21)00140-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UD5TG	34146499				2022-12-18	WOS:000687268300003
J	Suzuki, S				Suzuki, Shigeaki			Targeted molecular therapy for myasthenia gravis	LANCET NEUROLOGY			English	Editorial Material							ECULIZUMAB; EFFICACY; PHASE-3; REGAIN; SAFETY		[Suzuki, Shigeaki] Keio Univ, Sch Med, Dept Neurol, Tokyo 1608582, Japan	Keio University	Suzuki, S (corresponding author), Keio Univ, Sch Med, Dept Neurol, Tokyo 1608582, Japan.	sgsuzuki@z3.keio.jp						Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Howard JF, 2019, NEUROLOGY, V92, pE2661, DOI 10.1212/WNL.0000000000007600; Howard JF, 2017, LANCET NEUROL, V16, P976, DOI 10.1016/S1474-4422(17)30369-1; Howard JF, 2021, LANCET NEUROL, V20, P526, DOI 10.1016/S1474-4422(21)00159-9; Lascano AM, 2021, AUTOIMMUN REV, V20, DOI 10.1016/j.autrev.2020.102712; Mantegazza R, 2021, NEUROLOGY, V96, pE610, DOI 10.1212/WNL.0000000000011207; Narayanaswami P, 2021, NEUROLOGY, V96, P114, DOI 10.1212/WNL.0000000000011124; Oyama M, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420904207; Suzuki S, 2013, J NEUROL NEUROSUR PS, V84, P989, DOI 10.1136/jnnp-2012-304057; Tran C, 2021, EUR J NEUROL, V28, P1375, DOI 10.1111/ene.14675	10	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2021	20	7					499	500		10.1016/S1474-4422(21)00173-3	http://dx.doi.org/10.1016/S1474-4422(21)00173-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UD5TG	34146498				2022-12-18	WOS:000687268300017
J	Wasserlauf, J; Volgman, AS				Wasserlauf, Jeremiah; Volgman, Annabelle Santos			Monitoring for atrial fibrillation after stroke	LANCET NEUROLOGY			English	Editorial Material							OPEN-LABEL		[Wasserlauf, Jeremiah; Volgman, Annabelle Santos] Rush Univ, Med Ctr, Div Cardiol, Chicago, IL 60612 USA	Rush University	Volgman, AS (corresponding author), Rush Univ, Med Ctr, Div Cardiol, Chicago, IL 60612 USA.	annabelle_volgman@rush.edu						Benjamin EJ, 2021, CIRCULATION, V143, P372, DOI 10.1161/CIRCULATIONAHA.120.047633; DIENER HC, 2020, CIRC-ARRHYTHMIA ELEC, V75, P1804; Haeusler KG, 2021, LANCET NEUROL, V20, P426, DOI 10.1016/S1474-4422(21)00067-3; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; SANNA T, 2014, CIRCULATION, V370, P2478; Steinhubl SR, 2018, JAMA-J AM MED ASSOC, V320, P146, DOI 10.1001/jama.2018.8102; Wachter R, 2017, LANCET NEUROL, V16, P282, DOI 10.1016/S1474-4422(17)30002-9; Wasserlauf J, 2019, CIRC-ARRHYTHMIA ELEC, V12, DOI 10.1161/CIRCEP.118.006834; Yiin GSC, 2019, STROKE, V50, P21, DOI 10.1161/STROKEAHA.118.022249	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2021	20	6					410	411		10.1016/S1474-4422(21)00106-X	http://dx.doi.org/10.1016/S1474-4422(21)00106-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SG4TT	34022159				2022-12-18	WOS:000653434700001
J	Pantoni, L; Salvadori, E				Pantoni, Leonardo; Salvadori, Emilia			Location of infarcts and post-stroke cognitive impairment	LANCET NEUROLOGY			English	Editorial Material							STROKE; DEMENTIA		[Pantoni, Leonardo] Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Stroke & Dementia Lab, I-20157 Milan, Italy; [Salvadori, Emilia] Univ Florence, Neurosci Sect, NEUROFARBA Dept, Florence, Italy	University of Milan; Luigi Sacco Hospital; University of Florence	Pantoni, L (corresponding author), Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Stroke & Dementia Lab, I-20157 Milan, Italy.	leonardo.pantoni@unimi.it						Cova I, 2020, ACTA NEUROL SCAND, V142, P377, DOI 10.1111/ane.13319; Henon H, 2002, CLIN EXP HYPERTENS, V24, P677, DOI 10.1081/CEH-120015344; Moulin S, 2016, LANCET NEUROL, V15, P820, DOI 10.1016/S1474-4422(16)00130-7; Pantoni L, 2017, STROKE, V48, P1441, DOI 10.1161/STROKEAHA.117.016869; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Salvadori E, 2013, J NEUROL, V260, P2220, DOI 10.1007/s00415-013-6962-7; Tang EYH, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2569-5; Verdelho A, 2021, EUR STROKE J, V6, P5, DOI 10.1177/23969873211000258; Weaver NA, 2021, LANCET NEUROL, DOI [10.1111/S1474-4422(21)00060-0, DOI 10.1111/S1474-4422(21)00060-0]	10	1	1	5	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2021	20	6					413	414		10.1016/S1474-4422(21)00107-1	http://dx.doi.org/10.1016/S1474-4422(21)00107-1		MAY 2021	2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SG4TT	33901426				2022-12-18	WOS:000653434700003
J	Tiefenbach, J; Park, JJ; Singh, S; Demetriades, AK				Tiefenbach, Jakov; Park, Jay J.; Singh, Shashwat; Demetriades, Andreas K.			Diversity and inclusion in neurosurgery	LANCET NEUROLOGY			English	Letter									[Tiefenbach, Jakov; Park, Jay J.; Singh, Shashwat] Univ Edinburgh, Coll Med & Vet Med, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland; [Demetriades, Andreas K.] Royal Infirm Edinburgh NHS Trust, Dept Neurosurg, Edinburgh EH16 4SA, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Demetriades, AK (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Neurosurg, Edinburgh EH16 4SA, Midlothian, Scotland.	andreas.demetriades@gmail.com	DEMETRIADES, Andreas K/P-5806-2019	DEMETRIADES, Andreas K/0000-0002-2004-9448; Park, Jay Jaemin/0000-0001-8762-6986; Tiefenbach, Jakov/0000-0003-3163-384X				[Anonymous], 2021, LANCET NEUROL, V20, P161, DOI 10.1016/S1474-4422(21)00034-X; Gov.UK, LIST ETHN GROUPS; Health EducationYorkshire and Humber, NAT NEUR ST1 ST3 REC; Northern Ireland Medical & Dental Training Agency NHS Education for Scotland GIG Cymru NHS Wales NHS Health Education England, 2020 COMPETITION RAT	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2021	20	6					419	419		10.1016/S1474-4422(21)00112-5	http://dx.doi.org/10.1016/S1474-4422(21)00112-5		MAY 2021	1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SG4TT	34022164	Bronze			2022-12-18	WOS:000653434700006
J	Jordan, LC; DeBaun, MR; Donahue, MJ				Jordan, Lori C.; DeBaun, Michael R.; Donahue, Manus J.			Advances in neuroimaging to improve care in sickle cell disease	LANCET NEUROLOGY			English	Review							SILENT CEREBRAL INFARCTS; T-2-RELAXATION-UNDER-SPIN-TAGGING TRUST MRI; OXYGEN EXTRACTION FRACTION; BLOOD-TRANSFUSION THERAPY; CEREBROVASCULAR-DISEASE; CHILDREN; STROKE; ADULTS; ANEMIA; BRAIN	Sickle cell disease is associated with progressive and increased neurological morbidity throughout the lifespan. In people with sickle cell anaemia (the most common and severe type of sickle cell disease), silent cerebral infarcts are found in more than a third of adolescents by age 18 years and roughly half of young adults by age 30 years, many of whom have cognitive impairment despite having few or no conventional stroke risk factors. Common anatomical neuroimaging in individuals with sickle disease can assess structural brain injury, such as stroke and silent cerebral infarcts; however, emerging advanced neuroimaging methods can provide novel insights into the pathophysiology of sickle cell disease, including insights into the cerebral haemodynamic and metabolic contributors of neurological injury. Advanced neuroimaging methods, particularly methods that report on aberrant cerebral blood flow and oxygen delivery, have potential for triaging patients for appropriate disease-modifying or curative therapies before they have irreversible neurological injury, and for confirming the benefit of new therapies on brain health in clinical trials.	[Jordan, Lori C.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Neurol, Nashville, TN 37232 USA; [Jordan, Lori C.; Donahue, Manus J.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Jordan, Lori C.; Donahue, Manus J.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [DeBaun, Michael R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Vanderbilt Meharry Ctr Excellence Sickle Cell Dis, Nashville, TN 37232 USA; [Donahue, Manus J.] Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Meharry Medical College; Vanderbilt University; Vanderbilt University	Jordan, LC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Neurol, Nashville, TN 37232 USA.	lori.jordan@vumc.org						Abdullahi SU, 2021, PEDIATR HEMAT ONCOL, V38, P49, DOI 10.1080/08880018.2020.1810183; Abdullahi SU, 2019, PEDIATR NEUROL, V95, P73, DOI 10.1016/j.pediatrneurol.2019.01.008; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; ADAMS RJ, 1998, NEW ENGL J MED, V339, P5, DOI [DOI 10.1056/NEJM199807023390102, 10.1056/NEJM199807023390102]; Adams RJ, 2017, STROKE, V48, P686, DOI 10.1161/STROKEAHA.116.015412; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Andica C, 2020, J MAGN RESON IMAGING, V52, P1620, DOI 10.1002/jmri.27019; Bernaudin F, 2019, JAMA-J AM MED ASSOC, V321, P266, DOI 10.1001/jama.2018.20059; Bernaudin F, 2015, BLOOD, V125, P1653, DOI 10.1182/blood-2014-09-599852; Bush A, 2018, MAGN RESON IMAGING, V47, P137, DOI 10.1016/j.mri.2017.12.011; Bush A, 2017, MAGN RESON MED, V77, P2364, DOI 10.1002/mrm.26311; Bush AM, 2018, MAGN RESON MED, V80, P294, DOI 10.1002/mrm.27015; Bush AM, 2016, AM J HEMATOL, V91, P912, DOI 10.1002/ajh.24441; Carden MA, 2019, HAEMATOLOGICA, V104, P1710, DOI 10.3324/haematol.2018.207357; Chaturvedi S, 2018, AM J HEMATOL, V93, P1153, DOI 10.1002/ajh.25202; Chaturvedi S, 2016, AM J HEMATOL, V91, P5, DOI 10.1002/ajh.24235; Choudhury NA, 2018, BRIT J HAEMATOL, V183, P324, DOI 10.1111/bjh.14979; Croal PL, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.811; Darbari DS, 2018, AM J HEMATOL, V93, pE406, DOI 10.1002/ajh.25297; de la Fuente J, 2019, BIOL BLOOD MARROW TR, V25, P1197, DOI 10.1016/j.bbmt.2018.11.027; DeBaun MR, 2020, BLOOD ADV, V4, P1554, DOI 10.1182/bloodadvances.2019001142; DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731; DeBaun MR, 2019, BLOOD, V133, P615, DOI 10.1182/blood-2018-10-880575; DeBaun MR, 2016, BLOOD, V127, P829, DOI 10.1182/blood-2015-09-618579; DeBeer T, 2020, AM J HEMATOL, V95, pE228, DOI 10.1002/ajh.25863; Derdeyn CP, 2018, J CEREBR BLOOD F MET, V38, P1584, DOI 10.1177/0271678X17732884; Detterich JA, 2019, AM J HEMATOL, V94, P678, DOI 10.1002/ajh.25476; Donahue MJ, 2019, STROKE, V50, P240, DOI 10.1161/STROKEAHA.118.020478; Donahue MJ, 2018, J CEREBR BLOOD F MET, V38, P1391, DOI 10.1177/0271678X17721830; Eapen M, 2019, LANCET HAEMATOL, V6, pE585, DOI 10.1016/S2352-3026(19)30154-1; Fan AP, 2017, STROKE, V48, P2441, DOI 10.1161/STROKEAHA.117.017773; Farrell AT, 2019, BLOOD ADV, V3, P3982, DOI 10.1182/bloodadvances.2019000882; Fields ME, 2020, ANN NEUROL, V88, P995, DOI 10.1002/ana.25891; Fields ME, 2019, BLOOD, V133, P2436, DOI 10.1182/blood-2018-09-876318; Fields ME, 2018, NEUROLOGY, V90, pE1134, DOI 10.1212/WNL.0000000000005194; Fitzhugh CD, 2017, BLOOD ADV, V1, P652, DOI 10.1182/bloodadvances.2016002972; Ford AL, 2018, BLOOD, V132, P1714, DOI 10.1182/blood-2018-04-841247; Garnier Y, 2020, BLOOD, V136, P247, DOI 10.1182/blood.2020004853; Ghannam JY, 2020, BLOOD, V135, P1185, DOI 10.1182/blood.2019004001; Guilliams KP, 2019, STROKE, V50, P266, DOI 10.1161/STROKEAHA.118.020482; Guilliams KP, 2018, BLOOD, V131, P1012, DOI 10.1182/blood-2017-06-789842; Gupta A, 2016, STROKE, V47, P719, DOI 10.1161/STROKEAHA.115.011889; Hebbel RP, 2020, J CLIN INVEST, V130, P1062, DOI 10.1172/JCI133639; HEROLD S, 1986, STROKE, V17, P692, DOI 10.1161/01.STR.17.4.692; Hockham C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36077-w; Hood AM, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27899; Hou XR, 2020, NEUROIMAGE, V207, DOI 10.1016/j.neuroimage.2019.116365; Hua J, 2019, NEUROIMAGE, V187, P17, DOI 10.1016/j.neuroimage.2018.02.027; Hulbert ML, 2011, BLOOD, V117, P772, DOI 10.1182/blood-2010-01-261123; Jacob M, 2020, STROKE, V51, P1166, DOI 10.1161/STROKEAHA.119.027097; Jiang DR, 2018, MAGN RESON MED, V80, P1125, DOI 10.1002/mrm.27080; Jordan LC, 2018, NEUROLOGY, V91, pE781, DOI 10.1212/WNL.0000000000006047; Jordan LC, 2019, AM J HEMATOL, V94, pE155, DOI 10.1002/ajh.25455; Jordan LC, 2016, BRAIN, V139, P738, DOI 10.1093/brain/awv397; Juttukonda MR, 2019, J MAGN RESON IMAGING, V49, P466, DOI 10.1002/jmri.26213; Juttukonda MR, 2019, J CEREBR BLOOD F MET, V39, P1099, DOI 10.1177/0271678X17746808; Juttukonda MR, 2019, NEUROIMAGE, V187, P192, DOI 10.1016/j.neuroimage.2017.10.015; Juttukonda Meher R, 2017, NMR Biomed, V30, DOI 10.1002/nbm.3681; Kassim Adetola A, 2017, Hematol Oncol Stem Cell Ther, V10, P259, DOI 10.1016/j.hemonc.2017.05.008; Kassim AA, 2016, BLOOD, V127, P2038, DOI 10.1182/blood-2016-01-694562; Kosinski PD, 2017, BRIT J HAEMATOL, V176, P280, DOI 10.1111/bjh.14424; Lee L, 2019, PUBLIC HEALTH REP, V134, P599, DOI 10.1177/0033354919881438; Li WB, 2020, MAGN RESON MED, V83, P1066, DOI 10.1002/mrm.27972; Lin WL, 2018, J CEREBR BLOOD F MET, V38, P1481, DOI 10.1177/0271678X17722095; Liu PY, 2016, MAGN RESON MED, V75, P680, DOI 10.1002/mrm.25627; MERKEL KHH, 1978, STROKE, V9, P45, DOI 10.1161/01.STR.9.1.45; Miao X, 2018, BLOOD, V132, P1618, DOI 10.1182/blood-2018-04-840322; Mir SA, 2020, HEMOGLOBIN, V44, P47, DOI 10.1080/03630269.2020.1729175; Mohammed-Nafi'u R, 2020, NIGER POSTGRAD MED J, V27, P190, DOI 10.4103/npmj.npmj_39_20; Mutsaerts HJMM, 2015, NEUROIMAGE, V113, P143, DOI 10.1016/j.neuroimage.2015.03.043; Nielsen RB, 2017, ALZHEIMERS DEMENT, V13, P1143, DOI 10.1016/j.jalz.2017.02.007; Ohene-Frempong K, 1998, BLOOD, V91, P288; Oron AP, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01557-2; Partanen M, 2020, BRIT J HAEMATOL, V189, P1192, DOI 10.1111/bjh.16519; Penkert RR, 2018, HAEMATOLOGICA, V103, pE50, DOI 10.3324/haematol.2017.177360; Prussien KV, 2020, J PEDIATR PSYCHOL, V45, P145, DOI 10.1093/jpepsy/jsz100; Prussien KV, 2020, PEDIATR BLOOD CANCER, V67, DOI 10.1002/pbc.28001; Prussien KV, 2019, J PEDIATR PSYCHOL, V44, P948, DOI 10.1093/jpepsy/jsz031; Rab MAE, 2019, AM J HEMATOL, V94, P575, DOI 10.1002/ajh.25443; Rasmussen PM, 2015, J CEREBR BLOOD F MET, V35, P432, DOI 10.1038/jcbfm.2014.213; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Rigano P, 2018, BLOOD CELL MOL DIS, V69, P82, DOI 10.1016/j.bcmd.2017.08.017; Runge VM, 2017, INVEST RADIOL, V52, P317, DOI 10.1097/RLI.0000000000000374; Schlotman AA, 2021, PEDIATR NEUROL, V114, P29, DOI 10.1016/j.pediatrneurol.2020.10.006; Scothorn DJ, 2002, J PEDIATR-US, V140, P348, DOI 10.1067/mpd.2002.122498; Silva GS, 2009, STROKE, V40, P2408, DOI 10.1161/STROKEAHA.108.537415; Stotesbury H, 2018, NEUROLOGY, V90, pE2042, DOI 10.1212/WNL.0000000000005644; Tamnes CK, 2018, DEV COGN NEUROS-NETH, V33, P161, DOI 10.1016/j.dcn.2017.12.002; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P435, DOI 10.1037/rep0000183; Vaclavu L, 2019, HAEMATOLOGICA, V104, P690, DOI 10.3324/haematol.2018.206094; Waddle SL, 2020, J CEREBR BLOOD F MET, V40, P705, DOI 10.1177/0271678X19848098; Wang W, 2001, J PEDIATR-US, V139, P391, DOI 10.1067/mpd.2001.116935; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Watchmaker JM, 2018, J CEREBR BLOOD F MET, V38, P1618, DOI 10.1177/0271678X16682509; Wu YX, 2019, NAT MED, V25, P776, DOI 10.1038/s41591-019-0401-y	97	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2021	20	5					398	408		10.1016/S1474-4422(20)30490-7	http://dx.doi.org/10.1016/S1474-4422(20)30490-7			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WV8FC	33894194				2022-12-18	WOS:000717465200021
J	Spence, JD				Spence, J. David			Treatment of asymptomatic carotid stenosis	LANCET NEUROLOGY			English	Editorial Material							STROKE; RISK; ENDARTERECTOMY; THERAPY		[Spence, J. David] Western Univ, Stroke Prevent & Atherosclerosis Res Ctr, Robarts Res Inst, London, ON N6G 2V4, Canada	Western University (University of Western Ontario)	Spence, JD (corresponding author), Western Univ, Stroke Prevent & Atherosclerosis Res Ctr, Robarts Res Inst, London, ON N6G 2V4, Canada.	dspence@robarts.ca	Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098				Bohula EA, 2017, CIRCULATION, V136, P2440, DOI 10.1161/CIRCULATIONAHA.117.029095; Howard DPJ, 2021, LANCET NEUROL, V20, P193, DOI 10.1016/S1474-4422(20)30484-1; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Lokuge K, 2018, BRIT J SURG, V105, P26, DOI 10.1002/bjs.10717; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; Naylor AR, 2012, NAT REV CARDIOL, V9, P116, DOI 10.1038/nrcardio.2011.151; Paraskevas KI, 2018, STROKE VASC NEUROL, V3, P92, DOI 10.1136/svn-2017-000129; Poorthuis MHF, 2021, EUR J VASC ENDOVASC, V61, P365, DOI 10.1016/j.ejvs.2020.11.029; Spence JD, 2020, BMJ EVID-BASED MED, V25, P172, DOI 10.1136/bmjebm-2019-111300; Spence JD, 2010, ARCH NEUROL-CHICAGO, V67, P180, DOI 10.1001/archneurol.2009.289	11	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2021	20	3					163	+		10.1016/S1474-4422(21)00006-5	http://dx.doi.org/10.1016/S1474-4422(21)00006-5			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QK3CL	33609465				2022-12-18	WOS:000620258400003
J	van Dijck, JTJM; Kompanje, EJO; Nederkoorn, PJ; Peul, WC; Dippel, DWJ				van Dijck, Jeroen T. J. M.; Kompanje, Erwin J. O.; Nederkoorn, Paul J.; Peul, Wilco C.; Dippel, Diederik W. J.			Advanced consent for acute stroke trials reply	LANCET NEUROLOGY			English	Letter									[van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Leiden Univ Med Ctr, Univ Neurosurg Ctr Holland, Leiden, Netherlands; [van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Haaglanden Med Ctr, The Hague, Netherlands; [van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Haga Teaching Hosp, The Hague, Netherlands; [Kompanje, Erwin J. O.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Intens Care Adults, NL-3015 GD Rotterdam, Netherlands; [Dippel, Diederik W. J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, NL-3015 GD Rotterdam, Netherlands; [Kompanje, Erwin J. O.] Erasmus Univ, Dept Eth & Philosophy Med, Rotterdam, Netherlands; [Nederkoorn, Paul J.] Amsterdam Univ Med Ctr, Dept Neurol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Haaglanden Medical Center; Haga Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam	Kompanje, EJO (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Intens Care Adults, NL-3015 GD Rotterdam, Netherlands.; Kompanje, EJO (corresponding author), Erasmus Univ, Dept Eth & Philosophy Med, Rotterdam, Netherlands.	erwinkompanje@me.com	van Dijck, Jeroen/AAM-4123-2021	van Dijck, Jeroen/0000-0002-9893-632X; Dippel, Diederik/0000-0002-9234-3515	Dutch Heart Foundation; Dutch Brain Foundation; AngioCare BV; Covidien; EV3; Medac; Lamepro; Penumbra; Stryker; Top Medical; Netherlands Organisation for Health Research and Development; Health Holland Top Sector Life Sciences Health; Stryker European Operations BV; Thrombolytic Science, LLC; Cerenovus; Concentric	Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Brain Foundation; AngioCare BV; Covidien; EV3; Medac; Lamepro; Penumbra; Stryker; Top Medical; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Health Holland Top Sector Life Sciences Health; Stryker European Operations BV; Thrombolytic Science, LLC; Cerenovus; Concentric	DWJD reports that Erasmus MC received research grants from Dutch Heart Foundation, Dutch Brain Foundation, AngioCare BV, Covidien, EV3, Medac, Lamepro, Penumbra, Stryker, Top Medical, Concentric, The Netherlands Organisation for Health Research and Development, Health Holland Top Sector Life Sciences & Health, Stryker European Operations BV, Thrombolytic Science, LLC, and Cerenovus. WCP is part of the management team of the CENTER-TBI study (NCT02210221) and the principal investigator of the Net-QuRe (NL 5761), Ciao@TBI, RESET-ASDH, and the SPARTA trials. All other authors declare no competing interests.	Kompanje EJO, 2020, LANCET NEUROL, V19, P1033, DOI 10.1016/S1474-4422(20)30276-3	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2021	20	3					170	+		10.1016/S1474-4422(21)00028-4	http://dx.doi.org/10.1016/S1474-4422(21)00028-4			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QK3CL	33609469	Bronze			2022-12-18	WOS:000620258400008
J	Aerts, L; Lauwers, E; De Strooper, B				Aerts, Liesbeth; Lauwers, Elsa; De Strooper, Bart			Dementia and COVID-19: a health and research funding crisis	LANCET NEUROLOGY			English	Letter									[Aerts, Liesbeth; Lauwers, Elsa; De Strooper, Bart] Katholieke Univ Leuven, VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium; [Aerts, Liesbeth; Lauwers, Elsa; De Strooper, Bart] Katholieke Univ Leuven, Leuven Brain Inst, Dept Neurosci, Leuven, Belgium; [De Strooper, Bart] UCL, UK Dementia Res Inst, London WC1E 6BT, England	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of London; University College London	De Strooper, B (corresponding author), Katholieke Univ Leuven, VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium.; De Strooper, B (corresponding author), Katholieke Univ Leuven, Leuven Brain Inst, Dept Neurosci, Leuven, Belgium.; De Strooper, B (corresponding author), UCL, UK Dementia Res Inst, London WC1E 6BT, England.	b.strooper@ukdri.ucl.ac.uk		De Strooper, Bart/0000-0001-5455-5819				[Anonymous], 2020, LANCET NEUROL, V19, P879, DOI 10.1016/S1474-4422(20)30361-6; ERA-NET NEURON, 2020, STRAT RES AG TAK CHA; Rajewsky N, 2020, NATURE, V587, P377, DOI 10.1038/s41586-020-2715-9	3	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2021	20	2					90	90		10.1016/S1474-4422(21)00002-8	http://dx.doi.org/10.1016/S1474-4422(21)00002-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PV7ZK	33484651	Bronze			2022-12-18	WOS:000610201500009
J	Ribchester, RR; Mehta, AR				Ribchester, Richard R.; Mehta, Arpan R.			Focal Point Neuromuscular junctions: mind meeting matter	LANCET NEUROLOGY			English	Editorial Material															MRC [MR/R001162/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brown R, 2014, ANN CLIN TRANSL NEUR, V1, P867, DOI 10.1002/acn3.124; Gilley J, 2017, CELL REP, V21, P10, DOI 10.1016/j.celrep.2017.09.027; Hulse EJ, 2019, BRIT J ANAESTH, V123, P457, DOI 10.1016/j.bja.2019.04.061; Jones RA, 2017, CELL REP, V21, P2348, DOI 10.1016/j.celrep.2017.11.008; Tello JF, 1917, TRAB LAB INVEST BIO, V15, P99	5	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2021	20	2					93	93		10.1016/S1474-4422(20)30486-5	http://dx.doi.org/10.1016/S1474-4422(20)30486-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PV7ZK	33484653	Green Accepted			2022-12-18	WOS:000610201500012
J	Bartels, RHMA				Bartels, Ronald H. M. A.			A new dimension in degenerative cervical myelopathy	LANCET NEUROLOGY			English	Editorial Material									[Bartels, Ronald H. M. A.] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen	Bartels, RHMA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, NL-6525 GA Nijmegen, Netherlands.	ronald.bartels@radboudumc.nl	Bartels, R.H.M.A./L-4184-2015	Bartels, R.H.M.A./0000-0002-8638-4660				Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Boogaarts HD, 2015, EUR SPINE J, V24, pS139, DOI 10.1007/s00586-013-2781-x; Cheng JS, 2020, J CLIN MED, V9, pe535; Fehlings MG, 2020, LANCET NEUROL; Jablonski M, 2015, BRAIN RES, V1607, P1, DOI 10.1016/j.brainres.2014.08.060; Li ZX, 2017, BRAIN RES BULL, V131, P39, DOI 10.1016/j.brainresbull.2017.03.002; Srinivas S, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2019.1.FOCUS18596; Wilson JR, 2017, NEUROSURGERY, V80, pS33, DOI 10.1093/neuros/nyw083	8	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2021	20	2					82	83		10.1016/S1474-4422(20)30454-3	http://dx.doi.org/10.1016/S1474-4422(20)30454-3		JAN 2021	2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PV7ZK	33357511				2022-12-18	WOS:000610201500004
J	Kivipelto, M; Mangialasche, F				Kivipelto, Miia; Mangialasche, Francesca			Dementia research in 2020: moving forward despite the COVID-19 pandemic	LANCET NEUROLOGY			English	Editorial Material							PREVENTION		[Kivipelto, Miia; Mangialasche, Francesca] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Ctr Alzheimer Res, Stockholm, Sweden; [Kivipelto, Miia] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Kivipelto, Miia] Karolinska Univ Hosp, Theme Aging, Stockholm, Sweden; [Kivipelto, Miia] Imperial Coll London, Ageing Epidemiol Res Unit, Sch Publ Hlth, London, England; [Mangialasche, Francesca] Karolinska Inst, Aging Res Ctr, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Mangialasche, Francesca] Stockholm Univ, Stockholm, Sweden	Karolinska Institutet; University of Eastern Finland; Karolinska Institutet; Karolinska University Hospital; Imperial College London; Karolinska Institutet; Stockholm University	Kivipelto, M (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Ctr Alzheimer Res, Stockholm, Sweden.; Kivipelto, M (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.; Kivipelto, M (corresponding author), Karolinska Univ Hosp, Theme Aging, Stockholm, Sweden.; Kivipelto, M (corresponding author), Imperial Coll London, Ageing Epidemiol Res Unit, Sch Publ Hlth, London, England.	miia.kivipelto@ki.se	Kivipelto, Miia/AAS-3557-2021	Mangialasche, Francesca/0000-0002-2686-3926				Huynh K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19473-7; Karikari TK, 2020, LANCET NEUROL, V19, P422, DOI 10.1016/S1474-4422(20)30071-5; Kivipelto M, 2020, ALZHEIMERS DEMENT, V16, P1078, DOI 10.1002/alz.12123; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Palmqvist S, 2020, JAMA-J AM MED ASSOC, V324, P772, DOI 10.1001/jama.2020.12134; Soininen H, 2021, ALZHEIMERS DEMENT, V17, P29, DOI 10.1002/alz.12172; Taquet M, 2021, LANCET PSYCHIAT, V8, pE1	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2021	20	1					3	+		10.1016/S1474-4422(20)30453-1	http://dx.doi.org/10.1016/S1474-4422(20)30453-1			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PI1AM	33340483	Bronze			2022-12-18	WOS:000600831400004
J	Silbergleit, R; Dickert, NW				Silbergleit, Robert; Dickert, Neal W.			Context and principles must drive alternatives to consent in emergency research	LANCET NEUROLOGY			English	Editorial Material									[Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Dickert, Neal W.] Emory Univ, Div Cardiol, Dept Internal Med, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; Emory University	Silbergleit, R (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.	robert.silbergleit@umich.edu						Dickert NW, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010905; Dickert NW, 2017, AM J BIOETHICS, V17, P3, DOI 10.1080/15265161.2017.1388448; Kompanje EJO, 2020, LANCET NEUROL, V19, P1033, DOI 10.1016/S1474-4422(20)30276-3; Selker HP, 2012, JAMA-J AM MED ASSOC, V307, P1925, DOI 10.1001/jama.2012.426; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2020	19	12					968	969		10.1016/S1474-4422(20)30367-7	http://dx.doi.org/10.1016/S1474-4422(20)30367-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PG3EL	33098756				2022-12-18	WOS:000599622000005
J	[Anonymous]				[Anonymous]			A unified European action plan on stroke	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2020	19	12					963	963		10.1016/S1474-4422(20)30409-9	http://dx.doi.org/10.1016/S1474-4422(20)30409-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PG3EL	33181090	Bronze			2022-12-18	WOS:000599622000001
J	Lammy, S				Lammy, Simon			Management of traumatic brain injury in China versus Europe	LANCET NEUROLOGY			English	Letter							HYPOTENSION		[Lammy, Simon] Inst Neurol Sci, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Lammy, S (corresponding author), Inst Neurol Sci, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland.	lammy@doctors.org.uk	Lammy, Simon/HGC-9402-2022	Lammy, Simon/0000-0003-3199-0038				Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stassen W, 2014, SAMJ S AFR MED J, V104, P424, DOI [10.7196/SAMJ.7494, 10.7196/samj.7494]	5	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2020	19	11					886	886		10.1016/S1474-4422(20)30345-8	http://dx.doi.org/10.1016/S1474-4422(20)30345-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF3OI	33098789				2022-12-18	WOS:000581121200008
J	Spector, AR; Smart, SO; Berthaud, J; Ebong, I; Hamilton, RH; Flippen, CC; Gamaldo, CE				Spector, Andrew R.; Smart, Shaun O.; Berthaud, Jimmy; Ebong, Ima; Hamilton, Roy H.; Flippen, Charles C., II; Gamaldo, Charlene E.			Introducing the Society of Black Neurologists	LANCET NEUROLOGY			English	Letter									[Spector, Andrew R.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA; [Smart, Shaun O.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Berthaud, Jimmy] Univ Michigan, Div Vasc Neurol, Stroke Program, Ann Arbor, MI 48109 USA; [Flippen, Charles C., II] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Ebong, Ima] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Hamilton, Roy H.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Gamaldo, Charlene E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA	Duke University; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky; University of Pennsylvania; Johns Hopkins University	Spector, AR (corresponding author), Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA.	andrew.spector@duke.edu						Association of American Medical Colleges, 2020, DIV MED FACTS FIG 20; Association of American Medical Colleges, 2019, MATR US MED SCH RAC; Ebong I, 2020, MESSAGE SOC BLACK NE	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2020	19	11					892	+		10.1016/S1474-4422(20)30352-5	http://dx.doi.org/10.1016/S1474-4422(20)30352-5			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF3OI	33098795				2022-12-18	WOS:000581121200016
J	Vidailhet, M; Meneret, A; Roze, E				Vidailhet, Marie; Meneret, Aurelie; Roze, Emmanuel			Dystonia: genetics, phenomenology, and pathophysiology	LANCET NEUROLOGY			English	Editorial Material									[Vidailhet, Marie; Meneret, Aurelie; Roze, Emmanuel] Sorbonne Univ, Dept Neurol, Paris, France; [Vidailhet, Marie; Meneret, Aurelie; Roze, Emmanuel] Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, INSERM, U1127, Paris, France; [Vidailhet, Marie; Meneret, Aurelie; Roze, Emmanuel] Grp Hosp Pitie Salpetriere, Dept Neurol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Vidailhet, M (corresponding author), Sorbonne Univ, Dept Neurol, Paris, France.; Vidailhet, M (corresponding author), Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, INSERM, U1127, Paris, France.; Vidailhet, M (corresponding author), Grp Hosp Pitie Salpetriere, Dept Neurol, Paris, France.	marie.vidailhet@aphp.fr						Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Curie A, 2018, NEUROIMAGE-CLIN, V19, P454, DOI 10.1016/j.nicl.2018.04.001; Jinnah HA, 2019, NEUROBIOL DIS, V129, P159, DOI 10.1016/j.nbd.2019.05.014; Mencacci NE, 2020, BRAIN, V143, P2771, DOI 10.1093/brain/awaa217; Ribot B, 2019, PROG NEUROBIOL, V182, DOI 10.1016/j.pneurobio.2019.101678; van Egmond ME, 2019, MOVEMENT DISORD, V34, P317, DOI 10.1002/mds.27627; Weisheit Corinne E, 2018, Handb Clin Neurol, V147, P241, DOI 10.1016/B978-0-444-63233-3.00016-6; Wirth T, 2020, PARKINSONISM RELAT D, V74, P50, DOI 10.1016/j.parkreldis.2020.04.003; Zech M, 2020, LANCET NEUROL, V19, P908, DOI 10.1016/S1474-4422(20)30312-4	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2020	19	11					881	+		10.1016/S1474-4422(20)30366-5	http://dx.doi.org/10.1016/S1474-4422(20)30366-5			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF3OI	33098786				2022-12-18	WOS:000581121200005
J	[Anonymous]				[Anonymous]			Neglect during a crisis: the stark reality	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2020	19	11					879	879		10.1016/S1474-4422(20)30361-6	http://dx.doi.org/10.1016/S1474-4422(20)30361-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF3OI	33098784	Green Published, Bronze			2022-12-18	WOS:000581121200003
J	Barker, RA				Barker, Roger A.			Ending Parkinson's disease: a prescription for action	LANCET NEUROLOGY			English	Book Review																		Dorsey R., 2020, ENDING PARKINSONS DI	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2020	19	10					813	813		10.1016/S1474-4422(20)30302-1	http://dx.doi.org/10.1016/S1474-4422(20)30302-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF3NN		Bronze, Green Accepted			2022-12-18	WOS:000581119100018
J	Poole, N; Rosenzweig, I				Poole, Norman; Rosenzweig, Ivana			Dreaming of Godot Comment	LANCET NEUROLOGY			English	Editorial Material							REM-SLEEP		[Poole, Norman] South West London & St Georges Mental Hlth Natl H, St Georges Hosp, London SW17 0QT, England; [Rosenzweig, Ivana] Kings Coll London, Inst Psychiat Psychol & Neurosci, Sleep & Brain Plast Ctr, Dept Neuroimaging, London, England; [Rosenzweig, Ivana] Guys & St Thomas Natl Hlth Serv Fdn Trust, Sleep Disorders Ctr, London, England	St Georges University London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Poole, N (corresponding author), South West London & St Georges Mental Hlth Natl H, St Georges Hosp, London SW17 0QT, England.	norman.poole@gmail.com						Blumberg MS, 2020, CURR BIOL, V30, pR38, DOI 10.1016/j.cub.2019.11.045; DENNETT DC, 1990, PHILOS PHENOMEN RES, V50, P177, DOI 10.2307/2108038; Esslin M., 1960, TULANE DRAMA REV, V4, P3; Hobson JA, 2009, NAT REV NEUROSCI, V10, P803, DOI 10.1038/nrn2716; Hong CCH, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02087; Kumar D, 2020, NEURON, V107, P552, DOI 10.1016/j.neuron.2020.05.008; Siclari F, 2020, LANCET NEUROL, V19, P849, DOI 10.1016/S1474-4422(20)30275-1; Simor P, 2020, SLEEP MED REV, V52, DOI 10.1016/j.smrv.2020.101305; Spano G, 2020, ELIFE, V9, DOI 10.7554/eLife.56211; Tsunematsu T, 2020, ELIFE, V9, DOI 10.7554/eLife.52244	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2020	19	10					801	+		10.1016/S1474-4422(20)30315-X	http://dx.doi.org/10.1016/S1474-4422(20)30315-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF3NN	32949532				2022-12-18	WOS:000581119100006
J	[Anonymous]				[Anonymous]			Developing therapies for Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2020	19	10					797	797		10.1016/S1474-4422(20)30320-3	http://dx.doi.org/10.1016/S1474-4422(20)30320-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OF3NN	32949529	Bronze			2022-12-18	WOS:000581119100003
J	Tahara, M; Oeda, T; Sawada, H				Tahara, Masayuki; Oeda, Tomoko; Sawada, Hideyuki			Seeking transpaRiNcy for rituximab dosing in NMOSD Reply	LANCET NEUROLOGY			English	Letter							EFFICACY		[Tahara, Masayuki; Oeda, Tomoko; Sawada, Hideyuki] Natl Hosp Org Utano Natl Hosp, Clin Res Ctr, Kyoto 6168255, Japan; [Tahara, Masayuki; Oeda, Tomoko; Sawada, Hideyuki] Natl Hosp Org Utano Natl Hosp, Dept Neurol, Kyoto 6168255, Japan		Tahara, M (corresponding author), Natl Hosp Org Utano Natl Hosp, Clin Res Ctr, Kyoto 6168255, Japan.; Tahara, M (corresponding author), Natl Hosp Org Utano Natl Hosp, Dept Neurol, Kyoto 6168255, Japan.	tahara.masayuki.ne@mail.hosp.go.jp	Tahara, Masayuki/ABB-2213-2021	Tahara, Masayuki/0000-0002-8914-4750				Ciron J, 2018, REV NEUROL-FRANCE, V174, P255, DOI 10.1016/j.neurol.2017.11.005; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Igarashi T, 2002, ANN ONCOL, V13, P928, DOI 10.1093/annonc/mdf155; Kim SJ, 2002, FOURTH INTERNATIONAL SYMPOSIUM ON MULTIMEDIA SOFTWARE ENGINEERING, PROCEEDINGS, P2, DOI 10.1109/MMSE.2002.1181589; Tahara M, 2020, LANCET NEUROL, V19, P298, DOI 10.1016/S1474-4422(20)30066-1	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2020	19	9					716	+		10.1016/S1474-4422(20)30281-7	http://dx.doi.org/10.1016/S1474-4422(20)30281-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NE4GY	32822625	Bronze			2022-12-18	WOS:000562556500021
J	Wincewicz, A; Woltanowski, P				Wincewicz, Andrzej; Woltanowski, Piotr			Leopold Auerbach	LANCET NEUROLOGY			English	Biographical-Item													Woltanowski, Piotr/AAA-8745-2021; Wincewicz, Andrzej/ABD-6349-2021	Woltanowski, Piotr/0000-0002-2154-3587; 				AUERBACH L, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2020	19	9					723	723		10.1016/S1474-4422(20)30266-0	http://dx.doi.org/10.1016/S1474-4422(20)30266-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NE4GY	32822630				2022-12-18	WOS:000562556500010
J	Lubetzki, C; Zalc, B				Lubetzki, Catherine; Zalc, Bernard			Focal Point Remyelination: a brief history	LANCET NEUROLOGY			English	Editorial Material																		BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; Marburg O., 1906, SOGENANNTE AKUTE MUL, p37 47; PERIER O, 1965, BRAIN, V88, P937, DOI 10.1093/brain/88.5.937; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; SMITH KJ, 1981, BRAIN, V104, P383, DOI 10.1093/brain/104.2.383	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2020	19	8					649	649		10.1016/S1474-4422(20)30209-X	http://dx.doi.org/10.1016/S1474-4422(20)30209-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT8ZY	32702333				2022-12-18	WOS:000573228000008
J	Stirrups, R				Stirrups, Robert			How We Learn: The New Science of Education and the Brain	LANCET NEUROLOGY			English	Book Review														David, Michael/0000-0002-8724-2840				Dehaene S., 2014, CONSCIOUSNESS BRAIN	1	1	1	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2020	19	8					650	650		10.1080/13546805.2020.1865897	http://dx.doi.org/10.1080/13546805.2020.1865897			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT8ZY					2022-12-18	WOS:000573228000009
J	Biessels, GJ				Biessels, Geert Jan			A first lead in dementia prevention in people with diabetes	LANCET NEUROLOGY			English	Editorial Material									[Biessels, Geert Jan] Univ Med Ctr UMC Utrecht, UMC Utrecht, Dept Neurol, Brain Ctr, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Biessels, GJ (corresponding author), Univ Med Ctr UMC Utrecht, UMC Utrecht, Dept Neurol, Brain Ctr, NL-3508 GA Utrecht, Netherlands.	g.j.biessels@umcutrecht.nl			Netherlands Organisation for Scientific Research [918.1E616]; EU [847749]; Boehringer Ingelheim	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Boehringer Ingelheim(Boehringer Ingelheim)	GJB consults for and receives research support from Boehringer Ingelheim; all financial compensation for these services is transferred to the University Medical Center Utrecht. GJB is supported by a Vici grant 918.1E616 from the Netherlands Organisation for Scientific Research and by the EU's Horizon 2020 research and innovation programme Recognised (grant agreement no 847749).		0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2020	19	7					559	560		10.1016/S1474-4422(20)30174-5	http://dx.doi.org/10.1016/S1474-4422(20)30174-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MF5BW	32562671				2022-12-18	WOS:000545358600021
J	Rothwell, PM				Rothwell, Peter M.			Extended short-term follow-up for a trial of treatment of unruptured arteriovenous malformations	LANCET NEUROLOGY			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; INTERVENTIONAL THERAPY; MEDICAL-MANAGEMENT; ARUBA; MULTICENTER; ANEURYSM; DESIGN		[Rothwell, Peter M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Wolfson Ctr Prevent Stroke & Dementia, Oxford 0X3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Wolfson Ctr Prevent Stroke & Dementia, Oxford 0X3 9DU, England.	peter.rothwell@ndcn.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Cockroft KM, 2012, STROKE, V43, P1979, DOI 10.1161/STROKEAHA.112.652032; Magro E, 2017, J NEUROSURG, V126, P486, DOI 10.3171/2015.6.JNS15619; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Mohr JP, 2020, LANCET NEUROL, V19, P573, DOI 10.1016/S1474-4422(20)30181-2; Molyneux AJ, 2015, LANCET, V385, P691, DOI 10.1016/S0140-6736(14)60975-2; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Salman RAS, 2014, JAMA-J AM MED ASSOC, V311, P1661, DOI 10.1001/jama.2014.3200; van der Schaaf IC, 2002, STROKE, V33, P440, DOI 10.1161/hs0202.102335	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2020	19	7					558	559		10.1016/S1474-4422(20)30178-2	http://dx.doi.org/10.1016/S1474-4422(20)30178-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MF5BW	32562670				2022-12-18	WOS:000545358600003
J	Williamson, R				Williamson, Ruth			Clifford Saper: preeminent sleep scientist and private novelist	LANCET NEUROLOGY			English	Biographical-Item																		SAPER C, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2020	19	7					568	568		10.1016/S1474-4422(20)30105-8	http://dx.doi.org/10.1016/S1474-4422(20)30105-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MF5BW	32562679				2022-12-18	WOS:000545358600009
J	[Anonymous]				[Anonymous]			COVID-19: a catalyst for flexibility and creativity in neurology	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2020	19	7					557	557		10.1016/S1474-4422(20)30176-9	http://dx.doi.org/10.1016/S1474-4422(20)30176-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MF5BW	32562669	Bronze			2022-12-18	WOS:000545358600001
J	French, JA; Wechsler, RT				French, Jacqueline A.; Wechsler, Robert T.			Have new antiseizure medications improved clinical care over the past 30 years?	LANCET NEUROLOGY			English	Editorial Material							ANTIEPILEPTIC DRUGS; EPILEPSY		[French, Jacqueline A.] NYU, Langone Sch Med, New York, NY 10016 USA; [Wechsler, Robert T.] Idaho Comprehens Epilepsy Ctr, Boise, ID USA	New York University; NYU Langone Medical Center	French, JA (corresponding author), NYU, Langone Sch Med, New York, NY 10016 USA.	Jacqueline.french@nyulangone.org	French, Jacqueline A/G-6795-2013	French, Jacqueline A/0000-0003-2242-8027	Biogen; Cavion; Eisai; Engage; GW Pharma; Lundbeck; Neurelis; Ovid; Pfizer; SK Life Sciences; Sunovion; UCB Pharma; Xenon; Zogenix; Epilepsy Research Foundation; Epilepsy Study Consortium; National Institute of Neurological Disorders and Stroke	Biogen(Biogen); Cavion; Eisai(Eisai Co Ltd); Engage; GW Pharma; Lundbeck(Lundbeck Corporation); Neurelis; Ovid; Pfizer(Pfizer); SK Life Sciences; Sunovion; UCB Pharma(UCB Pharma SA); Xenon; Zogenix; Epilepsy Research Foundation; Epilepsy Study Consortium; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JAF receives New York University salary support from the Epilepsy Foundation and receives salary support from the Epilepsy Study Consortium on behalf of which she provides consulting work and attends scientific advisory boards for Acadia, Adamas, Aeovian (Aeonian), Anavex, Arvelle Therapeutics, Axcella Health, Axovant, Biogen, Biomotiv (Koutif Therapeutics), Blackfynn, Bloom Science, Bridge Valley Ventures, Cavion, Cerebral Therapeutics, Cerevel, Crossject, CuroNZ, Eisai, Empatica, Engage Therapeutics, Epitel, Fortress Biotech, GW Pharma, Idorsia, Ionis, Johnson & Johnson Pharmaceuticals, Lundbeck, Marinus, Neurelis, Neurocrine, Novartis, Otsuka Pharmaceutical Development, Ovid Therapeutics, Pfizer, Pfizer-Neusentis, Praxis, Redpin, Sage, Shire, SK Life Sciences, Springworks, Stoke, Sunovion, Supernus, Takeda, UCB Pharma, Ultragenyx, West Therapeutic Development, Xenon, Zogenix, and Zynerba, and reports research grants from Biogen, Cavion, Eisai, Engage, GW Pharma, Lundbeck, Neurelis, Ovid, Pfizer, SK Life Sciences, Sunovion, UCB Pharma, Xenon, Zogenix, Epilepsy Research Foundation, Epilepsy Study Consortium, and National Institute of Neurological Disorders and Stroke, and travel reimbursement related to research, advisory meetings, or presentation of results at scientific meetings from the Epilepsy Study Consortium, the Epilepsy Foundation, Adamas, Arvelle Therapeutics, Axovant, Biogen, Blackfynn, Crossject, CuroNz, Eisai, Engage, Idorsia, Lundbeck, Neurelis, Novartis, Otsuka, Ovid, Pfizer, Redpin, Sage, SK Life Science, Sunovion, Takeda, UCB Pharma, Ultragenyx, Xenon, and Zogenix; JAF is on the editorial board of Lancet Neurology and Neurology Today and is Chief Medical and Innovation Officer for the Epilepsy Foundation, for which New York University receives salary support. RTW is the owner of Consultants in Epilepsy and Neurology, the medical director of the Idaho Comprehensive Epilepsy Center, reports that all generated consulting fees and speaker honoraria are directed to Consultants in Epilepsy and Neurology in support of clinical activities, has served on the advisory board and received consulting fees from Adamas, Aquestive, Brain Sentinel, Eisai, Engage Therapeutics, Greenwich, LivaNova, Lundbeck, Otsuka, SK Life Sciences, Sunovion, Supernus, UCB Pharma, and Upsher-Smith, and has received speaker honoraria from Aquestive, Eisai, Greenwich, LivaNova, Lundbeck, SK Life Sciences, Sunovion, and UCB Pharma.	Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Chen ZB, 2018, JAMA NEUROL, V75, P279, DOI 10.1001/jamaneurol.2017.3949; Cihan E, 2018, AM EP SOC ANN M NEW; Kanner AM, 2018, EPILEPSY CURR, V18, P260, DOI 10.5698/1535-7597.18.4.260; Krauss GL, 2020, LANCET NEUROL, V19, P38, DOI 10.1016/S1474-4422(19)30399-0; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; Perucca E, 2020, LANCET NEUROL, V19, P544, DOI 10.1016/S1474-4422(20)30035-1; Ryvlin P, 2011, LANCET NEUROL, V10, P961, DOI 10.1016/S1474-4422(11)70193-4	8	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2020	19	6					476	478		10.1016/S1474-4422(20)30022-3	http://dx.doi.org/10.1016/S1474-4422(20)30022-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD6CK	32109410				2022-12-18	WOS:000544059200005
J	[Anonymous]				[Anonymous]			The fight against stroke must go on	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2020	19	5					369	369		10.1016/S1474-4422(20)30107-1	http://dx.doi.org/10.1016/S1474-4422(20)30107-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT6JQ	32333885	Bronze, Green Published			2022-12-18	WOS:000573045100002
J	Aguzzi, A; Frontzek, K				Aguzzi, Adriano; Frontzek, Karl			New paradigms of clinical trial design for genetic prion diseases	LANCET NEUROLOGY			English	Editorial Material									[Aguzzi, Adriano; Frontzek, Karl] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich	Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch		Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 1996, J MOL MED, V74, P111, DOI 10.1007/BF01575443; Aguzzi A, 2018, ANNU REV PHARMACOL, V58, P331, DOI 10.1146/annurev-pharmtox-010617-052745; Garber K, 2012, NAT BIOTECHNOL, V30, P731, DOI 10.1038/nbt0812-731; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Raymond GJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131175; Rinaldi C, 2018, NAT REV NEUROL, V14, P9, DOI 10.1038/nrneurol.2017.148; Vallabh SM, 2020, LANCET NEUROL, V19, P361, DOI 10.1016/S1474-4422(19)30403-X; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2020	19	4					284	285		10.1016/S1474-4422(20)30029-6	http://dx.doi.org/10.1016/S1474-4422(20)30029-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW1GS	32199088	Green Published			2022-12-18	WOS:000520920500007
J	Ranscombe, P				Ranscombe, Peter			Dispelling myths and legends about dementia	LANCET NEUROLOGY			English	Editorial Material																		[Anonymous], 2018, OLD FRUITMARKET	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2020	19	4					297	297		10.1016/S1474-4422(19)30072-9	http://dx.doi.org/10.1016/S1474-4422(19)30072-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW1GS	30803839				2022-12-18	WOS:000520920500015
J	Marignier, R				Marignier, Romain			Breaking boundaries between demyelinating disorders and autoimmune encephalitis	LANCET NEUROLOGY			English	Editorial Material									[Marignier, Romain] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Serv Neurol Sclerose Plaques Pathol Myeline & Neu, F-69008 Lyon, France; [Marignier, Romain] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Ctr Reference Malad Inflammatoires Rares Cerveau, F-69008 Lyon, France	CHU Lyon; CHU Lyon	Marignier, R (corresponding author), Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Serv Neurol Sclerose Plaques Pathol Myeline & Neu, F-69008 Lyon, France.; Marignier, R (corresponding author), Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, Ctr Reference Malad Inflammatoires Rares Cerveau, F-69008 Lyon, France.	romain.marignier@chu-lyon.fr						Armangue T, 2020, LANCET NEUROL, V19, P234, DOI 10.1016/S1474-4422(19)30488-0; Cobo-Calvo A, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000649; Cobo-Calvo A, 2019, CURR OPIN NEUROL, V32, P459, DOI 10.1097/WCO.0000000000000681; Dubey D, 2018, ANN NEUROL, V83, P166, DOI 10.1002/ana.25131; Hacohen Y, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000081; Hamid SHM, 2018, JAMA NEUROL, V75, P65, DOI 10.1001/jamaneurol.2017.3196; Mariotto S, 2019, NEUROLOGY, V93, pE1867, DOI 10.1212/WNL.0000000000008479; Ogawa R, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000322; Titulaer MJ, 2014, ANN NEUROL, V75, P411, DOI 10.1002/ana.24117; Waters P, 2020, JAMA NEUROL, V77, P82, DOI 10.1001/jamaneurol.2019.2940	10	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2020	19	3					199	200		10.1016/S1474-4422(20)30032-6	http://dx.doi.org/10.1016/S1474-4422(20)30032-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KN4TZ	32057302				2022-12-18	WOS:000514832700006
J	May, A				May, Arne			The need for continued care after sponsor closure	LANCET NEUROLOGY			English	Letter							CLUSTER HEADACHE; SPHENOPALATINE GANGLION; STIMULATION		[May, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20245 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	May, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20245 Hamburg, Germany.	a.may@uke.de						Becker WJ, 2019, LANCET NEUROL, V18, P1068, DOI 10.1016/S1474-4422(19)30364-3; Goadsby PJ, 2019, LANCET NEUROL, V18, P1081, DOI 10.1016/S1474-4422(19)30322-9; Jurgens TP, 2014, CEPHALALGIA, V34, P1100, DOI 10.1177/0333102414530524; Martelletti P, 2013, J HEADACHE PAIN, V14, DOI [10.1186/1129-2377-14-13, 10.1186/1129-2377-14-86]; Pietzsch JB, 2018, CEPHALALGIA, V38, P1455, DOI 10.1177/0333102418784689; Pietzsch JB, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0530-8; Robbins MS, 2016, HEADACHE, V56, P1093, DOI 10.1111/head.12866; Schoenen J, 2013, CEPHALALGIA, V33, P816, DOI 10.1177/0333102412473667	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2020	19	3					205	205		10.1016/S1474-4422(20)30024-7	http://dx.doi.org/10.1016/S1474-4422(20)30024-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KN4TZ	32085830	Bronze			2022-12-18	WOS:000514832700010
J	Aarabi, B				Aarabi, Bizhan			Personalising pain control with spinal cord stimulation	LANCET NEUROLOGY			English	Editorial Material							SYSTEM		[Aarabi, Bizhan] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Aarabi, B (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.	baarabi@som.umaryland.edu						Anaya CJ, 2020, NEUROMODULATION, V23, P64, DOI 10.1111/ner.12965; Farajidavar A, 2012, IEEE T NEUR SYS REH, V20, P478, DOI 10.1109/TNSRE.2012.2197220; Farajidavar A, 2010, IEEE ENG MED BIO, P1535, DOI 10.1109/IEMBS.2010.5626830; Maheshwari A, 2019, EXPERT REV MED DEVIC, V16, P95, DOI 10.1080/17434440.2019.1567325; Mekhail N, 2020, LANCET NEUROL, V19, P123, DOI 10.1016/S1474-4422(19)30414-4; Parker JL, 2020, NEUROMODULATION, V23, P82, DOI 10.1111/ner.12968; Russo M, 2018, NEUROMODULATION, V21, P38, DOI 10.1111/ner.12684; Wolf EW, 2015, NEUROMODULATION, V18, P448, DOI 10.1111/ner.12319	8	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2020	19	2					103	104		10.1016/S1474-4422(19)30484-3	http://dx.doi.org/10.1016/S1474-4422(19)30484-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE1XC	31870767				2022-12-18	WOS:000508351900008
J	Antonini, A				Antonini, Angelo			New routes of dopaminergic drug delivery in patients with Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material							DOUBLE-BLIND		[Antonini, Angelo] Univ Padua, Dept Neurosci, Movement Disorders Unit, I-35128 Padua, Italy	University of Padua	Antonini, A (corresponding author), Univ Padua, Dept Neurosci, Movement Disorders Unit, I-35128 Padua, Italy.	angelo.antonini@unipd.it	Antonini, Angelo/H-9726-2019	Antonini, Angelo/0000-0003-1040-2807				Antonini A, 2018, NAT REV NEUROL, V14, P693, DOI 10.1038/s41582-018-0083-y; Antonini A, 2018, MOVEMENT DISORD, V33, P900, DOI 10.1002/mds.27340; Antonini A, 2009, LANCET NEUROL, V8, P929, DOI 10.1016/S1474-4422(09)70225-X; Chaudhuri KR, 2019, MOVEMENT DISORD, V34, P816, DOI 10.1002/mds.27691; Grosset KA, 2013, J PARKINSON DIS, V3, P31, DOI 10.3233/JPD-120142; Katzenschlager R, 2018, LANCET NEUROL, V17, P749, DOI 10.1016/S1474-4422(18)30239-4; LeWitt PA, 2019, LANCET NEUROL, V18, P145, DOI 10.1016/S1474-4422(18)30405-8; Olanow CW, 2020, LANCET NEUROL, V19, P135, DOI 10.1016/S1474-4422(19)30396-5; Poewe W, 2015, MOVEMENT DISORD, V30, P114, DOI 10.1002/mds.26078; Stocchi F, 2014, PARKINSONISM RELAT D, V20, P204, DOI 10.1016/j.parkreldis.2013.10.027	10	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2020	19	2					105	106		10.1016/S1474-4422(19)30443-0	http://dx.doi.org/10.1016/S1474-4422(19)30443-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE1XC	31818698				2022-12-18	WOS:000508351900009
J	Wauters, E; Van Broeckhoven, C				Wauters, Eline; Van Broeckhoven, Christine			International view on genetic frontotemporal dementia	LANCET NEUROLOGY			English	Editorial Material							ONSET; AGE		[Van Broeckhoven, Christine] VIB Ctr Mol Neurol, Neurodegenerat Brain Dis Grp, Antwerp, Belgium; Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2610 Antwerp, Belgium; Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp	Van Broeckhoven, C (corresponding author), VIB Ctr Mol Neurol, Neurodegenerat Brain Dis Grp, Antwerp, Belgium.	christine.vanbroeckhoven@uantwerpen.vib.be						Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Desikan RS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002258; Ferrari R, 2017, J ALZHEIMERS DIS, V56, P1271, DOI 10.3233/JAD-160949; Greaves CV, 2019, J NEUROL, V266, P2075, DOI 10.1007/s00415-019-09363-4; Moore KM, 2019, LANCET NEUROL, DOI [10.1016/S1474-4422(19)30394-1, DOI 10.1016/S1474-4422(19)30394-1]; Sleegers K, 2015, ALZHEIMERS DEMENT, V11, P1452, DOI 10.1016/j.jalz.2015.02.013; Van Mossevelde S, 2017, CURR OPIN GENET DEV, V44, P117, DOI 10.1016/j.gde.2017.02.008; Wauters E, 2018, NEUROBIOL AGING, V67, P84, DOI 10.1016/j.neurobiolaging.2018.03.007	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2020	19	2					106	108						4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE1XC	31810827	hybrid			2022-12-18	WOS:000508351900010
J	[Anonymous]				[Anonymous]			Publication records versus scientific progress	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2020	19	2					101	101		10.1016/S1474-4422(19)30481-8	http://dx.doi.org/10.1016/S1474-4422(19)30481-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE1XC	31978355	Bronze			2022-12-18	WOS:000508351900006
J	Bohnen, NI; Albin, RL				Bohnen, Nicolaas I.; Albin, Roger L.			Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?	LANCET NEUROLOGY			English	Editorial Material									[Bohnen, Nicolaas I.] Univ Michigan, Udall Ctr, Dept Radiol, Ann Arbor, MI 48109 USA; [Bohnen, Nicolaas I.; Albin, Roger L.] Univ Michigan, Udall Ctr, Dept Neurol, Ann Arbor, MI 48109 USA; [Bohnen, Nicolaas I.; Albin, Roger L.] Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bohnen, NI (corresponding author), Univ Michigan, Udall Ctr, Dept Radiol, Ann Arbor, MI 48109 USA.; Bohnen, NI (corresponding author), Univ Michigan, Udall Ctr, Dept Neurol, Ann Arbor, MI 48109 USA.; Bohnen, NI (corresponding author), Ann Arbor Healthcare Syst, Ann Arbor, MI 48109 USA.	nbohnen@umich.edu			NINDS NIH HHS [R01 NS099535, P01 NS015655, P50 NS091856] Funding Source: Medline; RRD VA [I01 RX001631] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); RRD VA		Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Fereshtehnejad SM, 2019, BRAIN, V142, P2051, DOI 10.1093/brain/awz111; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Iranzo A, 2011, LANCET NEUROL, V10, P797, DOI 10.1016/S1474-4422(11)70152-1; Koprich JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017698; Ryan E, 2019, CURR OPIN NEUROL, V32, P589, DOI 10.1097/WCO.0000000000000715; Simuni T, 2020, LANCET NEUROL, V19, P71, DOI 10.1016/S1474-4422(19)30319-9	7	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2020	19	1					27	29		10.1016/S1474-4422(19)30355-2	http://dx.doi.org/10.1016/S1474-4422(19)30355-2			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3SM	31678033	Green Accepted			2022-12-18	WOS:000502286000019
J	Bril, V				Bril, Vera			Important advances in neuromuscular research in 2019	LANCET NEUROLOGY			English	Editorial Material									[Bril, Vera] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Bril, V (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Ellen & Martin Prosserman Ctr Neuromuscular Dis, Toronto, ON M5G 2C4, Canada.	vera.bril@utoronto.ca	BRIL, vera/ABA-6509-2020					European Medicines Agency, 2018, FLUOR QUIN ANT PRAC; Hanna MG, 2019, LANCET NEUROL, V18, P834, DOI 10.1016/S1474-4422(19)30200-5; Howard JF, 2019, NEUROLOGY, V92, pE2661, DOI 10.1212/WNL.0000000000007600; Morales D, 2019, JAMA NEUROL, V76, P827, DOI 10.1001/jamaneurol.2019.0887; Staff NP, 2019, JAMA NEUROL, V76, P753, DOI 10.1001/jamaneurol.2019.0886; US Food and Drug Administration Drug Safety Communications, 2013, FDA REQ LAB CHANG WA; Wolfe GI, 2016, NEW ENGL J MED, V375, P511, DOI 10.1056/NEJMoa1602489; Wolfe GI, 2019, LANCET NEUROL, V18, P259, DOI 10.1016/S1474-4422(18)30392-2; Xu M, 2019, NEUROLOGIST, V24, P75, DOI 10.1097/NRL.0000000000000230	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2020	19	1					14	+		10.1016/S1474-4422(19)30433-8	http://dx.doi.org/10.1016/S1474-4422(19)30433-8			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3SM	31839239				2022-12-18	WOS:000502286000011
J	Lizarraga, AA; Weinstock-Guttman, B				Lizarraga, Alexis A.; Weinstock-Guttman, Bianca			Multiple sclerosis in 2019: predicting progression	LANCET NEUROLOGY			English	Editorial Material									[Lizarraga, Alexis A.; Weinstock-Guttman, Bianca] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY 14202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lizarraga, AA (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo, NY 14202 USA.	aalizarr@buffalo.edu	Weinstock-Guttman, Bianca/AAI-4694-2021	Weinstock-Guttman, Bianca/0000-0001-6732-151X				Absinta M, 2019, JAMA NEUROL, V76, P1474, DOI 10.1001/jamaneurol.2019.2399; Bjornevik K, 2020, JAMA NEUROL, V77, P58, DOI 10.1001/jamaneurol.2019.3238; Canto E, 2019, JAMA NEUROL, V76, P1359, DOI 10.1001/jamaneurol.2019.2137; Elliott C, 2019, BRAIN, V142, P2787, DOI 10.1093/brain/awz212; Genovese AV, 2019, RADIOLOGY, V293, P424, DOI 10.1148/radiol.2019190306; Wallin MT, 2019, NEUROLOGY, V92, pE1029, DOI 10.1212/WNL.0000000000007035; Zivadinov R, 2019, AM J NEURORADIOL, V40, P446, DOI 10.3174/ajnr.A5987	7	1	1	2	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2020	19	1					12	+		10.1016/S1474-4422(19)30441-7	http://dx.doi.org/10.1016/S1474-4422(19)30441-7			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3SM	31839238				2022-12-18	WOS:000502286000010
J	Garcia, JBS; Neto, JOB				Santos Garcia, Joao Batista; Barbosa Neto, Jose Osvaldo			Living without the opioid epidemic: how far have we come?	LANCET NEUROLOGY			English	Editorial Material							STATES		[Santos Garcia, Joao Batista; Barbosa Neto, Jose Osvaldo] Univ Fed Maranhao, Pain & Palliat Care Dept, Sao Luis, Maranhao, Brazil	Universidade Federal do Maranhao	Garcia, JBS (corresponding author), Univ Fed Maranhao, Pain & Palliat Care Dept, Sao Luis, Maranhao, Brazil.	jbgarcia@uol.com.br	Neto, Jose Osvaldo Barbosa/F-5907-2013	Neto, Jose Osvaldo Barbosa/0000-0003-2005-3137				Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Garcia Joao Batista Santos, 2019, Pain Rep, V4, pe730, DOI 10.1097/PR9.0000000000000730; Gladden RM, 2019, MMWR-MORBID MORTAL W, V68, P737, DOI 10.15585/mmwr.mm6834a2; Haight BR, 2019, LANCET, V393, P778, DOI 10.1016/S0140-6736(18)32259-1; Hurd YL, 2019, AM J PSYCHIAT, V176, P911, DOI 10.1176/appi.ajp.2019.18101191; Singh S, 2019, INDIAN J PALLIAT CAR, V25, P567, DOI 10.4103/IJPC.IJPC_83_19; Zhu WJ, 2019, NEW ENGL J MED, V380, P1043, DOI 10.1056/NEJMsa1807069	7	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2020	19	1					16	+		10.1016/S1474-4422(19)30449-1	http://dx.doi.org/10.1016/S1474-4422(19)30449-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3SM	31839240				2022-12-18	WOS:000502286000012
J	Konig, IR				Koenig, Inke R.			Challenges in disentangling the genetic background of Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material									[Koenig, Inke R.] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Campus Lubeck, D-23562 Lubeck, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Lubeck	Konig, IR (corresponding author), Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Campus Lubeck, D-23562 Lubeck, Germany.	inke.koenig@imbs.uni-luebeck.de	König, Inke R/A-4544-2009	König, Inke R/0000-0003-0504-6465				Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593; Nalls MA, 2019, LANCET NEUROL, V18, P1091, DOI 10.1016/S1474-4422(19)30320-5; Rodriguez-Violante M, 2017, REV INVEST CLIN, V69, P308, DOI 10.24875/RIC.17002291; Singleton AB, 2017, J PARKINSON DIS, V7, pS89, DOI 10.3233/JPD-179009	5	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2019	18	12					1069	+		10.1016/S1474-4422(19)30387-4	http://dx.doi.org/10.1016/S1474-4422(19)30387-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM0CO	31701887				2022-12-18	WOS:000495892200004
J	Burnham, SC; Loi, SM; Doecke, J; Fedyashov, V; Dore, V; Villemagne, VL; Masters, CL				Burnham, Samantha C.; Loi, Samantha M.; Doecke, James; Fedyashov, Victor; Dore, Vincent; Villemagne, Victor L.; Masters, Colin L.			The dawn of robust individualised risk models for dementia	LANCET NEUROLOGY			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE		[Burnham, Samantha C.; Dore, Vincent] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Parkville, Vic 3052, Australia; [Burnham, Samantha C.] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Sch Med Sci, Joondalup, WA, Australia; [Loi, Samantha M.] Royal Melbourne Hosp, NorthWestern Mental Hlth, Neuropsychiat Unit, Parkville, Vic, Australia; [Loi, Samantha M.] Univ Melbourne, Dept Psychiat, Parkville, Vic, Australia; [Fedyashov, Victor; Masters, Colin L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Fedyashov, Victor] Univ Melbourne, ARC Training Ctr Cognit Comp Med Technol, Parkville, Vic, Australia; [Villemagne, Victor L.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Doecke, James] CSIRO, Australian E Hlth Res Ctr, Herston, Qld, Australia; [Dore, Vincent; Villemagne, Victor L.] Austin Hlth, Dept Mol Imaging & Therapy, Heidelberg, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Edith Cowan University; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Burnham, SC (corresponding author), CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Parkville, Vic 3052, Australia.; Burnham, SC (corresponding author), Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Sch Med Sci, Joondalup, WA, Australia.	samantha.burnham@csiro.au	Dore, Vincent/A-7750-2011; Villemagne, Victor/AAC-5406-2019; Burnham, Samantha/E-6967-2010	Dore, Vincent/0000-0002-8051-0558; Villemagne, Victor/0000-0002-5832-9875; Loi, Samantha/0000-0002-4953-4500; Burnham, Samantha/0000-0003-4805-5193; Masters, Colin/0000-0003-3072-7940				Bilgel M, 2019, ALZH DEMENT-DADM, V11, P205, DOI 10.1016/j.dadm.2019.01.005; Burnham SC, 2016, LANCET NEUROL, V15, P1044, DOI 10.1016/S1474-4422(16)30125-9; Ehrensperger MM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0069-y; Gomersall T, 2017, BRIT J HEALTH PSYCH, V22, P786, DOI 10.1111/bjhp.12255; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Li HM, 2019, ALZHEIMERS DEMENT, V15, P1059, DOI 10.1016/j.jalz.2019.02.007; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Marzanski M, 2000, J MED ETHICS, V26, P108, DOI 10.1136/jme.26.2.108; van Maurik IS, 2019, LANCET NEUROL, V18, P1034, DOI 10.1016/S1474-4422(19)30283-2; van Maurik IS, 2017, JAMA NEUROL, V74, P1481, DOI 10.1001/jamaneurol.2017.2712; Vos SJB, 2015, BRAIN, V138, P1327, DOI 10.1093/brain/awv029; Whitehouse P, 2004, LANCET NEUROL, V3, P124, DOI 10.1016/S1474-4422(03)00666-5	12	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2019	18	11					985	987		10.1016/S1474-4422(19)30353-9	http://dx.doi.org/10.1016/S1474-4422(19)30353-9			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JC8HI	31526626				2022-12-18	WOS:000489517000005
J	Lecky, F				Lecky, Fiona			Should plasma GFAP guide the management of patients with traumatic brain injury and a negative CT scan?	LANCET NEUROLOGY			English	Editorial Material									[Lecky, Fiona] Univ Sheffield, Ctr Urgent & Emergency Care Res CURE, Hlth Serv Res Sect, Sch Hlth & Related Res ScHARR, Sheffield S14DA, S Yorkshire, England	University of Sheffield	Lecky, F (corresponding author), Univ Sheffield, Ctr Urgent & Emergency Care Res CURE, Hlth Serv Res Sect, Sch Hlth & Related Res ScHARR, Sheffield S14DA, S Yorkshire, England.	f.e.lecky@sheffield.ac.uk						Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Lecky FE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016355; National Institute for Health and Care Excellence, 2017, HEAD INJ ASS EARL MA; Singh R, 2019, BRAIN INJURY, V33, P584, DOI 10.1080/02699052.2019.1566837; Steyerberg EW, LANCET NEUROL; US Food and Drug Administration, 2018, FDA AUTH MARK 1 BLOO; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	7	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2019	18	10					908	909		10.1016/S1474-4422(19)30327-8	http://dx.doi.org/10.1016/S1474-4422(19)30327-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6HN	31451408				2022-12-18	WOS:000485784000005
J	Balestrino, M				Balestrino, Maurizio			The risks and uses of dietary supplements	LANCET NEUROLOGY			English	Letter									[Balestrino, Maurizio] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, I-16132 Genoa, Italy; [Balestrino, Maurizio] IRCCS Policlin San Martino, Clin Neurol, Genoa, Italy	University of Genoa	Balestrino, M (corresponding author), Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, I-16132 Genoa, Italy.; Balestrino, M (corresponding author), IRCCS Policlin San Martino, Clin Neurol, Genoa, Italy.	mbalestrino@neurologia.unige.it						[Anonymous], 2019, LANCET NEUROL, V18, P415, DOI 10.1016/S1474-4422(19)30089-4; Kang SS, 2018, CARDIOVASC DRUG THER, V32, P233, DOI 10.1007/s10557-018-6790-1; Kley RA, 2013, COCHRANE DB SYST REV, V6	3	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2019	18	9					814	815		10.1016/S1474-4422(19)30292-3	http://dx.doi.org/10.1016/S1474-4422(19)30292-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IO1IZ	31397285				2022-12-18	WOS:000479136100010
J	[Anonymous]				[Anonymous]			Have your say on the future of European research	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2019	18	9					805	805		10.1016/S1474-4422(19)30270-4	http://dx.doi.org/10.1016/S1474-4422(19)30270-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IO1IZ	31397278	Bronze			2022-12-18	WOS:000479136100003
J	[Anonymous]				[Anonymous]			Adding stroke to the political agenda in Europe (vol 18, pg 513, 2019)	LANCET NEUROLOGY			English	Correction																		STUDIO F, 2019, LANCET NEUROL, V18, P513	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2019	18	8					E7	E7		10.1016/S1474-4422(19)30157-7	http://dx.doi.org/10.1016/S1474-4422(19)30157-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IH7ZF		Bronze			2022-12-18	WOS:000474722800001
J	Ayton, S; Bush, AI				Ayton, Scott; Bush, Ashley I.			Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegeneration	LANCET NEUROLOGY			English	Editorial Material							FERROPTOSIS; MODALITY		[Ayton, Scott; Bush, Ashley I.] Univ Melbourne, Melbourne Dementia Res Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bush, AI (corresponding author), Univ Melbourne, Melbourne Dementia Res Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	ashley.bush@florey.edu.au	Ayton, Scott/J-8000-2015; Bush, Ashley I/A-1186-2007; Ayton, Scott/AAJ-3414-2021	Ayton, Scott/0000-0002-3479-2427; Bush, Ashley I/0000-0001-8259-9069; 	Australian National Health and Medical Research Council; US National Institutes of Health	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SA and AIB report research grants from the Australian National Health and Medical Research Council and the US National Institutes of Health, relevant to this work. AIB is a shareholder in Alterity Ltd, Cogstate Ltd, Brighton Biotech LLC, Grunbiotics Pty Ltd, Eucalyptus Pty Ltd, and Mesoblast Ltd. He is a paid consultant for, and has a profit share interest in, Collaborative Medicinal Development Pty Ltd.	Arber CE, 2016, NEUROPATHOL APPL NEU; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hogarth P, 2017, MOL GENET METAB, V120, P278, DOI 10.1016/j.ymgme.2016.11.004; Klopstock T, 2019, LANCET NEUROL, V18, P631, DOI 10.1016/S1474-4422(19)30142-5; PERRY TL, 1985, ANN NEUROL, V18, P482, DOI 10.1002/ana.410180411; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335	9	1	1	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2019	18	7					616	617		10.1016/S1474-4422(19)30193-0	http://dx.doi.org/10.1016/S1474-4422(19)30193-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC7SE	31202464				2022-12-18	WOS:000471176500003
J	Chaturvedi, S				Chaturvedi, Seemant			Vertebral artery stenting: lifting the therapeutic fog	LANCET NEUROLOGY			English	Editorial Material							STENOSIS		[Chaturvedi, Seemant] Univ Maryland, Sch Med, Stroke Program, Baltimore, MD 21201 USA; [Chaturvedi, Seemant] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Chaturvedi, S (corresponding author), Univ Maryland, Sch Med, Stroke Program, Baltimore, MD 21201 USA.; Chaturvedi, S (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.	schaturvedi@som.umaryland.edu						Alexander MJ, 2019, STROKE, V50, P889, DOI 10.1161/STROKEAHA.118.023996; Barnett HJM, 2002, ARCH NEUROL-CHICAGO, V59, P359, DOI 10.1001/archneur.59.3.359; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Compter A, 2015, LANCET NEUROL, V14, P606, DOI 10.1016/S1474-4422(15)00017-4; Glass TA, 2002, ARCH NEUROL-CHICAGO, V59, P369, DOI 10.1001/archneur.59.3.369; Johnston SC, 2018, NEW ENGL J MED, V379, P215, DOI 10.1056/NEJMoa1800410; Markus HS, 2019, LANCET NEUROL, V18, P666, DOI 10.1016/S1474-4422(19)30149-8; Markus HS, 2017, NEUROLOGY, V89, P1229, DOI 10.1212/WNL.0000000000004385; Turan TN, 2017, NEUROLOGY, V88, P379, DOI 10.1212/WNL.0000000000003534; Wityk RJ, 1998, ARCH NEUROL-CHICAGO, V55, P470, DOI 10.1001/archneur.55.4.470	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2019	18	7					620	621		10.1016/S1474-4422(19)30191-7	http://dx.doi.org/10.1016/S1474-4422(19)30191-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC7SE	31130427				2022-12-18	WOS:000471176500006
J	Hohlfeld, R				Hohlfeld, Reinhard			Immune checkpoint blockade for treating progressive multifocal leukoencephalopathy	LANCET NEUROLOGY			English	Editorial Material							MULTIPLE-SCLEROSIS		[Hohlfeld, Reinhard] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, D-81377 Munich, Germany; [Hohlfeld, Reinhard] Munich Cluster Syst Neurol, Munich, Germany	University of Munich	Hohlfeld, R (corresponding author), Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, D-81377 Munich, Germany.; Hohlfeld, R (corresponding author), Munich Cluster Syst Neurol, Munich, Germany.	reinhard.hohlfeld@med.uni-muenchen.de						Cortese I, N ENGL J MED, V380, P1597; Gerdes LA, 2016, ANN NEUROL, V80, P294, DOI 10.1002/ana.24715; Kappos L, 2011, LANCET NEUROL, V10, P745, DOI 10.1016/S1474-4422(11)70149-1; Koralnik IJ, 2019, NEW ENGL J MED, V380, P1667, DOI 10.1056/NEJMe1904140; Major E, 2018, LANCET NEUROL, V17, P467, DOI 10.1016/S1474-4422(18)30040-1; Rauer S, 2019, NEW ENGL J MED, V380, P1676, DOI 10.1056/NEJMc1817193; Tan CS, 2012, JAIDS-J ACQ IMM DEF, V60, P244, DOI 10.1097/QAI.0b013e31825a313c; Walter O, 2019, NEW ENGL J MED, V380, P1674, DOI 10.1056/NEJMc1816198; Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112; Yshii LM, 2017, NAT REV NEUROL, V13, P755, DOI 10.1038/nrneurol.2017.144	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2019	18	7					623	624		10.1016/S1474-4422(19)30183-8	http://dx.doi.org/10.1016/S1474-4422(19)30183-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC7SE	31104991				2022-12-18	WOS:000471176500008
J	Mathis, S; Vallat, JM				Mathis, Stephane; Vallat, Jean-Michel			Focal Point The journal behind the nodes of Ranvier?	LANCET NEUROLOGY			English	Editorial Material																		Ranvier LA, 1871, CR HEBD ACAD SCI, V73, P1168; Rutherford W, 1875, OUTLINES PRACTICAL H; Schwann T., 1847, MICROSCOPICAL RES AC, P231; Secundi Plinii, 1831, HIST NATURELLE PLINE, P122; The Lancet, 1872, LANCET, V99, P477	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2019	18	7					628	628		10.1016/S1474-4422(19)30203-0	http://dx.doi.org/10.1016/S1474-4422(19)30203-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC7SE	31202467				2022-12-18	WOS:000471176500020
J	Rosand, J; Khatri, P; Lee, JM				Rosand, Jonathan; Khatri, Pooja; Lee, Jin-Moo			Recovery from brain injury: a surprising new drug target	LANCET NEUROLOGY			English	Editorial Material									[Rosand, Jonathan] Massachusetts Gen Hosp, Henry & Allison McCance Ctr Brain Hlth, Div Neurocrit Care, Ctr Genom Med, Boston, MA 02114 USA; [Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Khatri, Pooja] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [Lee, Jin-Moo] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; University of Cincinnati; Washington University (WUSTL)	Rosand, J (corresponding author), Massachusetts Gen Hosp, Henry & Allison McCance Ctr Brain Hlth, Div Neurocrit Care, Ctr Genom Med, Boston, MA 02114 USA.; Rosand, J (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	jrosand@mgh.harvard.edu			NINDS NIH HHS [U24 NS107230, R01 NS085419] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Lander E, 2019, NATURE, V567, P165, DOI 10.1038/d41586-019-00726-5; Normile D, 2018, SCIENCE, V362, P978, DOI 10.1126/science.362.6418.978; Zhou M, 2016, ELIFE, V5, DOI 10.7554/eLife.20985	4	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2019	18	5					421	422		10.1016/S1474-4422(19)30117-6	http://dx.doi.org/10.1016/S1474-4422(19)30117-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HS8SW	30981316				2022-12-18	WOS:000464140400008
J	Walloe, L				Walloe, Lars			Pitfalls in using neonatal brain NAA to predict infant development	LANCET NEUROLOGY			English	Letter									[Walloe, Lars] Univ Oslo, Div Physiol, Inst Basic Med Sci, NO-0317 Oslo, Norway	University of Oslo	Walloe, L (corresponding author), Univ Oslo, Div Physiol, Inst Basic Med Sci, NO-0317 Oslo, Norway.	lars.walloe@medisin.uio.no						Gunn AJ, 2019, LANCET NEUROL, V18, P21, DOI 10.1016/S1474-4422(18)30370-3; Lally PJ, 2019, LANCET NEUROL, V18, P35, DOI 10.1016/S1474-4422(18)30325-9	2	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2019	18	5					423	423		10.1016/S1474-4422(19)30111-5	http://dx.doi.org/10.1016/S1474-4422(19)30111-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HS8SW	30981318	Bronze			2022-12-18	WOS:000464140400009
J	Gauberti, M				Gauberti, Maxime			Reperfusion in acute ischaemic stroke by sonothrombolysis	LANCET NEUROLOGY			English	Editorial Material									[Gauberti, Maxime] Univ Caen Normandie, INSERM, Unite Mixte Rech S U1237, Physiopathol & Imaging Neurol Disorders, F-14074 Caen, France; [Gauberti, Maxime] CHU Caen Cote de Nacre, Dept Diagnost Imaging & Intervent Radiol, Ctr Hosp Univ CHU Caen, Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Gauberti, M (corresponding author), Univ Caen Normandie, INSERM, Unite Mixte Rech S U1237, Physiopathol & Imaging Neurol Disorders, F-14074 Caen, France.; Gauberti, M (corresponding author), CHU Caen Cote de Nacre, Dept Diagnost Imaging & Intervent Radiol, Ctr Hosp Univ CHU Caen, Caen, France.	gauberti@cyceron.fr		Gauberti, Maxime/0000-0003-0752-7342				Alexandrov AV, 2019, LANCET NEUROL, V18, P338, DOI 10.1016/S1474-4422(19)30026-2; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Bader KB, 2016, ADV EXP MED BIOL, V880, P339, DOI 10.1007/978-3-319-22536-4_19; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Campbell BCV, 2018, NEW ENGL J MED, V378, P1573, DOI 10.1056/NEJMoa1716405; Chen ZQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210516; Wilhelm-Schwenkmezger T, 2007, STROKE, V38, P1031, DOI 10.1161/01.STR.0000257966.32242.0b	7	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2019	18	4					320	321		10.1016/S1474-4422(19)30066-3	http://dx.doi.org/10.1016/S1474-4422(19)30066-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO7ZR	30878095	Green Published			2022-12-18	WOS:000461169400003
J	Guan, HZ				Guan, Hongzhi			Pictographs of encephalitis in Chinese characters	LANCET NEUROLOGY			English	Letter									[Guan, Hongzhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Guan, HZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China.	guanhz@263.net							0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2019	18	4					331	331		10.1016/S1474-4422(19)30077-8	http://dx.doi.org/10.1016/S1474-4422(19)30077-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO7ZR	30878098	Bronze			2022-12-18	WOS:000461169400010
J	Hankey, GJ				Hankey, Graeme J.			Prasugrel or clopidogrel for long-term secondary stroke prevention?	LANCET NEUROLOGY			English	Editorial Material							RISK		[Hankey, Graeme J.] Univ Western Australia, Harry Perkins Inst Med Res, Fac Hlth & Med Sci, Med Sch,QEII Med Ctr, Perth, WA 6009, Australia	Harry Perkins Institute of Medical Research; University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Harry Perkins Inst Med Res, Fac Hlth & Med Sci, Med Sch,QEII Med Ctr, Perth, WA 6009, Australia.	graeme.hankey@uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Gill D, 2018, STROKE, V49, P2761, DOI 10.1161/STROKEAHA.118.022792; Hao QK, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k5108; Hart RG, 2018, NEW ENGL J MED, V378, P2191, DOI 10.1056/NEJMoa1802686; Kelly PJ, 2018, J NEUROL NEUROSUR PS, V89, P211, DOI 10.1136/jnnp-2016-314817; Malhotra K, 2018, J NEUROL SCI, V390, P212, DOI 10.1016/j.jns.2018.05.001; Ogawa A, 2019, LANCET NEUROL, V18, P238, DOI 10.1016/S1474-4422(18)30449-6; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Sharma M, 2019, CIRCULATION; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	10	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2019	18	3					222	223		10.1016/S1474-4422(19)30018-3	http://dx.doi.org/10.1016/S1474-4422(19)30018-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL2BV	30784545				2022-12-18	WOS:000458509100006
J	LeWitt, PA; Hauser, RA; Pahwa, R				LeWitt, P. A.; Hauser, R. A.; Pahwa, R.			Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebocontrolled phase 3 trial (vol 18, pg 145, 2019)	LANCET NEUROLOGY			English	Correction													LeWitt, Peter/AAW-4988-2020					LeWitt PA, 2019, LANCET NEUROL, V18, P145, DOI 10.1016/S1474-4422(18)30405-8	1	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2019	18	3					E2	E2		10.1016/S1474-4422(18)30405-8	http://dx.doi.org/10.1016/S1474-4422(18)30405-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL2BV					2022-12-18	WOS:000458509100004
J	Tugemann, B				Tugemann, Bastian			The risk of PML from natalizumab	LANCET NEUROLOGY			English	Letter												tugemann@mailbox.org						Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Ho PR, 2017, LANCET NEUROL, V16, P925, DOI 10.1016/S1474-4422(17)30282-X; Hunt David, 2012, Pract Neurol, V12, P25, DOI 10.1136/practneurol-2011-000092; Kuesters G, 2015, NEUROLOGY S, V84; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2019	18	3					230	230		10.1016/S1474-4422(19)30021-3	http://dx.doi.org/10.1016/S1474-4422(19)30021-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL2BV	30784548				2022-12-18	WOS:000458509100011
J	de Visser, M				de Visser, Marianne			Evidence for treatment of spasticity in motor neuron disease	LANCET NEUROLOGY			English	Editorial Material							SCLEROSIS; SYMPTOMS		[de Visser, Marianne] Univ Amsterdam, Med Ctr, Dept Neurol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam	de Visser, M (corresponding author), Univ Amsterdam, Med Ctr, Dept Neurol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.devisser@amc.uva.nl						Ashworth NL, 2012, COCHRANE DB SYST REV, V2; Dorst J, 2017, THER ADV NEUROL DISO, V11, P1, DOI 10.1177/1756285617734734; Milinis K, 2018, ACTA NEUROL SCAND, V138, P47, DOI 10.1111/ane.12910; National Institute for Health and Care Excellence, MOT NEUR DIS ASS MAN; Patti F, 2016, J NEUROL NEUROSUR PS, V87, P944, DOI 10.1136/jnnp-2015-312591; Riva N, 2019, LANCET NEUROL, V18, P155, DOI 10.1016/S1474-4422(18)30406-X; Tartaglia MC, 2007, ARCH NEUROL-CHICAGO, V64, P232, DOI 10.1001/archneur.64.2.232; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1	8	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2019	18	2					130	131		10.1016/S1474-4422(18)30493-9	http://dx.doi.org/10.1016/S1474-4422(18)30493-9			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI0TY	30554829				2022-12-18	WOS:000456158200003
J	Rascol, O				Rascol, Olivier			CVT-301 for Parkinson's disease: dose and effect size issues	LANCET NEUROLOGY			English	Editorial Material							DOUBLE-BLIND; APOMORPHINE; PHARMACOKINETICS; FLUCTUATIONS; TRIAL		[Rascol, Olivier] Univ Toulouse, Ctr Invest Clin & Pharmacol Clin, Reseau NS PARK FCRIN, F-31300 Toulouse, France; [Rascol, Olivier] Univ Toulouse, Ctr COEN NeuroToul, CHU Toulouse, INSERM, F-31300 Toulouse, France	Universite de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse	Rascol, O (corresponding author), Univ Toulouse, Ctr Invest Clin & Pharmacol Clin, Reseau NS PARK FCRIN, F-31300 Toulouse, France.; Rascol, O (corresponding author), Univ Toulouse, Ctr COEN NeuroToul, CHU Toulouse, INSERM, F-31300 Toulouse, France.	olivier.rascol@univ-tlse3.fr						Dewey RB, 2001, ARCH NEUROL-CHICAGO, V58, P1385, DOI 10.1001/archneur.58.9.1385; Fox SH, 2018, MOVEMENT DISORD, V33, P1248, DOI 10.1002/mds.27372; Grosset KA, 2013, J PARKINSON DIS, V3, P31, DOI 10.3233/JPD-120142; Hauser RA, 2004, MOVEMENT DISORD, V19, P1409, DOI 10.1002/mds.20248; Hauser RA, 2016, MOVEMENT DISORD, V31, P1366, DOI 10.1002/mds.26697; Hauser RA, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/467131; Hsu A, 2015, J CLIN PHARMACOL, V55, P995, DOI 10.1002/jcph.514; LeWitt PA, 2019, LANCET NEUROL, V18, P145, DOI 10.1016/S1474-4422(18)30405-8; LeWitt PA, 2016, MOVEMENT DISORD, V31, P1356, DOI 10.1002/mds.26611; Martin K, 2004, BRIT J CLIN PHARMACO, V57, P86, DOI 10.1046/j.1365-2125.2003.01953.x; Nutt JG, 2008, MOVEMENT DISORD, V23, pS580, DOI 10.1002/mds.22037; Pahwa R, 2007, J NEUROL SCI, V258, P137, DOI 10.1016/j.jns.2007.03.013; Poewe W, 2015, MOVEMENT DISORD, V30, P114, DOI 10.1002/mds.26078; Rascol O, 2010, MOVEMENT DISORD, V25, P368, DOI 10.1002/mds.22922	14	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2019	18	2					128	130		10.1016/S1474-4422(18)30496-4	http://dx.doi.org/10.1016/S1474-4422(18)30496-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI0TY	30663600	Green Published			2022-12-18	WOS:000456158200002
J	[Anonymous]				[Anonymous]			Why are patients with epilepsy not getting treatment?	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2019	18	2					127	127		10.1016/S1474-4422(18)30489-7	http://dx.doi.org/10.1016/S1474-4422(18)30489-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HI0TY	30663599	Bronze			2022-12-18	WOS:000456158200001
J	Brayne, C				Brayne, Carol			Dementia research 2018: current and future population relevance	LANCET NEUROLOGY			English	Editorial Material									[Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB20SR, England	University of Cambridge	Brayne, C (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB20SR, England.	carol.brayne@medschl.cam.ac.uk	Brayne, Carol/AAA-4285-2020	Brayne, Carol/0000-0001-5307-663X				Chen L, 2018, RADIOLOGY, V288, P573, DOI 10.1148/radiol.2018171567; Department for Health and Social Care, 2018, PREVENTION IS BETTER; Kingston A, 2018, LANCET PUBLIC HEALTH, V3, pE447, DOI 10.1016/S2468-2667(18)30118-X; Milne R, 2018, J ALZHEIMERS DIS, V62, P487, DOI 10.3233/JAD-170813; Nachev Parashkev, 2018, F1000Res, V7, P620, DOI 10.12688/f1000research.15020.1; Pickett J, 2018, INT J GERIATR PSYCH, V33, P900, DOI 10.1002/gps.4868; Prince MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195133; Richard E, 2018, ALZ DEMEN, V13, P1198; United Nations Children's Fund (Unicef) The World Health Organization The International Bank for Reconstruction and Development/The World Bank, 2018, LEV TRENDS CHILD MAL	9	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2019	18	1					3	+		10.1016/S1474-4422(18)30465-4	http://dx.doi.org/10.1016/S1474-4422(18)30465-4			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE1CJ	30563681	Green Submitted			2022-12-18	WOS:000453007700005
J	Sejvar, JJ				Sejvar, J. J.			Bacterial meningitis: more can be done (vol 17, pg 1028, 2018)	LANCET NEUROLOGY			English	Correction																		Sejvar JJ, 2019, LANCET NEUROL, V18, pE1, DOI 10.1016/S1474-4422(18)30397-1	1	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2019	18	1					E1	E1		10.1016/S1474-4422(18)30397-1	http://dx.doi.org/10.1016/S1474-4422(18)30397-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE1CJ	30507382	hybrid			2022-12-18	WOS:000453007700001
J	Sepulveda-Falla, D; Villegas, A; Lopera, F; Glatzel, M				Sepulveda-Falla, Diego; Villegas, Andres; Lopera, Francisco; Glatzel, Markus			The Colombian-German network for neurodegenerative research: UndoAD	LANCET NEUROLOGY			English	Letter									[Sepulveda-Falla, Diego; Villegas, Andres; Lopera, Francisco] Univ Antioquia, Neurosci Grp Antioquia, Fac Med, Medellin, Colombia; [Sepulveda-Falla, Diego; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany	Universidad de Antioquia; University of Hamburg; University Medical Center Hamburg-Eppendorf	Glatzel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany.	m.glatzel@uke.de	Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011; Sepulveda-Falla, Diego/GLU-9062-2022	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Sepulveda-Falla, Diego/0000-0003-0176-2042				Sepulveda-Falla D, 2014, J CLIN INVEST, V124, P1552, DOI 10.1172/JCI66407; Sepulveda-Falla D, 2012, J ALZHEIMERS DIS, V32, P1, DOI 10.3233/JAD-2012-120907; Sepulveda-Falla D, 2011, BRAIN PATHOL, V21, P452, DOI 10.1111/j.1750-3639.2010.00469.x; Tariot Pierre N, 2018, Alzheimers Dement (N Y), V4, P150, DOI 10.1016/j.trci.2018.02.002	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2019	18	1					29	29		10.1016/S1474-4422(18)30458-7	http://dx.doi.org/10.1016/S1474-4422(18)30458-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE1CJ	30563680	Bronze			2022-12-18	WOS:000453007700020
J	Shah, AM; Al-Chalabi, A				Shah, Apeksha M.; Al-Chalabi, Ammar			New therapies for neuromuscular diseases in 2018	LANCET NEUROLOGY			English	Editorial Material									[Shah, Apeksha M.; Al-Chalabi, Ammar] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Dept Basic & Clin Neurosci, London SE5 9RX, England; [Shah, Apeksha M.] Barts Hlth NHS Trust, Royal London Hosp, Dept Neurol, London, England; [Al-Chalabi, Ammar] Kings Coll Hosp London, Dept Neurol, London, England	University of London; King's College London; Barts Health NHS Trust; Royal London Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Shah, AM (corresponding author), Kings Coll London, Maurice Wohl Clin Neurosci Inst, Dept Basic & Clin Neurosci, London SE5 9RX, England.; Shah, AM (corresponding author), Barts Hlth NHS Trust, Royal London Hosp, Dept Neurol, London, England.	ammar.al-chalabi@kcl.ac.uk	Al-Chalabi, Ammar/E-5361-2010	Al-Chalabi, Ammar/0000-0002-4924-7712				Adams D, 2018, NEW ENGL J MED, V379, P11, DOI 10.1056/NEJMoa1716153; Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549; Benson MD, 2018, NEW ENGL J MED, V379, P22, DOI 10.1056/NEJMoa1716793; Gaj T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aar3952; van Schaik IN, 2018, LANCET NEUROL, V17, P35, DOI 10.1016/S1474-4422(17)30378-2	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2019	18	1					12	13		10.1016/S1474-4422(18)30414-9	http://dx.doi.org/10.1016/S1474-4422(18)30414-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE1CJ	30563673				2022-12-18	WOS:000453007700010
J	[Anonymous]				[Anonymous]			The data to put neurology on top of the public-health agenda	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2019	18	1					1	1		10.1016/S1474-4422(18)30439-3	http://dx.doi.org/10.1016/S1474-4422(18)30439-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE1CJ	30563671	Bronze			2022-12-18	WOS:000453007700003
J	Hashizume, A; Katsuno, M				Hashizume, Atsushi; Katsuno, Masahisa			IGF-1 for spinal and bulbar muscular atrophy: hope and challenges	LANCET NEUROLOGY			English	Editorial Material									[Hashizume, Atsushi; Katsuno, Masahisa] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan	Nagoya University	Katsuno, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan.	ka2no@med.nagoya-u.ac.jp						Fernandez-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5; Grunseich C, 2018, LANCET NEUROL, V17, P1043, DOI 10.1016/S1474-4422(18)30320-X; Hijikata Y, 2018, NEUROLOGY, V90, pE1501, DOI 10.1212/WNL.0000000000005360; Katsuno M, EFFICACY SAFETY LEUP; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019; Rinaldi C, 2012, MOL MED, V18, P1261, DOI 10.2119/molmed.2012.00271	9	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2018	17	12					1026	1027		10.1016/S1474-4422(18)30359-4	http://dx.doi.org/10.1016/S1474-4422(18)30359-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA3AA	30337274				2022-12-18	WOS:000450119300004
J	Roman, LS; Menon, BK; Blasco, J				Roman, L. S.; Menon, B. K.; Blasco, J.			Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data (vol 17, pg 895, 2018)	LANCET NEUROLOGY			English	Correction													MENON, BIJOY K/B-7718-2014					Roman LS, 2018, LANCET NEUROL, V17, P895, DOI 10.1016/S1474-4422(18)30242-4	1	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2018	17	12					E2	E3		10.1016/S1474-4422(18)30364-8	http://dx.doi.org/10.1016/S1474-4422(18)30364-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA3AA		Bronze			2022-12-18	WOS:000450119300002
J	Sejvar, JJ				Sejvar, James J.			Bacterial meningitis: more can be done	LANCET NEUROLOGY			English	Editorial Material							SYSTEMATIC ANALYSIS; NATIONAL BURDEN; GLOBAL BURDEN; DISEASE		[Sejvar, James J.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.	zea3@cdc.gov						Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Mohammed I, 2017, PATHOG GLOB HEALTH, V111, P1, DOI 10.1080/20477724.2016.1274068; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Tartof S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063605; Zunt JR, 2018, LANCET NEUROL, V17, P1061, DOI 10.1016/S1474-4422(18)30387-9	5	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2018	17	12					1028	+		10.1016/S1474-4422(18)30397-1	http://dx.doi.org/10.1016/S1474-4422(18)30397-1			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA3AA	30507382	hybrid			2022-12-18	WOS:000450119300006
J	[Anonymous]				[Anonymous]			Will Europe be ready for the treatment of Alzheimer's disease?	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2018	17	12					1025	1025		10.1016/S1474-4422(18)30409-5	http://dx.doi.org/10.1016/S1474-4422(18)30409-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA3AA	30507381	Bronze			2022-12-18	WOS:000450119300003
J	Hacke, W; Hachinski, V				Hacke, Werner; Hachinski, Vladimir			Response to the growing dementia burden must be broader	LANCET NEUROLOGY			English	Letter							STROKE		[Hacke, Werner] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Hachinski, Vladimir] Western Univ, Dept Clin Neurol Sci, London, ON N6A 5A5, Canada	Ruprecht Karls University Heidelberg; Western University (University of Western Ontario)	Hachinski, V (corresponding author), Western Univ, Dept Clin Neurol Sci, London, ON N6A 5A5, Canada.	vladimir.hachinski@lhsc.on.ca	Hacke, Werner/ABE-8661-2020					[Anonymous], 2018, LANCET NEUROL, V17, P651, DOI [10.1016/S0140-6736(18)31258-3, 10.1016/S1474-4422(18)30256-4]; Friberg L, 2018, EUR HEART J, V39, P453, DOI 10.1093/eurheartj/ehx579; Hachinski V, INT J STROKE; Hachinski V., 2018, TREATABLE POTENTIALL, DOI [10.1017/9781316662007, DOI 10.1017/9781316662007]; Hachinski V, 2015, STROKE, V46, P3039, DOI 10.1161/STROKEAHA.115.011237; Kuzma E, 2018, ALZHEIMERS DEMENT, V14, P1416, DOI 10.1016/j.jalz.2018.06.3061; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Sposato LA, 2015, JAMA NEUROL, V72, P1529, DOI 10.1001/jamaneurol.2015.2816	8	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2018	17	11					934	934		10.1016/S1474-4422(18)30361-2	http://dx.doi.org/10.1016/S1474-4422(18)30361-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX3PG	30353864	Bronze, Green Submitted			2022-12-18	WOS:000447637500007
J	Salman, RA; Frantzias, J; Lee, RJ				Salman, Al-Shahi R.; Frantzias, J.; Lee, R. J.			Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data (vol 17, pg 885, 2018)	LANCET NEUROLOGY			English	Correction																		ALSHAHI SR, 2018, LANCET NEUROL, V17, P885	1	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2018	17	11					933	933		10.1016/S1474-4422(18)30354-5	http://dx.doi.org/10.1016/S1474-4422(18)30354-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX3PG		Green Published, hybrid			2022-12-18	WOS:000447637500006
J	Naylor, AR; Saratzis, A				Naylor, A. Ross; Saratzis, Athanasios			The fate of severe restenosis after carotid interventions	LANCET NEUROLOGY			English	Letter									[Naylor, A. Ross; Saratzis, Athanasios] Glenfield Hosp Leicester, Leicester Vasc Inst, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England		Naylor, AR (corresponding author), Glenfield Hosp Leicester, Leicester Vasc Inst, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England.	ross.naylor@uhl-tr.nhs.uk		Saratzis, Athanasios/0000-0002-3399-094X				Bonati LH, 2018, LANCET NEUROL, V17, P587, DOI 10.1016/S1474-4422(18)30195-9; Fokkema M, 2015, ANN SURG, V261, P598, DOI 10.1097/SLA.0000000000000799; Kumar R, 2017, EUR J VASC ENDOVASC, V53, P766, DOI 10.1016/j.ejvs.2017.02.016; Naylor AR, 2018, EUR J VASC ENDOVASC, V55, P3, DOI 10.1016/j.ejvs.2017.06.021	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2018	17	10					842	843		10.1016/S1474-4422(18)30315-6	http://dx.doi.org/10.1016/S1474-4422(18)30315-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT9LD	30264723	Bronze			2022-12-18	WOS:000444862200010
J	Stys, PK				Stys, Peter K.			Myelocortical multiple sclerosis: a new disease subtype?	LANCET NEUROLOGY			English	Editorial Material							DEMYELINATION; LESIONS		[Stys, Peter K.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada	University of Calgary	Stys, PK (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.	pstys@ucalgary.ca						Azevedo CJ, 2018, ANN NEUROL, V83, P223, DOI 10.1002/ana.25150; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Bo L, 2007, ARCH NEUROL-CHICAGO, V64, P76, DOI 10.1001/archneur.64.1.76; Caprariello AV, 2018, P NATL ACAD SCI USA, V115, P5528, DOI 10.1073/pnas.1721115115; Galton CJ, 2000, BRAIN, V123, P484, DOI 10.1093/brain/123.3.484; Klaver R, 2013, PRION, V7, P66, DOI 10.4161/pri.23499; Kuhlmann T, 2017, ACTA NEUROPATHOL, V133, P13, DOI 10.1007/s00401-016-1653-y; Thompson AJ, 2018, LANCET, V391, P1622, DOI 10.1016/S0140-6736(18)30481-1; Trapp BD, 2018, LANCET NEUROL, V17, P870, DOI 10.1016/S1474-4422(18)30245-X; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2018	17	10					832	834		10.1016/S1474-4422(18)30333-8	http://dx.doi.org/10.1016/S1474-4422(18)30333-8			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT9LD	30264718				2022-12-18	WOS:000444862200004
J	[Anonymous]				[Anonymous]			Novel ways to manage chronic pain are needed	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2018	17	10					829	829		10.1016/S1474-4422(18)30331-4	http://dx.doi.org/10.1016/S1474-4422(18)30331-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT9LD	30264717	Bronze			2022-12-18	WOS:000444862200001
J	Braillon, A; Bewley, S				Braillon, Alain; Bewley, Susan			EURAP registry: inadequate monitoring of prescribed drugs in pregnancy	LANCET NEUROLOGY			English	Letter									[Braillon, Alain] Univ Hosp, Dept Med, F-80000 Amiens, France; [Bewley, Susan] Kings Coll London, Womens Hlth Acad Ctr, London, England	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of London; King's College London	Braillon, A (corresponding author), Univ Hosp, Dept Med, F-80000 Amiens, France.	braillon.alain@gmail.com						Braillon A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2334; Braillon A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2582; Charlton R, 2015, PHARMACOEPIDEM DR S, V24, P1144, DOI 10.1002/pds.3847; ROBERT E, 1982, LANCET, V2, P937, DOI 10.1016/s0140-6736(82)90908-4; Tomson T, 2018, LANCET NEUROL, V17, P530, DOI 10.1016/S1474-4422(18)30107-8	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2018	17	9					741	741		10.1016/S1474-4422(18)30280-1	http://dx.doi.org/10.1016/S1474-4422(18)30280-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ3AO	30129471	Bronze			2022-12-18	WOS:000441532100007
J	[Anonymous]				[Anonymous]			A wake-up call to improve care for patients with meningitis	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2018	17	9					731	731		10.1016/S1473-3099(18)30287-1	http://dx.doi.org/10.1016/S1473-3099(18)30287-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ3AO	30129467	hybrid			2022-12-18	WOS:000441532100001
J	Atassi, N				Atassi, Nazem			When a negative trial in ALS has a positive effect on research	LANCET NEUROLOGY			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; DOUBLE-BLIND; DEXPRAMIPEXOLE; PLACEBO		[Atassi, Nazem] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Atassi, N (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02114 USA.	natassi@mgh.harvard.edu						Abe K, 2017, LANCET NEUROL, V16, P505, DOI 10.1016/S1474-4422(17)30115-1; Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Ludolph AC, 2018, LANCET NEUROL, V17, P681, DOI 10.1016/S1474-4422(18)30176-5; Miller RG, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000100	6	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2018	17	8					653	U2		10.1016/S1474-4422(18)30210-2	http://dx.doi.org/10.1016/S1474-4422(18)30210-2			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GN5BH	29934197				2022-12-18	WOS:000439057500003
J	van Schaik, IN; Bril, V; van Geloven, N				van Schaik, I. N.; Bril, V; van Geloven, N.			Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled (vol 17, pg 35, 2018)	LANCET NEUROLOGY			English	Correction													BRIL, vera/ABA-6509-2020					IN VS, 2018, LANCET NEUROL, V17, P35	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2018	17	8					661	661		10.1186/s13063-016-1466-2	http://dx.doi.org/10.1186/s13063-016-1466-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GN5BH		Green Published, gold			2022-12-18	WOS:000439057500007
J	Al-Chalabi, A; Fang, T; Al Khleifat, A; Meurgey, JH; Jones, A; Leigh, PN; Bensimon, G				Al-Chalabi, Ammar; Fang, Ton; Al Khleifat, Ahmad; Meurgey, Jacques-Henri; Jones, Ashley; Leigh, P. Nigel; Bensimon, Gilbert			Stage of prolonged survival in ALS reply	LANCET NEUROLOGY			English	Letter									[Al-Chalabi, Ammar; Fang, Ton; Al Khleifat, Ahmad; Meurgey, Jacques-Henri; Jones, Ashley] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London SE5 9RS, England; [Al-Chalabi, Ammar] Kings Coll Hosp London, London SE5 9RS, England; [Leigh, P. Nigel] Brighton & Sussex Med Sch, Dept Neurol, Sussex, England; [Bensimon, Gilbert] Hop La Pitie Salpetriere, Dept Pharmacol, Paris, France	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Al-Chalabi, A (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London SE5 9RS, England.; Al-Chalabi, A (corresponding author), Kings Coll Hosp London, London SE5 9RS, England.	ammar.al-chalabi@kcl.ac.uk	Leigh, Peter/AAD-5638-2019; Al-Chalabi, Ammar/E-5361-2010	Al-Chalabi, Ammar/0000-0002-4924-7712; Fang, Ton/0000-0003-2119-9015; Al Khleifat, Ahmad/0000-0002-7406-9831	Mitsubishi-Tanabe Pharma; Chronos Therapeutics; Orion Pharma; Cytokinetics; Rhone Poulenc-Sanofi; MRC [MR/R024804/1] Funding Source: UKRI	Mitsubishi-Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Chronos Therapeutics; Orion Pharma; Cytokinetics; Rhone Poulenc-Sanofi; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AA-C reports consultancies from Mitsubishi-Tanabe Pharma, Chronos Therapeutics, Orion Pharma, and Cytokinetics. AA-C was chief trial investigator for Orion Pharma (NCT02487407) and Cytokinetics (NCT02496767). PNL reports grants and personal fees from Rhone Poulenc-Sanofi. All other authors declare no competing interests.	Balendra R, 2015, J NEUROL NEUROSUR PS, V86, P45, DOI 10.1136/jnnp-2013-306865; Fang T, 2018, LANCET NEUROL, V17, P416, DOI 10.1016/S1474-4422(18)30054-1; Langford VL, 2014, 25 INT S ALS MND2014; Roche JC, 2012, BRAIN, V135, P847, DOI 10.1093/brain/awr351; Seibold H, 2018, STAT METHODS MED RES, V27, P3104, DOI 10.1177/0962280217693034	5	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2018	17	7					579	580		10.1016/S1474-4422(18)30208-4	http://dx.doi.org/10.1016/S1474-4422(18)30208-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK8RP	29914702	Bronze			2022-12-18	WOS:000436495200010
J	Ross, OA; Bu, GJ				Ross, Owen A.; Bu, Guojun			A novel link between trafficking and Lewy body disorders	LANCET NEUROLOGY			English	Editorial Material							APOLIPOPROTEIN-E; DISEASE RISK; THERAPY; LRP9		[Ross, Owen A.; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Ross, OA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu		Ross, Owen/0000-0003-4813-756X	National Institutes of Health [R01NS078086, U54NS10069, P50 NS072187, R01AG057181, R01AG035355, R37AG027924, R01AG046205, RF1AG051504, RF1AG056130, P01NS074969, P50AG016574]; US Department of Defense [W81XWH-17-1-0249]; Little Family Foundation; Mangurian Foundation; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969, R01NS078086, P50NS072187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG051504, R01AG035355, R01AG046205, R37AG027924, RF1AG056130, P50AG016574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Little Family Foundation; Mangurian Foundation; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We declare no competing interests. OAR is supported by National Institutes of Health grants R01NS078086, U54NS10069, and P50 NS072187, US Department of Defense award W81XWH-17-1-0249, The Little Family Foundation, and the Mangurian Foundation for Lewy body research. GB is supported by National Institutes of Health grants R01AG057181, R01AG035355, R37AG027924, R01AG046205, RF1AG051504, RF1AG056130, P01NS074969, P50AG016574, and a grant from the Cure Alzheimer's Fund.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Boucher R, 2008, HISTOCHEM CELL BIOL, V130, P315, DOI 10.1007/s00418-008-0436-5; Brodeur J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-31; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Doray B, 2008, TRAFFIC, V9, P1551, DOI 10.1111/j.1600-0854.2008.00786.x; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Quadri M, 2018, LANCET NEUROL, V17, P597, DOI 10.1016/S1474-4422(18)30179-0; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	10	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2018	17	7					571	573		10.1016/S1474-4422(18)30214-X	http://dx.doi.org/10.1016/S1474-4422(18)30214-X			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK8RP	29887160				2022-12-18	WOS:000436495200003
J	[Anonymous]				[Anonymous]			Difficult choices in treating Parkinson's disease psychosis	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2018	17	7					569	569		10.1016/S1474-4422(18)30209-6	http://dx.doi.org/10.1016/S1474-4422(18)30209-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK8RP	29858161	Bronze			2022-12-18	WOS:000436495200001
J	Dubois, B; Epelbaum, S; Nyasse, F				Dubois, B.; Epelbaum, S.; Nyasse, F.			Accelerated long-term forgetting in asymptomatic APOE epsilon 4 carriers (vol 17, pg 394, 2018)	LANCET NEUROLOGY			English	Correction													Epelbaum, Stephane/AAZ-5544-2020	Epelbaum, Stephane/0000-0003-4059-2891				Zimmermann JF, 2018, LANCET NEUROL, V17, P394, DOI 10.1016/S1474-4422(18)30078-4	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2018	17	6					495	495		10.1016/S1474-4422(18)30156	http://dx.doi.org/10.1016/S1474-4422(18)30156			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1RD					2022-12-18	WOS:000432463400012
J	Sechi, E; Keegan, BM; Flanagan, EP				Sechi, Elia; Keegan, B. Mark; Flanagan, Eoin P.			Applying the 2017 McDonald diagnostic criteria for multiple sclerosis	LANCET NEUROLOGY			English	Letter									[Sechi, Elia; Keegan, B. Mark; Flanagan, Eoin P.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Flanagan, Eoin P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Flanagan, EP (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.; Flanagan, EP (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	flanagan.eoin@mayo.edu	Sechi, Elia/AAN-7592-2021	Sechi, Elia/0000-0003-4698-663X	Biogen	Biogen(Biogen)	BMK has research funded by Biogen, and receives publishing royalties for Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases; he is a member of the editorial board of Multiple Sclerosis and Related Disorders. ES and EPF declare no competing interests.	Keegan BM, 2016, NEUROLOGY, V87, P1713, DOI 10.1212/WNL.0000000000003235; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Schmalstieg WF, 2012, NEUROLOGY, V78, P540, DOI 10.1212/WNL.0b013e318247cc8c; Thompson AJ, 2000, ANN NEUROL, V47, P831; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2	5	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2018	17	6					498	499		10.1016/S1474-4422(18)30166-2	http://dx.doi.org/10.1016/S1474-4422(18)30166-2			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1RD	29778359	Bronze			2022-12-18	WOS:000432463400018
J	[Anonymous]				[Anonymous]			Strong alliances to improve stroke care	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2018	17	6					481	481		10.1016/S1474-4422(18)30177-7	http://dx.doi.org/10.1016/S1474-4422(18)30177-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GG1RD	29778350	Bronze			2022-12-18	WOS:000432463400001
J	Uniyal, R; Garg, RK; Malhotra, HS; Kumar, N; Pandey, S				Uniyal, Ravi; Garg, Ravindra Kumar; Malhotra, Hardeep Singh; Kumar, Neeraj; Pandey, Shweta			Intravenous versus subcutaneous immunoglobulin	LANCET NEUROLOGY			English	Letter									[Uniyal, Ravi; Garg, Ravindra Kumar; Malhotra, Hardeep Singh; Kumar, Neeraj; Pandey, Shweta] King George Med Univ, Dept Neurol, Lucknow 226003, Uttar Pradesh, India	King George's Medical University	Uniyal, R (corresponding author), King George Med Univ, Dept Neurol, Lucknow 226003, Uttar Pradesh, India.	raviuniyal@kgmcindia.edu	Malhotra, Hardeep Singh/E-6773-2011	Malhotra, Hardeep Singh/0000-0003-0438-4446				Berger M, 2015, MUSCLE NERVE, V51, P315, DOI 10.1002/mus.24526; Berger M, 2013, J CLIN IMMUNOL, V33, P984, DOI 10.1007/s10875-013-9876-3; Bonilla FA, 2008, IMMUNOL ALLERGY CLIN; Pollard JD, 2011, J PERIPHER NERV SYST, V16, P15, DOI 10.1111/j.1529-8027.2011.00323.x; van Schaik IN, 2018, LANCET NEUROL, V17, P35, DOI 10.1016/S1474-4422(17)30378-2	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2018	17	5					393	393		10.1016/S1474-4422(18)30106-6	http://dx.doi.org/10.1016/S1474-4422(18)30106-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC7JA	29656737				2022-12-18	WOS:000429968100010
J	Caprariello, AV; Stys, PK				Caprariello, Andrew V.; Stys, Peter K.			Two steps forward for myelin repair in multiple sclerosis	LANCET NEUROLOGY			English	Editorial Material							REMYELINATION; BRAIN		[Caprariello, Andrew V.; Stys, Peter K.] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada	University of Calgary	Stys, PK (corresponding author), Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.	pstys@ucalgary.ca	Caprariello, Andrew/L-2291-2019	Caprariello, Andrew/0000-0002-2529-5621				ADAMS CWM, 1977, BRIT MED BULL, V33, P15, DOI 10.1093/oxfordjournals.bmb.a071388; Berghoff SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14241; Brugarolas P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18747-3; Cantuti-Castelvetri L, 2018, SCIENCE, V359, P684, DOI 10.1126/science.aan4183; Fard MK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7816; Giovannoni G, 2016, NEUROLOGY, V87, P1985, DOI 10.1212/WNL.0000000000003319; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; JEFFERY ND, 1995, J NEUROCYTOL, V24, P775, DOI 10.1007/BF01191213; Mount CW, 2017, NEURON, V95, P743, DOI 10.1016/j.neuron.2017.07.009; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pihl-Jensen G, 2015, CNS DRUGS, V29, P277, DOI 10.1007/s40263-015-0239-x; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325	12	1	1	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2018	17	4					297	298		10.1016/S1474-4422(18)30070-X	http://dx.doi.org/10.1016/S1474-4422(18)30070-X			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ3AO	29496303				2022-12-18	WOS:000427458000007
J	Wilson, L; von Steinbuechel, N; Menon, DK; Maas, AIR				Wilson, Lindsay; von Steinbuechel, Nicole; Menon, David K.; Maas, Andrew I. R.			Outcome assessment after traumatic brain injury Reply	LANCET NEUROLOGY			English	Letter									[Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland; [von Steinbuechel, Nicole] Unid Med Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium	University of Stirling; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Antwerp; University of Antwerp	Wilson, L (corresponding author), Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland.	j.t.l.wilson@stir.ac.uk	Maas, Andrew IR/C-5584-2013; Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019	Maas, Andrew IR/0000-0003-1612-1264; Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328	European Union FP7 programme [602150]; Idorsia Pharmaceuticals; NeuroTraumaSciences; Laantasman AB; GlaxoSmithKline; Ornim Medical; Pfizer	European Union FP7 programme; Idorsia Pharmaceuticals; NeuroTraumaSciences; Laantasman AB; GlaxoSmithKline(GlaxoSmithKline); Ornim Medical; Pfizer(Pfizer)	All authors report grants from the European Union FP7 programme (grant number 602150). LW reports personal fees from Idorsia Pharmaceuticals. DKM reports personal fees from NeuroTraumaSciences, Laantasman AB, GlaxoSmithKline, Ornim Medical, and Pfizer, and grants from GlaxoSmithKline.	Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139	5	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2018	17	4					299	300		10.1016/S1474-4422(18)30045-0	http://dx.doi.org/10.1016/S1474-4422(18)30045-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ3AO	29553376				2022-12-18	WOS:000427458000011
J	Meyfroidt, G; Baguley, IJ; Menon, DK				Meyfroidt, G.; Baguley, I. J.; Menon, D. K.			Paroxysmal sympathetic hyperactivity: the storm after acute brain injury (vol 16, pg 721, 2017)	LANCET NEUROLOGY			English	Correction													Baguley, Ian/AAM-5828-2021					Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4	1	1	1	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2018	17	3					203	203		10.1016/S1474-4422(17)30259-4	http://dx.doi.org/10.1016/S1474-4422(17)30259-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FW1WE		Green Accepted, Green Submitted			2022-12-18	WOS:000425090000008
J	Cabrera, LY; Illes, J				Cabrera, Laura Y.; Illes, Judy			Balancing ethics and care in disorders of consciousness	LANCET NEUROLOGY			English	Editorial Material							STIMULATION; STATE		[Cabrera, Laura Y.] Michigan State Univ, Ctr Eth & Humanities Life Sci, Dept Translat Sci & Mol Med, E Lansing, MI 48824 USA; [Illes, Judy] Univ British Columbia, Neuroeth Canada, Div Neurol, Dept Med, Vancouver, BC V6T 2B5, Canada	Michigan State University; University of British Columbia	Illes, J (corresponding author), Univ British Columbia, Neuroeth Canada, Div Neurol, Dept Med, Vancouver, BC V6T 2B5, Canada.	jilles@mail.ubc.ca			ERA-NET NEURON grant [ERN-14424]; Canadian Institutes of Health Research grant [EOG120257]	ERA-NET NEURON grant; Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	We declare no competing interests. LYC and JI are supported in part by ERA-NET NEURON grant ERN-14424. Past related support from Canadian Institutes of Health Research grant EOG120257 to JI is also gratefully acknowledged.	Cabral E, 2017, JAMA NEUROL, V74, P501, DOI 10.1001/jamaneurol.2016.5994; Cabrera LY, 2017, STEREOT FUNCT NEUROS, V95, P100; Corazzol M, 2017, CURR BIOL, V27, pR994, DOI 10.1016/j.cub.2017.07.060; Fins JJ, 2015, RIGHTS COME MIND BRA; Schiff ND, 2009, ARCH NEUROL-CHICAGO, V66, P697, DOI 10.1001/archneurol.2009.79; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141	7	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2018	17	2					112	113		10.1016/S1474-4422(17)30402-7	http://dx.doi.org/10.1016/S1474-4422(17)30402-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT0PA	29153410				2022-12-18	WOS:000422828500008
J	Parashos, SA				Parashos, Sotirios A.			Parkinson's disease physiotherapy: specialisation adds value	LANCET NEUROLOGY			English	Editorial Material									[Parashos, Sotirios A.] Struthers Parkinsons Ctr, Golden Valley, MN 55427 USA		Parashos, SA (corresponding author), Struthers Parkinsons Ctr, Golden Valley, MN 55427 USA.	sotirios.parashos@parknicollet.com						Abbruzzese G, 2016, PARKINSONISM RELAT D, V22, pS60, DOI 10.1016/j.parkreldis.2015.09.005; [Anonymous], 2016, EBC RES PROJ VAL TRE; Bombieri F, 2017, PARKINSONISM RELAT D, V38, P8, DOI 10.1016/j.parkreldis.2017.02.004; Ypinga JHL, 2017, LANCET NEUROL	4	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2018	17	2					108	109		10.1016/S1474-4422(17)30437-4	http://dx.doi.org/10.1016/S1474-4422(17)30437-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT0PA	29246469				2022-12-18	WOS:000422828500005
J	Fornage, M				Fornage, Myriam			The genetic architecture of dementia with Lewy bodies is shaping up	LANCET NEUROLOGY			English	Editorial Material							GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; RISK LOCI; METAANALYSIS; ALZHEIMERS		[Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Fornage, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA.	myriam.fornage@uth.tmc.edu			NIA NIH HHS [U01 AG052409] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Ferrari R, 2017, J NEUROL NEUROSUR PS, V88, P152, DOI 10.1136/jnnp-2016-314411; Guerreiro R, 2018, LANCET NEUROL, V17, P64, DOI 10.1016/S1474-4422(17)30400-3; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Tagliafierro L, 2016, NEUROGENETICS, V17, P145, DOI 10.1007/s10048-016-0478-0; Vergouw LJM, 2017, PARKINSONISM RELAT D, V43, P1, DOI 10.1016/j.parkreldis.2017.07.009	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2018	17	1					25	26		10.1016/S1474-4422(17)30411-8	http://dx.doi.org/10.1016/S1474-4422(17)30411-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ7VE	29262999				2022-12-18	WOS:000418570500016
J	Lees, AJ				Lees, Andrew J.			Advice for those trying to find a cure for the shaking palsy	LANCET NEUROLOGY			English	Letter							PARKINSONS-DISEASE; MUCUNA-PRURIENS; DOUBLE-BLIND		[Lees, Andrew J.] Natl Hosp, Queen Sq, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Lees, AJ (corresponding author), Natl Hosp, Queen Sq, London WC1N 3BG, England.	andrew.lees@ucl.ac.uk	Lees, Andrew J/A-6605-2009	Lees, Andrew J/0000-0002-2476-4385				[Anonymous], 2003, CHASE CHANCE CREATIV; Burroughs W.S., 1953, JUNKIE; Burroughs WS, 1966, NEW STATESMAN; Buurroughs WS, 1969, THE YAGE LETT; Cilia R, 2017, NEUROLOGY, V89, P432, DOI 10.1212/WNL.0000000000004175; Easton A., 2017, LANCET NEUROL, V16, P778; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1672, DOI 10.1136/jnnp.2003.028761; STIBE CMH, 1988, LANCET, V1, P403; Weil RS, 2016, BRAIN, V139, P2827, DOI 10.1093/brain/aww175	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2018	17	1					27	28		10.1016/S1474-4422(17)30430-1	http://dx.doi.org/10.1016/S1474-4422(17)30430-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ7VE	29263002	Bronze			2022-12-18	WOS:000418570500020
J	Mercuri, E				Mercuri, Eugenio			Neuromuscular disorders: 2017, a year to remember	LANCET NEUROLOGY			English	Editorial Material							DUCHENNE MUSCULAR-DYSTROPHY; ATROPHY		[Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Paediat Neurol Unit, Dept Womens & Childrens Hlth, I-00168 Rome, RM, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Paediat Neurol Unit, Dept Womens & Childrens Hlth, I-00168 Rome, RM, Italy.	mercuri@rm.unicatt.it	Mercuri, Eugenio/G-1351-2015	Mercuri, Eugenio/0000-0002-9851-5365				Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Le Guiner C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16105; McDonald CM, 2017, LANCET, V390, P1489, DOI 10.1016/S0140-6736(17)31611-2; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192	6	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2018	17	1					12	13		10.1016/S1474-4422(17)30418-0	http://dx.doi.org/10.1016/S1474-4422(17)30418-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ7VE	29262992				2022-12-18	WOS:000418570500008
J	LeWitt, P				LeWitt, Peter			Portrayal of progressive supranuclear palsy in the 16th century	LANCET NEUROLOGY			English	Letter							DYSTONIA		[LeWitt, Peter] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [LeWitt, Peter] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	LeWitt, P (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.; LeWitt, P (corresponding author), Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA.	plewitt1@hfhs.org	LeWitt, Peter/AAW-4988-2020					Barclay CL, 1997, J NEUROL NEUROSUR PS, V62, P352, DOI 10.1136/jnnp.62.4.352; Batla A, 2010, J NEUROL SCI, V298, P148, DOI 10.1016/j.jns.2010.08.010; Bologna M, 2013, J NEUROL NEUROSUR PS, V84, P681, DOI 10.1136/jnnp-2012-303993; Goetz CG, 1996, MOVEMENT DISORD, V11, P617, DOI 10.1002/mds.870110604; JANKOVIC J, 1984, NEUROL CLIN, V2, P473, DOI 10.1016/S0733-8619(18)31085-5; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2017	16	12					956	957		10.1016/S1474-4422(17)30366-6	http://dx.doi.org/10.1016/S1474-4422(17)30366-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8DJ	29165255	Bronze			2022-12-18	WOS:000415315400013
J	Terkelsen, AJ; Karlsson, P; Lauria, G; Freeman, R; Finnerup, NB; Jensen, TS				Terkelsen, A. J.; Karlsson, P.; Lauria, G.; Freeman, R.; Finnerup, N. B.; Jensen, T. S.			AJT has participated in an investigator-sponsored study provided by Sanofi Genzyme and Alynylam Pharmaceuticals (vol 16, pg 934, 2017)	LANCET NEUROLOGY			English	Correction													Finnerup, Nanna Brix/ABA-8219-2020	Finnerup, Nanna Brix/0000-0001-5541-0240	Sanofi Genzyme; Alynylam Pharmaceuticals	Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); Alynylam Pharmaceuticals	Terkelsen A J, Karlsson P, Lauria G, Freeman R, Finnerup N B, Jensen T S. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol 2017; 16: 934-44. The declaration of interests section of this article should have stated, "AJT has participated in an investigator-sponsored study provided by Sanofi Genzyme and Alynylam Pharmaceuticals." This correction has been made to the online version as of Oct 16, 2017.	Terkelsen AJ, 2017, LANCET NEUROL, V16, P934, DOI 10.1016/S1474-4422(17)30329-0	1	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2017	16	12					954	954		10.1016/S1474-4422(17)30361-7	http://dx.doi.org/10.1016/S1474-4422(17)30361-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8DJ		Bronze			2022-12-18	WOS:000415315400007
J	Scholz, SW				Scholz, Sonja W.			Restless legs syndrome: is it all in the genes?	LANCET NEUROLOGY			English	Editorial Material							SYNDROME RLS; DEPRESSION		[Scholz, Sonja W.] NINDS, Neurodegenerat Dis Res Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Scholz, Sonja W.] Johns Hopkins Univ, Dept Neurol, Med Ctr, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Scholz, SW (corresponding author), NINDS, Neurodegenerat Dis Res Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Scholz, SW (corresponding author), Johns Hopkins Univ, Dept Neurol, Med Ctr, Baltimore, MD 21218 USA.	sonja.scholz@nih.gov	Scholz, Sonja W./R-5524-2017; Scholz, Sonja/AAN-6601-2021	Scholz, Sonja W./0000-0002-6623-0429; Scholz, Sonja/0000-0002-6623-0429	Intramural Research Program of the National Institutes of Health (National Institute of Neurological Disorders and Stroke) [1ZIA-NS003154-2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003154] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (National Institute of Neurological Disorders and Stroke); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I declare no competing interests. This research was supported by the Intramural Research Program of the National Institutes of Health (National Institute of Neurological Disorders and Stroke; project number 1ZIA-NS003154-2).	Allen RP, 2000, SLEEP MED, V1, P11, DOI 10.1016/S1389-9457(99)00012-X; Li YP, 2012, AM J EPIDEMIOL, V176, P279, DOI 10.1093/aje/kws016; Pearson VE, 2006, SLEEP MED, V7, P25, DOI 10.1016/j.sleep.2005.05.006; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Schormair B, 2017, LANCET NEUROL, V16, P898, DOI 10.1016/S1474-4422(17)30327-7; Sevim S, 2004, J NEUROL NEUROSUR PS, V75, P226; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171	8	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2017	16	11					859	860		10.1016/S1474-4422(17)30330-7	http://dx.doi.org/10.1016/S1474-4422(17)30330-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FJ3WM	29029839				2022-12-18	WOS:000412663200003
J	Anderson, CS				Anderson, Craig S.			NOR-TEST-ing tenecteplase in acute ischaemic stroke	LANCET NEUROLOGY			English	Editorial Material									[Anderson, Craig S.] UNSW, Fac Med, George Inst Global Hlth, Sydney, NSW, Australia; [Anderson, Craig S.] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth China, Beijing 100088, Peoples R China	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Peking University	Anderson, CS (corresponding author), UNSW, Fac Med, George Inst Global Hlth, Sydney, NSW, Australia.; Anderson, CS (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth China, Beijing 100088, Peoples R China.	canderson@georgeinstitute.org.cn	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Anderson, Craig/0000-0002-7248-4863	National Health and Medical Research Council of Australia; Boehringer Ingelheim; Takeda	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Boehringer Ingelheim(Boehringer Ingelheim); Takeda(Takeda Pharmaceutical Company Ltd)	I am principal investigator of the ENCHANTED study, which was funded from the National Health and Medical Research Council of Australia, and have received speaker fees and travel reimbursement from Boehringer Ingelheim and Takeda.	Anderson CS, 2016, NEW ENGL J MED, V374, P2313, DOI 10.1056/NEJMoa1515510; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Logallo N, 2017, LANCET NEUROL; Parsons M, 2012, N ENGL J MED	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2017	16	10					762	763		10.1016/S1474-4422(17)30277-6	http://dx.doi.org/10.1016/S1474-4422(17)30277-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG5PI	28800868				2022-12-18	WOS:000410379900002
J	Callaghan, BC; O'Brien, PD; Hinder, LM; Feldman, EL				Callaghan, Brian C.; O'Brien, Phillipe D.; Hinder, Lucy M.; Feldman, Eva L.			Obesity and the nervous system: more questions Reply	LANCET NEUROLOGY			English	Letter							HELICOBACTER-PYLORI INFECTION; MIGRAINE		[Callaghan, Brian C.; O'Brien, Phillipe D.; Hinder, Lucy M.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Callaghan, BC (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48104 USA.	bcallagh@med.umich.edu	O'Brien, Phillipe D/I-3318-2019; O'Brien, Phillipe/W-4268-2019	O'Brien, Phillipe D/0000-0002-6365-3477; Feldman, Eva/0000-0002-9162-2694; Hinder, Lucy/0000-0002-5206-8010	K23 grant from the National Institutes of Health [NS079417]; Impeto Medical Inc; Patient-Centered Outcomes Research Institute (PCORI); NIDDK [R24 DK082841, R01 DK107956]; Novo Nordisk Foundation [NNF14SA0006]; Program for Neurology Research Discovery; A Alfred Taubman Medical Research Institute	K23 grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Impeto Medical Inc; Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Program for Neurology Research Discovery; A Alfred Taubman Medical Research Institute	BCC reports a K23 grant from the National Institutes of Health (no. NS079417), research funding from Impeto Medical Inc, and a grant from the Patient-Centered Outcomes Research Institute (PCORI); performs medical legal consultations; and acts as a consultant for the Immune Tolerance Network. ELF reports grants from NIDDK (no. R24 DK082841, no. R01 DK107956), Novo Nordisk Foundation (no. NNF14SA0006), the Program for Neurology Research & Discovery, and the A Alfred Taubman Medical Research Institute. All other authors declare no competing interests.	Gelaye B, 2017, NEUROLOGY, V88, P1795, DOI [10.1212/WNL.0000000000003919, 10.1212/wnl.0000000000003919]; Kountouras J, 2007, EUR J NEUROL, V14, P976, DOI 10.1111/j.1468-1331.2007.01827.x; Kountouras J, 2006, NEUROLOGY, V66, P938, DOI 10.1212/01.wnl.0000203644.68059.5f; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4; Peterlin BL, 2016, HEADACHE, V56, P622, DOI 10.1111/head.12788	5	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2017	16	10					774	774		10.1016/S1474-4422(17)30293-4	http://dx.doi.org/10.1016/S1474-4422(17)30293-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG5PI	28920882				2022-12-18	WOS:000410379900013
J	Kountouras, J; Polyzos, SA; Katsinelos, P; Kotronis, G; Doulberis, M				Kountouras, Jannis; Polyzos, Stergios A.; Katsinelos, Panagiotis; Kotronis, Georgios; Doulberis, Michael			Obesity and the nervous system: more questions	LANCET NEUROLOGY			English	Letter							HELICOBACTER-PYLORI; EXTRAGASTRIC DISEASES		[Kountouras, Jannis; Polyzos, Stergios A.; Katsinelos, Panagiotis; Kotronis, Georgios; Doulberis, Michael] Aristotle Univ Thessaloniki, Dept Med, Med Clin 2, Ippokrat Hosp, Thessaloniki 55133, Greece	Aristotle University of Thessaloniki	Kountouras, J (corresponding author), Aristotle Univ Thessaloniki, Dept Med, Med Clin 2, Ippokrat Hosp, Thessaloniki 55133, Greece.	jannis@med.auth.gr	Polyzos, Stergios/H-2844-2019; Doulberis, Michael/Y-5118-2018	Polyzos, Stergios/0000-0001-9232-4042; Doulberis, Michael/0000-0002-0396-5081; Kotronis, Georgios/0000-0003-3767-6365				Franceschi F, 2015, HELICOBACTER, V20, P40, DOI 10.1111/hel.12256; Kountouras J, 2007, EUR J NEUROL, V14, P976, DOI 10.1111/j.1468-1331.2007.01827.x; Kountouras J, 2017, FREE RADICAL RES, V51, P73, DOI 10.1080/10715762.2016.1271122; Kountouras J, 2008, LANCET NEUROL, V7, P1080, DOI 10.1016/S1474-4422(08)70247-3; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2017	16	10					772	773		10.1016/S1474-4422(17)30291-0	http://dx.doi.org/10.1016/S1474-4422(17)30291-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG5PI	28920879	Bronze			2022-12-18	WOS:000410379900011
J	Byrne, LM; Rodrigues, FB; Blennow, K				Byrne, L. M.; Rodrigues, F. B.; Blennow, K.			Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis (vol 16, pg 601, 2017)	LANCET NEUROLOGY			English	Correction													Byrne, Lauren/C-4572-2017; Rodrigues, Filipe Brogueira/R-2679-2017	Byrne, Lauren/0000-0003-1650-4273; Rodrigues, Filipe Brogueira/0000-0002-5567-7938				BYME LM, 2017, LANCET NEUROL, V16, P601	1	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2017	16	9					683	683		10.1016/S1474-4422(17)30255-7	http://dx.doi.org/10.1016/S1474-4422(17)30255-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC8ZW		Green Published, hybrid			2022-12-18	WOS:000407131400008
J	Finsterer, J				Finsterer, Josef			Low risk of ischaemic stroke in hyperhomocysteinaemia	LANCET NEUROLOGY			English	Editorial Material							HOMOCYSTEINE LEVELS; FOLIC-ACID; ASSOCIATION; PREVENTION		[Finsterer, Josef] Rudolfstiftung Hosp, A-1180 Vienna, Austria	Rudolfstiftung Hospital	Finsterer, J (corresponding author), Rudolfstiftung Hosp, A-1180 Vienna, Austria.	fifigs1@yahoo.de						Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Huo Y, 2015, JAMA-J AM MED ASSOC, V313, P1325, DOI 10.1001/jama.2015.2274; JAIN S, 1986, Neuroepidemiology, V5, P1, DOI 10.1159/000110808; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Mittal M, 2017, FOOD NUTR BULL, V38, P209, DOI 10.1177/0379572117697535; Pang H, 2016, CLIN THER, V38, P1184, DOI 10.1016/j.clinthera.2016.03.007; Spence JD, 2017, LANCET NEUROL, V16, P750, DOI 10.1016/S1474-4422(17)30180-1; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Wang WJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00070; Wong CW, 2015, HONG KONG MED J, V21, P155, DOI 10.12809/hkmj144383	10	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2017	16	9					682	683		10.1016/S1474-4422(17)30260-0	http://dx.doi.org/10.1016/S1474-4422(17)30260-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC8ZW	28816114				2022-12-18	WOS:000407131400005
J	Liu, G; Locascio, JJ; Corvol, JC				Liu, G.; Locascio, J. J.; Corvol, J-C			Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts (vol 16, pg 620, 2017)	LANCET NEUROLOGY			English	Correction													Corvol, Jean-Christophe/F-2124-2017	Corvol, Jean-Christophe/0000-0001-7325-0199				Liu GQ, 2017, LANCET NEUROL, V16, P620, DOI 10.1016/S1474-4422(17)30122-9	1	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2017	16	9					683	683		10.1016/S1474-4422(17)30254-5	http://dx.doi.org/10.1016/S1474-4422(17)30254-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC8ZW		Bronze			2022-12-18	WOS:000407131400007
J	Saft, C				Saft, Carsten			Identifying modifiers of Huntington's disease progression	LANCET NEUROLOGY			English	Editorial Material							INSTABILITY; REPEAT		[Saft, Carsten] Ruhr Univ Bochum, Dept Neurol, Huntington Ctr NRW, St Josef Hosp, D-44791 Bochum, Germany	Ruhr University Bochum	Saft, C (corresponding author), Ruhr Univ Bochum, Dept Neurol, Huntington Ctr NRW, St Josef Hosp, D-44791 Bochum, Germany.	carsten.saft@ruhr-uni-bochum.de		Saft, Carsten/0000-0002-3983-7292	Teva Pharma GmbH; Biogen; CHDI	Teva Pharma GmbH(Teva Pharmaceutical Industries); Biogen(Biogen); CHDI	As an earlier REGISTRY investigator I was involved in collecting data for the REGISTRY study. I was, however, not involved in study design, or in the analysis or interpretation of the data used in the work by Hensman Moss and colleagues. I have received: honoraria from Temmler Pharma GmbH and Co, Desitin Arzneimittel GmbH, and TEVA GmbH for scientific talks; institutional compensation, travel, or accommodation payments in the context of the REGISTRY study of the Euro-HD-Network, the ENROLL-HD study (Cure Huntington's Disease Initiative [CHDI]), in the context of the MitoNet-study, the ACR16-Study (Neurosearch), the AFQ-Study (Novartis), the Selisistat-Studies (Siena Biotech), the PRIDE-HD-Studies (TEVA), the Amaryllis-Study (Pfizer), Ipsen, Antisense-Study (IONIS); and support for a research project with Teva Pharma GmbH, Biogen, and the CHDI.	Arning L, 2013, NEUROGENETICS, V14, P171, DOI 10.1007/s10048-013-0365-x; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Genetic Modifiers of Huntington's Disease (GeM-HD) Consortium, 2015, CELL, V3, P5162; Hensman Moss DJ, 2017, LANCET NEUROL; Landwehrmeyer GB, 2017, MOV DISORD CLIN PRAC, V4, P212, DOI 10.1002/mdc3.12388; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Morales F, 2016, DNA REPAIR, V40, P57, DOI 10.1016/j.dnarep.2016.01.001; Orth M, 2011, J NEUROL NEUROSUR PS, V82, P1409, DOI 10.1136/jnnp.2010.209668; Paulsen JS, 2014, LANCET NEUROL, V13, P1193, DOI 10.1016/S1474-4422(14)70238-8; Saft C, 2014, LANCET NEUROL, V13, P1165, DOI 10.1016/S1474-4422(14)70260-1; Schmidt MHM, 2016, DNA REPAIR, V38, P117, DOI 10.1016/j.dnarep.2015.11.008; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7	13	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2017	16	9					679	680		10.1016/S1474-4422(17)30179-5	http://dx.doi.org/10.1016/S1474-4422(17)30179-5			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC8ZW	28642122				2022-12-18	WOS:000407131400003
J	Lamberink, HJ; Otte, WM; Geerts, AT				Lamberink, H. J.; Otte, W. M.; Geerts, A. T.			Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis (vol 16, pg 523, 2017)	LANCET NEUROLOGY			English	Correction																		Lamberink HJ, 2017, LANCET NEUROL, V16, P523, DOI 10.1016/S1474-4422(17)30114-X	1	1	1	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2017	16	8					584	584		10.1016/S1474-4422(17)30114-X	http://dx.doi.org/10.1016/S1474-4422(17)30114-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA1LP		Green Submitted			2022-12-18	WOS:000405201300012
J	Knecht, S; Petsch, S; Studer, B				Knecht, Stefan; Petsch, Sebastian; Studer, Bettina			Atrial fibrillation in high-risk patients with ischaemic stroke	LANCET NEUROLOGY			English	Letter							MORTALITY; COHORT		[Knecht, Stefan; Petsch, Sebastian; Studer, Bettina] Mauritius Hosp Meerbusch, Dept Neurol, D-40670 Meerbusch, Germany; [Knecht, Stefan; Studer, Bettina] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Fac Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Knecht, S (corresponding author), Mauritius Hosp Meerbusch, Dept Neurol, D-40670 Meerbusch, Germany.; Knecht, S (corresponding author), Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Fac Med, D-40225 Dusseldorf, Germany.	stefan.knecht@stmtk.de	Studer, Bettina/AAI-8179-2021; Studer, Bettina/AFV-9290-2022	Studer, Bettina/0000-0002-9483-385X; Studer, Bettina/0000-0002-9483-385X				Knecht S, 2016, J NEUROL NEUROSUR PS, V87, P526, DOI 10.1136/jnnp-2015-310344; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; McGrath ER, 2013, NEUROLOGY, V81, P825, DOI 10.1212/WNL.0b013e3182a2cc15; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Wachter R, 2017, LANCET NEUROL, V16, P282, DOI 10.1016/S1474-4422(17)30002-9	5	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2017	16	7					498	498		10.1016/S1474-4422(17)30172-2	http://dx.doi.org/10.1016/S1474-4422(17)30172-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX4MH	28653643	Bronze			2022-12-18	WOS:000403208400008
J	[Anonymous]				[Anonymous]			Prepublication and clinical practice: challenges ahead	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2017	16	6					409	409		10.1016/S1474-4422(17)30131-X	http://dx.doi.org/10.1016/S1474-4422(17)30131-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EU1WD	28504101				2022-12-18	WOS:000400815800001
J	Biousse, V; Newman, NJ				Biousse, Valerie; Newman, Nancy J.			Diagnosis and classification of optic neuropathies Reply	LANCET NEUROLOGY			English	Letter									[Biousse, Valerie; Newman, Nancy J.] Emory Univ, Sch Med, Emory Eye Ctr, Atlanta, GA 30322 USA	Emory University	Biousse, V (corresponding author), Emory Univ, Sch Med, Emory Eye Ctr, Atlanta, GA 30322 USA.	vbiouss@emory.edu	Newman, Nancy/AAB-2532-2021		(Department of Ophthalmology) from Research to Prevent Blindness Inc, New York; National Institutes of Health(NIH)/National Eye Institute [P30-EY06360]; NIH/National Institute of Neurological Disorders and Stroke [RO1NSO89694]	(Department of Ophthalmology) from Research to Prevent Blindness Inc, New York; National Institutes of Health(NIH)/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	VB and NJN are consultants for GenSight Biologics. NJN is a consultant for Santhera Pharmaceuticals. VB and NJN are supported in part by an unrestricted departmental grant (Department of Ophthalmology) from Research to Prevent Blindness Inc, New York, by National Institutes of Health(NIH)/National Eye Institute core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine), and by NIH/National Institute of Neurological Disorders and Stroke (RO1NSO89694).	Biousse V, 2016, LANCET NEUROL, V15, P1355, DOI 10.1016/S1474-4422(16)30237-X; Bruce BB, 2014, J NEURO-OPHTHALMOL, V34, P288, DOI 10.1097/WNO.0000000000000153	2	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2017	16	5					343	+		10.1016/S1474-4422(17)30093-5	http://dx.doi.org/10.1016/S1474-4422(17)30093-5			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER4PH	28414647	Bronze			2022-12-18	WOS:000398782100010
J	Cramer, SC				Cramer, Steven C.			Can allogeneic stem cells improve outcomes after stroke?	LANCET NEUROLOGY			English	Editorial Material							NEUROPROTECTIVE THERAPY; CLINICAL-TRIALS; RECOVERY; REHABILITATION		[Cramer, Steven C.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Dept Anat & Neurobiol, Dept Neurol, Irvine, CA 92697 USA; [Cramer, Steven C.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Dept Phys Med & Rehabil, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cramer, SC (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Dept Anat & Neurobiol, Dept Neurol, Irvine, CA 92697 USA.; Cramer, SC (corresponding author), Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Dept Phys Med & Rehabil, Irvine, CA 92697 USA.	scramer@uci.edu			MicroTransponder; Dart Neuroscience; Toyama; RAND Corporation; Roche; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	MicroTransponder; Dart Neuroscience; Toyama; RAND Corporation; Roche(Roche Holding); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	I received personal fees from MicroTransponder, Dart Neuroscience, Toyama, RAND Corporation, and Roche.	Cramer SC, 2007, STROKE, V38, P1393, DOI 10.1161/01.STR.0000260087.67462.80; Cramer SC, 2017, STROKE, V48, P813, DOI 10.1161/STROKEAHA.116.015501; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dorman PJ, 1996, STROKE, V27, P1507, DOI 10.1161/01.STR.27.9.1507; GROTTA J, 1995, J INTERN MED, V237, P89, DOI 10.1111/j.1365-2796.1995.tb01145.x; Guadagno JV, 2008, BRAIN, V131, P2666, DOI 10.1093/brain/awn175; Hess DC, 2017, LANCET NEUROLOGY; Lin Yi, 2011, Adv Hematol, V2011, P427863, DOI 10.1155/2011/427863; Ministry. of Justice, 2015, FOR RES PREF NAT REG; WHO, 2018, TOP 10 CAUS DEATH; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098	11	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2017	16	5					335	336		10.1016/S1474-4422(17)30075-3	http://dx.doi.org/10.1016/S1474-4422(17)30075-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER4PH	28320634	Green Accepted, Green Submitted			2022-12-18	WOS:000398782100003
J	Lochner, P; Brigo, F; Nardone, R; Lesmeister, M; Fassbender, K				Lochner, Piergiorgio; Brigo, Francesco; Nardone, Raffaele; Lesmeister, Martin; Fassbender, Klaus			Diagnosis and classification of optic neuropathies	LANCET NEUROLOGY			English	Letter							NERVE SHEATH DIAMETER; SONOGRAPHIC ASSESSMENT; TRANSORBITAL SONOGRAPHY; RELIABILITY		[Lochner, Piergiorgio; Lesmeister, Martin; Fassbender, Klaus] Univ Saarland, Med Ctr, Dept Neurol, D-66421 Homburg, Germany; [Brigo, Francesco] Univ Verona, Dept Neurosci Biomed & Movement, Sect Clin Neurol, Verona, Italy; [Nardone, Raffaele] Paracelsus Med Univ, Dept Neurol, Christian Doppler Klin, Salzburg, Austria	Saarland University; University of Verona; Paracelsus Private Medical University	Lochner, P (corresponding author), Univ Saarland, Med Ctr, Dept Neurol, D-66421 Homburg, Germany.	piergiorgio.lochner@gmail.com	Lochner, Piergiorgio/AAB-6784-2020; Brigo, Francesco/H-6513-2013	Lochner, Piergiorgio/0000-0002-2101-6066; Fassbender, Klaus/0000-0003-3596-868X; Brigo, Francesco/0000-0003-0928-1577; Lesmeister, Martin/0000-0001-5228-6483				Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Bauerle J, 2011, J NEUROL, V258, P2014, DOI 10.1007/s00415-011-6059-0; Biousse V, 2016, LANCET NEUROL, V15, P1355, DOI 10.1016/S1474-4422(16)30237-X; Fichtner J, 2016, J NEUROL NEUROSUR PS, V87, P650, DOI 10.1136/jnnp-2015-310853; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Lochner P, 2014, AM J NEURORADIOL, V35, P2371, DOI 10.3174/ajnr.A4051; Lochner P, 2017, J NEUROIMAGING, V27, P92, DOI 10.1111/jon.12405; Lochner P, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0594-3; Lochner P, 2016, J ULTRASOUND, V19, P41, DOI 10.1007/s40477-014-0144-z; Strapazzon G, 2014, NEUROLOGY, V82, P1914, DOI 10.1212/WNL.0000000000000457	10	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2017	16	5					342	+		10.1016/S1474-4422(17)30092-3	http://dx.doi.org/10.1016/S1474-4422(17)30092-3			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER4PH	28414645				2022-12-18	WOS:000398782100009
J	Politis, M				Politis, Marios			Disease progression in LRRK2 parkinsonism	LANCET NEUROLOGY			English	Editorial Material							TRANSPORTER; SEROTONIN		[Politis, Marios] Kings Coll London, Inst Psychiat Psychol & Neurosci, Neurodegenerat Imaging Grp, London SE5 9NU, England	University of London; King's College London	Politis, M (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Neurodegenerat Imaging Grp, London SE5 9NU, England.	marios.politis@kcl.ac.uk	Politis, Marios/GYQ-9446-2022					Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Lin MK, 2014, GENOME MED, V6, DOI 10.1186/gm566; Pagano G, 2017, ANN NEUROL, V81, P171, DOI 10.1002/ana.24859; Politis M, 2010, NEUROLOGY, V75, P1920, DOI 10.1212/WNL.0b013e3181feb2ab; Politis M, 2011, NEUROBIOL DIS, V43, P609, DOI 10.1016/j.nbd.2011.05.009; Politis M, 2010, NEUROBIOL DIS, V40, P216, DOI 10.1016/j.nbd.2010.05.028; Wile DJ, 2017, LANCET NEUROL, V16, P351, DOI 10.1016/S1474-4422(17)30056-X; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	9	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2017	16	5					334	335		10.1016/S1474-4422(17)30082-0	http://dx.doi.org/10.1016/S1474-4422(17)30082-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER4PH	28414642				2022-12-18	WOS:000398782100002
J	Jensen, RH				Jensen, R. H.			The most important advances in headache research in 2016 (vol 16, pg 5, 2017)	LANCET NEUROLOGY			English	Correction																		Jensen RH, 2017, LANCET NEUROL, V16, P5, DOI 10.1016/S1474-4422(16)30338-6	1	1	1	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2017	16	4					261	261		10.1016/S1474-4422(16)30338-6	http://dx.doi.org/10.1016/S1474-4422(16)30338-6			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN9RF	27979355				2022-12-18	WOS:000396336600010
J	Testai, FD				Testai, Fernando D.			The relevance of atrial fibrillation in stroke prevention	LANCET NEUROLOGY			English	Editorial Material									[Testai, Fernando D.] Univ Illinois, Dept Neurol & Rehabil, Med Ctr, Inst Neuropsychiat, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Testai, FD (corresponding author), Univ Illinois, Dept Neurol & Rehabil, Med Ctr, Inst Neuropsychiat, Chicago, IL 60612 USA.	testai@uic.edu						Al-Qudah ZA, 2015, J VASC INTERV NEUROL, V8, P4; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Norberg Johannes, 2013, Clin Epidemiol, V5, P475, DOI 10.2147/CLEP.S53420; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Wachter R, 2017, LANCET NEUROL; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Zoni-Berisso M, 2014, CLIN EPIDEMIOL, V6, P213, DOI 10.2147/CLEP.S47385	13	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2017	16	4					253	255		10.1016/S1474-4422(17)30016-9	http://dx.doi.org/10.1016/S1474-4422(17)30016-9			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN9RF	28187921				2022-12-18	WOS:000396336600003
J	Evans, AC; Karama, S; Vasung, L; Iturria-Medina, Y				Evans, Alan C.; Karama, Sherif; Vasung, Lana; Iturria-Medina, Yasser			Understanding brain development: a major step	LANCET NEUROLOGY			English	Editorial Material									[Evans, Alan C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Karama, Sherif] McGill Univ, Douglas Hosp Res Ctr, Montreal, PQ, Canada; [Iturria-Medina, Yasser] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Vasung, Lana] Univ Geneva, Dept Pediat, Geneva, Switzerland	McGill University; McGill University; McGill University; University of Geneva	Evans, AC (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	alan.acehigh@gmail.com	Karama, Sherif/AAT-2683-2021; Vasung, Lana/AAE-8791-2019; Evans, Alan C/B-2373-2013	Vasung, Lana/0000-0003-0172-3174; Evans, Alan C/0000-0003-3841-6098; Iturria Medina, Yasser/0000-0002-9345-0347	Biospective; Fonds de Recherche Sante, Quebec; SNSF [P300PB-167804]	Biospective; Fonds de Recherche Sante, Quebec; SNSF(Swiss National Science Foundation (SNSF))	ACE has received consulting fees from Biospective. SK is supported by the Fonds de Recherche Sante, Quebec. LV is supported by SNSF (grant number P300PB-167804).Y I-M declares no competing interests.	Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637; Cusack R, 2016, ANN NY ACAD SCI, V1369, P7, DOI 10.1111/nyas.13036; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fulcher BD, 2016, P NATL ACAD SCI USA, V113, P1435, DOI 10.1073/pnas.1513302113; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022; LAMANTIA AS, 1990, J NEUROSCI, V10, P2156; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Segovia KN, 2008, ANN NEUROL	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2017	16	3					178	179		10.1016/S1474-4422(16)30232-0	http://dx.doi.org/10.1016/S1474-4422(16)30232-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK4ZC	27692495				2022-12-18	WOS:000393935700006
J	Bracard, S; Ducrocq, X; Guillemin, F; Moulin, T; Mas, JL				Bracard, Serge; Ducrocq, Xavier; Guillemin, Francis; Moulin, Thierry; Mas, Jean-Louis			Mechanical thrombectomy after intravenous thrombolysis for acute ischaemic stroke Reply	LANCET NEUROLOGY			English	Letter									[Bracard, Serge] Hop Cent, Dept Diagnost & Intervent Neuroradiol, 29 Ave Marechal Lattre Tassigny, F-54035 Nancy, France; [Ducrocq, Xavier] CHU Nancy, Dept Neurol, Nancy, France; [Guillemin, Francis] Univ Lorraine, Dept Clin Epidemiol, INSERM, CIC EC 1433, Nancy, France; [Guillemin, Francis] Univ Hosp Nancy, Nancy, France; [Moulin, Thierry] Univ Hosp Besancon, Dept Neurol, Besancon, France; [Mas, Jean-Louis] St Anne Hosp, Dept Neruol, Paris, France; [Mas, Jean-Louis] Paris Descartes Univ, INSERM, U894, Paris, France	CHU de Nancy; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine; Universite de Franche-Comte; CHU Besancon; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bracard, S (corresponding author), Hop Cent, Dept Diagnost & Intervent Neuroradiol, 29 Ave Marechal Lattre Tassigny, F-54035 Nancy, France.	s.bracard@chru-nancy.fr	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Moulin, thierry/0000-0002-6639-8117	French Ministry of Health; General Electric Medical Systems	French Ministry of Health; General Electric Medical Systems(General Electric)	SB reports grants from the French Ministry of Health during the conduct of the study, personal fees from General Electric Medical Systems, and non-financial support from Microvention Europe. The other authors declare no competing interests.	Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6	1	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2017	16	2					104	104		10.1016/S1474-4422(16)30378-7	http://dx.doi.org/10.1016/S1474-4422(16)30378-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EH6VA	28102147	Bronze			2022-12-18	WOS:000391910800008
J	Smith, EE				Smith, Eric E.			Defining early CAA: insights from a rare monogenic disorder	LANCET NEUROLOGY			English	Editorial Material							CEREBRAL AMYLOID ANGIOPATHY; ALZHEIMERS-DISEASE; DUTCH TYPE; HEMORRHAGE		[Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada	University of Calgary	Smith, EE (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.	eesmith@ucalgary.ca	Smith, Eric E/C-5443-2012	Smith, Eric E/0000-0003-3956-1668	Canadian Institutes of Health Research, Brain Canada; Heart and Stroke Foundation of Canada; Alzheimer Society of Canada; Alberta Innovates [201300690] Funding Source: researchfish	Canadian Institutes of Health Research, Brain Canada; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alzheimer Society of Canada; Alberta Innovates	I have received research funding for the study of CAA from the Canadian Institutes of Health Research, Brain Canada, the Heart and Stroke Foundation of Canada, and the Alzheimer Society of Canada. My employer, the University of Calgary, was contracted by Pfizer to be a recruitment site for a clinical trial in cerebral amyloid angiopathy (NCT01821118).	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bornebroek M, 1996, BRAIN PATHOL, V6, P111, DOI 10.1111/j.1750-3639.1996.tb00793.x; Dumas A, 2012, ANN NEUROL, V72, P76, DOI 10.1002/ana.23566; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Peca S, 2013, NEUROLOGY, V81, P1659, DOI 10.1212/01.wnl.0000435291.49598.54; van Etten ES, 2016, NEUROLOGY, DOI [10.1212/WNL.0000000000003486, DOI 10.1212/WNL.0000000000003486]; van Opstal AM, 2016, LANCET NEUROL; van Rooden S, 2016, STROKE, V47, P3041, DOI 10.1161/STROKEAHA.116.014418	8	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2017	16	2					98	99		10.1016/S1474-4422(16)30380-5	http://dx.doi.org/10.1016/S1474-4422(16)30380-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EH6VA	27989552				2022-12-18	WOS:000391910800002
J	Jensen, RH				Jensen, Rigmor Hoejland			The most important advances in headache research in 2016	LANCET NEUROLOGY			English	Editorial Material							DOUBLE-BLIND; EPISODIC MIGRAINE; EFFICACY; SAFETY; TRIAL		[Jensen, Rigmor Hoejland] Rigshosp Glostrup, Dept Neurol, Danish Headache Ctr, Glostrup, Denmark		Jensen, RH (corresponding author), Rigshosp Glostrup, Dept Neurol, Danish Headache Ctr, Glostrup, Denmark.	rigmor.jensen@regionh.dk						Bigal ME, 2015, LANCET NEUROL, V14, P1081, DOI 10.1016/S1474-4422(15)00249-5; Eising E, 2016, HUM GENET, V135, P425, DOI 10.1007/s00439-016-1638-x; Gaist D, 2016, BRAIN, V139, P2015, DOI 10.1093/brain/aww099; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Jurgens TP, 2016, CEPHALALGIA, V36, P1098, DOI 10.1177/0333102416669292; Kurth T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2610; Sun H, 2016, LANCET NEUROL, V15, P382, DOI 10.1016/S1474-4422(16)00019-3; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Voss T, 2016, CEPHALALGIA, V36, P887, DOI 10.1177/0333102416653233	9	1	1	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2017	16	1					5	7		10.1016/S1474-4422(16)30338-6	http://dx.doi.org/10.1016/S1474-4422(16)30338-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE8IP	27979355				2022-12-18	WOS:000389869200004
J	van de Beek, D; Brouwer, MC				van de Beek, Diederik; Brouwer, Matthijs C.			Neurological infections in 2016: Zika and the rest	LANCET NEUROLOGY			English	Editorial Material							MENINGITIS; ADULTS		[van de Beek, Diederik; Brouwer, Matthijs C.] Acad Med Ctr, Amsterdam Neurosci, Dept Neurol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	van de Beek, D (corresponding author), Acad Med Ctr, Amsterdam Neurosci, Dept Neurol, Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X; Brouwer, Matthijs/0000-0001-7775-7843				Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024; Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Heemskerk AD, 2016, NEW ENGL J MED, V374, P124, DOI 10.1056/NEJMoa1507062; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; van de Beek D, 2016, MICROBIOL INFECT S3, V22, pS37; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193	8	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2017	16	1					17	18		10.1016/S1474-4422(16)30344-1	http://dx.doi.org/10.1016/S1474-4422(16)30344-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE8IP	27979342	Bronze			2022-12-18	WOS:000389869200011
J	Appelros, P				Appelros, Peter			Mortality after thrombolysis	LANCET NEUROLOGY			English	Letter							ISCHEMIC-STROKE; TRIAL; IST-3		[Appelros, Peter] Univ Orebro, Fac Med & Hlth, Dept Neurol, SE-70182 Orebro, Sweden	Orebro University	Appelros, P (corresponding author), Univ Orebro, Fac Med & Hlth, Dept Neurol, SE-70182 Orebro, Sweden.	peter.appelros@regionorebrolan.se		Appelros, Peter/0000-0003-2810-6977				Berge E, 2016, LANCET NEUROL, V15, P1028, DOI 10.1016/S1474-4422(16)30139-9; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Wardlaw JM, 2014, COCHRANE DB SYST REV, V7, P109	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2016	15	13					1304	1305		10.1016/S1474-4422(16)30289-7	http://dx.doi.org/10.1016/S1474-4422(16)30289-7			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB6XV	27839641				2022-12-18	WOS:000387529800013
J	van den Noort, M; Bosch, P; Staudte, H; Yeo, S; Lim, S				van den Noort, Maurits; Bosch, Peggy; Staudte, Heike; Yeo, Suijung; Lim, Sabina			Management of movement disorders in children	LANCET NEUROLOGY			English	Letter									[van den Noort, Maurits; Lim, Sabina] Kyung Hee Univ, Res Grp Pain & Neurosci, Seoul 130701, South Korea; [van den Noort, Maurits] Free Univ Brussels, Brussels Inst Appl Linguist, Brussels, Belgium; [Bosch, Peggy; Staudte, Heike] LVR Klin Bedburg Hau, Inst Psychiat Res, Bedburg Hau, Germany; [Bosch, Peggy] Radboud Univ Nijmegen, Donders Ctr Cognit, Nijmegen, Netherlands; [Yeo, Suijung] Sang Ji Univ, Dept Acupuncture & Meridian Oriental Med, Wonju, South Korea	Kyung Hee University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Radboud University Nijmegen	van den Noort, M (corresponding author), Kyung Hee Univ, Res Grp Pain & Neurosci, Seoul 130701, South Korea.; van den Noort, M (corresponding author), Free Univ Brussels, Brussels Inst Appl Linguist, Brussels, Belgium.	info@mauritsvandennoort.com	Lim, Sabina/I-5026-2017; Bosch, Peggy/A-9159-2012	Lim, Sabina/0000-0003-0509-6681; Bosch, Peggy/0000-0003-2397-5188				Air EL, 2011, J NEUROSURG-PEDIATR, V8, P566, DOI 10.3171/2011.8.PEDS11153; Johnston MV, 2011, SEMIN PEDIATR NEUROL, V18, P133, DOI 10.1016/j.spen.2011.06.009; Koy A, 2016, LANCET NEUROL, V15, P719, DOI 10.1016/S1474-4422(16)00132-0	3	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2016	15	13					1302	1302		10.1016/S1474-4422(16)30286-1	http://dx.doi.org/10.1016/S1474-4422(16)30286-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB6XV	27839638	Bronze			2022-12-18	WOS:000387529800009
J	Berkhemer, OA; Dippel, DWJ				Berkhemer, Olvert A.; Dippel, Diederik W. J.			Intra-arterial therapy for acute ischaemic stroke	LANCET NEUROLOGY			English	Editorial Material							THROMBECTOMY; TRIAL		[Berkhemer, Olvert A.] Acad Med Ctr, Dept Radiol, POB 22660, NL-1100 DD Amsterdam, Netherlands; [Berkhemer, Olvert A.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Berkhemer, Olvert A.] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Berkhemer, Olvert A.; Dippel, Diederik W. J.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Berkhemer, OA (corresponding author), Acad Med Ctr, Dept Radiol, POB 22660, NL-1100 DD Amsterdam, Netherlands.; Berkhemer, OA (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.; Berkhemer, OA (corresponding author), Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.; Berkhemer, OA (corresponding author), Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands.	o.a.berkhemer@amc.uva.nl	Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515				Bai J, 2015, INT J STROKE, V10, P143, DOI 10.1111/ijs.12434; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Berkhemer OA, 2016, NEUROLOGY; Bracard S, 2016, LANCET NEUROL; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hrobjartsson A, 2012, BMJ; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Saver JL, 2015, N ENGL J MED; Yoo AJ, 2016, LANCET NEUROL, V15, P685, DOI 10.1016/S1474-4422(16)00124-1	11	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2016	15	11					1105	1107		10.1016/S1474-4422(16)30197-1	http://dx.doi.org/10.1016/S1474-4422(16)30197-1			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX3MJ	27567240				2022-12-18	WOS:000384276900003
J	Kivimaki, M; Batty, GD				Kivimaki, Mika; Batty, G. David			Evidence-based prevention and treatment of dementia	LANCET NEUROLOGY			English	Letter									[Kivimaki, Mika; Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England	University of London; University College London	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Smith, Anthony D./A-4233-2010; Refsum, Helga/A-4073-2010; Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018	Smith, Anthony D./0000-0002-1095-6722; Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753	Medical Research Council [MR/K026992/1, MR/K013351/1] Funding Source: Medline; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		NICE, DIS DEM FRAILT LAT L; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4	3	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2016	15	10					1005	1005		10.1016/S1474-4422(16)30075-8	http://dx.doi.org/10.1016/S1474-4422(16)30075-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT1ZJ	27450473				2022-12-18	WOS:000381280300011
J	Chennu, S; Stamatakis, EA; Menon, DK				Chennu, Srivas; Stamatakis, Emmanuel A.; Menon, David K.			The see-saw brain: recovering consciousness after brain injury	LANCET NEUROLOGY			English	Editorial Material							DISORDERS		[Chennu, Srivas] Univ Cambridge, Div Neurosurg, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Stamatakis, Emmanuel A.; Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge Biomed Campus, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge	Menon, DK (corresponding author), Univ Cambridge, Div Anaesthesia, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	dkm13@cam.ac.uk		Chennu, Srivas/0000-0002-6840-2941; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	National Institute for Health Research [NF-SI-0512-10090] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], LANCET NEUROL, DOI DOI 10.1016/S1474-4422(16)00111-3; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Turner-Stokes L, 2014, CLIN MED, V14, P4, DOI 10.7861/clinmedicine.14-1-4; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vatansever D, 2015, J NEUROSCI, V35, P15254, DOI 10.1523/JNEUROSCI.2135-15.2015; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157	12	1	1	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2016	15	8					781	782		10.1016/S1474-4422(16)30027-8	http://dx.doi.org/10.1016/S1474-4422(16)30027-8			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO1NR	27131916	Green Submitted			2022-12-18	WOS:000377545800005
J	Flanigan, KM				Flanigan, Kevin M.			Duchenne muscular dystrophy: meeting the therapeutic challenge	LANCET NEUROLOGY			English	Editorial Material							NONSENSE MUTATION; ATALUREN		[Flanigan, Kevin M.] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Flanigan, KM (corresponding author), Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA.	kevin.flanigan@nationwidechildrens.org		Flanigan, Kevin/0000-0001-6440-3376				[Anonymous], SEARCH ORPH DRUG DES; Burton TM, 2016, FDA PANEL VOTES NOT; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Ferlini A, 2015, NEUROMUSCULAR DISORD, V25, P184, DOI 10.1016/j.nmd.2014.09.004; Food and Drug Administration, 2015, FDA ISS DRAFT GUID D; Griggs RC, 2013, MUSCLE NERVE, V48, P27, DOI 10.1002/mus.23831; Haas M, 2015, NEUROMUSCULAR DISORD, V25, P5, DOI 10.1016/j.nmd.2014.11.011; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Straub V, 2016, LANCET NEUROL, V15, P882, DOI 10.1016/S1474-4422(16)30035-7; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4	12	1	2	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2016	15	8					785	787		10.1016/S1474-4422(16)30078-3	http://dx.doi.org/10.1016/S1474-4422(16)30078-3			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO1NR	27302348				2022-12-18	WOS:000377545800008
J	Kaski, D; Bronstein, AM				Kaski, Diego; Bronstein, Adolfo M.			Functional (psychogenic) saccadic oscillations and oculogyric crises Reply	LANCET NEUROLOGY			English	Letter									[Kaski, Diego] Natl Hosp Neurol & Neurosurg, Dept Neurootol, Queen Sq, London WC1N 3BG, England; Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Div Brain Sci, London, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London	Kaski, D (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Neurootol, Queen Sq, London WC1N 3BG, England.	d.kaski@imperial.ac.uk	Kaski, Diego/GQY-5716-2022	Kaski, Diego/0000-0002-0591-646X	Medical Research Council [MR/J004685/1] Funding Source: Medline; MRC [MR/J004685/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Fekete R, 2012, J NEUROL NEUROSUR PS, V83, P202, DOI 10.1136/jnnp-2011-300733; Baizabal-Carvallo JF, 2016, J NEUROPSYCH CLIN N, V28, P195, DOI 10.1176/appi.neuropsych.15050104; Kaski D, 2015, LANCET NEUROL, V14, P1196, DOI 10.1016/S1474-4422(15)00226-4	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2016	15	8					791	792		10.1016/S1474-4422(16)00121-6	http://dx.doi.org/10.1016/S1474-4422(16)00121-6			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO1NR	27302356	Green Submitted			2022-12-18	WOS:000377545800016
J	Salman, RAS; McGoohan, K; Rodrigues, M; Dichgans, M				Salman, Rustam Al-Shahi; McGoohan, Katie; Rodrigues, Mark; Dichgans, Martin			Dementia after stroke due to intracerebral haemorrhage	LANCET NEUROLOGY			English	Editorial Material							CEREBRAL AMYLOID ANGIOPATHY		[Salman, Rustam Al-Shahi; McGoohan, Katie; Rodrigues, Mark] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Dichgans, Martin] Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany	University of Edinburgh; University of Munich	Salman, RAS (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	Rustam.Al-Shahi@ed.ac.uk	Dichgans, Martin/HCH-3247-2022	Dichgans, Martin/0000-0002-0654-387X; Rodrigues, Mark/0000-0002-4507-6872; Al-Shahi Salman, Rustam/0000-0002-2108-9222	Stroke Association [TSAPGF2014/02] Funding Source: researchfish; MRC [G1002605] Funding Source: UKRI; Medical Research Council [G1002605] Funding Source: Medline	Stroke Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bath PM, 2015, INT J STROKE, V10, P469, DOI 10.1111/ijs.12466; Charidimou A, 2015, BRAIN, V138, P2126, DOI 10.1093/brain/awv162; Greenberg SM, 2014, LANCET NEUROL, V13, P419, DOI 10.1016/S1474-4422(14)70003-1; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; Moulin S, 2016, LANCET NEUROL, V15, P820, DOI 10.1016/S1474-4422(16)00130-7; Murao K, 2013, REV NEUROL-FRANCE, V169, P772, DOI 10.1016/j.neurol.2013.07.021; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2016	15	8					779	780		10.1016/S1474-4422(16)30092-8	http://dx.doi.org/10.1016/S1474-4422(16)30092-8			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO1NR	27302345				2022-12-18	WOS:000377545800004
J	Hachinski, V; Sposato, LA; Kapral, M				Hachinski, Vladimir; Sposato, Luciano A.; Kapral, Moira			Preventing both stroke and dementia	LANCET NEUROLOGY			English	Letter									[Hachinski, Vladimir; Sposato, Luciano A.] Univ Western Ontario, London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON NGA 5AS, Canada; [Kapral, Moira] Univ Toronto, Dept Med, Univ Hlth Network, Toronto, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hachinski, V (corresponding author), Univ Western Ontario, London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON NGA 5AS, Canada.	Vladimir.Hachinski@lhsc.on.ca	Sposato, Luciano A/D-7782-2012	Sposato, Luciano A/0000-0001-6425-9343				Hachinski V, 2015, STROKE, V46, P3039, DOI 10.1161/STROKEAHA.115.011237; Jin Ya-Ping, 2006, Alzheimers Dement, V2, P171, DOI 10.1016/j.jalz.2006.03.006; Sposato LA, 2015, JAMA NEUROL, V72, P1529, DOI 10.1001/jamaneurol.2015.2816; United Nations General Assembly, 2012, HIGH LEV M GEN ASS P; Wu YT, 2016, LANCET NEUROL, V15, P116, DOI 10.1016/S1474-4422(15)00092-7	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2016	15	7					659	659		10.1016/S1474-4422(16)30041-2	http://dx.doi.org/10.1016/S1474-4422(16)30041-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM7OG	27302230	Bronze			2022-12-18	WOS:000376549300011
J	[Anonymous]				[Anonymous]			A persistent pain	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2016	15	6					533	533		10.1016/S1474-4422(16)30004-7	http://dx.doi.org/10.1016/S1474-4422(16)30004-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI9PW	27302112				2022-12-18	WOS:000373835900001
J	Hunsberger, JG; Rao, M; Kurtzberg, J				Hunsberger, J. G.; Rao, M.; Kurtzberg, J.			Accelerating stem cell trials for Alzheimer's disease (vol 2, pg 219, 2016)	LANCET NEUROLOGY			English	Correction																		Hunsberger JG, 2016, LANCET NEUROL, V15, P219, DOI 10.1016/S1474-4422(15)00332-4	1	1	1	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2016	15	2					135	135		10.1016/S1474-4422(15)00332-4	http://dx.doi.org/10.1016/S1474-4422(15)00332-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DA9GC					2022-12-18	WOS:000368116000009
J	Chio, A; Lauria, G				Chio, Adriano; Lauria, Giuseppe			Degenerative neuromuscular diseases: crucial gene and cell machinery discoveries	LANCET NEUROLOGY			English	Editorial Material							NUCLEOCYTOPLASMIC TRANSPORT; REPEAT EXPANSION		[Chio, Adriano] Univ Turin, Rita Levi Montalcini Dept Neurosci, I-10124 Turin, Italy; [Chio, Adriano] Neurosci Inst Turin, Turin, Italy; [Chio, Adriano] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Lauria, Giuseppe] IRCCS Fdn, Carlo Besta Neurol Inst, Dept Clin Neurosci, Milan, Italy	University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta	Chio, A (corresponding author), Univ Turin, Rita Levi Montalcini Dept Neurosci, I-10124 Turin, Italy.	adriano.chio@unito.it	lauria, giuseppe/AAN-5371-2020; Lauria, Giuseppe/T-1378-2017	lauria, giuseppe/0000-0001-9773-020X; Lauria, Giuseppe/0000-0001-9773-020X; Chio, Adriano/0000-0001-9579-5341				Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	5	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2016	15	1					12	13		10.1016/S1474-4422(15)00361-0	http://dx.doi.org/10.1016/S1474-4422(15)00361-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CY3MM	26700898	Green Submitted			2022-12-18	WOS:000366313900007
J	Goldstein, C; Chervin, R				Goldstein, Cathy; Chervin, Ronald			Waking up to sleep research in 2015	LANCET NEUROLOGY			English	Editorial Material									[Goldstein, Cathy] Univ Michigan, Dept Neurol, Ann Arbor, MI 48104 USA; [Chervin, Ronald] Sleep Disorders Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Goldstein, C (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48104 USA.	cathygo@med.umich.edu						Cowie MR, 2015, NEW ENGL J MED, V373, P1095, DOI 10.1056/NEJMoa1506459; Osorio RS, 2015, NEUROLOGY, V84, P1964, DOI 10.1212/WNL.0000000000001566; Prather AA, 2015, SLEEP, V38, P1353, DOI 10.5665/sleep.4968; Trotti LM, 2015, ANN NEUROL, V78, P454, DOI 10.1002/ana.24459; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886	5	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2016	15	1					15	17		10.1016/S1474-4422(15)00344-0	http://dx.doi.org/10.1016/S1474-4422(15)00344-0			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CY3MM	26700900				2022-12-18	WOS:000366313900009
J	McDermott, CJ; Stavroulakis, T				McDermott, Christopher J.; Stavroulakis, Theocharis			Gastrostomy in amyotrophic lateral sclerosis: effects of non-invasive ventilation reply	LANCET NEUROLOGY			English	Letter									[McDermott, Christopher J.; Stavroulakis, Theocharis] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield S10 2HQ, S Yorkshire, England	University of Sheffield	McDermott, CJ (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci, 385A Glossop Rd, Sheffield S10 2HQ, S Yorkshire, England.	c.j.mcdermott@sheffield.ac.uk	Stavroulakis, Theocharis/AAH-8564-2019; McDermott, Christopher/AAU-4988-2020; McDermott, Chris/GQZ-3919-2022	McDermott, Christopher/0000-0002-1269-9053; Shaw, Pamela/0000-0002-8925-2567; /0000-0002-3535-7822					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2015	14	12					1153	1153		10.1016/S1474-4422(15)00294-X	http://dx.doi.org/10.1016/S1474-4422(15)00294-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW2WZ	26581966	Bronze			2022-12-18	WOS:000364855100010
J	Albin, RL				Albin, Roger L.			Out of one mutation, many Huntington's disease effects	LANCET NEUROLOGY			English	Editorial Material									[Albin, Roger L.] Vet Affairs Ann Arbor Healthcare Syst, Neurol Serv & Geriatr Res, Educ & Clin Ctr, Ann Arbor, MI 48109 USA; [Albin, Roger L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Albin, Roger L.] Univ Michigan, Udall Ctr Excellence Parkinson Dis Res, Ann Arbor, MI 48109 USA; [Albin, Roger L.] Michigan Alzheimer Dis Ctr, Ann Arbor, MI 48109 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Albin, RL (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Neurol Serv & Geriatr Res, Educ & Clin Ctr, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	ralbin@umich.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088302, P50NS091856, R56NS082941] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS091856, R56 NS082941, R21 NS088302] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albin RL, 2015, MOVEMENT DISORD, V30, P1319, DOI 10.1002/mds.26318; Aylward EH, 2014, MOVEMENT DISORD, V29, P1429, DOI 10.1002/mds.26013; Carroll JB, 2015, LANCET NEUROL, V14, P1135, DOI 10.1016/S1474-4422(15)00177-5; Jafar-Nejad P, 2011, P NATL ACAD SCI USA, V108, P2142, DOI 10.1073/pnas.1018748108; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Niccolini F, 2015, BRAIN, V138, P3016, DOI 10.1093/brain/awv214; Paul D, 2013, THE PKU PARADOX; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259	8	1	1	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2015	14	11					1071	1072		10.1016/S1474-4422(15)00247-1	http://dx.doi.org/10.1016/S1474-4422(15)00247-1			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT7DY	26466773				2022-12-18	WOS:000362975200005
J	[Anonymous]				[Anonymous]			Maximising the value of research for brain health	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2015	14	11					1065	1065		10.1016/S1474-4422(15)00251-3	http://dx.doi.org/10.1016/S1474-4422(15)00251-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT7DY	26466772	Bronze			2022-12-18	WOS:000362975200001
J	Grossman, M				Grossman, Murray			Integrated multimodal imaging in neurodegenerative disease	LANCET NEUROLOGY			English	Editorial Material							FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE		[Grossman, Murray] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Grossman, Murray] Univ Penn, Penn Frontotemporal Degenerat Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Grossman, M (corresponding author), Univ Penn, Dept Neurol, 2 Gibson, Philadelphia, PA 19104 USA.	mgrossma@upenn.edu			NIA NIH HHS [R01 AG038490, AG017586, P01 AG017586, AG038490] Funding Source: Medline; NINDS NIH HHS [NS053488, P50 NS053488, R01 NS044266, NS044266] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044266, P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038490, P01AG017586] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Irwin DJ, 2015, ACTA NEUROPATHOL, V129, P469, DOI 10.1007/s00401-014-1380-1; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; McMillan CT, 2012, NEUROLOGY, V78, P1761, DOI 10.1212/WNL.0b013e31825830bd; McMillan CT, 2014, NEUROBIOL AGING, V35, P1473, DOI 10.1016/j.neurobiolaging.2013.11.029; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Teipel S, 2015, LANCET NEUROL; Thompson PM, 2013, NEUROIMAGE, V80, P475, DOI 10.1016/j.neuroimage.2013.05.013; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7	15	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2015	14	10					973	975		10.1016/S1474-4422(15)00182-9	http://dx.doi.org/10.1016/S1474-4422(15)00182-9			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR2VI	26318838	Green Accepted			2022-12-18	WOS:000361188400005
J	Ferro, JM				Ferro, Jose M.			ischaemic stroke of undetermined cause	LANCET NEUROLOGY			English	Editorial Material							CRYPTOGENIC STROKE; ATRIAL-FIBRILLATION		Univ Lisbon, Hosp Santa Maria, Dept Neurosci, P-1649035 Lisbon, Portugal	Universidade de Lisboa; Hospital Santa Maria	Ferro, JM (corresponding author), Univ Lisbon, Hosp Santa Maria, Dept Neurosci, P-1649035 Lisbon, Portugal.	jmferro@fm.ul.pt	Ferro, José/ABA-1779-2021	Ferro, Jose/0000-0002-2343-9097				Fonseca AC, 2015, EUR J NEUROL, V22, P618, DOI 10.1111/ene.12673; Handke M, 2007, NEW ENGL J MED, V357, P2262, DOI 10.1056/NEJMoa071422; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Li L, 2015, LANCET NEUROL; Malnick SDH, 2014, NEW ENGL J MED, V371, P1259, DOI 10.1056/NEJMc1409495; Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2015	14	9					871	872		10.1016/S1474-4422(15)00149-0	http://dx.doi.org/10.1016/S1474-4422(15)00149-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP4YZ	26227433	hybrid			2022-12-18	WOS:000359889800004
J	Fugate, JE; Rabistein, AA				Fugate, J. E.; Rabistein, A. A.			Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions (vol 14, pg 914, 2015)	LANCET NEUROLOGY			English	Correction																		Fugate JE, 2015, LANCET NEUROL, V14, P914, DOI 10.1016/S1474-4422(15)00111-8	1	1	1	2	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2015	14	9					874	874		10.1016/S1474-4422(15)00111-8	http://dx.doi.org/10.1016/S1474-4422(15)00111-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP4YZ					2022-12-18	WOS:000359889800006
J	Wu, CY; Chang, KC				Wu, Ching-Yi; Chang, Ku-Chou			Constraint-induced movement therapy translated into practice	LANCET NEUROLOGY			English	Editorial Material							STROKE; TRIAL		[Wu, Ching-Yi] Chang Gung Univ, Coll Med, Dept Occupat Therapy, Taoyuan 333, Taiwan; [Wu, Ching-Yi] Chang Gung Univ, Coll Med, Grad Inst Behav Sci, Taoyuan 333, Taiwan; [Wu, Ching-Yi] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan 333, Taiwan; [Chang, Ku-Chou] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Div Cerebrovasc Dis, Kaohsiung, Taiwan; [Chang, Ku-Chou] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Chang, Ku-Chou] Yuh Ing Jr Coll, Dept Senior Citizen Serv Management, Kaohsiung, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Wu, CY (corresponding author), Chang Gung Univ, Coll Med, Dept Occupat Therapy, Taoyuan 333, Taiwan.	cywu@mail.cgu.edu.tw		Wu, Ching-yi/0000-0003-4726-2916				Barzel A, 2015, LANCET NEUROL; Brennan DM, 2011, IEEE ENG MED BIO, P1819, DOI 10.1109/IEMBS.2011.6090518; KNAPP HD, 1963, EXP NEUROL, V7, P305, DOI 10.1016/0014-4886(63)90077-3; Koyama T, 2007, NEUROREHABILITATION, V22, P287; Kwakkel G, 2015, LANCET NEUROL, V14, P224, DOI 10.1016/S1474-4422(14)70160-7; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P160, DOI 10.1177/1545968308320642; Page SJ, 2013, CLIN REHABIL, V27, P494, DOI 10.1177/0269215512464795; Stinear CM, 2014, STROKE, V45, P205, DOI 10.1161/STROKEAHA.113.003537; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095	10	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2015	14	9					869	871		10.1016/S1474-4422(15)00183-0	http://dx.doi.org/10.1016/S1474-4422(15)00183-0			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP4YZ	26231623				2022-12-18	WOS:000359889800003
J	[Anonymous]				[Anonymous]			Time for action on atrial fibrillation	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2015	14	9					867	867		10.1016/S1474-4422(15)00194-5	http://dx.doi.org/10.1016/S1474-4422(15)00194-5			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CP4YZ	26293556	Bronze			2022-12-18	WOS:000359889800001
J	Sandercock, PAG				Sandercock, Peter A. G.			A call to revolutionise acute stroke care and research	LANCET NEUROLOGY			English	Editorial Material							ISCHEMIC-STROKE; MORTALITY; SERVICES		Univ Edinburgh, Edinburgh EH16 4SB, Midlothian, Scotland	University of Edinburgh	Sandercock, PAG (corresponding author), Univ Edinburgh, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	peter.sandercock@ed.ac.uk						Adeoye O, 2014, STROKE, V45, P3019, DOI 10.1161/STROKEAHA.114.006293; Asplund K, 2015, STROKE, V46, P806, DOI 10.1161/STROKEAHA.114.007212; AVERTTrial Collaboration group, 2015, LANCET; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fisher M, 2015, LANCET NEUROL, V14, P758, DOI 10.1016/S1474-4422(15)00054-X; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Langhorne P, 2012, LANCET NEUROL, V11, P341, DOI 10.1016/S1474-4422(12)70024-8; Lindsay P, 2014, INT J STROKE, V9, P4, DOI 10.1111/ijs.12371; Morris S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4757; Mullen MT, 2014, STROKE, V45, P3381, DOI 10.1161/STROKEAHA.114.006021; Pandian JD, 2015, INT J STROKE, V10, P609, DOI 10.1111/ijs.12475; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Whiteley WN, 2014, STROKE, V45, P3612, DOI 10.1161/STROKEAHA.114.006890	17	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2015	14	7					674	675		10.1016/S1474-4422(15)00088-5	http://dx.doi.org/10.1016/S1474-4422(15)00088-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK4LS	26067109				2022-12-18	WOS:000356195900005
J	Simonato, M; Brooks-Kayal, AR; Engel, J				Simonato, M.; Brooks-Kayal, A. R.; Engel, J., Jr.			The challenge and promise of anti-epileptic therapy development in animal models (vol 13, pg 949, 2014)	LANCET NEUROLOGY			English	Correction													Simonato, Michele/AIA-0028-2022	Simonato, Michele/0000-0002-3586-2693				Simonato M, 2014, LANCET NEUROL, V13, P949, DOI 10.1016/S1474-4422(14)70076-6	1	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2015	14	7					677	677		10.1016/S1474-4422(15)00086-1	http://dx.doi.org/10.1016/S1474-4422(15)00086-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK4LS					2022-12-18	WOS:000356195900007
J	Tagliati, M				Tagliati, Michele			Multiple-source current steering: a new arrow in the DBS quiver	LANCET NEUROLOGY			English	Editorial Material							DEEP BRAIN-STIMULATION; RANDOMIZED CONTROLLED-TRIAL; PARKINSONS-DISEASE		Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Tagliati, M (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA.	michele.tagliati@cshs.org		Tagliati, Michele/0000-0002-6722-8208				Alterman RL, 2011, ANN NEUROL, V70, P5, DOI 10.1002/ana.22453; Bronstein JM, 2015, NEUROMODULATION, V18, P85, DOI 10.1111/ner.12227; Butson CR, 2011, NEUROIMAGE, V54, P2096, DOI 10.1016/j.neuroimage.2010.10.059; Cheung T, 2013, BRAIN STIMUL, V6, P746, DOI 10.1016/j.brs.2013.03.010; de Noriega FR, 2015, STEREOT FUNCT NEUROS, V93, P114, DOI 10.1159/000368443; Deuschl Gunther, 2013, Handb Clin Neurol, V116, P107, DOI 10.1016/B978-0-444-53497-2.00010-3; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; POLLAK P, 1993, REV NEUROL, V149, P175; Timmermann L, 2015, LANCET NEUROL, V14, P693, DOI 10.1016/S1474-4422(15)00087-3; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929	10	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2015	14	7					670	+		10.1016/S1474-4422(15)00099-X	http://dx.doi.org/10.1016/S1474-4422(15)00099-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK4LS	26027942				2022-12-18	WOS:000356195900002
J	Voltz, R				Voltz, Raymond			Assisted nutrition: a difficult decision in patients with amyotrophic lateral sclerosis	LANCET NEUROLOGY			English	Editorial Material							PERCUTANEOUS ENDOSCOPIC GASTROSTOMY		Univ Hosp Cologne, Dept Palliat Med, D-50924 Cologne, Germany	University of Cologne	Voltz, R (corresponding author), Univ Hosp Cologne, Dept Palliat Med, D-50924 Cologne, Germany.	raymond.voltz@uk-koeln.de						Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Dorst J, 2015, J NEUROL, V262, P849, DOI 10.1007/s00415-015-7646-2; Greenaway LP, 2015, J NEUROL, V262, P1002, DOI 10.1007/s00415-015-7665-z; Lule D, 2014, J NEUROL, V261, P518, DOI 10.1007/s00415-013-7229-z; Maessen M, 2014, J NEUROL, V261, P1894, DOI 10.1007/s00415-014-7424-6; Moran C, 2015, CURR OPIN GASTROEN, V31, P137, DOI 10.1097/MOG.0000000000000152; ProGas Study Group, 2015, LANCET NEUROL; Sarfaty M, 2013, AMYOTROPH LAT SCL FR, V14, P528, DOI 10.3109/21678421.2013.812659; Stavroulakis T, 2016, BMJ SUPPORT PALLIAT, V6, P52, DOI 10.1136/bmjspcare-2013-000609; Stutzki R, 2014, AMYOTROPH LAT SCL FR, V15, P68, DOI 10.3109/21678421.2013.837928; Voltz Raymond, 2013, Handb Clin Neurol, V118, P141, DOI 10.1016/B978-0-444-53501-6.00011-1	11	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2015	14	7					671	672		10.1016/S1474-4422(15)00103-9	http://dx.doi.org/10.1016/S1474-4422(15)00103-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK4LS	26027941	hybrid			2022-12-18	WOS:000356195900003
J	[Anonymous]				[Anonymous]			Increasing the power of public awareness campaigns	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2015	14	7					669	669		10.1016/S1474-4422(15)00105-2	http://dx.doi.org/10.1016/S1474-4422(15)00105-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK4LS	26067108	hybrid			2022-12-18	WOS:000356195900001
J	Drouin, E; Piloquet, P; Pereon, Y				Drouin, Emmanuel; Piloquet, Philippe; Pereon, Yann			The first illustrations of neurons by Camillo Golgi	LANCET NEUROLOGY			English	Letter									[Drouin, Emmanuel] Univ Tours, Ctr Etud Super Renaissance, Tours, France; [Piloquet, Philippe] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires Nantes Anger, F-44093 Nantes, France	Universite de Tours; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Drouin, E (corresponding author), Univ Tours, Ctr Etud Super Renaissance, Tours, France.	Yann.Pereon@univ-nantes.fr						D'Angelo E, 2011, BRAIN RES REV, V66, P5, DOI 10.1016/j.brainresrev.2010.10.002; Golgi C., 1883, RIV SPERIMENTALE FRE, V9, P1	2	1	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2015	14	6					567	567		10.1016/S1474-4422(15)00051-4	http://dx.doi.org/10.1016/S1474-4422(15)00051-4			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI5WG	25987274				2022-12-18	WOS:000354829900008
J	Menon, P; Geevasinga, N; Yiannikas, C; Howells, J; Kiernan, MC; Vucic, S				Menon, P.; Geevasinga, N.; Yiannikas, C.; Howells, J.; Kiernan, M. C.; Vucic, S.			Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study (vol 14, pg 478, 2015)	LANCET NEUROLOGY			English	Correction													Kiernan, Matthew C/E-4460-2011					Menon P, 2015, LANCET NEUROL, V14, P478, DOI 10.1016/S1474-4422(15)00014-9	1	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2015	14	6					566	566		10.1016/S1474-4422(15)00014-9	http://dx.doi.org/10.1016/S1474-4422(15)00014-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI5WG					2022-12-18	WOS:000354829900006
J	[Anonymous]				[Anonymous]			Teaming up to tackle neurodegenerative diseases	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2015	14	3					235	235		10.1016/S1474-4422(15)70029-3	http://dx.doi.org/10.1016/S1474-4422(15)70029-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB4JM	25728431	Bronze			2022-12-18	WOS:000349594000001
J	Epstein, JA; Ingram, DA; Hirbe, AC; Gutmann, DH				Epstein, Jonathan A.; Ingram, David A., Jr.; Hirbe, Angela C.; Gutmann, David H.			A multidisciplinary approach in neurofibromatosis 1 Reply	LANCET NEUROLOGY			English	Letter							DIAGNOSIS; NF1; TYPE-1; CELLS		[Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Epstein, Jonathan A.] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ingram, David A., Jr.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Ingram, David A., Jr.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hirbe, Angela C.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Washington University (WUSTL)	Epstein, JA (corresponding author), Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Philadelphia, PA 19104 USA.	gutmannd@neuro.wustl.edu		Gutmann, David/0000-0002-3127-5045; Epstein, Jonathan/0000-0001-8637-4465				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; DeBella K, 2000, PEDIATRICS, V105, P608, DOI 10.1542/peds.105.3.608; DeBella K, 2000, NEUROLOGY, V54, P1646, DOI 10.1212/WNL.54.8.1646; Feyrter F., 1949, VIRCHOWS ARCH PATH A, V317, P221; Filho JRLF, 2008, PEDIATR RADIOL, V38, P305, DOI 10.1007/s00247-007-0712-x; Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Gutmann DH, 2014, NEUROLOGY, V83, P463, DOI 10.1212/WNL.0000000000000652; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Hirbe AC, 2014, LANCET NEUROL, V13, P834, DOI 10.1016/S1474-4422(14)70063-8; Lasater EA, 2008, HUM MOL GENET, V17, P2336, DOI 10.1093/hmg/ddn134; Li F, 2006, HUM MOL GENET, V15, P1921, DOI 10.1093/hmg/ddl114; Li F, 2014, CIRCULATION, V129, P1213, DOI 10.1161/CIRCULATIONAHA.113.006320; NORTON KK, 1995, NEUROBIOL DIS, V2, P13, DOI 10.1006/nbdi.1995.0002; Nunley KS, 2009, ARCH DERMATOL, V145, P883, DOI 10.1001/archdermatol.2009.169; Radtke Heather B, 2007, J Genet Couns, V16, P387, DOI 10.1007/s10897-007-9101-8; SALYER WR, 1974, ANGIOLOGY, V25, P510, DOI 10.1177/000331977402500803; Terzi YK, 2009, GENET COUNSEL, V20, P195; Xu J, 2007, CIRCULATION, V116, P2148, DOI 10.1161/CIRCULATIONAHA.107.707752; Xu JW, 2009, CIRC RES, V105, P304, DOI 10.1161/CIRCRESAHA.109.201509	20	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					30	31		10.1016/S1474-4422(14)70298-4	http://dx.doi.org/10.1016/S1474-4422(14)70298-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25496893				2022-12-18	WOS:000346885300020
J	Gorelick, PB; Farooq, MU				Gorelick, Philip B.; Farooq, Muhammad U.			Stroke: an emphasis on guidelines	LANCET NEUROLOGY			English	Editorial Material							HEALTH-CARE PROFESSIONALS; STATEMENT; PREVENTION; RISK		[Gorelick, Philip B.; Farooq, Muhammad U.] Mercy Hlth Hauenstein Neurosci Ctr, Grand Rapids, MI 49503 USA; [Gorelick, Philip B.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine	Gorelick, PB (corresponding author), Mercy Hlth Hauenstein Neurosci Ctr, Grand Rapids, MI 49503 USA.	pgorelic@mercyhealth.com						Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Gorelick PB, 2014, STROKE, V45, P945, DOI 10.1161/STROKEAHA.114.004560; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lackland DT, 2012, STROKE, V43, P1998, DOI 10.1161/STR.0b013e31825bcdac; Meschia J, 2014, STROKE, DOI 10.10.1161/STR.0000000000000046; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	13	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					2	3		10.1016/S1474-4422(14)70290-X	http://dx.doi.org/10.1016/S1474-4422(14)70290-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25496879				2022-12-18	WOS:000346885300002
J	Langbehn, DR				Langbehn, Douglas R.			Criteria for success in safety and tolerability trials	LANCET NEUROLOGY			English	Editorial Material							HUNTINGTONS-DISEASE; CLINICAL-TRIALS		[Langbehn, Douglas R.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Langbehn, Douglas R.] Univ Iowa, Coll Publ Hlth, Dept Biostat Secondary, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Langbehn, DR (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	douglas-langbehn@uiowa.edu	Langbehn, Douglas/AFS-2143-2022	Langbehn, Douglas/0000-0002-7803-4679				Huntington Study Group Reach2HD Investigators, 2014, LANCET NEUROL; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Sampaio C, 2014, MOVEMENT DISORD, V29, P1419, DOI 10.1002/mds.26021; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					24	25		10.1016/S1474-4422(14)70265-0	http://dx.doi.org/10.1016/S1474-4422(14)70265-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25467849				2022-12-18	WOS:000346885300014
J	Sabater, L; Gaig, C; Gelpi, E				Sabater, L.; Gaig, C.; Gelpi, E.			A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study (vol 13, pg 575, 2014)	LANCET NEUROLOGY			English	Correction													Sabater, Lidia/U-7570-2019					Sabater L, 2014, LANCET NEUROL, V13, P575, DOI 10.1016/S1474-4422(14)70051-1	1	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					28	28		10.1016/S1474-4422(14)70051-1	http://dx.doi.org/10.1016/S1474-4422(14)70051-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ		Green Accepted			2022-12-18	WOS:000346885300017
J	Schmidt, D				Schmidt, Dieter			Epilepsy: redefining the boundaries	LANCET NEUROLOGY			English	Editorial Material							DEFINITION		Epilepsy Res Grp, D-14163 Berlin, Germany	Epilepsy Research Group	Schmidt, D (corresponding author), Epilepsy Res Grp, D-14163 Berlin, Germany.	dbschmidt@t-online.de						Berg AT, 2014, BRAIN, V137, P3213, DOI 10.1093/brain/awu294; Berkovic SF, 2014, BRAIN, V137, P2400, DOI 10.1093/brain/awu194; Chowdhury FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110136; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Hauser A, 2014, EPILEPSIA, V55, P488, DOI 10.1111/epi.12587; Sillanpaa M, 2006, EPILEPSY BEHAV, V8, P713, DOI 10.1016/j.yebeh.2006.02.014; Wandschneider B, 2014, BRAIN, V137, P2469, DOI 10.1093/brain/awu175	7	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2015	14	1					8	9		10.1016/S1474-4422(14)70292-3	http://dx.doi.org/10.1016/S1474-4422(14)70292-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX4DZ	25496882				2022-12-18	WOS:000346885300005
J	Hankey, GJ				Hankey, Graeme J.			Intermittent pneumatic compression after stroke	LANCET NEUROLOGY			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; DEEP-VEIN THROMBOSIS; ISCHEMIC-STROKE; THIGH-LENGTH; METAANALYSIS; MULTICENTER; STOCKINGS; RISK		[Hankey, Graeme J.] Univ Western Australia, Queen Elizabeth II Med Ctr, Perkins Inst Med Res, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia	University of Western Australia; University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Perkins Inst Med Res, Sch Med & Pharmacol, Perth, WA 6009, Australia.	graeme.hankey@uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				CLOTS (Clots in Legs Or sTockings after Stroke)Trials Collaboration, 2014, LANCET NEUROLOGY; Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7; Dennis M, 2013, LANCET, V382, P516, DOI 10.1016/S0140-6736(13)61050-8; Dennis M, 2011, J NEUROL NEUROSUR PS, V82, P1067, DOI 10.1136/jnnp.2010.235945; Geeganage CM, 2013, J STROKE CEREBROVASC, V22, P1018, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.005; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Luengo-Fernandez R, 2013, STROKE, V44, P2854, DOI 10.1161/STROKEAHA.113.001584; Whiteley WN, 2013, LANCET NEUROL, V12, P539, DOI 10.1016/S1474-4422(13)70079-6	9	1	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2014	13	12					1163	1165		10.1016/S1474-4422(14)70263-7	http://dx.doi.org/10.1016/S1474-4422(14)70263-7			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU5XG	25453449	hybrid			2022-12-18	WOS:000345676300003
J	Kirkpatrick, PJ; Turner, CL				Kirkpatrick, Peter J.; Turner, Carole L.			Simvastatin in subarachnoid haemorrhage: beyond the short-term Reply	LANCET NEUROLOGY			English	Letter									[Kirkpatrick, Peter J.; Turner, Carole L.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	University of Cambridge	Kirkpatrick, PJ (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England.	clt29@medschl.cam.ac.uk						Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249	2	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2014	13	11					1073	1074		10.1016/S1474-4422(14)70225-X	http://dx.doi.org/10.1016/S1474-4422(14)70225-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR7TZ	25316013				2022-12-18	WOS:000343783900014
J	Goldstein, DA; Saltmiras, DA				Goldstein, Daniel A.; Saltmiras, David A.			Neurodevelopmental toxicity: still more questions than answers	LANCET NEUROLOGY			English	Letter							PESTICIDE EXPOSURE; GLYPHOSATE; OUTCOMES; HEALTH		[Goldstein, Daniel A.; Saltmiras, David A.] Monsanto Co, St Louis, MO 63017 USA	Monsanto	Goldstein, DA (corresponding author), Monsanto Co, St Louis, MO 63017 USA.	daniel.a.goldstein@monsanto.com						Barbosa ER, 2001, MOVEMENT DISORD, V16, P565, DOI 10.1002/mds.1105; Bradberry Sally M, 2004, Toxicol Rev, V23, P159, DOI 10.2165/00139709-200423030-00003; Burns CJ, 2013, J TOXICOL ENV HEAL B, V16, P127, DOI 10.1080/10937404.2013.783383; European Commission, 2002, REV REP ACT SUBST GL; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Malhotra RC, 2010, J CLIN NEUROSCI, V17, P1472, DOI 10.1016/j.jocn.2010.02.026; Meagher DJ, 2010, BMJ-BRIT MED J, V322, P144; Mink PJ, 2011, REGUL TOXICOL PHARM, V61, P172, DOI 10.1016/j.yrtph.2011.07.006; Science Media Center, EXP REACT IND CHEM N; Wang G, 2011, PARKINSONISM RELAT D, V17, P486, DOI 10.1016/j.parkreldis.2011.02.003; WHO/FAO, FAO WHO M PEST RES 2	12	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2014	13	7					645	645		10.1016/S1474-4422(14)70087-0	http://dx.doi.org/10.1016/S1474-4422(14)70087-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AK5RI	24943335				2022-12-18	WOS:000338483600006
J	Greenberg, SM; Salman, RAS; Biessels, GJ; van Buchem, M; Cordonnier, C; Lee, JM; Montaner, J; Schneider, JA; Smith, EE; Vernooij, M; Werring, DJ				Greenberg, Steven M.; Salman, Rustam Al-Shahi; Biessels, Geert Jan; van Buchem, Mark; Cordonnier, Charlotte; Lee, Jin-Moo; Montaner, Joan; Schneider, Julie A.; Smith, Eric E.; Vernooij, Meike; Werring, David J.			Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? Reply	LANCET NEUROLOGY			English	Letter							CLINICAL SPECTRUM		[Greenberg, Steven M.] Massachusetts Gen Hosp, MGH Stroke Res Ctr, Boston, MA 02114 USA; [Salman, Rustam Al-Shahi] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Biessels, Geert Jan] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [van Buchem, Mark] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Cordonnier, Charlotte] Univ Lille Nord France, Lille Univ Hosp, Dept Neurol, Lille, France; [Lee, Jin-Moo] Washington Univ, Sch Med, Dept Neurol, Dept Radiol, St Louis, MO 63110 USA; [Lee, Jin-Moo] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO USA; [Montaner, Joan] Vail dHebron Univ Hosp & Res Inst, Dept Neurol, Barcelona, Spain; [Montaner, Joan] Autonomous Univ Barcelona, Res Inst, Barcelona, Spain; [Schneider, Julie A.] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Vernooij, Meike] Erasmus Univ, Dept Radiol & Epidemiol, Med Ctr, Rotterdam, Netherlands; [Werring, David J.] UCL Inst Neurol, London, England	Harvard University; Massachusetts General Hospital; University of Edinburgh; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Washington University (WUSTL); Washington University (WUSTL); Autonomous University of Barcelona; Rush University; Rush University; University of Calgary; Erasmus University Rotterdam; Erasmus MC; University of London; University College London	Greenberg, SM (corresponding author), Massachusetts Gen Hosp, MGH Stroke Res Ctr, Boston, MA 02114 USA.	sgreenberg@mgh.harvard.edu	Cordonnier, Charlotte/O-3258-2017; Demchuk, Andrew M/E-1103-2012; Smith, Eric E/C-5443-2012; Werring, David/Q-8435-2019; Vernooij, Meike Willemijn/E-4061-2016; van Buchem, Mark/AAC-9843-2022; Montaner, Joan/D-3063-2015; Lee, Jin-Moo/K-2024-2015	Cordonnier, Charlotte/0000-0002-5697-6892; Demchuk, Andrew M/0000-0002-4930-7789; Smith, Eric E/0000-0003-3956-1668; Werring, David/0000-0003-2074-1861; van Buchem, Mark/0000-0003-1881-1998; Montaner, Joan/0000-0003-4845-2279; Lee, Jin-Moo/0000-0002-3979-0906; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Vernooij, Meike/0000-0003-4658-2176	MRC [G1002605] Funding Source: UKRI; Medical Research Council [G1002605] Funding Source: Medline; NIA NIH HHS [R01 AG026484] Funding Source: Medline; NINDS NIH HHS [R01 NS048283, R01 NS040525, R01 NS067905] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Charidimou A, 2013, NEUROLOGY, V81, P626, DOI 10.1212/WNL.0b013e3182a08f2c; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; GREENBERG SM, 1993, NEUROLOGY, V43, P2073, DOI 10.1212/WNL.43.10.2073; Greenberg SM, 2014, LANCET NEUROL, V13, P419, DOI 10.1016/S1474-4422(14)70003-1; Greenberg SM, 2009, STROKE, V40, P2382, DOI 10.1161/STROKEAHA.109.548974; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311	6	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2014	13	6					540	540		10.1016/S1474-4422(14)70097-3	http://dx.doi.org/10.1016/S1474-4422(14)70097-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI8YK	24849857	Green Accepted			2022-12-18	WOS:000337212700013
J	Holmes, D				Holmes, David			Bruno Dubois: transforming the diagnosis of Alzheimer's disease	LANCET NEUROLOGY			English	Editorial Material																			0	1	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2014	13	6					541	541		10.1016/S1474-4422(14)70106-1	http://dx.doi.org/10.1016/S1474-4422(14)70106-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI8YK	24849858				2022-12-18	WOS:000337212700014
J	Sturkenboom, IHWM; Graff, MJL; Hendriks, JCM				Sturkenboom, I. H. W. M.; Graff, M. J. L.; Hendriks, J. C. M.			Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial (vol 13, pg 557, 2014)	LANCET NEUROLOGY			English	Correction													Graff, M.J.L./L-4333-2015; Sturkenboom, Ingrid/D-9623-2016	Sturkenboom, Ingrid/0000-0003-1229-2568				Sturkenboom IHWM, 2014, LANCET NEUROL, V13, P557, DOI 10.1016/S1474-4422(14)70055-9	1	1	1	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2014	13	6					536	536		10.1016/S1474-4422(14)70023-7	http://dx.doi.org/10.1016/S1474-4422(14)70023-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI8YK		Bronze			2022-12-18	WOS:000337212700008
J	Barkhof, F; Ciccarelli, O				Barkhof, Frederik; Ciccarelli, Olga			Daclizumab in multiple sclerosis: a high-yield extension study	LANCET NEUROLOGY			English	Editorial Material									[Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, NL-1007 MB Amsterdam, Netherlands; [Ciccarelli, Olga] UCL, Queen Sq Ctr, London, England; [Ciccarelli, Olga] Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Barkhof, F (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	f.barkhof@vumc.nl	Barkhof, Frederik/AAJ-6226-2020; Ciccarelli, Olga/AAY-3328-2020	Barkhof, Frederik/0000-0003-3543-3706; Ciccarelli, Olga/0000-0001-7485-1367				Bielekova B, 2009, ARCH NEUROL-CHICAGO, V66, P483, DOI 10.1001/archneurol.2009.50; Giovannoni G, 2014, LANCET NEUROL, V13, P472, DOI 10.1016/S1474-4422(14)70039-0; Gold R, 2013, LANCET, V381, P2167, DOI 10.1016/S0140-6736(12)62190-4; O'Connor PW, 2011, NEUROLOGY, V76, P1858, DOI 10.1212/WNL.0b013e31821e7c8a; Sheridan JP, 2011, MULT SCLER J, V17, P1441, DOI 10.1177/1352458511414755; Vellinga MM, 2008, NEUROLOGY, V70, P1150, DOI 10.1212/01.wnl.0000265393.03231.e5; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2014	13	5					443	+		10.1016/S1474-4422(14)70056-0	http://dx.doi.org/10.1016/S1474-4422(14)70056-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG0LX	24656610				2022-12-18	WOS:000335108100004
J	Klockgether, T				Klockgether, Thomas			Spinocerebellar ataxia type 2: progression before diagnosis	LANCET NEUROLOGY			English	Editorial Material							DISEASE		[Klockgether, Thomas] Univ Hosp Bonn, Dept Neurol, D-53105 Bonn, Germany; [Klockgether, Thomas] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Klockgether, T (corresponding author), Univ Hosp Bonn, Dept Neurol, D-53105 Bonn, Germany.	klockgether@uni-bonn.de						Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Berg D, 2013, LANCET NEUROL, V12, P514, DOI 10.1016/S1474-4422(13)70047-4; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Jacobi H, 2013, LANCET NEUROL, V12, P650, DOI 10.1016/S1474-4422(13)70104-2; Konczak J, 2010, STROKE, V41, P2191, DOI 10.1161/STROKEAHA.110.583641; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Velazquez-Perez L, 2014, LANCET NEUROL	8	1	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAY	2014	13	5					445	446		10.1016/S1474-4422(14)70044-4	http://dx.doi.org/10.1016/S1474-4422(14)70044-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG0LX	24657152				2022-12-18	WOS:000335108100005
J	Molyneux, AJ				Molyneux, Andrew J.			Is screening of relatives for cerebral aneurysms justified?	LANCET NEUROLOGY			English	Editorial Material							FAMILIAL INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; RISK		Univ Oxford, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	University of Oxford	Molyneux, AJ (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford OX3 9DU, England.	andy.molyneux@nds.ox.ac.uk						Bor ASE, 2008, BRAIN, V131, P2662, DOI 10.1093/brain/awn187; Bor ASE, 2010, NEUROLOGY, V74, P1671, DOI 10.1212/WNL.0b013e3181e04297; Bor ASE, 2014, LANCET NEUROL; Okamoto K, 2003, STROKE, V34, P422, DOI 10.1161/01.STR.0000053851.17964.C6; Struycken PM, 2003, EUR J HUM GENET, V11, P737, DOI 10.1038/sj.ejhg.5201039; Wermer MJH, 2005, STROKE, V36, P836, DOI 10.1161/01.STR.0000158906.79898.3a	6	1	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	APR	2014	13	4					343	344		10.1016/S1474-4422(13)70309-0	http://dx.doi.org/10.1016/S1474-4422(13)70309-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CB6NN	24618353				2022-12-18	WOS:000349743800004
J	Holmes, D				Holmes, David			Paul Krack: deeper brain stimulation	LANCET NEUROLOGY			English	Biographical-Item																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2014	13	3					243	243		10.1016/S1474-4422(14)70035-3	http://dx.doi.org/10.1016/S1474-4422(14)70035-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC1NW	24556005	Bronze			2022-12-18	WOS:000332264300007
J	[Anonymous]				[Anonymous]			Alemtuzumab and the value of neurological research	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2014	13	3					233	233		10.1016/S1474-4422(14)70032-8	http://dx.doi.org/10.1016/S1474-4422(14)70032-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AC1NW	24556003				2022-12-18	WOS:000332264300001
J	Gresa-Arribas, N; Titulaer, MJ; Torrents, A				Gresa-Arribas, N.; Titulaer, M. J.; Torrents, A.			Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study (vol 13, pg 167, 2014)	LANCET NEUROLOGY			English	Correction																		Gresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5	1	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2014	13	2					135	135		10.1016/S1474-4422(13)20292-8	http://dx.doi.org/10.1016/S1474-4422(13)20292-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301QE					2022-12-18	WOS:000330546200007
J	[Anonymous]				[Anonymous]			The beginning of the end of consistency in AED prescribing?	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2014	13	2					127	127		10.1016/S1474-4422(14)70006-7	http://dx.doi.org/10.1016/S1474-4422(14)70006-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	301QE	24457186				2022-12-18	WOS:000330546200001
J	Olesen, J				Olesen, Jes			Highlights in headache research in 2013	LANCET NEUROLOGY			English	Editorial Material							MIGRAINE; BURDEN		Univ Copenhagen, Glostrup Hosp, Danish Headache Ctr, Dept Neurol N39, DK-2600 Glostrup, Denmark	University of Copenhagen	Olesen, J (corresponding author), Univ Copenhagen, Glostrup Hosp, Danish Headache Ctr, Dept Neurol N39, DK-2600 Glostrup, Denmark.	jes.olesen@regionh.dk		Olesen, Jes/0000-0002-6712-2702				Amin FM, 2013, LANCET NEUROL, V12, P454, DOI 10.1016/S1474-4422(13)70067-X; [Anonymous], 2013, CEPHALALGIA, V9, P627; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Ho TW, 2012, HEADACHE, V52, P224, DOI 10.1111/j.1526-4610.2011.02052.x; Ho TW, 2008, LANCET, V372, P2115, DOI 10.1016/S0140-6736(08)61626-8; Marcus R, 2014, CEPHALALGIA, V34, P114, DOI 10.1177/0333102413500727; Schoenen J, 2013, CEPHALALGIA, V33, P816, DOI 10.1177/0333102412473667; Steiner TJ, 2010, J HEADACHE PAIN, V11, P451, DOI 10.1007/s10194-010-0264-6; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	9	1	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JAN	2014	13	1					5	7		10.1016/S1474-4422(13)70279-5	http://dx.doi.org/10.1016/S1474-4422(13)70279-5			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	280AL	24331782				2022-12-18	WOS:000329000900004
J	Krageloh-Mann, I				Kraegeloh-Mann, Ingeborg			Characterisation of Aicardi-Goutieres syndrome	LANCET NEUROLOGY			English	Editorial Material							PROGRESSIVE FAMILIAL ENCEPHALOPATHY; MUTATIONS; TREX1		Univ Childrens Hosp, Dept Paediat Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf	Krageloh-Mann, I (corresponding author), Univ Childrens Hosp, Dept Paediat Neurol, D-72076 Tubingen, Germany.	ingeborg.kraegeloh-mann@med.uni-tuebingen.de						AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Crow YJ, 2014, CLIN EXP IMMUNOL, V175, P1, DOI 10.1111/cei.12115; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Lee-Kirsch MA, 2014, CLIN EXP IMMUNOL, V175, P17, DOI 10.1111/cei.12160; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8	8	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2013	12	12					1131	1132		10.1016/S1474-4422(13)70262-X	http://dx.doi.org/10.1016/S1474-4422(13)70262-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	265BG	24183310				2022-12-18	WOS:000327924100004
J	Adelson, PD; Bell, MJ; Wisniewski, SR				Adelson, P. David; Bell, Michael J.; Wisniewski, Stephen R.			Hypothermia in paediatric traumatic brain injury Reply	LANCET NEUROLOGY			English	Letter							CHILDREN		[Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Bell, Michael J.; Wisniewski, Stephen R.] Pittsburgh Sch Med, Pittsburgh, PA USA; [Bell, Michael J.; Wisniewski, Stephen R.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Barrow Neurological Institute; Phoenix Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Adelson, PD (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA.	dadelson@phoenixchildrens.com	Adelson, David/W-2083-2019					Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2003, PEDIAT CRIT CARE M S, V4, pS45; Bell MJ, 2013, PEDIATR CRIT CARE ME, DOI [10.1097/PCC.013013e3182975e2f, DOI 10.1097/PCC.013013E3182975E2F]; Fink EL, 2012, PEDIATR CRIT CARE ME, V13, P80, DOI 10.1097/PCC.0b013e3181fe27c7; Smith CM, 2011, PEDIATR CRIT CARE ME, V12, P449, DOI 10.1097/PCC.0b013e3181f390dd	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2013	12	9					849	850		10.1016/S1474-4422(13)70205-9	http://dx.doi.org/10.1016/S1474-4422(13)70205-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	210WU	23948173				2022-12-18	WOS:000323866600013
J	Selmaj, K; Li, DKB; Hartung, HP				Selmaj, K.; Li, D. K. B.; Hartung, H-P			Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study (vol 12, pg 756, 2013)	LANCET NEUROLOGY			English	Correction																		Selmaj K, 2013, LANCET NEUROL, V12, P756, DOI 10.1016/S1474-4422(13)70102-9	1	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	SEP	2013	12	9					846	846		10.1016/S1474-4422(13)70183-2	http://dx.doi.org/10.1016/S1474-4422(13)70183-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	210WU		Bronze			2022-12-18	WOS:000323866600006
J	Mehanna, R; Jankovic, J				Mehanna, R.; Jankovic, J.			Movement disorders in cerebrovascular disease (vol 12, pg 597, 2013)	LANCET NEUROLOGY			English	Correction																		Mehanna R, 2013, LANCET NEUROL, V12, P597, DOI 10.1016/S1474-4422(13)70057-7	1	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2013	12	8					733	733		10.1016/S1474-4422(13)70057-7	http://dx.doi.org/10.1016/S1474-4422(13)70057-7			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	195GP					2022-12-18	WOS:000322690600006
J	Quaglio, G; Karapiperis, T; Di Luca, M; de Campos, AC; Dan, B				Quaglio, Gianluca; Karapiperis, Theodoros; Di Luca, Monica; de Campos, Antonio Correia; Dan, Bernard			Europe to take up brain disorders challenge	LANCET NEUROLOGY			English	Letter									[Quaglio, Gianluca; Karapiperis, Theodoros; de Campos, Antonio Correia] European Parliament, Sci & Technol Opt Assessment, B-1047 Brussels, Belgium; [Di Luca, Monica] European Brain Council, Brussels, Belgium; [Di Luca, Monica] Federat European Neurosci Soc, Vienna, Austria; [Dan, Bernard] Univ Libre Brussels, Brussels, Belgium; [Dan, Bernard] European Acad Childhood Disabil, Brussels, Belgium	Universite Libre de Bruxelles	Quaglio, G (corresponding author), European Parliament, Sci & Technol Opt Assessment, B-1047 Brussels, Belgium.	gianluca.quaglio@europarl.europa.eu		Dan, Bernard/0000-0002-2051-9876				Chessa A, 2013, SCIENCE, V339, P650, DOI 10.1126/science.1227970; Henderson C, 2009, LANCET, V373, P1928, DOI 10.1016/S0140-6736(09)61046-1; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; The Lancet Neurology, 2013, LANCET NEUROL, V12, P525	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2013	12	8					737	738		10.1016/S1474-4422(13)70122-4	http://dx.doi.org/10.1016/S1474-4422(13)70122-4			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	195GP	23768776	Bronze			2022-12-18	WOS:000322690600011
J	Jacobi, H; Reetz, K; du Montcel, ST				Jacobi, H.; Reetz, K.; du Montcel, Tezenas S.			Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data (vol 12, pg 650, 2013)	LANCET NEUROLOGY			English	Correction													Reetz, Kathrin/H-9510-2012; Tezenas du Montcel, Sophie/A-6207-2012	Reetz, Kathrin/0000-0002-9730-9228; Tezenas du Montcel, Sophie/0000-0002-2866-4330				Jacobi H, 2013, LANCET NEUROL, V12, P650, DOI 10.1016/S1474-4422(13)70104-2	1	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUL	2013	12	7					630	630		10.1016/S1474-4422(13)70104-2	http://dx.doi.org/10.1016/S1474-4422(13)70104-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172CH					2022-12-18	WOS:000320977100006
J	Byrne, S; Jordan, I; Redmond, J				Byrne, Susan; Jordan, Iain; Redmond, Janice			Prevalence and treatment of anti-NMDA receptor encephalitis	LANCET NEUROLOGY			English	Letter									[Byrne, Susan; Redmond, Janice] St James Hosp, Dept Neurol, Dublin 8, Ireland; [Jordan, Iain] Royal Coll Surgeons Ireland, Dublin 2, Ireland	Trinity College Dublin; Royal College of Surgeons - Ireland	Byrne, S (corresponding author), St James Hosp, Dept Neurol, Dublin 8, Ireland.	suabyrne@gmail.com	Redmond, Janice/Z-1987-2018; Sediva, Anna/AAE-2774-2019	Sediva, Anna/0000-0001-7730-2304; Redmond, Janice/0000-0002-9974-7811; Byrne, Susan/0000-0001-6731-0343; Jordan, Iain/0000-0003-2836-2460				Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Zandi MS, 2011, J NEUROL, V258, P686, DOI 10.1007/s00415-010-5788-9	2	1	4	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAY	2013	12	5					424	424		10.1016/S1474-4422(13)70069-3	http://dx.doi.org/10.1016/S1474-4422(13)70069-3			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	142ZS	23602155				2022-12-18	WOS:000318836700009
J	Drouin, E; Pereon, Y				Drouin, Emmanuel; Pereon, Yann			Unique drawings by Duchenne de Boulogne	LANCET NEUROLOGY			English	Letter									[Drouin, Emmanuel] Univ Tours, Ctr Etud Super Renaissance, Tours, France; [Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires Nantes Anger, Atlantic Gene Therapies Biotherapy Inst Rare Dis, F-44093 Nantes, France	Universite de Tours; Nantes Universite; CHU de Nantes	Drouin, E (corresponding author), Univ Tours, Ctr Etud Super Renaissance, Tours, France.	yann.pereon@univ-nantes.fr						Darwin Charles, 1872, EXPRESSION EMOTIONS, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Duchenne de Boulogne G, 1855, ELECT LOCALISEE SON; Duchenne de Boulogne Guillaume-Benjamin, 1862, MECANISME PHYSIONOMI	3	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2013	12	4					330	331		10.1016/S1474-4422(13)70027-9	http://dx.doi.org/10.1016/S1474-4422(13)70027-9			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SZ	23518327	Bronze			2022-12-18	WOS:000318531600009
J	Odekerken, VJJ; de Haan, RJ; Schurrman, PR; de Bie, RMA				Odekerken, Vincent J. J.; de Haan, Rob J.; Schurrman, P. Richard; de Bie, Rob M. A.			Subthalamic versus globus pallidus deep brain stimulation Reply	LANCET NEUROLOGY			English	Letter									[Odekerken, Vincent J. J.; de Bie, Rob M. A.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [de Haan, Rob J.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Schurrman, P. Richard] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Odekerken, VJJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands.	r.m.debie@amc.uva.nl						Krack P, 2013, LANCET NEUROL, V12, P25, DOI 10.1016/S1474-4422(12)70270-3; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8	2	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2013	12	4					329	329		10.1016/S1474-4422(13)70046-2	http://dx.doi.org/10.1016/S1474-4422(13)70046-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SZ	23518325				2022-12-18	WOS:000318531600006
J	[Anonymous]				[Anonymous]			A shifting view of neurodevelopmental disability	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	APR	2013	12	4					323	323		10.1016/S1474-4422(13)70063-2	http://dx.doi.org/10.1016/S1474-4422(13)70063-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SZ	23518322				2022-12-18	WOS:000318531600001
J	Lansberg, MG; Albers, GW				Lansberg, Maarten G.; Albers, Gregory W.			Selection of patients for intra-arterial therapy Reply	LANCET NEUROLOGY			English	Letter							MALIGNANT PROFILE; DWI MISMATCH; TISSUE		[Lansberg, Maarten G.; Albers, Gregory W.] Stanford Univ, Palo Alto, CA 94305 USA	Stanford University	Lansberg, MG (corresponding author), Stanford Univ, 1215 Welch Rd, Palo Alto, CA 94305 USA.	GAlbers@stanfordmed.org		Lansberg, Maarten/0000-0002-3545-6927; Albers, Gregory/0000-0003-0263-4632				Davalos A, 2004, NEUROLOGY, V62, P2187, DOI 10.1212/01.WNL.0000130570.41127.EA; Inoue M, 2012, STROKE, V43, P2494, DOI 10.1161/STROKEAHA.112.653329; Lansberg MG, 2008, STROKE, V39, P2491, DOI 10.1161/STROKEAHA.107.508572; Mishra NK, 2013, INT STROK C 2013 HON, P3887; Mlynash M, 2011, STROKE, V42, P1270, DOI 10.1161/STROKEAHA.110.601609	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2013	12	3					225	226		10.1016/S1474-4422(13)70019-X	http://dx.doi.org/10.1016/S1474-4422(13)70019-X			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SW	23415563				2022-12-18	WOS:000318531300008
J	Louis, ED				Louis, Elan D.			Essential tremor: a unique diagnostic code in ICD-10-CM	LANCET NEUROLOGY			English	Editorial Material							QUALITY-OF-LIFE; DISORDER; COMMON		[Louis, Elan D.] Columbia Univ, Gertrude H Sergievsky Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Louis, Elan D.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10027 USA; [Louis, Elan D.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Louis, Elan D.] Columbia Univ, Neurol Inst, Unit 198, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University	Louis, ED (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, 710 W 168th St, New York, NY 10027 USA.	EDL2@columbia.edu						[Anonymous], ICD 10 CM INT CLASS; Benito-Leon J, 2006, NAT CLIN PRACT NEURO, V2, P666, DOI 10.1038/ncpneuro0347; Bergen DC, 2012, EPILEPSIA, V53, P3, DOI 10.1111/j.1528-1167.2012.03550.x; Chandran V, 2013, PARKINSONISM RELAT D, V19, P62, DOI 10.1016/j.parkreldis.2012.06.011; LaRoia H, 2011, NEUROEPIDEMIOLOGY, V37, P1, DOI 10.1159/000328866; Leon-Chisen Nelly, 2012, Hosp Health Netw, V86, P12; Louis ED, 2001, MOVEMENT DISORD, V16, P914, DOI 10.1002/mds.1184; Louis ED, 2007, NEUROEPIDEMIOLOGY, V28, P181, DOI 10.1159/000104096; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Nguyen HV, 2007, ACTA NEUROL SCAND, V116, P289, DOI 10.1111/j.1600-0404.2007.00863.x	10	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	MAR	2013	12	3					223	224		10.1016/S1474-4422(12)70325-3	http://dx.doi.org/10.1016/S1474-4422(12)70325-3			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SW	23415561				2022-12-18	WOS:000318531300006
J	[Anonymous]				[Anonymous]			NINDS boosts research for biomarkers in Parkinson's disease	LANCET NEUROLOGY			English	Editorial Material																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	MAR	2013	12	3					217	217		10.1016/S1474-4422(13)70029-2	http://dx.doi.org/10.1016/S1474-4422(13)70029-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	138SW	23415560	Bronze			2022-12-18	WOS:000318531300001
J	Harden, CL; Pennell, PB				Harden, C. L.; Pennell, P. B.			Neuroendocrine considerations in the treatment of men and women with epilepsy (vol 12, pg 72, 2013)	LANCET NEUROLOGY			English	Correction																		Harden CL, 2013, LANCET NEUROL, V12, P72, DOI 10.1016/S1474-4422(12)70239-9	1	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	FEB	2013	12	2					128	128		10.1016/S1474-4422(12)70239-9	http://dx.doi.org/10.1016/S1474-4422(12)70239-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	081NZ		Green Accepted			2022-12-18	WOS:000314330200007
J	Berg, AT				Berg, Anne T.			Epilepsy: clinical implications of recent advances	LANCET NEUROLOGY			English	Editorial Material							DISORDERS; EXPOSURE; DRUG; AGE		Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Epilepsy Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Berg, AT (corresponding author), Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Epilepsy Ctr, Chicago, IL 60611 USA.	atberg@luriechildrens.org						Adelow C, 2012, NEUROLOGY, V78, P396, DOI 10.1212/WNL.0b013e318245f461; Dedeurwaerdere S, 2012, EPILEPSIA, V53, P1113, DOI 10.1111/j.1528-1167.2012.03520.x; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; Meador KJ, 2012, NEUROLOGY, V78, P1207, DOI 10.1212/WNL.0b013e318250d824; Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644	8	1	1	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JAN	2013	12	1					8	10		10.1016/S1474-4422(12)70293-4	http://dx.doi.org/10.1016/S1474-4422(12)70293-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	055PR	23237890				2022-12-18	WOS:000312429400005
J	Easton, JD; Lopes, RD; Bahit, MC				Easton, J. D.; Lopes, R. D.; Bahit, M. C.			Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial (vol 11, pg 503, 2012)	LANCET NEUROLOGY			English	Correction													Walters, Darren/A-7069-2011					Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3	1	1	1	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2012	11	12					1021	1021						1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	044CX					2022-12-18	WOS:000311598100009
J	Saidha, S; Sotirchos, ES; Ibrahim, MA				Saidha, S.; Sotirchos, E. S.; Ibrahim, M. A.			Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study (vol 11, pg 963, 2012)	LANCET NEUROLOGY			English	Correction													Sotirchos, Elias/R-8979-2019	Sotirchos, Elias/0000-0002-8812-1637				Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2	1	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2012	11	12					1021	1021		10.1016/S1474-4422(12)70275-2	http://dx.doi.org/10.1016/S1474-4422(12)70275-2			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	044CX					2022-12-18	WOS:000311598100007
J	Gilliam, FG; Perucca, P				Gilliam, Frank G.; Perucca, Piero			The adverse effects of antiepileptic drugs differ in patients with migraine reply	LANCET NEUROLOGY			English	Letter									[Gilliam, Frank G.] Geisinger Hlth Syst, Dept Neurol, Danville, PA 17822 USA; [Perucca, Piero] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Geisinger Health System; McGill University	Gilliam, FG (corresponding author), Geisinger Hlth Syst, Dept Neurol, Danville, PA 17822 USA.	fggilliam@geisinger.edu		Perucca, Piero/0000-0002-7855-7066				Geddes JR, 2009, BRIT J PSYCHIAT, V194, P4, DOI 10.1192/bjp.bp.107.048504; Luykx J, 2009, CLIN PHARMACOL THER, V85, P283, DOI 10.1038/clpt.2008.203	2	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	NOV	2012	11	11					935	935		10.1016/S1474-4422(12)70248-X	http://dx.doi.org/10.1016/S1474-4422(12)70248-X			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028KW		Bronze			2022-12-18	WOS:000310422200009
J	Holmes, D				Holmes, D.			Size isn't everything, comparatively speaking (vol 11, pg 844, 2012)	LANCET NEUROLOGY			English	Correction																		Holmes D, 2012, LANCET NEUROL, V11, P934, DOI 10.1016/S1474-4422(12)70218-1	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	NOV	2012	11	11					934	934		10.1016/S1474-4422(12)70218-1	http://dx.doi.org/10.1016/S1474-4422(12)70218-1			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028KW	22995689				2022-12-18	WOS:000310422200006
J	Jox, RJ; Bernat, JL; Laureys, S; Racine, E				Jox, R. J.; Bernat, J. L.; Laureys, S.; Racine, E.			Disorders of consciousness: responding to requests for novel diagnostic and therapeutic interventions (vol 11, pg 732, 2012)	LANCET NEUROLOGY			English	Correction													Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011	Laureys, Steven/0000-0002-3096-3807; 				Jox RJ, 2012, LANCET NEUROL, V11, P732, DOI 10.1016/S1474-4422(12)70154-0	1	1	1	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2012	11	10					841	841		10.1016/S1474-4422(12)70154-0	http://dx.doi.org/10.1016/S1474-4422(12)70154-0			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	018BG					2022-12-18	WOS:000309634300007
J	Puoti, G; Bizzi, A; Forloni, G; Safar, JG; Tagliavini, F; Gambetti, P				Puoti, G.; Bizzi, A.; Forloni, G.; Safar, J. G.; Tagliavini, F.; Gambetti, P.			human prion diseases: molecular insights and diagnosis (vol 11, pg 618, 2012)	LANCET NEUROLOGY			English	Correction													Tagliavini, Fabrizio/AAO-7891-2021; Puoti, Gianfranco/AAB-8288-2019; Forloni, Gianluigi/AAB-2115-2020; Bizzi, Alberto/K-3141-2016; Safar, Jiri G/G-6512-2013	Tagliavini, Fabrizio/0000-0003-1039-7315; Forloni, Gianluigi/0000-0001-5374-3914; Bizzi, Alberto/0000-0002-0253-5274; 				Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7	1	1	1	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	OCT	2012	11	10					841	841		10.1016/S1474-4422(12)70202-8	http://dx.doi.org/10.1016/S1474-4422(12)70202-8			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	018BG					2022-12-18	WOS:000309634300006
J	Bonati, LH				Bonati, Leo H.			Restenosis after carotid artery stenting: remaining issues	LANCET NEUROLOGY			English	Editorial Material							ENDARTERECTOMY; ULTRASOUND; CRITERIA; STENOSIS; TRIAL		[Bonati, Leo H.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Bonati, Leo H.] Univ Basel Hosp, Stroke Unit, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Bonati, LH (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	bonatil@uhbs.ch	Bonati, Leo/G-4058-2012	Bonati, Leo/0000-0003-1163-8133				Arquizan C, 2011, STROKE, V42, P1015, DOI 10.1161/STROKEAHA.110.589309; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Bonati LH, 2009, LANCET NEUROL, V8, P908, DOI 10.1016/S1474-4422(09)70227-3; Bonati LH, COCHRANE DA IN PRESS; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Lal BK, 2004, J VASC SURG, V39, P58, DOI 10.1016/j.jvs.2003.10.043; Lal BK, 2012, OPTN SRTR ANN REP; Nederkoorn PJ, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-36	9	1	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	SEP	2012	11	9					740	741		10.1016/S1474-4422(12)70179-5	http://dx.doi.org/10.1016/S1474-4422(12)70179-5			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994DS	22857849				2022-12-18	WOS:000307911700002
J	Perucca, P; Gilliam, FG				Perucca, P.; Gilliam, F. G.			Adverse effects of antiepileptic drugs (vol 11, pg 792, 2012)	LANCET NEUROLOGY			English	Correction																		Perucca P, 2012, LANCET NEUROL, V11, P792, DOI 10.1016/S1474-4422(12)70153-9	1	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	SEP	2012	11	9					746	746		10.1016/S1474-4422(12)70153-9	http://dx.doi.org/10.1016/S1474-4422(12)70153-9			1	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994DS					2022-12-18	WOS:000307911700006
J	Frisoni, GB; Trojanowski, JQ				Frisoni, Giovanni B.; Trojanowski, John Q.			Primary or secondary prevention for AD: who cares?	LANCET NEUROLOGY			English	Letter							ALZHEIMERS-DISEASE		[Frisoni, Giovanni B.] Natl Ctr Alzheimers & Mental Dis, IRCCS Fatebenefratelli, I-25125 Brescia, Italy; [Trojanowski, John Q.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res,Inst Aging, Philadelphia, PA 19104 USA	IRCCS Fatebenefratelli; University of Pennsylvania; Pennsylvania Medicine	Frisoni, GB (corresponding author), Natl Ctr Alzheimers & Mental Dis, IRCCS Fatebenefratelli, I-25125 Brescia, Italy.	gfrisoni@fatebenefratelli.it; trojanow@mail.med.upenn.edu	Frisoni, Giovanni B./K-1360-2016; Frisoni, Giovanni/K-1360-2016	Frisoni, Giovanni B./0000-0002-6419-1753; Frisoni, Giovanni/0000-0001-7075-7082	NIA NIH HHS [P30 AG010124] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brunden KR, 2012, BIOL ALZHEIMERS DIS, P455; Colombia at the centre of preclinical AD research, 2012, LANCET NEUROL, V11, P567; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; Klunk WE, 2007, J NEUROSCI, V27, P6174, DOI 10.1523/JNEUROSCI.0730-07.2007; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	AUG	2012	11	8					661	662		10.1016/S1474-4422(12)70143-6	http://dx.doi.org/10.1016/S1474-4422(12)70143-6			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	983AX	22705337	Bronze, Green Accepted			2022-12-18	WOS:000307089700011
J	Abou-Khalil, BW				Abou-Khalil, Bassel W.			Another option for first-line treatment of partial epilepsy?	LANCET NEUROLOGY			English	Editorial Material							NEWLY-DIAGNOSED EPILEPSY; TONIC CLONIC SEIZURES; RELEASE CARBAMAZEPINE; LAMOTRIGINE; VALPROATE; PATTERNS		Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA	Vanderbilt University	Abou-Khalil, BW (corresponding author), Vanderbilt Univ, Dept Neurol, 221 Kirkland Hall, Nashville, TN 37232 USA.	bassel.abou-khalil@vanderbilt.edu						Baulac M, 2012, LANCET NEUROL, V11, P579, DOI 10.1016/S1474-4422(12)70105-9; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; MARCIANI MG, 1985, NEUROLOGY, V35, P1537, DOI 10.1212/WNL.35.11.1537; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; Meador KJ, 2001, NEUROLOGY, V56, P1177, DOI 10.1212/WNL.56.9.1177; Mintzer S, 2009, ANN NEUROL, V65, P448, DOI 10.1002/ana.21615; Park SP, 2008, EPILEPSY BEHAV, V12, P102, DOI 10.1016/j.yebeh.2007.08.002; Rattya J, 2001, NEUROLOGY, V56, P31, DOI 10.1212/WNL.56.1.31; Saetre E, 2007, EPILEPSIA, V48, P1292, DOI 10.1111/j.1528-1167.2007.01128.x	11	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422			LANCET NEUROL	Lancet Neurol.	JUL	2012	11	7					568	569		10.1016/S1474-4422(12)70137-0	http://dx.doi.org/10.1016/S1474-4422(12)70137-0			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	969YN	22683225				2022-12-18	WOS:000306095400002
